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HIV infection remains of major public health impor-
tance in Europe. In 2012, 131 202 new HIV infections 
were diagnosed in 52 of the 53 countries of the WHO 
European Region1. Of those infections, 55 494 were offi-
cially reported to ECDC/WHO Regional Office for Europe 
by 51 countries; 29 381 of which were from the European 
Union and European Economic Area (EU/EEA)2, while 
75 708 infections were reported through the database of 
the Federal Statistics Agency of the Russian Federation 
[1]. The surveillance data suggest an overall rate of 7.8 
diagnoses per 100 000 population for the WHO European 
Region and 5.8 per 100 000 for the EU/EEA. The rates 
are highest in the East of the Region (Table  A). The 
main transmission mode varies by geographical area, 
illustrating the diversity in the epidemiology of HIV in 
Europe; heterosexual transmission is the main mode of 
transmission in the WHO European Region, while sexual 
transmission between men is the most common mode in 
the EU/EEA and transmission through injecting drug use 
remains substantial in the East of the Region.
In 2012, 16 534 AIDS cases were diagnosed in 50 coun-
tries of the WHO European Region3, of which 6 461 were 
officially reported to ECDC/WHO by 49 countries, and 
10 073 were obtained through the Ukrainian Centre for 
Socially Dangerous Disease Control [3] due to incom-
plete reporting by Ukraine through TESSy4. Although the 
number of AIDS cases increased in all reporting coun-
tries in the East of the Region, the number of AIDS cases 
has continued to decline in many countries. 
A total of 15 153 592 HIV tests performed for diagnos-
tic purposes were reported by 30 countries for 2012. A 
majority of countries reported increasing numbers of 
1 No data available from Uzbekistan.
2 Liechtenstein is not presented separately in the tables as their data 
are included in the data reported by Switzerland (see Annex 5).
3 No data available from Russia, Sweden or Uzbekistan.
4 No data available from Russia, Sweden or Uzbekistan.
HIV tests performed annually during the period 2006–
2012. Higher testing rates were reported by countries in 
the East and lower rates by countries in the Centre. Data 
from countries in the West showed varied levels and 
trends (Table 27). 
European Union and European 
Economic Area
In 2012, 29 381 HIV diagnoses were reported by 30 EU/
EEA countries, with a rate of 5.8 per 100 000 popula-
tion (Table  1). The five countries with the highest rates 
of HIV diagnoses in 2012 were Estonia (23.5), Latvia 
(16.6), Belgium (11.1), the United Kingdom (10.3) and 
Luxembourg (10.3). The lowest rates were reported by 
Slovakia (0.9) and Croatia (1.7). Since the start of report-
ing on the HIV epidemic, 455 757 HIV diagnoses have 
been reported in the EU/EEA; 324 181 were in men and 
128 325 in women (Tables 2 and 3), 3 251 not having gen-
der information available. 
In 2012, the male-to-female ratio was 3.2 (Table  A). 
Young people aged 15 to 24 years accounted for 10.6% of 
all HIV diagnoses reported, but this varied widely from 
4.4% in Slovenia to 32.5% in Romania (Figure B).
Similar to recent years, the highest proportion of HIV 
diagnoses was reported in men who have sex with men 
(MSM) (40.4%), followed by heterosexual transmission 
(33.8%) including heterosexually-acquired cases origi-
nating from sub-Saharan African countries. For 18.7% 
of the cases, the transmission mode was unknown. 
(Table A).
The rate of HIV diagnoses per 100 000 population 
appears to have remained fairly stable over time, with 
a rate of 6.4 per 100 000 in 2006 (28 318 cases) com-
pared to 6.2 per 100 000 (30 900 cases) in 2012 when 
adjusted for reporting delay (Table  1, Annex  6). Trends 
Overview of HIV and AIDS in Europe
Table A: Characteristics of HIV diagnoses reported in the WHO European Region, the EU/EEA, and by geographical 
area, 2012
Geographical areas WHO European Region West Centre East EU/EEA 
Reporting countries/number of countries 51/53 23/23 15/15 13/15 30/31
Number of HIV diagnoses 55 494 27 315 3 715 24 464 29 381
Rate of diagnoses per 100 000 population 7.8 6.6 1.9 22 5.8
Percentage age 15-24 years 10.3% 9.8% 15.4% 10.1% 10.6%
Male-to-female ratio 2.1 3.1 4.5 1.4 3.2
Transmission mode
Heterosexual 45.6% 35.3% 24.6% 60.2% 33.8%*
Men having sex with men 22.8% 41.7% 26.2% 1.2% 40.4%
Injecting drug use 17.8% 5.1% 7.3% 33.6% 6.1%
Unknown 12.3% 17% 36.9% 3.2% 18.7%
No data from: Russia and Uzbekistan; countries with no data on age and transmission mode are excluded
* includes individuals (12%) originating from sub-Saharan African countries
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by transmission mode show that the number of HIV 
diagnoses among MSM has increased by 11% since 
2006 (Table 8). In contrast, the number of cases among 
people who inject drugs (PWID) has decreased by 7% 
(Table 8), although a slight increase compared to recent 
years was observed in 2012 due to ongoing outbreaks in 
Greece and Romania (Table 5). The numbers of HIV diag-
noses due to heterosexual transmission, mother-to-child 
transmission and blood transfusion have decreased con-
tinuously between 2006 and 2012 (Table 8). 
In 2012, information on CD4 cell counts at the time of 
diagnosis was available in 20 countries for 16 150 cases 
(55% of all cases reported in 2012) (Table  14). Half of 
these cases (49%) were reported as late presenters (CD4 
cell count <350/mm3), including the 30% of cases with 
advanced HIV infection (CD4 <200/mm3). The proportion 
of late presenters was highest among heterosexually 
acquired cases reported as originating from sub-Saha-
ran African countries (62%) and among PWID (56%). The 
lowest proportions of late presenters were observed in 
MSM (38%) and in cases of mother-to-child transmis-
sion (23%) (Table 14, Figure F).
In 2012, 4 313 AIDS cases were diagnosed and reported 
by 29 EU/EEA countries5, which is a rate of 0.8 cases per 
100 000 population (Table  15). The highest rates were 
reported by Latvia (6.8), Estonia (2.7), Portugal (2.4) and 
Spain (1.7). In the EU/EEA, the number of AIDS cases has 
consistently declined since the mid-1990s.
WHO European Region
In 2012, 131 202 new HIV infections were diagnosed in 
52 of the 53 countries of the WHO European Region6. Of 
those infections, 55 494 were officially reported to ECDC/
WHO Regional Office for Europe by 51 countries while 
5 No data available from Sweden.
6 No data available from Uzbekistan.
75 708 infections were reported through the database of 
the Federal Statistics Agency of the Russian Federation 
[1]. Since the beginning of the epidemic and up to 31 
December 2012, there have been a cumulative total of 
at least 1 496 201 diagnoses of HIV infection in the WHO 
European Region. This number includes a cumulative 
total of 839 337 infections officially reported to ECDC 
and the WHO Regional Office for Europe and 719 445 
infections reported in Russia as of 31 December 2012 [2] 
minus the 62 581 cases officially reported to ECDC/WHO 
by Russia in 2010. 
Forty-four percent of newly diagnosed infections (24 464 
cases) were reported in the East, 49% (27 315 cases) 
in the West and 7% (3 715 cases) in the Centre of the 
Region, while the rate (cases per 100 000 population) 
was highest in the East at 22.0, over three times higher 
than in the West (6.6 per 100 000) and almost twelve 
times higher than in the Centre (1.9 per 100 000). The 
highest rates were reported by Ukraine (37.1), Estonia 
(23.5) and Moldova (21.3).
The majority of new HIV infections (37%) were reported 
in the age group 30–39 years old, while 10% were 
reported among 15–24 year-olds. The male-to-female 
ratio was 2.1; lowest in the East (1.4) and highest in 
the Centre (4.5) (Table  A). Most frequently, reported 
cases were acquired through heterosexual transmis-
sion (46%), although the picture is more heterogeneous 
at sub-regional level, illustrating the wide diversity in 
the epidemiology of HIV in Europe. Eighteen percent of 
the new HIV cases were infected through injecting drug 
use, 23% through sex between men and 1% were due to 
mother-to-child transmission (MTCT). For 12% of cases 
the transmission mode was reported as unknown. 
In the West, sexual transmission between men remains 
the main transmission mode, followed by heterosexual 
transmission, together accounting for 77% of all infec-
tions. In the Centre, levels of HIV remain low and stable, 































 Rates may increase in the coming years due to reporting delays
Data from Russia not included.
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though there is evidence of increasing sexual transmis-
sion between men in many countries. In 2011 and 2012, 
there was a marked increase in the number of cases 
infected through injecting drug use compared with 
2010, mainly due to an outbreak in Romania. In the East, 
the number of HIV infections continued to increase. 
Heterosexual contact, followed by injecting drug use, 
is reported to be the dominant mode of transmission. 
Heterosexual transmission among PWID is known to be 
of significant importance, but the proportion of inde-
pendent versus PWID-related heterosexual transmission 
is unknown as information on the probable source of 
infection is missing for the majority of cases. 
Between 2006 and 2012, the rate of newly diagnosed 
HIV infections per 100 000 population increased by 
7%, from 7.3 (49 424 cases) to 7.8 (55 494 cases) in the 
51 countries that have reported consistently. Trends 
by transmission mode show increases in infections 
acquired due to heterosexual contact (19% increase), 
sex between men (14% increase) and mother-to-child 
transmission (61% increase), whereas infections due to 
injecting drug use decreased by 14%.
In 2012, 30 countries in the WHO European Region 
provided information on CD4 cell count at the time of 
diagnosis for 18 369 (33%) cases (Table 14). Half of these 
cases were reported as late presenters (CD4 cell count 
<350/mm3), including 30% of cases with advanced HIV 
infection (CD4 <200/mm3).
In 2012, 16 534 AIDS cases were diagnosed in 50 coun-
tries of the WHO European Region7, of which 6 461 were 
officially reported to ECDC/WHO by 49 countries, and 
10 073 were obtained through the Ukrainian Centre for 
Socially Dangerous Disease Control [3] due to incomplete 
reporting by Ukraine through The European Surveillance 
System. Seventy-three percent (12 132 cases) of the total 
16 534 AIDS cases were reported by countries in the 
East, 22% (3 564 cases) in the West and 5% (838 cases) 
in the Centre of the Region. The number of cases per 
100 000 population was 10.9 in the East, over thirteen 
times higher than in the West (0.9 per 100 000) and 27 
times higher than in the Centre (0.4 per 100 000). Due 
to incomplete reporting, the number of AIDS cases is 
underestimated, particularly in the East.
Between 2006 and 2012, among the 49 countries with 
consistent official data8, the rate of reported AIDS diag-
noses declined by 29%, from 1.4 per 100 000 population 
(9 311 cases) in 2006 to 1.0 per 100 000 population (6 461 
cases) in 2012. If the complete number of AIDS cases 
diagnosed in Ukraine is included, the pattern reverses 
to show a slight increase from a rate of 2.0 per 100 000 
(14 089 cases) in 2006 to 2.3 per 100 000 (16 534 cases) 
in 2012. In the East, the number of AIDS cases is increas-
ing rapidly and has more than doubled over the same 
period, from 5 699 cases (5.6 per 100 000) to 12 132 
cases (10.9 per 100 000 population). 
7 No data available from Russia, Sweden or Uzbekistan.
8 Russia, Sweden, Ukraine and Uzbekistan not included.
Conclusions
The most recent surveillance data indicate that the 
number of people living with HIV in Europe continues to 
increase and that HIV is concentrated in key populations 
at higher risk of HIV infection such as men who have sex 
with men; people originating from high-endemic coun-
tries, mainly sub-Saharan Africa; and people who inject 
drugs and their sexual partners. Recent increases of HIV 
among PWID in the EU/EEA and West indicate that even 
low numbers can rapidly evolve into an outbreak when 
public health interventions are insufficient. 
The relatively high proportion of late diagnoses in many 
countries indicates a delay in HIV testing and many 
cases are already eligible for treatment when they are 
diagnosed. The high and increasing number of AIDS 
cases in the East is indicative of late HIV diagnosis, low 
treatment coverage and delayed initiation of life-saving 
HIV treatment. The wide availability of treatment and 
recommendations for earlier initiation [4] has widened 
the scope of HIV surveillance to include monitoring of 
access to care and treatment. Improved access to and 
earlier initiation of treatment, particularly for key popu-
lations, is of importance throughout Europe but needs to 
be urgently addressed in the East. 
Throughout Europe, HIV counselling and testing ser-
vices need to be continuously promoted and accessible 
and targeted at key populations that are at higher risk 
in order to ensure earlier diagnosis and initiation of 
HIV treatment and linkage to care. This will result in 
improved treatment outcomes and clinical benefits, as 
well as contribute to preventing or further reducing HIV 
transmission. Equal access to HIV prevention, testing, 
treatment and care for all population groups should be 
ensured in order for countries to reach the global goal of 
universal access [5] for all in need.
Interventions to control the epidemic need to be based 
on evidence and adapted to national and local epide-
miology. From the surveillance data presented in this 
report the following can be concluded:
•	 For	 the	 countries	 in	 the	 EU/EEA	 and	 West,	 interven-
tions to prevent and control HIV among MSM are the 
cornerstones of the HIV response. In addition, as 
more than one third of the heterosexually acquired 
HIV cases were reported as originating from high 
endemic countries (mainly from sub-Saharan Africa), 
countries need to ensure that interventions for pre-
vention, treatment and care are accessible to these 
migrant populations. The observed increase in HIV 
cases among people who inject drugs in a number of 
countries [6] demonstrates the need to maintain or 
scale up harm reduction programmes in the EU/EEA. 
•	 For	the	countries	in	the	Centre,	as	the	epidemic	among	
MSM is increasing, the priority is to strengthen inter-
ventions to prevent and treat HIV in this group.
•	 For	the	countries	in	the	East,	interventions	to	prevent	
and treat HIV among people who inject drugs, includ-
ing harm reduction programmes and improved access 
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to treatment, need to continue to form the corner-
stone of the HIV response. In couples where one of the 
partners is engaged in a high-risk behaviour, such as 
injecting drug use, prevention interventions should 
address the risk of heterosexual transmission.
Although the number of countries conducting enhanced 
HIV surveillance and reporting surveillance data at 
European level has gradually increased over time, the 
overall picture is still incomplete; in 2012, 51 of the 53 
countries submitted data. Data quality and complete-
ness of such key variables as transmission mode and 
CD4 cell count at time of diagnosis is still to be improved 
in many countries. This is of vital importance to allow 
monitoring the HIV epidemic and the response to HIV, 
in particular the access to and uptake of HIV testing 
services. 
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ВИЧ-инфекция остается серьезной проблемой 
общественного здравоохранения в Европе. В 2012 
г. 131 202 новых случая ВИЧ-инфекции было зареги-
стрировано в 52 из 53 стран Европейского региона 
ВОЗ 1. Из них о 55 494 случаях 51 страна официально 
сообщила в ECDC/Европейское бюро ВОЗ (ECDC/ВОЗ); 
из этого числа случаев сообщения о 29 381 случае 
поступило из стран, входящих в Европейский союз и 
Европейскую экономическую зону (ЕС/ЕЭЗ) 2, и 75 708 
случаев были зарегистрированы в базе данных 
Федеральной службы государственной статистики 
Российской Федерации [1]. По данным эпиднадзора, 
общая частота диагностированных случаев ВИЧ-
инфекции составила в странах Европейского региона 
ВОЗ 7,8 случая на 100 000 населения и в странах 
ЕС/ЕЭЗ – 5,8 случая на 100 000 населения. Самые 
высокие показатели зарегистрированы на Востоке 
Региона (Таблица А). Основной путь передачи отли-
чается в зависимости от географической области, 
иллюстрируя широкое разнообразие эпидемиологии 
ВИЧ-инфекции в Европе; основной путь передачи в 
Европейском регионе ВОЗ – гетеросексуальный; в 
странах ЕС/ЕЭЗ доминирует передача ВИЧ при сек-
суальных контактах между мужчинами; частота 
передачи при употреблении инъекционных наркоти-
ков остается значительной на Востоке Региона. 
В 2012 г. в 50 странах Европейского региона ВОЗ 3 
диагностировано 16 534 случая СПИДа, из которых о 
6 461 случае 49 стран официально сообщили в ECDC/
ВОЗ, и из-за неполного сообщения Украиной данных 
в систему TESSy4 данные о 10 073 случаях были полу-
чены из Украинского центра контроля за социально 
1 Нет данных из Узбекистана.
2 Лихтенштейн отдельно в таблицах не представлен, так как 
относящиеся к нему данные включены в данные, сообщенные 
Швейцарией.
3 Нет данных из Российской Федерации, Швеции и Узбекистана.
4 Нет данных из Российской Федерации, Швеции и Узбекистана.
опасными болезнями [3]. Хотя на Востоке Региона 
во всех сообщивших данные странах число случаев 
СПИДа увеличилось, во многих других странах число 
случаев СПИДа продолжало снижаться. 
По сообщениям из 30 стран, в 2012 г. общее число 
тестов на ВИЧ, проведенных с диагностической целью, 
составило 15 153 592. Большинство стран сообщали об 
увеличении числа ежегодно проводимых тестов на 
ВИЧ в период с 2006 по 2012 г. Более высокая частота 
тестирования зарегистрирована на Востоке, и более 
низкая – в Центре. Данные о тестировании на ВИЧ, 
полученные от стран, расположенных на Западе, 
указывали на различия в показателях и тенденциях 
(Таблица 27). 
Европейский союз и 
Европейская экономическая 
зона
В 2012 г. 30 стран ЕС/ЕЭЗ сообщили о 29 381 диагно-
стированном случае ВИЧ-инфекции при частоте 5,8 
случаев на 100 000 населения (Таблица 1). В 2012 г. 
самая высокая частота случаев ВИЧ-инфекции заре-
гистрирована в 5 странах: Эстония (23,5), Латвия 
(16,6), Бельгия (11,1), Соединенное Королевство 
(10,3) и Люксембург (10,3). Самые низкие показатели 
частоты случаев зарегистрированы в Словакии (0,9) 
и Хорватии (1,7). С начала предоставления отчетности 
по эпидемии ВИЧ-инфекции в странах ЕС/ЕЭЗ зареги-
стрировано 455 757 случаев ВИЧ-инфекции, из них 
324 181 случай у мужчин и 128 325 случаев у женщин 
(Таблицы 2 и 3); для 3 251 случая информации о поло-
вой принадлежности не было. 
В 2012 г. соотношение случаев среди мужчин и жен-
щин составило 3,2 (Таблица А). Молодые люди в 
возрасте от 15 до 24 лет составляли 10,6% всех заре-
гистрированных случаев ВИЧ-инфекции с широким 
ВИЧ/СПИД в Европе – обзор ситуации
Таблица А: Характеристики диагностированных случаев ВИЧ-инфекции, с разбивкой по географическим 
областям, страны Европейского региона ВОЗ и ЕС/ЕЭЗ, 2012 г.
Географическая область Европейский регион ВОЗ Запад Центр Восток ЕС/ЕЭЗ 
Страны, предоставившие отчетность/число стран 51/53 23/23 15/15 13/15 30/31
Число диагностированных случаев ВИЧ-инфекции 55 494 27 315 3 715 24 464 29 381
Частота на 100 000 населения 7.8 6.6 1.9 22 5.8
Процент случаев в возрасте 15-24 лет 10.3% 9.8% 15.4% 10.1% 10.6%
Соотношение мужчин и женщин 2.1 3.1 4.5 1.4 3.2
Transmission mode
Гетеросексуальный 45.6% 35.3% 24.6% 60.2% 33.8%*
Мужчины, практикующие секс с мужчинами 22.8% 41.7% 26.2% 1.2% 40.4%
Люди, употребляющие инъекционные наркотики 17.8% 5.1% 7.3% 33.6% 6.1%
Неизвестно 12.3% 17% 36.9% 3.2% 18.7%
Нет данных из Российской Федерации и Узбекистана; страны, по которым нет данных о возрасте и пути передачи, исключены из подсчета.
* Включая выходцев из стран Африки южнее Сахары (12%)
xii
SURVEILLANCE REPORTHIV/AIDS surveillance in Europe 2012
разбросом от 4,4% в Словении до 32,5% в Румынии 
(Рисунок В). 
Как и в предыдущие годы, самая высокая доля 
случаев ВИЧ-инфекции зарегистрирована среди 
мужчин, практикующих секс с мужчинами (МСМ) 
– 40,4%, затем следует гетеросексуальный путь 
передачи (33,8%), включая случаи заражения гете-
росексуальным путем у выходцев из стран Африки 
южнее Сахары. Для 18,7% случаев путь передачи был 
неизвестен (Таблица А). 
В течение длительного времени частота диагностиро-
ванных случаев ВИЧ-инфекции на 100 000 населения 
оставалась достаточно стабильной: в 2006 г. – 6,4 на 
100 000 населения (28 318 случаев) по сравнению с 
6,2 на 100 000 (30 900 случаев) в 2012 г. (с поправкой 
на задержку сообщения) (Таблица 1, Приложение 6). 
Тенденции в отношении путей передачи указывают 
на то, что число случаев ВИЧ-инфекции среди МСМ 
выросло с 2006 г. на 11% (Таблица 8). Наоборот, число 
диагностированных случаев среди людей, употребля-
ющих инъекционные наркотики (ЛУИН), снизилось на 
7% (Таблица 8), хотя по сравнению с предыдущими 
годами в 2012 г. этот показатель незначительно 
вырос в связи со вспышками в Греции и Румынии 
(Таблица 5). В период с 2006 по 2012 г. число случаев 
заражения при гетеросексуальных контактах, через 
передачу ВИЧ от матери ребенку (ПМР) и при пере-
ливании крови постоянно снижалось.
В 2012 г. информация о числе клеток CD4 на момент 
постановки диагноза была получена от 20 стран 
для 16 150 случаев (55% всех случаев, зарегистри-
рованных в 2012 г.) (Таблица 14). Среди них почти 
половина случаев (49%) зарегистрирована как слу-
чаи, выявленные на поздних стадиях (число клеток 
CD4 <350/мм3), включая 30% случаев с продвинутой 
стадией ВИЧ-инфекции (число клеток CD4 <200/mm3). 
Доля диагнозов, поставленных на поздних стадиях, 
была самой высокой при заражении гетеросексу-
альным путем у выходцев из стран Африки южнее 
Сахары (62%) и среди ЛУИН (56%). Самая низкая 
доля диагнозов, поставленных на поздних стадиях, 
зарегистрирована среди МСМ (38%) и при ПМР (23%) 
(Таблица 14, Рисунок F).
В 2012 г. в 29 странах ЕС/ЕЭЗ5 было диагностировано 
и зарегистрировано 4 313 случаев СПИДа при частоте 
0,8 случая на 100 000 населения (Таблица 15). Самая 
высокая частота зарегистрирована в Латвии (6,8), 
Эстонии (2,7), Португалии (2,4) и Испании (1,7). В 
странах ЕС/ЕЭЗ число случаев СПИДа постоянно сни-
жалось, начиная с середины 1990-х гг. 
Европейский регион ВОЗ
В 2012 г. в 52 из 53 стран Европейского региона 
ВОЗ6 было зарегистрировано 131 202 новых случая 
ВИЧ-инфекции. Из них 51 страна официально сооб-
щила о 55 494 случаях в ECDC/ВОЗ, и 75 708 случаев 
были зарегистрированы в базе данных Федеральной 
службы государственной статистики Российской 
Федерации [1]. С момента начала эпидемии и по 
31 декабря 2012 г. совокупное общее число диа-
гностированных случаев ВИЧ-инфекции составило 
в Европейском регионе ВОЗ 1 496 201. В это число 
вошло совокупное общее число 839 337 случаев ВИЧ-
инфекции, о которых страны официально сообщили 
в ECDC/ВОЗ, и 719 445 случаев, зарегистрированных в 
России на 31 декабря 2012 г. [2], минус 62 581 случай, 
о котором Российская Федерация официально сооб-
щила в ECDC/ВОЗ в 2010 г. 
Из всех впервые диагностированных случаев ВИЧ-
инфекции 44% (24 464) зарегистрировано на Востоке, 
49% (27 315) – на Западе и 7% (3 715) – в Центре 
5 Нет данных из Швеции.
6 Нет данных из Узбекистана.
Рисунок А: Частота зарегистрированных случаев ВИЧ-инфекции на 100 000 населения, с разбивкой по году 
































 Из-за задержки сообщения в ближайшие годы частота может увеличиться. 
Данные из Российской Федерации не включены.
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Региона; при этом частота (число случаев на 100 000 
населения) была самой высокой на Востоке – 22,0; 
этот показатель более чем в три раза выше, чем на 
Западе (6,6 на 100 000) и почти в 12 раз выше, чем в 
Центре (1,9 на 100 000). Самая высокая частота была 
зарегистрирована в Украине (37,1), Эстонии (23,5) и 
Молдове (21,3). 
Большинство новых случаев ВИЧ-инфекции (37%) 
зарегистрировано в возрастной группе 30–39 лет, и 
10% – в возрастной группе 15–24 года. Соотношение 
случаев у мужчин и женщин составило 2,1; самое 
низкое – на Востоке (1,4) и самое высокое – в Центре 
(4,5) (Таблица А). Чаще всего заражение происхо-
дило при гетеросексуальных контактах (46%), хотя 
на субрегиональном уровне картина была более раз-
нородной, что демонстрирует широкое разнообразие 
эпидемиологии ВИЧ-инфекции в Европе. В 18% слу-
чаев заражение произошло при инъекционном 
употреблении наркотиков, в 23% – при сексуальных 
отношениях между мужчинами, и 1% новых случаев 
инфицирования был обусловлен ПМР. В 12% случаев 
путь заражения был неизвестен. 
На Западе секс между мужчинами остается основным 
путем заражения, затем следует гетеросексуаль-
ная передача, что в совокупности составляет 77% 
всех случаев ВИЧ-инфекции. В Центре уровни ВИЧ-
инфекции остаются низкими и стабильными, хотя 
имеются данные о повышении частоты половой пере-
дачи среди МСМ во многих странах. В 2011 и 2012 гг. 
был отмечен значительный рост (по сравнению с 2010 
г.) числа людей, инфицированных при употреблении 
инъекционных наркотиков, связанный, главным 
образом, со вспышкой в Румынии. На Востоке число 
случаев ВИЧ-инфекции продолжало расти. Согласно 
сообщениям, основным путем передачи являются 
гетеросексуальные контакты, затем следует упо-
требление инъекционных наркотиков. Известно, 
что гетеросексуальная передача вируса среди ЛУИН 
играет важную роль, однако доля связанных и не свя-
занных с употреблением инъекционных наркотиков 
случаев гетеросексуальной передачи неизвестна, так 
как для большинства случаев отсутствует информа-
ция о вероятном источнике заражения. 
В период между 2006 и 2012 г. в 51 стране (предо-
ставлявших отчетность регулярно) частота впервые 
диагностированных случаев ВИЧ-инфекции на 
100 000 населения увеличилась на 7% – с 7,3 (49 424 
случая) до 7,8 (55 494 случая). Тенденция в отношении 
пути передачи вируса показывает, что число слу-
чаев заражения гетеросексуальным путем выросло 
на 19%; среди МСМ – на 14%, а число случаев зара-
жения при ПМР увеличилось на 61%; при этом число 
случаев заражения при употреблении инъекционных 
наркотиков снизилось на 14%. 
В 2012 г. 30 стран Европейского региона ВОЗ предо-
ставили информацию по числу клеток CD4 на момент 
постановки диагноза для 18 369 случаев (33%) 
(Таблица 14). Половина этих случаев была выявлена 
на поздних стадиях (число клеток CD4 <350/мм3), 
включая 30% случаев с продвинутой стадией ВИЧ-
инфекции (CD4 <200/мм3).
В 2012 г. в 50 странах Европейского региона ВОЗ7 
было диагностировано 16 534 случаев СПИДа, из кото-
рых о 6 461 случае 49 стран официально сообщили в 
ECDC/ВОЗ, и из-за неполного сообщения Украиной 
данных в Европейскую систему эпиднадзора сведе-
ния о 10 073 случаях были получены из Украинского 
центра контроля за социально опасными болезнями 
[3]. Из общего числа случаев СПИДа (16 534 случая) 
73% (12 132 случая) зарегистрировано на Востоке, 
22% (3 564 случая) – на Западе и 5% (838 случаев) 
– в Центре Региона. На Востоке частота случаев на 
100 000 населения составила 10,9, что более чем в 13 
раз выше, чем на Западе (0,9 на 100 000), и в 27 раз 
выше, чем в Центре (0,4 на 100 000). Из-за неполной 
отчетности число случаев СПИДа занижено, особенно 
на Востоке. 
Между 2006 и 2012 г. среди 49 стран, постоянно 
предоставлявших отчетность 8, частота диагности-
рованных случаев СПИДа снизилась на 29% - с 1,4 на 
100 000 населения (9 311 случаев) в 2006 г. до 1,0 на 
100 000 населения (6 461 случай) в 2012 г. Если вклю-
чить общее числа случаев СПИДа, диагностированных 
в Украине, тенденция меняется на противополож-
ную, демонстрируя небольшое повышение частоты: 
с 2,0 на 100 000 населения (14 089 случая) в 2006 г. 
до 2,3 на 100 000 населения (16 534 случаев) в 2012 г. 
На Востоке число случаев СПИДа быстро росло и за 
этот же период увеличилось более чем вдвое – с 5 699 
случаев (5,6 на 100 000 населения) до 12 132 (10,9 на 
100 000 населения). 
Выводы
Самые последние данные эпиднадзора показывают, 
что в Европе число людей, живущих с ВИЧ, продолжает 
расти, и что случаи ВИЧ-инфекции сконцентрированы 
в ключевых группах населения повышенного риска, 
таких как МСМ; выходцы из высоко эндемичных 
стран, в основном из стран Африки южнее Сахары; 
ЛУИН и их половые партнеры. Недавний рост числа 
случаев ВИЧ-инфекции среди ЛУИН в странах ЕС/
ЕЭЗ и на Западе Европейского региона показывает, 
что если вмешательства в области общественного 
здравоохранения недостаточно эффективны, даже 
при небольшом числе случаев может происходить 
быстрое развитие вспышки заболевания. 
Относительно высокая доля случаев поздней поста-
новки диагноза во многих странах указывает на 
несвоевременное тестирование на ВИЧ, поэтому в 
момент постановки диагноза многие люди уже нуж-
даются в лечении. Высокое и продолжающее расти 
число случаев СПИДа на Востоке Региона указывает 
на запоздалую постановку диагноза, низкий охват 
лечением и позднее начало лечения ВИЧ-инфекции, 
7 Нет данных из Российской Федерации, Швеции и Узбекистана.
8 Не включены Российская Федерация, Швеция, Украина и 
Узбекистан.
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спасающего жизнь. Широкая доступность лечения и 
рекомендации по более раннему началу лечения [4] 
расширили задачи эпиднадзора за ВИЧ-инфекцией, в 
которые теперь входит мониторинг доступа к помощи 
и лечению. В масштабах всей Европы необходимо 
обеспечить улучшение доступа к лечению и его более 
раннее начало, особенно для ключевых групп насе-
ления повышенного риска; самые безотлагательные 
меры в этом направлении необходимо предпринять 
на Востоке.
По всей Европе необходимо продолжать пропа-
гандировать услуги по тестированию на ВИЧ и 
консультированию и расширять доступ к ним, чтобы 
обеспечить раннюю постановку диагноза, своев-
ременное начало лечения и оказание помощи при 
ВИЧ-инфекции. Это приведет к улучшению исходов 
лечения и клинических показателей, а также будет 
содействовать профилактике и дальнейшему сниже-
нию уровней передачи ВИЧ-инфекции. Необходимо 
обеспечить справедливый доступ к услугам по про-
филактике, тестированию, лечению и оказанию 
помощи при ВИЧ-инфекции для всех групп населе-
ния. Это необходимо для того, чтобы страны могли 
достигнуть глобальной цели – обеспечить всеобщий 
доступ к этим услугам для всех, кто в них нуждается 
[5]. 
Необходимо, чтобы вмешательства по контролю 
эпидемии основывались на научных данных и были 
адаптированы к национальным и местным эпиде-
миологическим условиям. На основании данных 
эпиднадзора, представленных в этом докладе, можно 
сделать следующие выводы:
•	 Для	 стран	 ЕС/ЕЭЗ	 и	 стран,	 расположенных	 на	
Западе Региона, краеугольным камнем ответ-
ных действий в отношении ВИЧ-инфекции 
являются меры, направленные на профилактику 
ВИЧ-инфекции и борьбу с ней среди МСМ. Кроме 
того, поскольку более одной трети случаев зара-
жения ВИЧ-инфекцией гетеросексуальным путем 
были выявлены у выходцев из высоко эндемичных 
регионов (в основном из Африки южнее Сахары), 
страны должны обеспечить доступ к меропри-
ятиям по профилактике, лечению и помощи 
при ВИЧ-инфекции для этих групп мигрантов. 
Наблюдавшийся в ряде стран рост числа случаев 
ВИЧ-инфекции среди ЛУИН [6], указывает на необ-
ходимость поддержания уровня или расширения 
масштаба мер по снижению вреда в странах ЕС/
ЕЭЗ.
•	 Для	 стран,	 расположенных	 в	 Центре,	 учитывая,	
что масштаб эпидемии среди МСМ увеличивается, 
приоритетом является укрепление мероприятий по 
предупреждению и лечению ВИЧ-инфекции в этой 
группе. 
•	 Для	 стран,	 расположенных	 на	 Востоке,	 мероприя-
тия по предупреждению и лечению ВИЧ-инфекции 
среди ЛУИН, в том числе программы по снижению 
вреда и улучшению доступа к лечению, должны 
оставаться краеугольным камнем ответных мер в 
отношении ВИЧ-инфекции. Мероприятия по про-
филактике для пар, в которых один из партнеров 
практикует поведение высокого риска (например, 
употребляет инъекционные наркотики), должны 
быть направлены на снижение риска гетеросексу-
альной передачи.
Хотя число стран, которые проводят расширенный 
эпиднадзор за ВИЧ-инфекцией и предоставляют 
отчетность, на европейский уровень постепенно 
увеличивается, общая картина остается неполной; 
в 2012 г. данные представила 51 из 53 стран. Во мно-
гих странах качество данных и их полнота по таким 
ключевым переменным, как путь передачи и число 
клеток CD4 во время постановки диагноза, нужда-
ются в улучшении. Это исключительно важно для 
обеспечения возможности осуществлять монито-
ринг эпидемии ВИЧ-инфекции и ответных действий в 
связи с ней; особенно это касается доступа к услугам 
по тестированию на ВИЧ и их использования. 
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1.1 HIV diagnoses
In 2012, 29 381 HIV diagnoses were reported by 30 EU/
EEA countries giving a rate of 5.8 per 100 000 population 
(Table  1). The overall rate for men was 9.1 per 100 000 
population (Table  2) and for women, 2.7 per 100 000 
population (Table  3). The highest rates were observed 
in Estonia (23.5; 315 cases), Latvia (16.6; 339 cases), 
Belgium (11.1; 1 227 cases), the United Kingdom (10.3; 
6 358 cases) and Luxembourg (10.3; 54 cases). The low-
est rates were reported by Slovakia (0.9; 50 cases) and 
Croatia (1.7; 74 cases).
Overall in the EU/EEA, as in 2011, 11% of HIV diagno-
ses were reported among young people between 15 
and 24 years of age (the age group comprising 12% of 
the EU/EEA population). Romania, Hungary and Estonia 
reported more than 15% of their HIV diagnoses among 
young people (Figure  B). In eleven countries, this pro-
portion was lower than 10%. 
The overall male-to-female ratio was 3.2. The ratio was 
highest in Croatia (23.7), Slovenia (14.0), Hungary (13.3) 
and Slovakia (7.3) (Figure  C). The predominant mode of 
transmission in these countries was sex between men. 
Twenty-seven countries provided information on the 
country of birth or country of nationality. It appears 
that cases originating from countries in sub-Saharan 
Africa disproportionately influence the figures on mode 
of transmission (Table  B). Among 29 381 HIV diagno-
ses reported in the EU/EEA, 4 055 (14%) were in cases 
reported to have come from countries in sub-Saharan 
Africa (Table 12). For heterosexually acquired cases and 
cases transmitted from mother to child, the proportions 
are even higher: 35% and 38%, respectively (Table B). 
Data on transmission mode indicate the following 
(Table 12a, Tables 4–7):
•	 Male-to-male	 transmission	 is	 the	 predominant	 mode	
of transmission in EU/EEA countries, accounting for 
40% (11 877 diagnoses) of the number of HIV diag-
noses in 2012 (Table  4). Transmission among MSM 
accounted for more than half of the HIV cases in 
nine countries (Croatia, Cyprus, the Czech Republic, 
Germany, Hungary, the Netherlands, Slovakia, 
Slovenia and Spain) and more than 30% in another 
ten countries (Austria, Belgium, Bulgaria, Denmark, 
Finland, Ireland, Italy, Luxembourg, Norway and the 
United Kingdom) (Figure D). 
•	 Heterosexual	 contact	 is	 the	 second	 most	 commonly	
reported mode, accounting for 34% of infections 
(9 944 diagnoses). These include 12% (3 478) originat-
ing from sub-Saharan countries with a generalised 
HIV epidemic (Table  B). The highest proportions of 
heterosexually transmitted cases originating from 
countries with generalised epidemics were observed 
in Malta (67%), Ireland (63%), Belgium (53%) and 
Sweden (53%) (Figure E).
•	 Six	 percent	 (1	785	 cases)	 of	 HIV	 diagnoses	 were	
reported in PWID (Table  5). Injecting drug use was 
reported as the predominant mode of transmission 
in three countries: Greece, Lithuania and Romania. 
In these three countries, transmission among PWID 
accounted for more than 30% of reported HIV cases. 
•	 Of	the	remainder,	214	(1%)	were	reported	as	mother-to-
child transmission (Table 7); 38% of those originated 
from sub-Saharan countries. Fifty-three diagnoses 
were reported to be due to transfusion of blood and 
its products, and seven cases were hospital-acquired 
infections (Table 12a).
•	 Transmission	 mode	 was	 reported	 as	 ‘unknown’	 for	
5 501 diagnoses (19%).
In 2012, 24 EU/EEA countries were able to provide 
information on the probable source of infection when 
the infection was acquired through heterosexual con-
tact (Table  10). This information was reported for 31% 
of cases (3 067). Among those, HIV diagnoses were 
reported in 938 individuals with a partner originating 
from a country with a generalised epidemic, 60 with a 
partner who injects drugs and 13 with a bisexual partner. 
Information on CD4 cell count at the time of HIV diag-
nosis was provided by 20 countries (Table 14) for 16 150 
HIV diagnoses (55%) in adults and adolescents. All these 
countries apart from Portugal were able to provide CD4 
cell counts for more than 50% of their reported cases. 
Almost half (49%) of these cases were late presenters 
with a CD4 cell count less than 350/mm3, including 30% 
of cases with advanced HIV infection (CD4 <200/mm3). 
Among countries with more than 50% data complete-
ness on CD4 cell count, the percentage of late presenters 
(CD4 <350/mm3) ranged from below 35% in the Czech 
Republic, Cyprus and Romania, to 66% in Slovenia. 
1 HIV and AIDS in the European Union and 
European Economic Area
Table B: Number and percentage of HIV diagnoses in cases from countries in sub-Saharan Africa (with generalised HIV 
epidemic) and overall totals, by mode of transmission, EU/EEA, 2012 (n=29 381)
Reported HIV diagnoses Heterosexual IDU MSM MTCT Nosocomial Unknown Total
HIV diagnoses in cases from 
countries with generalised epidemics 3 476 (35%) 11 (0.6%) 184 (1.5%) 82 (38.3%) 16 (26.7%) 286 (5.2%) 4 055 (13.8%)
Total number of cases 9 944 1 785 11 877 214 60 5 501 29 381
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Figure C: Male-to-female ratio in HIV infections, by country, EU/EEA, 2012 (n=29 327)

































Figure B: Percentage of HIV diagnoses in people between 15 and 24 years old, by country, EU/EEA, 2012 (n=29 381)
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Figure D: Percentage of HIV diagnoses in MSM among all reported HIV cases, by country, EU/EEA, 2012 (n=29 381)

































Figure E: Proportion of HIV diagnoses in persons originating from countries with a generalised HIV epidemic among all 
cases reported as heterosexually acquired, EU/EEA, 2012 (n=9 944)
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When analysing CD4 cell count by transmission mode, 
the highest proportion of low CD4 (less than 350/mm3) 
was observed among heterosexually acquired cases, 
especially among those originating from sub-Saharan 
countries (62%). The lowest proportion with CD4 less 
than 350/mm3, as well as CD4 less than 200/mm3, was 
observed among cases due to mother-to-child transmis-
sion (23% and 14%) and MSM (38% and 20%) (Figure F). 
Fourteen countries reported CD4 less than 350/mm3 in 
more than half of the heterosexually acquired cases, 
thirteen countries for more than half of the PWID cases 
and three countries for more than half of the MSM cases. 
1.2 Trends in HIV diagnoses
The trend of reported HIV diagnoses for the period 
2006–2012 continues to be relatively stable, although 
the overall rate of HIV diagnoses per 100 000 population 
decreased slightly from 6.4 per 100 000 in 2006 (28 318 
cases) to 5.8 per 100 000 (29 381 cases) in 2012 when 
not adjusted for the reporting delay in a number of coun-
tries (Table  1). If data were adjusted for reporting delay 
(methods in Annex 1; results in Annex 6), the estimated 
adjusted rate for 2012 would be 6.2 per 100 000 popula-
tion (30 900 cases). In the previous HIV/AIDS surveillance 
report [1], 28 651 HIV diagnoses were reported for 2011, 
but this number has now increased by 2 000 cases and 
may still increase further in the next year.
Trends at national level varied widely. Since 2006, rates 
of HIV diagnoses have more than doubled in Greece, 
the Czech Republic, Romania and Hungary, while 
Iceland, Bulgaria, Slovakia and Lithuania have reported 
increases of more than 50%. However, rates appear to 
have decreased by 20% or more in Denmark, France, 
Estonia and Portugal (Table 1).
Since 2006, 25 EU/EEA countries have consistently 
reported data on transmission mode. Data from Estonia 
and Poland are excluded from this analysis because 
more than 50% of their data on transmission mode in are 
missing. Data from Spain and Italy were also excluded 
because population coverage increased over this time 
period. Data on transmission mode from the countries 
consistently reporting indicate the following (Tables 8a, 
Figure G): 
Figure F: Percentage of CD4 cell count <350/mm3 and <200/mm3, by mode of transmission, EU/EEA, 2012 (n=16 150)
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Figure G: Trends of reported HIV diagnoses, by transmission mode and year of diagnosis, adjusted for reporting delay, 
EU/EEA, 2006–2012, logarithmic scale
Data included from: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Latvia, 
Lithuania, Luxembourg, Malta, Netherlands, Norway, Portugal, Romania, Slovakia, Slovenia, Sweden and United Kingdom.
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•	 The	number	of	HIV	diagnoses	among	MSM	 increased	
by 11%, from 7 661 cases in 2006 to 8 491 cases in 
2012, with a peak of 8 883 cases in 2010. Between 
2006 and 2012, increases of more than 100% were 
observed in Slovakia, the Czech Republic, Hungary, 
Cyprus, Bulgaria and Romania. Increases of more 
than 50% were observed in Croatia, Luxembourg and 
Ireland. 
•	 The	 number	 of	 heterosexually	 acquired	 cases	
decreased by 35% from 10 781 in 2006 to 7 057 in 
2012, with a consistently decreasing trend. This was 
mainly due to a decrease among cases originating 
from countries with a generalised epidemic, mainly 
from sub-Saharan Africa (5 726 in 2006, 2 954 in 2012) 
(Figure G). 
•	 The	 number	 of	 HIV	 diagnoses	 among	 PWID	 has	
declined by 7% since 2006. However, following the 
decrease between 2006 (1 397 cases) and 2010 (971 
cases), there has been an increase observed in 2011 
and 2012 with 1 297 cases reported in 2012. In most 
countries, the numbers reported among PWID have 
been low or decreasing. However, an almost twenty-
fold increase was reported in Greece (from 25 cases in 
2010 to 484 cases in 2012) and in Romania (from nine 
cases in 2010 to 170 cases in 2012).
•	 The	 number	 of	 diagnoses	 of	 HIV	 transmitted	 from	
mother to child decreased by 22%, from 246 in 2006 
to 191 in 2012.
•	 The	number	of	HIV	diagnoses	due	to	nosocomial	infec-
tion has decreased by 61% from 18 cases in 2006 to 
seven in 2012. The number of cases due to transfusion 
of blood and its products has decreased by 50%, from 
74 in 2006 to 37 cases in 2012.
•	 The	 number	 of	 cases	 reported	 to	 have	 an	 unknown	
mode of transmission has increased consistently 
since 2006. Over the period in question, there was an 
increase of 24%, from 3 065 in 2006 to 3 792 cases in 
2012. This increase is an underestimate as countries 
reporting incomplete data were excluded. 
•	 Reporting	delays	differ	significantly	between	transmis-
sion categories for some countries. When adjustments 
for reporting delay were made, the number of reported 
HIV cases increased for each transmission category 
ranging from 2% to 20% (Figure G).
1.3 AIDS cases, morbidity and 
mortality
In 2012, 4 313 diagnoses of AIDS were reported by 29 
EU/EEA countries (no data from Sweden), resulting in 
a rate of 0.8 cases per 100 000 population (Table  15). 
The highest rates were reported by Latvia (6.8, 139 
cases), Estonia (2.7, 36 cases), Portugal (2.4, 249 cases) 
and Spain (1.7, 777 cases). In the EU/EEA overall, there 
has been a 48% decrease in reported AIDS cases from 
8 213 cases (1.6 per 100 000) in 2006 to 5 520 (1.1 per 
100 000) in 2011. However, since 2006 an increase of 
more than 20% was reported in Bulgaria, Croatia, the 
Czech Republic, Greece, Lithuania, Hungary and Latvia. 
The number of cases also increased in Estonia, Slovakia 
and Slovenia, although the numbers were relatively 
small. The number of AIDS diagnoses has been stable 
in Romania since 2006, whereas in other countries a 
decrease in the numbers of AIDS diagnoses has been 
observed.
In the EU/EEA, the most common AIDS-indicative dis-
eases diagnosed in 2012 were Pneumocystis pneumonia 
(25%), oesophageal candidiasis (13%) and pulmonary 
tuberculosis (10%) (Table 24). The most common indica-
tive diseases for MSM were Pneumocystis pneumonia, 
Kaposi’s sarcoma and oesophageal candidiasis; for 
PWID, pulmonary tuberculosis, oesophageal candidiasis 
and HIV wasting syndrome; for cases due to heterosexual 
transmission, Pneumocystis pneumonia, oesophageal 
candidiasis and pulmonary tuberculosis (Figure H). 
In the EU/EEA, 1 017 individuals diagnosed with AIDS 
were reported to have died of AIDS during 2012 
(Table 25). This figure has been consistently decreasing 
since 2006 (3410 reported deaths), although delays in 
reporting affect the latest figures. From the beginning of 
Figure H: Percentage and number of the three most common AIDS-indicative diseases by transmission mode, EU/EEA, 
2012 (n=4 308 cases)
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the HIV epidemic to the end of 2012, a cumulative total 
of 334 299 individuals had been diagnosed with AIDS 
in the EU/EEA (Table  15). The cumulative total of cases 
reported as known to have died by the end of 2012 was 
183 022 (Table 25). These figures suggest that more than 
150 000 people were living with an AIDS diagnosis by the 
end of 2012 in the EU/EEA.
1.4 Conclusions
HIV surveillance data suggest that the epidemic in EU/
EEA countries continues with a slight decrease in the 
number of reported HIV cases since the peak in 2010. 
Surveillance data for 2012 include national data from 
Italy for the first time and increased coverage in Spain. 
Data from Croatia are also included because the country 
joined the European Union in 2013. Despite the improved 
coverage, the overall true number of reported cases 
can be expected to increase in the coming years due to 
delays in reporting in many countries.
These data provide evidence that the prevalence of peo-
ple living with HIV continues to increase, with men who 
have sex with men identified as the key population at 
risk. This is particularly evident in countries with low 
reported overall rates such as Croatia, Slovenia, the 
Czech Republic and Hungary where two thirds or more 
of all these countries’ cases are MSM. Heterosexual 
transmission is the second most important transmis-
sion category while the proportion of heterosexually 
acquired cases originating from sub-Saharan African 
countries continues to decrease. Transmission among 
people who inject drugs remains at a low level. However, 
further increases have occurred in Romania and Greece 
which have been affected by recent outbreaks [2,3]. The 
decreasing number of cases infected through mother-to-
child transmission reflects effective antenatal screening 
programmes and the availability of prophylactic treat-
ment in most countries. 
It is of concern that 49% of the newly reported HIV cases 
with information on CD4 cell count are diagnosed as 
late presenters or with indication of advanced infection, 
i.e. with low CD4 cell counts. This suggests persistent 
problems with access to, and uptake of, HIV testing and 
counselling in many countries. There is strong evidence 
supporting the fact that delayed initiation of antiretro-
viral treatment decreases both the longer term clinical 
benefits and the preventive effect of the treatment in 
inhibiting further HIV transmission. 
The steady flow of new infections shows that it is impor-
tant to sustain HIV prevention interventions in the 
context of economic austerity. Interventions to control 
the epidemic need to be based on evidence and adapted 
to the epidemiological pattern in each country. It is 
important that countries developing their prevention 
programmes continue their efforts to improve surveil-
lance systems and data quality which enables more 
meaningful conclusions to be drawn and hence bet-
ter scaled interventions. Prevention and control of HIV 
infection in key populations, such as MSM or heterosex-
uals are the cornerstones of HIV prevention in many EU/
EEA countries. In addition, as more than one third of the 
heterosexually acquired HIV cases were reported in peo-
ple originating from highly endemic countries (mainly 
sub-Saharan Africa), health authorities need to ensure 
that interventions for prevention, treatment and care are 
accessible to these migrant populations. The observed 
increase of HIV cases among people who inject drugs in 
a number of countries demonstrates the importance of 
maintaining or scaling up harm reduction activities in 
the EU/EEA. 
HIV counselling and testing need to be promoted to 
ensure early diagnosis, access and adherence to treat-
ment to prevent or reduce further transmission, decrease 
the number of late presenters and improve the longer 
term treatment outcomes for the individuals concerned. 
Equal access to HIV treatment and care for all population 
groups in need should be ensured in order for countries 
to fulfil their national and international commitments.
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2 HIV and AIDS in the WHO European Region
2.1 HIV and AIDS diagnoses in 
the WHO European Region
HIV diagnoses
In 2012, 131 202 new HIV infections were diagnosed in 
52 of the 53 countries of the WHO European Region1. Of 
those infections, 55 494 were officially reported to ECDC/
WHO Regional Office for Europe by 51 countries, while 
75 708 infections were reported through the database of 
the Federal Statistics Agency of the Russian Federation 
[1]. Since the beginning of the epidemic and up to 31 
December 2012, there has been a cumulative total of at 
least 1 496 201 diagnoses of HIV infection in the WHO 
European Region. This number includes a cumulative 
total of 839 337 infections officially reported to ECDC 
and the WHO Regional Office for Europe and 719 445 
infections reported in Russia as of 31 December 2012 [2] 
minus the 62 581 cases officially reported to ECDC/WHO 
by Russia in 2010. 
The rate of newly diagnosed HIV infections in the WHO 
European Region in 2012 was 7.8 per 100 000 popula-
tion. For men, the rate was 8.8 per 100 000 population 
(Table  2) and for women, 3.9 per 100 000 population 
(Table  3). Forty-four percent of newly diagnosed infec-
tions (24 464 cases) were reported in the East, 49% 
(27 315 cases) in the West and 7% (3 715 cases) in 
the Centre of the Region, while the rate of cases per 
100 000 population was highest in the East (22.0 per 
100 000), over three times higher than in the West (6.6 
per 100 000) and almost twelve times higher than in the 
Centre (1.9 per 100 000).
Rates of HIV infections diagnosed in 2012 also var-
ied widely across countries. Three countries reported 
rates of more than 20 cases per 100 000 population: 
Ukraine (37.1), Estonia (23.5) and Moldova (21.3) while 
rates between 10 and 20 per 100 000 population were 
reported in 10 countries: Latvia (16.6), San Marino 
(15.5), Belarus (13.1), Kyrgyzstan (12.8), Kazakhstan 
(12.4), Georgia (11.9), Belgium (11.1), United Kingdom 
(10.3), Luxembourg (10.3) and Tajikistan (10.2) (Table 1). 
Rates below 2 per 100 000 were reported in Croatia 
(1.7), Serbia (1.7), Turkey (1.4), Slovakia (0.9), Bosnia 
and Herzegovina (0.7), the former Yugoslav Republic of 
Macedonia (0.7), Monaco (0.0) and Turkmenistan (0.0). 
1 No data available from Uzbekistan.
Among cases newly diagnosed in 2012, the major-
ity (37%) were in the age group 30–39 years (data not 
shown), while 10% were 15–24-year-olds (Table  A). The 
male-to-female ratio was 2.1, lowest in the East of the 
Region (1.4) and highest in the Centre (4.5) and 3.1 in 
the West (Table A). At country level, the highest male-to-
female ratios were observed in Croatia (23.7), Slovenia 
(14.0), Hungary (13.2), Bosnia and Herzegovina (11.5) 
and Serbia (11.5) and the lowest in San Marino (0.7), 
Moldova (1.0), Belarus (1.2), Ukraine (1.3), Kazakhstan 
(1.4), Kyrgyzstan (1.4), Sweden (1.5), Latvia (1.8) and 
Tajikistan (1.9) (Figures C, K, O).
Data on transmission mode for 2012 indicate the follow-
ing (Table A, Tables 4–7): 
•	 Forty-six	 percent	 of	 cases	 newly	 diagnosed	 (25	285	
cases) were infected through heterosexual transmis-
sion, although the picture is more heterogeneous at 
sub-regional level (Table  6, Table  A). Among cases 
reported as infected through heterosexual contact, 
15% were in persons originating from countries with 
generalised epidemics (Table C).
•	 Twenty-three	 percent	 were	 infected	 through	 sex	
between men (12 656 cases) (Table 4).
•	 Eighteen	percent	of	new	HIV	infections	were	acquired	
through injecting drug use (9 876) (Table 5).
•	 Of	the	remaining	cases,	1.0%	(562	cases)	were	infected	
through mother-to-child transmission (Table  7) and 
0.6% (311 cases) through other transmission routes 
(nosocomial infection, transfusion or use of other 
blood products). Sixteen percent of children infected 
through MTCT were born to mothers originating from 
countries with generalised epidemics (Table C). 
•	 Transmission	mode	was	reported	as	unknown	or	miss-
ing for 12% (6 804 cases).
Information about probable country of infection was 
reported by 25 of the 51 countries, for 15% of newly 
diagnosed infections (8 200 cases). Most of the cases 
for whom HIV infection was reported as acquired abroad 
(1996 cases, 24% of the sample) were infected in sub-
Saharan Africa (699 cases) or central and eastern Europe 
(665 cases) (Table 13).
In 2012, 30 countries (15 in the West, nine in the Centre 
and six in the East) provided information on CD4 cell 
Table C: Number and percentage of HIV diagnoses in cases from countries in sub-Saharan Africa (with generalised HIV 
epidemic) and overall totals, by mode of transmission, WHO European Region, 2012 
Reported HIV diagnoses Heterosexual IDU MSM MTCT Nosocomial Unknown Total
HIV diagnoses in cases from countries 
with generalised epidemics 3 660 (14.5%) 12 (0.1%) 186 (1.5%) 87 (15.5%) 16 (5.1%) 319 (4.7%) 4 280 (7.7%)
Total number of diagnoses 25 285 9 876 12 656 562 311 6 804 55 494
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count at the time of HIV diagnosis for 18 369 cases (33% 
of the new infections) (Table  14). Half (50%) of these 
cases were late presenters with CD4 cell counts below 
350/mm3, including 30% with advanced HIV infection 
(CD4<200/mm3). CD4 cell count data were available for 
more than 50% of the reported cases in 27 countries. 
The distribution of late presenters varies across trans-
mission categories. 
Trends in HIV diagnoses 
The rate of newly diagnosed HIV infections per 100 000 
population increased by 7% between 2006 and 2012, 
from 7.3 in 2006 (49 424 cases) to 7.8 in 2012 (55 494 
cases) in the 51 countries that have consistently reported 
HIV surveillance data since 20062 (Figure I). The increase 
is mainly driven by an upward trend in the East where the 
number of infections increased from 18 448 to 24 464; a 
32% increase in the rate of cases per 100 000 popula-
tion, from 16.7 in 2006 to 22.0 in 2012 (Figure  I). In the 
Centre, the rate increased by 90%, from 1.0 (1 832 cases) 
to 1.9 (3 715 cases) whereas it decreased by 14%, from 
2 Data from Russia and Uzbekistan not included.
7.7 (26 939 cases) to 6.6 (27 315) in the West (Figure  I, 
Table  1). Presenting the data on a logarithmic scale, 
allowing better comparison of rates of change regardless 
of starting point, visually shows that the highest relative 
increase in rates occurred in the Centre (Figure I).
Many countries reported increasing numbers of HIV 
tests performed during 2006–2012, notably in the East 
of the Region (Table  27). The total number of tests per-
formed in the 30 countries with data for both 2006 and 
2012 increased by 36%, from 11 127 558 to 15 153 592. 
Among the 46 countries consistently reporting data on 
transmission mode for the period 2006–20123 (Table 8, 
Figure J):
•	 the	 number	 of	 heterosexually	 acquired	 infections	
(including cases originating from countries with gen-
eralised epidemics) increased by 19% from 18 492 in 
2006 to 22 022 in 2012, although at sub-regional level 
the trends differ;
3 Data from Estonia, Italy, Poland, Russia, Spain, Turkey and 
Uzbekistan not included.
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•	 the	 number	 of	 cases	 infected	 through	 sex	 between	
men increased by 14% from 8 121 in 2006 to 9 271 in 
2012; 
•	 the	 number	 of	 cases	 infected	 through	 injecting	 drug	
use decreased by 14% from 10 900 in 2006 to 9 382 in 
2012;
•	 the	 number	 of	 children	 infected	 through	 mother-to-
child transmission increased by 61%, from 328 cases 
in 2006 to 527 in 2012; 
•	 of	 the	 number	 of	 HIV	 infections	 transmitted	 through	
other means, nosocomial transmission increased 
by 81% from 57 cases in 2006 to 103 cases in 2012, 
whereas transmission due to transfusion of blood and 
its products decreased by 49% from 92 in 2006 to 47 
in 2012; and
•	 the	number	of	 infections	 reported	with	unknown	 risk	
factors increased by 17%, from 3 905 in 2006 to 4 567 
in 2012.
AIDS cases, morbidity and mortality
In 2012, 16 534 AIDS cases were diagnosed in 50 coun-
tries of the WHO European Region4, of which 6 461 were 
officially reported to ECDC/WHO by 49 countries, and 
10 073 were obtained through the Ukrainian Centre for 
Socially Dangerous Disease Control [3] (Table  15 foot-
note) due to incomplete reporting by Ukraine through 
The European Surveillance System. These numbers 
equal a rate of 2.3 cases per 100 000 population for the 
full number of cases (Figure K) and a rate of 1.0 for the 
officially reported cases (Table  15). Due to incomplete 
reporting, the number of AIDS cases is underestimated, 
particularly in the East. 
Considering the 16 534 AIDS cases, 73% (12 132 cases) 
were reported by countries in the East, 22% (3 564 
cases) in the West and 5% (838 cases) in the Centre of 
the Region. The rate of cases per 100 000 population 
was 10.9 in the East, over thirteen times higher than in 





















Figure J: Trends in reported HIV infections, by transmission mode and year of diagnosis, WHO European Region, 
2006–2012




























Figure K: AIDS cases per 100 000 population, by geographical area and year of diagnosis, 2006–2012
Data from Sweden, Russia and Uzbekistan not included. Data from Ukraine were obtained through the Ukrainian Centre for Socially Dangerous Diseases Control [3] 
due to significant under-reporting in The European Surveillance System (Table 15 footnote).
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the West (0.9 per 100 000) and 27 times higher than in 
the Centre (0.4 per 100 000). 
The rate of reported AIDS diagnoses in 2012 varied 
widely between countries. The highest rates were 
reported in Ukraine (22.2), Georgia (8.1), Latvia (6.8), 
San Marino (6.2), Belarus (5.6) and Moldova (5.1) and 
the lowest rates (0.3 or less) were reported in Andorra, 
Austria, Bosnia and Herzegovina, the Czech Republic, 
Germany, Iceland, Slovakia and Turkey. 
The trends in the numbers of newly diagnosed AIDS 
cases and rates of cases per 100 000 during 2006–2012 
based on data from the 50 countries show a small 
increase from 2.0 in 2006 (14 089 cases) to 2.3 (16 534 
cases) in 2012 with a low point in 2009 (Figure  K). For 
the 49 countries that officially reported through The 
European Surveillance System (Ukraine not included), 
the rate decreased by 29% from 1.4 (9 311 cases) in 
2006 to 1.0 (6 461 cases) in 2012. However, it should 
be noted that reporting delays influence the number of 
cases reported in 2012 reinforcing the recent apparent 
decrease.
In the 15 countries in the Centre, the rate and number 
of cases have remained fairly stable at 0.3 per 100 000 
population (656 cases) in 2006 and 0.4 (838 cases) in 
2012. By contrast, in the East (including Ukraine) the 
rate more than doubled from 5.3 per 100 000 (5 701 
cases) in 2006 to 10.9 per 100 000 (12 132 cases) in 2012 
(Figure  K). In the West, the downward trend continued 
with a 61% decrease from 2.3 per 100 000 (7 690 cases) 
to 0.9 per 100 000 (3 564 cases) in 2012. 
Since the beginning of the epidemic, there has been a 
cumulative total of at least 437 617 AIDS diagnoses in the 
WHO European Region. In addition to the 361 141 cases 
officially reported to ECDC/WHO, this figure includes 
the cumulative 19 350 AIDS diagnoses reported by the 
Russian Federal AIDS Centre as of 31 October 2013 [4] 
and the cumulative 57 126 AIDS diagnoses reported by 
the Ukrainian Centre for Socially Dangerous Disease 
Control as of 31 December 2012 [3]. 
In the WHO European Region, 5 458 deaths among cases 
diagnosed with AIDS were reported in 2012: 1 583 offi-
cially reported to ECDC/WHO and 3 875 through the 
Ukrainian Centre for Socially Dangerous Disease Control 
[3] (Table 25). Based on countries with consistent data5, 
this number is 14% lower than the number reported for 
2006 (6 318). The cumulative number of people ever 
diagnosed with AIDS reported to have died by the end of 
2012 is 226 675, including 196 056 officially reported to 
ECDC/WHO (Table 25). 
Data from Sweden, Russia and Uzbekistan not included. 
Data from Ukraine were obtained through the Ukrainian 
Centre for Socially Dangerous Disease Control [3] due to 
significant under-reporting in The European Surveillance 
System (Table 15 footnote).
5 Russia, Sweden and Uzbekistan not included.
2.2 HIV and AIDS diagnoses in 
the East
HIV diagnoses in the East
In 2012, 13 of the 15 countries in the East reported 
24 458 newly diagnosed HIV infections, giving a rate of 
21.9 per 100 000 population (Table  1), the highest rate 
of the three geographical areas. An additional 75 708 
new HIV infections were reported in Russia through the 
database of the Federal Statistics Agency of the Russian 
Federation [1] increasing the total number of cases in the 
East to 100 166.
The highest rates in 2012 were reported by Ukraine (37.1), 
Estonia (23.5), Moldova (21.3), Latvia (16.6), San Marino 
(15.5), Belarus (13.1), Kyrgyzstan (12.8) and Kazakhstan 
(12.4) and the lowest rates were reported by Bosnia 
and Herzegovina (0.7), the former Yugoslav Republic of 
Macedonia (0.7), Slovakia (0.9), Turkey (1.4), Croatia (1.7) 
and Serbia (1.7) as well as Monaco and Turkmenistan 
that reported zero cases. Sixty-nine percent of new HIV 
infections in the East were reported by Ukraine. 
Among cases diagnosed in 2012 with information about 
age and gender, the majority (41%) were reported in the 
age group 30–39 years (data not shown) while 10%were 
aged 15–24 years (Table A). 
The male-to-female ratio was 1.4, the lowest of the three 
geographical areas, showing that overall more men 
than women are being diagnosed with HIV in the East. 
Looking only at cases infected through heterosexual 
transmission the pattern reverses and the ratio drops 
to 0.8 (Figure  L). However, in three countries (Armenia, 
Estonia and Latvia) the ratio remains above one, indicat-
ing that in those countries, men remain more affected 
than women even among cases infected heterosexually. 
In the West and the Centre, the average male-to-female 
ratio among cases infected through heterosexual trans-
mission is 0.9 and 1.9, respectively (data not shown), 
suggesting that in the East as well as the West hetero-
sexual transmission affects women more than men while 
the opposite is the case in the Centre. 
Since 2008, the reported predominant mode of trans-
mission in the East has changed from injecting drug use 
to heterosexual contact. Information on transmission 
modes as reported by the countries for 2012 indicates 
the following (Table A, Tables 4–7): 
•	 The	majority	of	new	infections	were	acquired	through	
heterosexual contact, accounting for 60% of new HIV 
infections (14 761 cases).
•	 Injecting	drug	use	was	the	second	most	common	mode	
of transmission, amounting to 34% of new HIV infec-
tions (8 213 cases). Just 1.2% of cases were reported 
among men having sex with men (303 cases).
•	 The	 number	 of	 HIV	 infections	 due	 to	 mother-to-child	
transmission was 1.3% (330 cases).
•	 Transmission	mode	 was	 unknown	 for	 3%	 of	 the	 new	
infections (793 cases).
11
HIV/AIDS surveillance in Europe 2012SURVEILLANCE REPORT
In 2012, only six countries in the East provided (partial) 
information on the probable source of infection when 
the infection was acquired through heterosexual contact 
but the information was reported as unknown for 84% 
(1 010) of the cases. Across all 13 countries, informa-
tion was lacking for 98.7% of cases (14 526) (Table  10). 
In Azerbaijan, Georgia and Tajikistan information was 
available for 21%, 34% and 11% of cases, respectively, 
and here the probable source of infection for the het-
erosexually acquired cases was reported to be sexual 
partners who inject drugs in 50%, 45% and 35% of 
cases, respectively. This variable, if well reported, could 
provide important information on the extent to which the 
increasing numbers of new cases reported as heterosex-
ually acquired are occurring among sexual partners of 
people who inject drugs, thus providing crucial informa-
tion to guide prevention efforts. 
Eight countries (Armenia, Azerbaijan, Estonia, Georgia, 
Kyrgyzstan, Latvia, Lithuania and Moldova) provided 
information about the probable country of infection for 
cases diagnosed in 2012, making up only 14% of newly 
diagnosed infections in the East (3 541 cases). In this 
small sample, 26% of cases were reported as acquired 
abroad, of which 13% were acquired in other countries 
of central and eastern Europe, while the country of infec-
tion was unknown for 12% (Table 13).
Trends in HIV diagnoses in the East
In the 13 countries in the East with consistent data for 
2006–2012 the rate of reported HIV infections has 
increased by 31% from 16.7 per 100 000 in 2006 to 21.9 
per 100 000 in 2012 (Table  1, Figure  I). The increas-
ing trend in the number of newly diagnosed infections 
should not be assessed without noting the simultaneous 
increase of 81% in the number of HIV tests performed in 
11 of the 13 countries: from 3 960 599 in 2006 to 7 149 660 
in 2012 (Table 27).
Since 2006, all countries with consistent data, except 
Estonia and Latvia, have reported increasing num-
bers and rates of HIV diagnoses. Rates of diagnoses 
per 100 000 population increased more than threefold 
in Armenia and Tajikistan and more than twofold in 
Azerbaijan, and Kyrgyzstan. In Belarus and Georgia, 
rates increased by 72% and 92%, respectively (Table 1).
Information on transmission modes in 12 countries in 
the East with consistent data on HIV transmission modes 
since 20066 indicates the following (Table 8b, Figure M):
•	 The	 number	 of	 infections	 through	 injecting	 drug	 use	
decreased by 15%, from 9 552 in 2006 to 8 141 in 2012, 
although increasing numbers were reported in some 
countries. 
6 Data from Estonia, Russia and Uzbekistan not included.
Figure L: Male-to-female ratio in all cases newly diagnosed with HIV and in cases infected through heterosexual 
transmission, by country, WHO European Region: East, 2012 
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Figure N: Distribution of the three most common AIDS-indicative diseases per transmission mode, WHO European 
Region: East, 2012 (n=2 058 cases)



























Figure M: Trends in reported HIV infections, by transmission mode and year of diagnosis, adjusted for reporting delay, 











































Data from Estonia, Russia and Uzbekistan not included.
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•	 The	 number	 of	 HIV	 infections	 acquired	 through	 het-
erosexual contact doubled from 7 014 cases in 2006 to 
14 589 in 2012 (Table A). In Armenia, Kazakhstan and 
Kyrgyzstan the increase was more than threefold and 
in Azerbaijan and Tajikistan around sixfold.
•	 The	 number	 of	 HIV	 infections	 acquired	 through	 sex	
between men has increased almost fourfold, from 
80 in 2006 to 302 in 2012. The majority of countries 
reported increasing numbers of infections among 
MSM. 
•	 The	 number	 of	 children	 infected	 through	 mother-to-
child transmission has increased fivefold, from 67 in 
2006 to 326 in 2012. 
•	 The	number	of	infections	due	to	nosocomial	transmis-
sion more than doubled from 39 cases in 2006 to 96 in 
2012. 
•	 The	number	of	cases	for	which	the	mode	of	transmis-
sion was unknown decreased by 16%, from 814 in 
2006 to 682 in 2012.
On a logarithmic scale allowing comparison of rates 
of change regardless of starting point, the data reveal 
the dramatic relative increase in the rate of infections 
reported as acquired through sex between men and 
shows this increase to be much steeper than that of 
other transmission modes (Figure M).
AIDS cases, morbidity and mortality in the East
In 2012, 12 132 cases of AIDS were diagnosed in 13 
of the 15 countries in the East7, of which 2 059 cases 
were officially reported to ECDC/WHO by 12 countries 
(due to incomplete data reported by Ukraine through 
The European Surveillance System, the total numbers 
of cases were obtained from the Ukrainian Centre for 
Socially Dangerous Disease Control [3], Table  15 foot-
note). Due to incomplete reporting, the number of AIDS 
cases is underestimated. In 2012, the highest rates were 
reported by Ukraine (22.2), Georgia (8.1), Latvia (6.8), 
Belarus (5.6) and Moldova (5.1).
In the East, (including Ukraine) the rate increased by 95% 
from 5.6 per 100 000 (5 688 cases) in 2006 to 10.9 per 
100 000 (12 132 cases) in 2012 (Figure K), corresponding 
to a 113% increase in the number of cases. All countries 
with consistent data have reported increases in the num-
ber of AIDS diagnoses between 2006 and 2012 (except 
Turkmenistan with zero cases). A more than tenfold 
increase was reported in two countries (Azerbaijan and 
Tajikistan) and a twofold increase or more in four coun-
tries (Armenia, Georgia, Kyrgyzstan and Moldova) over 
the same period. 
The most common AIDS-indicative diseases diag-
nosed in 2012 were pulmonary tuberculosis (34%), 
wasting syndrome due to HIV (29%) and oesophageal 
candidiasis (25%) (Table  24). By transmission mode, 
the most common diseases for cases infected through 
injecting drug use and heterosexual contact were 
7 No data reported by Russia or Uzbekistan.
pulmonary tuberculosis, wasting syndrome and oesoph-
ageal candidiasis; for MSM, Pneumocystis pneumonia, 
oesophageal candidiasis and pulmonary tuberculosis 
(Figure N). 
In the East, 4 493 deaths among cases diagnosed with 
AIDS were reported for 2012, including 618 officially 
reported to ECDC/WHO (Table 25). Assessing the change 
between 2006 and 2012 based on countries with com-
plete reporting8, a 58% increase in the number of deaths 
is observed (from 2 849 in 2006 to 4 493 in 2012).
2.3 HIV and AIDS diagnoses in 
the Centre
HIV diagnoses in the Centre
The HIV epidemic in the Centre remains at a low and 
stable level although there is evidence of increasing 
transmission in many countries, especially through sex-
ual contact between men. In 2012, 3 715 new infections 
were reported from 15 countries; a rate of 1.9 per 100 000 
population (Table 1). The highest rates were reported for 
Cyprus (6.7), Albania (2.9) and Poland (2.8) and the low-
est by Slovakia (0.9), Bosnia and Herzegovina (0.7), the 
former Yugoslav Republic of Macedonia (0.7), Monaco 
(0.0) and Turkmenistan (0.0). 
Among cases newly diagnosed in 2012, the most affected 
age group was 30–39 year-olds with 34% of cases (data 
not shown) whereas 15% were diagnosed among 15–24 
year-olds (Table  A). The male-to-female ratio was 4.5, 
the highest male-to-female ratios were observed in 
Croatia (24), Slovenia (14), Hungary (13), Bosnia and 
Herzegovina (12) and Serbia (12) (Figure O).
Information on transmission modes for 2012 indicates 
the following (Table A, Tables 4–7):
•	 Men	 having	 sex	with	men	 accounted	 for	 26%	 of	 new	
infections (975 cases).
•	 Twenty-five	 percent	 of	 HIV	 infections	 were	 acquired	
through heterosexual contact (915 cases).
•	 Seven	 percent	 were	 infected	 through	 injecting	 drug	
use (273 cases).
•	 Mother-to-child	 transmission	 accounted	 for	 0.9%	 (33	
cases).
•	 Transmission	mode	was	unknown	for	35%	of	 the	new	
infections (1 215 cases).
In 2012 sex between men was the predominant reported 
mode of transmission in an increasing majority of coun-
tries: Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, 
the Czech Republic, the former Yugoslav Republic of 
Macedonia, Hungary, Poland, Serbia, Slovakia and 
Slovenia whereas heterosexual transmission was the 
main mode of transmission in Albania, Montenegro and 
Turkey. 
8 Russia and Uzbekistan not included.
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Figure O: Male-to-female ratio in newly diagnosed HIV infections, by country, WHO European Region: Centre, 2012 












































Figure P: Trends of reported HIV infections, by transmission mode and year of diagnosis, WHO European Region: Centre, 
2006–2012
Data from Poland and Turkey not included.
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Trends in HIV diagnoses in the Centre
In the 15 countries in the Centre, rates of new HIV 
infections have almost doubled from 1.0 per 100 000 
population in 2006 to 1.9 per 100 000 population in 2012 
(Figure  I). Rates increased in all 15 countries and of the 
10 countries with more than 50 HIV cases in 2012, the 
rate more than doubled between 2006 and 2012 in five: 
Albania (from 1.0 to 2.6), the Czech Republic (from 0.9 to 
2.0), Hungary (from 0.8 to 2.2), Romania (from 0.9 to 2.3) 
and Turkey (from 0.4 to 1.4). 
The observed increase should be viewed in light of the 
evidence of increased HIV testing activities in all coun-
tries of the Centre: six countries with complete data for 
2006–2012 and nine with partial data for the period. 
Since 2006, information on transmission mode from 13 
countries with consistent data (Poland and Turkey not 
included) shows the following (Table 8b, Figure P):
•	 The	 number	 of	 cases	 infected	 through	 sex	 between	
men almost tripled, from 251 in 2006 to 703 in 2012.
•	 The	 number	 of	 cases	 infected	 through	 heterosexual	
transmission increased by 48% (from 298 cases in 2006 
to 443 cases in 2012).
•	 The	number	of	cases	 infected	through	injecting	drug	
use increased fourfold, from 57 in 2006 to 225 in 2012.
•	 The	number	of	HIV	infections	transmitted	from	mother	
to child remained low and stable at 18 children in 2006 
and 17 in 2012.
•	 The	number	of	new	infections	reported	with	unknown	
transmission mode increased by 74% from 98 cases in 
2006 to 171 in 2012.
AIDS cases, morbidity and mortality in the 
Centre
In 2012, 838 AIDS diagnoses were reported by the 15 
countries in the Centre, giving a rate of 0.4 per 100 000 
population (Table  15). The highest rates were reported 
by Albania (1.4, 40 cases), Romania (1.4, 293 cases), 
Montenegro (1.1, 7 cases) and Bulgaria (0.9, 65 cases). 
In the other countries, AIDS rates were around or below 
0.5 per 100 000 population.
In the Centre, the rate of new AIDS cases increased by 
33% from 0.3 per 100 000 (656 cases) in 2006 to 0.4 
per 100 000 (838 cases) in 2012 (Figure  K). At country 
level trends were heterogeneous. Of the seven countries 
reporting more than 30 AIDS cases in 2012, a fivefold 
increase in the number of cases was reported in Albania 
(from 8 to 40 cases), a fourfold increase in Bulgaria 
(from 16 to 65), a threefold increase in Turkey (from 30 
to 95) and a twofold increase in Hungary (from 22 to 48) 
while three other countries with more than 30 cases in 
2012 reported stable (Romania and Serbia) or decreas-
ing (Poland) numbers over the same period. 
The most common AIDS-indicative diseases diagnosed 
in 2012 were wasting syndrome due to HIV (19%), 
Pneumocystis pneumonia (12%), pulmonary tuberculo-
sis (9%) and oesophageal candidiasis (9%) (Table  24). 
By transmission mode, the most common diseases for 
MSM are Pneumocystis pneumonia, wasting syndrome 
due to HIV and oesophageal candidiasis; for IDUs, 
wasting syndrome due to HIV, pulmonary tuberculosis 
and oesophageal candidiasis; for heterosexuals, wast-
ing syndrome due to HIV, pulmonary tuberculosis and 
oesophageal candidiasis (Figure Q).
Some 252 individuals diagnosed with AIDS were reported 
to have died during 2012 in the Centre (Table 25); a 21% 
decrease since 2006. 
2.4 HIV and AIDS diagnoses in 
the West
HIV diagnoses in the West
In the West, 27 315 newly diagnosed HIV infections were 
reported in 2012 from the 23 countries, giving a rate 
of 6.6 per 100 000 population (Table  1, Table  A). The 
reported data suggest that sexual transmission between 
Figure Q: Distribution of the three most common AIDS-indicative diseases per transmission mode, WHO European 
Region: Centre, 2012 (n=836 cases)
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men remains the main transmission mode, followed by 
heterosexual transmission, together accounting for 77% 
of new infections. Of newly diagnosed HIV infections 
in 2012, 10% were reported in 15–24-year-olds and the 
male-to-female ratio was 3.1 (Table A). 
The distribution by transmission mode is, as in previous 
years, influenced by the number of infections diagnosed 
in individuals originating from countries with general-
ised epidemics, especially for heterosexually acquired 
infections. 
Information with respect to transmission mode for 2012 
indicates the following (Table A, Tables 4–7):
•	 Sex	between	men	accounted	for	42%	of	new	infections	
(11 378 cases).
•	 35%	 of	 the	 HIV	 cases	were	 acquired	 through	 hetero-
sexual contact (9 654 cases). 
•	 5%	of	HIV	 infections	were	acquired	 through	 injecting	
drug use (1 390 cases).
•	 Mother-to-child	 transmission	 accounted	 for	 0.7%	 of	
infections (193 cases).
•	 Transmission	 mode	 was	 unknown	 for	 17%	 of	 infec-
tions (4 640 cases).
Trends in HIV diagnoses in the West
During the period 2006 to 2012 in the 23 countries in 
the West with consistent data, the average rate of newly 
diagnosed HIV infections has remained relatively stable 
with a 14% decrease from 7.7 per 100 000 population 
(26 939 cases) in 2006 to 6.6 per 100 000 population 
(27 315 cases), not taking into account reporting delay 
for the most recent years.
Rates increased in eight and decreased in 15 countries. 
However, the decreases may be influenced by reporting 
delays in several countries. Rates above 10 per 100 000 
population were reported in four countries (Belgium 
(11.1), Luxembourg (10.3), San Marino (15.5) and the 
United Kingdom (10.3)). 
Since 2006, information on transmission mode in 21 
countries (data not included from Italy or Spain) shows 
the following (Table 8b, Figure R):
•	 The	 number	 of	 heterosexually	 acquired	 infections	
decreased by 36% (from 10 967 cases in 2006 to 6 987 
cases in 2012), mainly due to a decrease in the number 
of cases originating from countries with generalised 
epidemics (see Section 1.2).
•	 The	 number	 of	 HIV	 infections	 among	MSM	 increased	
by 6% from 7 779 in 2006 to 8 263 in 2012.
•	 New	 diagnoses	 of	 cases	 infected	 through	 injecting	
drug use decreased by 21%, from 1 287 in 2006 to 
1 016 in 2012.
•	 Newly	 diagnosed	 HIV	 infections	 due	 to	 mother-to-
child transmission decreased by 51%, from 243 in 
2006 to 177 in 2012.
•	 The	 number	 of	 cases	 with	 unknown	 transmission	
mode has increased by 26%, with 2 948 cases in 2006 
and 3 714 in 2012.
The presentation of trends by transmission group 
largely mirrors the pattern for the whole of the EU/EEA 
as described in Section 1.2. 
AIDS cases, morbidity and mortality in the 
West
For 2012, 3 562 AIDS diagnoses were reported by 22 of 
the 23 countries in the West9, giving a rate of 0.8 per 
100 000 population (Table 15). Between 2006 and 2012, 
the number of AIDS cases decreased by 54% from 7 690 
to 3 562, equalling a 58% reduction in the number of 
cases per 100 000, from 1.9 to 0.8. 
The most common AIDS-indicative diseases diagnosed 
in the West in 2012 were Pneumocystis pneumonia 
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Figure R: Trends of reported HIV infections, by transmission mode and year of diagnosis, WHO European Region: West, 
2006–2012
Data from Italy and Spain not included.
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(28%) and oesophageal candidiasis (13%) (Table 24). By 
transmission mode, the most common AIDS-indicative 
diseases for MSM were Pneumocystis pneumonia, 
Kaposi’s sarcoma and oesophageal candidiasis; for 
IDU, Pneumocystis pneumonia, oesophageal candidi-
asis, pulmonary tuberculosis; and for heterosexuals, 
Pneumocystis pneumonia, extrapulmonary tuberculosis, 
oesophageal candidiasis (Figure S). 
In the West, 713 individuals diagnosed with AIDS were 
reported to have died during 2012, continuing the 
decreasing trend from 3 158 deaths in 2006 and 1 146 in 
2011 (Table 25). 
2.5 Number of HIV tests 
performed
The numbers of HIV tests performed annually for diag-
nostic purposes (i.e. excluding unlinked anonymous 
tests and screening of blood donations) by country are 
presented in Table  27. In 2012, 28 countries reported 
a total of 15 153 592 HIV tests performed. The highest 
HIV testing rates were reported by Kazakhstan (125 per 
1 000 population), San Marino (120 per 1 000 popula-
tion), Moldova (96 per 1 000 population), Kyrgyzstan (86 
per 1 000 population), France (80 per 1 000 population) 
and Belarus (73 per 100 000 population) and the low-
est rates per 1 000 population were reported by Albania 
(1.1), Greece (1.9), Georgia (3.5), Serbia (8.8), the former 
Yugoslav Republic of Macedonia (8.8) and Poland (9.3). 
Despite the incomplete reporting for this variable, some 
trend patterns can be observed. Of the 23 countries with 
consistent data during 2006–2012, 11 reported con-
tinuously increasing numbers of HIV tests performed 
(Armenia, Azerbaijan, Belarus, Belgium, Bulgaria, 
Greece, Kazakhstan, Kyrgyzstan, Poland, Serbia and 
Tajikistan). Four countries reported increasing numbers 
up to 2011 (Estonia, Montenegro and Romania) or up to 
2010 (the Czech Republic). Of the 43 countries with more 
than one data point, an increase was evident in 33 of 
them. 
Data on the number of HIV tests can support the inter-
pretation of trends in newly diagnosed HIV infections. 
The presented data, however, are derived from different 
sources, ranging from annual reports from national HIV 
testing sites, to extrapolations from information system-
atically gathered in laboratory networks performing HIV 
tests and to estimates based on national surveys. In con-
trast to the East and the Centre, many countries in the 
West do not systematically collect data on the number 
of HIV tests and in some cases only estimates are avail-
able. When comparing the reported testing rates across 
countries, it is important to keep these differences in 
mind. Further, the data do not provide detailed informa-
tion on who is being tested or to what extent testing is 
targeted at high-risk populations. With respect to initia-
tives to increase the uptake of HIV testing in Europe, the 
lack of good quality HIV testing data is complicating the 
evaluation of such efforts.
2.6 Conclusions
HIV infection remains of major public health importance 
in Europe. In 2012, 131 202 new HIV infections were diag-
nosed in 52 of the 53 countries of the WHO European 
Region10. Of those, 55 494 were officially reported to 
ECDC/WHO Regional Office for Europe by 51 countries, 
while 75 708 infections were reported through the data-
base of the Russian Federal Statistics Agency. 
The data suggest continuing HIV transmission in many 
countries. Furthermore, they strengthen the evidence 
base that in Europe the number of people living with HIV 
is increasing and that HIV remains concentrated in key 
populations at higher risk, such as MSM, people from 
countries with generalised epidemics, and people who 
inject drugs and their sexual partners. The dominant 
transmission mode varies by country and geographical/
epidemiological area, illustrating the wide diversity in 
the epidemiology of HIV in Europe. Despite the relatively 
low absolute number of cases diagnosed as acquired 
through injecting drug use and through sex between 
10 No data available from Uzbekistan.
Figure S: Distribution of the three most common AIDS-indicative diseases per transmission mode, WHO European 
Region: West, 2012 (n=3 562 cases)
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men, PWID and MSM remain disproportionately affected 
by the HIV epidemic, given the relatively small sizes of 
the respective populations.
In the western part of the Region, the highest propor-
tion of HIV infections continues to be diagnosed in MSM. 
HIV responses in this part of Europe need to be based 
on evidence-informed prevention interventions target-
ing this key population. In addition, given the relatively 
high numbers of HIV infections in people originating 
from countries with generalised epidemics, countries 
should ensure equal access to prevention, testing, treat-
ment and care services for migrant populations. 
In the Centre, levels of HIV infection remain at a low 
level, although there is evidence of an increasing trend 
in new HIV infections mostly driven by sexual trans-
mission. The epidemic in this part of Europe is diverse 
but sexual transmission between men dominates over 
heterosexual transmission in an increasing majority of 
countries. 
In the East, the number and rate of newly diagnosed HIV 
infections is the highest in the Region and the number 
of cases has continued to increase. Heterosexual con-
tact, followed by injecting drug use, is the dominant 
reported mode of transmission. The amount of inde-
pendent versus PWID-related heterosexual transmission 
remains unknown as information on the probable source 
of infection is missing for the majority of heterosexually 
acquired cases. Information about probable country of 
infection is poorly reported too, leaving insufficient solid 
evidence regarding the extent to which people become 
infected in their home country or abroad, including 
during periods of labour migration to neighbouring coun-
tries. Overall, men remain disproportionally affected by 
the epidemic and in a few countries this is the case even 
among people infected through heterosexual transmis-
sion, suggesting that male labour migrants as well as 
possible misclassification of men infected through sex 
with other men may contribute to the increase in hetero-
sexually acquired cases in those countries. On average, 
however, women account for the majority of hetero-
sexual infections pointing towards potential ongoing 
transmission from male PWID and male labour migrants 
to their female partners. 
Curbing the HIV epidemic in the East and reaching the 
goal of universal access to prevention, treatment and 
care will not be achieved without implementing com-
prehensive prevention strategies for people who inject 
drugs, including harm reduction interventions. In 
couples where one of the partners is engaged in high-
risk behaviour, such as injecting drug use, prevention 
interventions should address the risk of heterosexual 
transmission.
It is a concern that 50% of newly diagnosed HIV infec-
tions with information on CD4 cell counts have a low 
count (<350/mm3) at the time of diagnosis, including 
30% with CD4<200/mm3; these so-called late presenters 
reflect the low access to, and uptake of, HIV testing and 
counselling. Delayed initiation of antiretroviral treatment 
decreases the clinical benefits, as well as the preven-
tive value of the treatment in further HIV transmission. 
Throughout Europe, HIV counselling and testing services 
need to be promoted and accessible and targeted at key 
populations at higher risk in order to ensure earlier diag-
nosis and timely initiation of HIV treatment and care. 
This will result in improved treatment outcomes and 
clinical benefits, as well as contribute to preventing or 
reducing further HIV transmission.
The number of diagnosed AIDS cases has continued 
to decline in Europe, except in the East. The high and 
increasing number of AIDS cases in the countries in the 
East is indicative of late HIV diagnosis, low treatment 
coverage and delayed initiation of life-saving HIV treat-
ment. The wide availability of treatment broadens the 
perspectives of HIV surveillance to include monitoring 
of access to care and treatment in the future. Improved 
access to and earlier initiation of treatment, particularly 
for key populations, is needed throughout Europe but 
particularly in the East. 
The number of countries conducting enhanced sur-
veillance for HIV in Europe has increased over recent 
years. Enhanced HIV surveillance in Europe is essential 
to provide the strategic information for monitoring the 
epidemic and guiding the public health response to HIV. 
Interventions to control the epidemic need to be based 
on evidence and adapted to national and local epidemi-
ology. In order to achieve this aim, countries in Europe 
need to ensure that surveillance data are of high quality 
and are encouraged to provide, in particular, complete 
case reports with information on transmission mode, 
CD4 cell count and probable country and source of 
infection. Also, achieving full coverage of reporting by 
all 53 countries in the WHO European Region is of vital 
importance.
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Table 1: HIV infections newly diagnosed and rates per 100 000 population, by country and year of diagnosis  
(2006–2012) and cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 323 3.9 336 4.1 347 4.2 301 3.6 317 3.8 309 3.7 306 3.6 7 598 Austria
W Belgium 1 018 9.7 1 070 10.1 1 091 10.2 1 130 10.5 1 198 11.1 1 182 10.7 1 227 11.1 25 724 Belgium
C Bulgaria 91 1.2 126 1.6 123 1.6 171 2.2 163 2.2 201 2.7 157 2.1 1 630 Bulgaria
C Croatia 57 1.3 49 1.1 71 1.6 54 1.2 70 1.6 77 1.8 74 1.7 1 025 Croatia
C Cyprus 35 4.6 46 5.9 37 4.7 38 4.8 41 5.0 54 6.4 58 6.7 794 Cyprus
C Czech Republic 91 0.9 121 1.2 148 1.4 156 1.5 180 1.7 153 1.5 212 2.0 1 887 Czech Republic
W Denmark 245 4.5 306 5.6 285 5.2 236 4.3 275 5.0 266 4.8 201 3.6 6 339 Denmark
E Estonia 668 49.7 633 47.2 545 40.6 411 30.7 376 28.1 366 27.3 315 23.5 8 377 Estonia
W Finland 191 3.6 187 3.5 147 2.8 172 3.2 184 3.4 172 3.2 156 2.9 3 061 Finland
W France 5 695 9.0 5 679 8.9 5 764 9.0 5 448 8.5 5 536 8.6 5 376 8.3 4 066 6.2 54 406 France
W Germany 2 666 3.2 2 800 3.4 2 850 3.5 2 885 3.5 2 919 3.6 2 888 3.5 2 953 3.6 45 987 Germany
W Greece 501 4.5 552 4.9 603 5.4 592 5.3 626 5.5 940 8.3 1 059 9.4 12 700 Greece
C Hungary 81 0.8 119 1.2 145 1.5 140 1.4 182 1.8 162 1.7 219 2.2 2 334 Hungary
W Iceland 11 3.7 13 4.2 10 3.2 15 4.7 24 7.6 23 7.2 19 5.9 299 Iceland
W Ireland 353 8.4 391 9.1 405 9.2 395 8.9 330 7.4 323 7.1 339 7.4 6 528 Ireland
W Italy 1 805 7.5 1 960 6.3 2 038 5.5 2 588 4.8 3 932 6.7 3 748 6.3 3 898 6.4 23 132 Italy
E Latvia 299 13.0 350 15.3 358 15.8 275 12.2 274 12.2 299 14.4 339 16.6 5 527 Latvia
E Lithuania 100 2.9 106 3.1 95 2.8 180 5.4 153 4.6 166 5.4 160 5.3 2 060 Lithuania
W Luxembourg 51 10.9 44 9.2 57 11.8 54 10.9 49 9.8 48 9.4 54 10.3 1 169 Luxembourg
W Malta 24 5.9 14 3.4 28 6.8 19 4.6 18 4.3 21 5.1 30 7.2 187 Malta
W Netherlands 1 117 6.8 1 219 7.5 1 288 7.9 1 173 7.1 1 157 7.0 1 083 6.5 976 5.8 20 821 Netherlands
W Norway 276 5.9 248 5.3 299 6.3 282 5.9 258 5.3 269 5.5 242 4.9 5 137 Norway
C Poland 810 2.1 806 2.1 837 2.2 952 2.5 954 2.5 1 115 2.9 1 085 2.8 16 562 Poland
W Portugal 1 917 18.2 1 861 17.8 1 900 18.2 1 708 16.4 1 511 14.5 1 218 11.8 721 7.0 31 147 Portugal
C Romania 187 0.9 173 0.8 259 1.2 253 1.2 274 1.3 427 2.0 489 2.3 5 570 Romania
C Slovakia 27 0.5 39 0.7 53 1.0 53 1.0 28 0.5 49 0.9 50 0.9 456 Slovakia
C Slovenia 33 1.6 37 1.8 48 2.4 48 2.4 35 1.7 55 2.7 45 2.2 588 Slovenia
W Spain 1 765 9.9 2 671 11.0 3 188 11.4 3 340 10.2 3 575 10.9 3 244 9.9 3 210 8.5 25 731 Spain
W Sweden 392 4.3 479 5.3 416 4.5 421 4.5 449 4.8 382 4.1 363 3.8 10 329 Sweden
W United Kingdom 7 489 12.5 7 381 12.2 7 268 12.0 6 672 10.8 6 358 10.3 6 211 10.0 6 358 10.3 128 652 United Kingdom
Total EU/EEA 28 318 6.4 29 816 6.5 30 703 6.6 30 162 6.2 31 446 6.4 30 827 6.2 29 381 5.8 455 757 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 32 1.0 44 1.4 54 1.7 62 1.9 44 1.4 75 2.6 81 2.9 577 Albania
W Andorra 1 1.3 4 4.9 3 3.6 2 2.4 4 4.8 2 2.4 2 2.4 61 Andorra
E Armenia 67 2.1 107 3.3 136 4.2 149 4.6 149 4.6 182 5.6 227 6.9 1 381 Armenia
E Azerbaijan 239 2.8 437 5.1 433 5.0 455 5.1 459 5.1 548 6.0 517 5.6 3 784 Azerbaijan
E Belarus 733 7.6 993 10.3 883 9.2 1 073 11.2 1 063 11.2 1 194 12.7 1 223 13.1 13 623 Belarus
C Bosnia and Herzegovina 11 0.3 4 0.1 9 0.2 6 0.2 7 0.2 27 0.7 25 0.7 223 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 8 0.4 5 0.2 4 0.2 6 0.3 5 0.2 1 0.0 14 0.7 55 former Yugoslav Republic of Macedonia, the
E Georgia 272 6.2 340 7.8 350 8.1 385 8.9 455 10.4 424 9.6 526 11.9 3 641 Georgia
W Israel 336 5.0 365 5.3 394 5.5 387 5.3 424 5.7 453 6.0 487 6.4 7 517 Israel
E Kazakhstan 1 745 11.5 1 979 12.9 2 335 15.0 2 081 13.2 1 988 12.5 2 006 12.5 2 014 12.4 19 774 Kazakhstan
E Kyrgyzstan 244 4.8 409 8.0 553 10.6 696 13.2 567 10.6 614 11.4 700 12.8 4 609 Kyrgyzstan
E Moldova 621 17.4 731 20.4 793 22.2 704 19.7 703 19.7 721 20.3 757 21.3 7 834 Moldova
W Monaco 1 3.0 1 3.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 34 Monaco
C Montenegro 5 0.8 11 1.8 11 1.8 14 2.2 15 2.4 9 1.5 13 2.1 142 Montenegro
E Russia*** - - - - 62 581 44.1 - - 62 581 Russia
W San Marino 2 6.7 0 0.0 4 12.5 1 3.2 6 19.2 8 25.1 5 15.5 81 San Marino
C Serbia**** 88 1.2 91 1.2 118 1.6 131 1.8 148 2.0 127 1.7 125 1.7 2 850 Serbia
W Switzerland 760 10.2 757 10.1 768 10.1 658 8.5 607 7.8 562 7.1 643 8.1 33 403 Switzerland
E Tajikistan 204 2.9 305 4.3 331 4.5 418 5.6 1 052 13.8 955 12.2 814 10.2 4 585 Tajikistan
C Turkey 276 0.4 348 0.5 395 0.6 470 0.7 523 0.7 653 0.9 1 068 1.4 5 450 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 Turkmenistan
E Ukraine 13 256 28.4 13 496 29.0 15 671 33.9 16 241 35.3 16 643 36.4 17 336 38.0 16 872 37.1 187 316 Ukraine
E Uzbekistan 2 205 8.4 3 169 11.9 3 061 11.3 4 055 14.8 3 795 13.7 - - 24 057 Uzbekistan
Total non-EU/EEA 21 106 9.1 23 596 10.2 26 306 11.3 27 994 11.9 91 238 24.1 25 897 12.3 26 113 12.3 383 580 Total non-EU/EEA
Geographic area Geographic area
West 26 939 7.7 28 338 7.8 29 153 7.8 28 479 7.2 29 757 7.4 28 728 7.1 27 315 6.6 450 043 West
Centre 1 832 1.0 2 019 1.1 2 312 1.2 2 554 1.4 2 669 1.4 3 185 1.7 3 715 1.9 40 143 Centre
East 20 653 15.1 23 055 16.8 25 544 18.6 27 123 19.6 90 258 32.1 24 811 22.3 24 464 22.0 349 151 East
Total WHO European Region 49 424 7.3 53 412 7.8 57 009 8.1 58 156 8.0 122 684 14.0 56 724 8.0 55 494 7.8 839 337 Total WHO European Region
* Country-specific comments are in Annex 5
** Cumulative total is the total number of cases reported by country since the start of reporting
*** 75 708 new HIV infections were reported through the database of the Federal Statistics Agency of the Russian Federation for 2012 (http://www.fedstat.ru/
indicator/data.do?id=41719&referrerType=0&referrerId=946905) and a cumulative 719 445 infections were reported as of 31 December 2012 (Rospotrebnadzor. 
National Report on the implementing the National Project “Health”. Moscow 2013)
**** Excluding 38 HIV cases from Kosovo (without prejudice to positions on status, and is in line with UNSCR 1244 and the IСJ Opinion on the Kosovo Declaration of 
Independence)
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Table 1: HIV infections newly diagnosed and rates per 100 000 population, by country and year of diagnosis  
(2006–2012) and cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 323 3.9 336 4.1 347 4.2 301 3.6 317 3.8 309 3.7 306 3.6 7 598 Austria
W Belgium 1 018 9.7 1 070 10.1 1 091 10.2 1 130 10.5 1 198 11.1 1 182 10.7 1 227 11.1 25 724 Belgium
C Bulgaria 91 1.2 126 1.6 123 1.6 171 2.2 163 2.2 201 2.7 157 2.1 1 630 Bulgaria
C Croatia 57 1.3 49 1.1 71 1.6 54 1.2 70 1.6 77 1.8 74 1.7 1 025 Croatia
C Cyprus 35 4.6 46 5.9 37 4.7 38 4.8 41 5.0 54 6.4 58 6.7 794 Cyprus
C Czech Republic 91 0.9 121 1.2 148 1.4 156 1.5 180 1.7 153 1.5 212 2.0 1 887 Czech Republic
W Denmark 245 4.5 306 5.6 285 5.2 236 4.3 275 5.0 266 4.8 201 3.6 6 339 Denmark
E Estonia 668 49.7 633 47.2 545 40.6 411 30.7 376 28.1 366 27.3 315 23.5 8 377 Estonia
W Finland 191 3.6 187 3.5 147 2.8 172 3.2 184 3.4 172 3.2 156 2.9 3 061 Finland
W France 5 695 9.0 5 679 8.9 5 764 9.0 5 448 8.5 5 536 8.6 5 376 8.3 4 066 6.2 54 406 France
W Germany 2 666 3.2 2 800 3.4 2 850 3.5 2 885 3.5 2 919 3.6 2 888 3.5 2 953 3.6 45 987 Germany
W Greece 501 4.5 552 4.9 603 5.4 592 5.3 626 5.5 940 8.3 1 059 9.4 12 700 Greece
C Hungary 81 0.8 119 1.2 145 1.5 140 1.4 182 1.8 162 1.7 219 2.2 2 334 Hungary
W Iceland 11 3.7 13 4.2 10 3.2 15 4.7 24 7.6 23 7.2 19 5.9 299 Iceland
W Ireland 353 8.4 391 9.1 405 9.2 395 8.9 330 7.4 323 7.1 339 7.4 6 528 Ireland
W Italy 1 805 7.5 1 960 6.3 2 038 5.5 2 588 4.8 3 932 6.7 3 748 6.3 3 898 6.4 23 132 Italy
E Latvia 299 13.0 350 15.3 358 15.8 275 12.2 274 12.2 299 14.4 339 16.6 5 527 Latvia
E Lithuania 100 2.9 106 3.1 95 2.8 180 5.4 153 4.6 166 5.4 160 5.3 2 060 Lithuania
W Luxembourg 51 10.9 44 9.2 57 11.8 54 10.9 49 9.8 48 9.4 54 10.3 1 169 Luxembourg
W Malta 24 5.9 14 3.4 28 6.8 19 4.6 18 4.3 21 5.1 30 7.2 187 Malta
W Netherlands 1 117 6.8 1 219 7.5 1 288 7.9 1 173 7.1 1 157 7.0 1 083 6.5 976 5.8 20 821 Netherlands
W Norway 276 5.9 248 5.3 299 6.3 282 5.9 258 5.3 269 5.5 242 4.9 5 137 Norway
C Poland 810 2.1 806 2.1 837 2.2 952 2.5 954 2.5 1 115 2.9 1 085 2.8 16 562 Poland
W Portugal 1 917 18.2 1 861 17.8 1 900 18.2 1 708 16.4 1 511 14.5 1 218 11.8 721 7.0 31 147 Portugal
C Romania 187 0.9 173 0.8 259 1.2 253 1.2 274 1.3 427 2.0 489 2.3 5 570 Romania
C Slovakia 27 0.5 39 0.7 53 1.0 53 1.0 28 0.5 49 0.9 50 0.9 456 Slovakia
C Slovenia 33 1.6 37 1.8 48 2.4 48 2.4 35 1.7 55 2.7 45 2.2 588 Slovenia
W Spain 1 765 9.9 2 671 11.0 3 188 11.4 3 340 10.2 3 575 10.9 3 244 9.9 3 210 8.5 25 731 Spain
W Sweden 392 4.3 479 5.3 416 4.5 421 4.5 449 4.8 382 4.1 363 3.8 10 329 Sweden
W United Kingdom 7 489 12.5 7 381 12.2 7 268 12.0 6 672 10.8 6 358 10.3 6 211 10.0 6 358 10.3 128 652 United Kingdom
Total EU/EEA 28 318 6.4 29 816 6.5 30 703 6.6 30 162 6.2 31 446 6.4 30 827 6.2 29 381 5.8 455 757 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 32 1.0 44 1.4 54 1.7 62 1.9 44 1.4 75 2.6 81 2.9 577 Albania
W Andorra 1 1.3 4 4.9 3 3.6 2 2.4 4 4.8 2 2.4 2 2.4 61 Andorra
E Armenia 67 2.1 107 3.3 136 4.2 149 4.6 149 4.6 182 5.6 227 6.9 1 381 Armenia
E Azerbaijan 239 2.8 437 5.1 433 5.0 455 5.1 459 5.1 548 6.0 517 5.6 3 784 Azerbaijan
E Belarus 733 7.6 993 10.3 883 9.2 1 073 11.2 1 063 11.2 1 194 12.7 1 223 13.1 13 623 Belarus
C Bosnia and Herzegovina 11 0.3 4 0.1 9 0.2 6 0.2 7 0.2 27 0.7 25 0.7 223 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 8 0.4 5 0.2 4 0.2 6 0.3 5 0.2 1 0.0 14 0.7 55 former Yugoslav Republic of Macedonia, the
E Georgia 272 6.2 340 7.8 350 8.1 385 8.9 455 10.4 424 9.6 526 11.9 3 641 Georgia
W Israel 336 5.0 365 5.3 394 5.5 387 5.3 424 5.7 453 6.0 487 6.4 7 517 Israel
E Kazakhstan 1 745 11.5 1 979 12.9 2 335 15.0 2 081 13.2 1 988 12.5 2 006 12.5 2 014 12.4 19 774 Kazakhstan
E Kyrgyzstan 244 4.8 409 8.0 553 10.6 696 13.2 567 10.6 614 11.4 700 12.8 4 609 Kyrgyzstan
E Moldova 621 17.4 731 20.4 793 22.2 704 19.7 703 19.7 721 20.3 757 21.3 7 834 Moldova
W Monaco 1 3.0 1 3.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 34 Monaco
C Montenegro 5 0.8 11 1.8 11 1.8 14 2.2 15 2.4 9 1.5 13 2.1 142 Montenegro
E Russia*** - - - - 62 581 44.1 - - 62 581 Russia
W San Marino 2 6.7 0 0.0 4 12.5 1 3.2 6 19.2 8 25.1 5 15.5 81 San Marino
C Serbia**** 88 1.2 91 1.2 118 1.6 131 1.8 148 2.0 127 1.7 125 1.7 2 850 Serbia
W Switzerland 760 10.2 757 10.1 768 10.1 658 8.5 607 7.8 562 7.1 643 8.1 33 403 Switzerland
E Tajikistan 204 2.9 305 4.3 331 4.5 418 5.6 1 052 13.8 955 12.2 814 10.2 4 585 Tajikistan
C Turkey 276 0.4 348 0.5 395 0.6 470 0.7 523 0.7 653 0.9 1 068 1.4 5 450 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 Turkmenistan
E Ukraine 13 256 28.4 13 496 29.0 15 671 33.9 16 241 35.3 16 643 36.4 17 336 38.0 16 872 37.1 187 316 Ukraine
E Uzbekistan 2 205 8.4 3 169 11.9 3 061 11.3 4 055 14.8 3 795 13.7 - - 24 057 Uzbekistan
Total non-EU/EEA 21 106 9.1 23 596 10.2 26 306 11.3 27 994 11.9 91 238 24.1 25 897 12.3 26 113 12.3 383 580 Total non-EU/EEA
Geographic area Geographic area
West 26 939 7.7 28 338 7.8 29 153 7.8 28 479 7.2 29 757 7.4 28 728 7.1 27 315 6.6 450 043 West
Centre 1 832 1.0 2 019 1.1 2 312 1.2 2 554 1.4 2 669 1.4 3 185 1.7 3 715 1.9 40 143 Centre
East 20 653 15.1 23 055 16.8 25 544 18.6 27 123 19.6 90 258 32.1 24 811 22.3 24 464 22.0 349 151 East
Total WHO European Region 49 424 7.3 53 412 7.8 57 009 8.1 58 156 8.0 122 684 14.0 56 724 8.0 55 494 7.8 839 337 Total WHO European Region
* Country-specific comments are in Annex 5
** Cumulative total is the total number of cases reported by country since the start of reporting
*** 75 708 new HIV infections were reported through the database of the Federal Statistics Agency of the Russian Federation for 2012 (http://www.fedstat.ru/
indicator/data.do?id=41719&referrerType=0&referrerId=946905) and a cumulative 719 445 infections were reported as of 31 December 2012 (Rospotrebnadzor. 
National Report on the implementing the National Project “Health”. Moscow 2013)
**** Excluding 38 HIV cases from Kosovo (without prejudice to positions on status, and is in line with UNSCR 1244 and the IСJ Opinion on the Kosovo Declaration of 
Independence)
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Table 1a: HIV infections newly diagnosed and rates per 100 000 population, by country and year of statistics  
(2006–2012) and cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 323 3.9 336 4.1 347 4.2 301 3.6 317 3.8 309 3.7 306 3.6 7 598 Austria
W Belgium 1 018 9.7 1 070 10.1 1 091 10.2 1 130 10.5 1 198 11.1 1 182 10.7 1 227 11.1 25 724 Belgium
C Bulgaria 91 1.2 126 1.6 123 1.6 171 2.2 163 2.2 201 2.7 157 2.1 1 630 Bulgaria
C Croatia 57 1.3 49 1.1 71 1.6 54 1.2 70 1.6 77 1.8 74 1.7 1 025 Croatia
C Cyprus 35 4.6 46 5.9 37 4.7 38 4.8 41 5.0 54 6.4 58 6.7 794 Cyprus
C Czech Republic 91 0.9 121 1.2 148 1.4 156 1.5 180 1.7 153 1.5 212 2.0 1 887 Czech Republic
W Denmark 245 4.5 306 5.6 285 5.2 236 4.3 275 5.0 266 4.8 201 3.6 6 339 Denmark
E Estonia 668 49.7 633 47.2 545 40.6 411 30.7 372 27.8 370 27.6 315 23.5 8 377 Estonia
W Finland 191 3.6 187 3.5 147 2.8 172 3.2 184 3.4 172 3.2 156 2.9 3 061 Finland
W France 5 695 9.0 5 679 8.9 5 764 9.0 5 448 8.5 5 536 8.6 5 376 8.3 4 066 6.2 54 406 France
W Germany 2 666 3.2 2 800 3.4 2 850 3.5 2 885 3.5 2 918 3.6 2 889 3.5 2 954 3.6 45 987 Germany
W Greece 573 5.2 520 4.7 655 5.8 607 5.4 610 5.4 969 8.6 1 187 10.5 12 700 Greece
C Hungary 81 0.8 119 1.2 145 1.5 141 1.4 182 1.8 162 1.7 219 2.2 2 334 Hungary
W Iceland 11 3.7 13 4.2 10 3.2 15 4.7 24 7.6 23 7.2 19 5.9 299 Iceland
W Ireland 353 8.4 391 9.1 405 9.2 395 8.9 330 7.4 321 7.0 341 7.4 6 528 Ireland
W Italy 1 805 7.5 1 960 6.3 2 038 5.5 2 588 4.8 3 932 6.7 3 748 6.3 3 898 6.4 23 132 Italy
E Latvia 299 13.0 350 15.3 358 15.8 275 12.2 274 12.2 299 14.4 339 16.6 5 527 Latvia
E Lithuania 100 2.9 106 3.1 95 2.8 180 5.4 153 4.6 166 5.4 160 5.3 2 060 Lithuania
W Luxembourg 56 11.9 47 9.9 68 14.1 64 13.0 63 12.5 73 14.3 83 15.8 1 169 Luxembourg
W Malta 22 5.4 16 3.9 28 6.8 18 4.4 19 4.6 21 5.1 30 7.2 187 Malta
W Netherlands 1 117 6.8 1 219 7.5 1 288 7.9 1 173 7.1 1 157 7.0 1 083 6.5 976 5.8 20 821 Netherlands
W Norway 276 5.9 248 5.3 299 6.3 282 5.9 258 5.3 269 5.5 242 4.9 5 137 Norway
C Poland 741 1.9 708 1.9 788 2.1 701 1.8 1 246 3.3 1 332 3.5 1 019 2.6 16 314 Poland
W Portugal 1 917 18.2 1 861 17.8 1 900 18.2 1 708 16.4 1 511 14.5 1 218 11.8 721 7.0 31 147 Portugal
C Romania 187 0.9 173 0.8 259 1.2 253 1.2 274 1.3 427 2.0 489 2.3 5 570 Romania
C Slovakia 27 0.5 39 0.7 53 1.0 53 1.0 28 0.5 49 0.9 50 0.9 456 Slovakia
C Slovenia 33 1.6 37 1.8 48 2.4 48 2.4 35 1.7 55 2.7 45 2.2 588 Slovenia
W Spain 1 765 9.9 2 671 11.0 3 188 11.4 3 340 10.2 3 575 10.9 3 244 9.9 3 210 8.5 25 731 Spain
W Sweden 385 4.3 528 5.8 441 4.8 485 5.2 493 5.3 461 4.9 441 4.7 10 329 Sweden
W United Kingdom 7 489 12.5 7 381 12.2 7 268 12.0 6 672 10.8 6 358 10.3 6 211 10.0 6 358 10.3 128 652 United Kingdom
Total EU/EEA 28 317 6.4 29 740 6.5 30 742 6.6 30 000 6.1 31 776 6.4 31 180 6.3 29 553 5.9 455 509 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 32 1.0 44 1.4 49 1.5 62 1.9 48 1.5 72 2.5 90 3.2 577 Albania
W Andorra 1 1.3 3 3.7 4 4.8 2 2.4 6 7.1 2 2.4 2 2.4 61 Andorra
E Armenia 66 2.1 109 3.4 136 4.2 149 4.6 148 4.6 182 5.6 228 7.0 1 381 Armenia
E Azerbaijan 239 2.8 437 5.1 433 5.0 455 5.1 459 5.1 548 6.0 517 5.6 3 784 Azerbaijan
E Belarus 733 7.6 993 10.3 883 9.2 1 073 11.2 1 063 11.2 1 196 12.8 1 223 13.1 13 623 Belarus
C Bosnia and Herzegovina 17 0.4 4 0.1 9 0.2 7 0.2 7 0.2 28 0.7 25 0.7 223 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 8 0.4 5 0.2 4 0.2 6 0.3 5 0.2 1 0.0 14 0.7 55 former Yugoslav Republic of Macedonia, the
E Georgia 276 6.3 344 7.9 351 8.1 385 8.9 455 10.4 424 9.6 526 11.9 3 641 Georgia
W Israel 336 5.0 365 5.3 394 5.5 387 5.3 424 5.7 453 6.0 487 6.4 7 517 Israel
E Kazakhstan 1 745 11.5 1 979 12.9 2 335 15.0 2 081 13.2 1 988 12.5 2 006 12.5 2 014 12.4 19 774 Kazakhstan
E Kyrgyzstan 244 4.8 409 8.0 551 10.6 687 13.0 570 10.7 598 11.1 724 13.2 4 609 Kyrgyzstan
E Moldova 621 17.4 731 20.4 793 22.2 704 19.7 703 19.7 721 20.3 757 21.3 7 834 Moldova
W Monaco 1 3.0 1 3.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 34 Monaco
C Montenegro 5 0.8 11 1.8 11 1.8 14 2.2 15 2.4 9 1.5 13 2.1 142 Montenegro
E Russia - - - - 62 581 44.1 - - 62 581 Russia
W San Marino 2 6.7 0 0.0 4 12.5 1 3.2 6 19.2 8 25.1 5 15.5 81 San Marino
C Serbia*** 88 1.2 91 1.2 118 1.6 131 1.8 148 2.0 127 1.7 125 1.7 2 850 Serbia
W Switzerland 760 10.2 757 10.1 768 10.1 658 8.5 607 7.8 562 7.1 643 8.1 33 403 Switzerland
E Tajikistan 204 2.9 305 4.3 331 4.5 418 5.6 1 004 13.2 989 12.7 828 10.3 4 585 Tajikistan
C Turkey 260 0.4 399 0.6 393 0.6 470 0.7 489 0.7 699 0.9 1 068 1.4 5 450 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 Turkmenistan
E Ukraine 13 256 28.4 13 496 29.0 15 671 33.9 16 241 35.3 16 643 36.4 17 336 38.0 16 872 37.1 187 316 Ukraine
E Uzbekistan 2 205 8.4 3 169 11.9 3 061 11.3 4 041 14.8 3 809 13.7 - - 24 057 Uzbekistan
Total non-EU/EEA 21 099 9.1 23 652 10.2 26 299 11.3 27 972 11.9 91 178 24.1 25 961 12.3 26 161 12.3 383 580 Total non-EU/EEA
Geographic area Geographic area
West 27 007 7.8 28 359 7.8 29 242 7.8 28 567 7.2 29 801 7.4 28 860 7.1 27 553 6.7 450 043 West
Centre 1 753 0.9 1 972 1.1 2 256 1.2 2 305 1.2 2 931 1.5 3 446 1.8 3 658 1.9 39 895 Centre
East 20 656 15.1 23 061 16.8 25 543 18.6 27 100 19.6 90 222 32.1 24 835 22.4 24 503 22.0 349 151 East
Total WHO European Region 49 416 7.3 53 392 7.8 57 041 8.2 57 972 8.0 122 954 14.1 57 141 8.1 55 714 7.8 839 089 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
*** Excluding 38 HIV cases from Kosovo (without prejudice to positions on status, and is in line with UNSCR 1244 and the IСJ Opinion on the Kosovo Declaration of 
Independence)
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Table 1a: HIV infections newly diagnosed and rates per 100 000 population, by country and year of statistics  
(2006–2012) and cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 323 3.9 336 4.1 347 4.2 301 3.6 317 3.8 309 3.7 306 3.6 7 598 Austria
W Belgium 1 018 9.7 1 070 10.1 1 091 10.2 1 130 10.5 1 198 11.1 1 182 10.7 1 227 11.1 25 724 Belgium
C Bulgaria 91 1.2 126 1.6 123 1.6 171 2.2 163 2.2 201 2.7 157 2.1 1 630 Bulgaria
C Croatia 57 1.3 49 1.1 71 1.6 54 1.2 70 1.6 77 1.8 74 1.7 1 025 Croatia
C Cyprus 35 4.6 46 5.9 37 4.7 38 4.8 41 5.0 54 6.4 58 6.7 794 Cyprus
C Czech Republic 91 0.9 121 1.2 148 1.4 156 1.5 180 1.7 153 1.5 212 2.0 1 887 Czech Republic
W Denmark 245 4.5 306 5.6 285 5.2 236 4.3 275 5.0 266 4.8 201 3.6 6 339 Denmark
E Estonia 668 49.7 633 47.2 545 40.6 411 30.7 372 27.8 370 27.6 315 23.5 8 377 Estonia
W Finland 191 3.6 187 3.5 147 2.8 172 3.2 184 3.4 172 3.2 156 2.9 3 061 Finland
W France 5 695 9.0 5 679 8.9 5 764 9.0 5 448 8.5 5 536 8.6 5 376 8.3 4 066 6.2 54 406 France
W Germany 2 666 3.2 2 800 3.4 2 850 3.5 2 885 3.5 2 918 3.6 2 889 3.5 2 954 3.6 45 987 Germany
W Greece 573 5.2 520 4.7 655 5.8 607 5.4 610 5.4 969 8.6 1 187 10.5 12 700 Greece
C Hungary 81 0.8 119 1.2 145 1.5 141 1.4 182 1.8 162 1.7 219 2.2 2 334 Hungary
W Iceland 11 3.7 13 4.2 10 3.2 15 4.7 24 7.6 23 7.2 19 5.9 299 Iceland
W Ireland 353 8.4 391 9.1 405 9.2 395 8.9 330 7.4 321 7.0 341 7.4 6 528 Ireland
W Italy 1 805 7.5 1 960 6.3 2 038 5.5 2 588 4.8 3 932 6.7 3 748 6.3 3 898 6.4 23 132 Italy
E Latvia 299 13.0 350 15.3 358 15.8 275 12.2 274 12.2 299 14.4 339 16.6 5 527 Latvia
E Lithuania 100 2.9 106 3.1 95 2.8 180 5.4 153 4.6 166 5.4 160 5.3 2 060 Lithuania
W Luxembourg 56 11.9 47 9.9 68 14.1 64 13.0 63 12.5 73 14.3 83 15.8 1 169 Luxembourg
W Malta 22 5.4 16 3.9 28 6.8 18 4.4 19 4.6 21 5.1 30 7.2 187 Malta
W Netherlands 1 117 6.8 1 219 7.5 1 288 7.9 1 173 7.1 1 157 7.0 1 083 6.5 976 5.8 20 821 Netherlands
W Norway 276 5.9 248 5.3 299 6.3 282 5.9 258 5.3 269 5.5 242 4.9 5 137 Norway
C Poland 741 1.9 708 1.9 788 2.1 701 1.8 1 246 3.3 1 332 3.5 1 019 2.6 16 314 Poland
W Portugal 1 917 18.2 1 861 17.8 1 900 18.2 1 708 16.4 1 511 14.5 1 218 11.8 721 7.0 31 147 Portugal
C Romania 187 0.9 173 0.8 259 1.2 253 1.2 274 1.3 427 2.0 489 2.3 5 570 Romania
C Slovakia 27 0.5 39 0.7 53 1.0 53 1.0 28 0.5 49 0.9 50 0.9 456 Slovakia
C Slovenia 33 1.6 37 1.8 48 2.4 48 2.4 35 1.7 55 2.7 45 2.2 588 Slovenia
W Spain 1 765 9.9 2 671 11.0 3 188 11.4 3 340 10.2 3 575 10.9 3 244 9.9 3 210 8.5 25 731 Spain
W Sweden 385 4.3 528 5.8 441 4.8 485 5.2 493 5.3 461 4.9 441 4.7 10 329 Sweden
W United Kingdom 7 489 12.5 7 381 12.2 7 268 12.0 6 672 10.8 6 358 10.3 6 211 10.0 6 358 10.3 128 652 United Kingdom
Total EU/EEA 28 317 6.4 29 740 6.5 30 742 6.6 30 000 6.1 31 776 6.4 31 180 6.3 29 553 5.9 455 509 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 32 1.0 44 1.4 49 1.5 62 1.9 48 1.5 72 2.5 90 3.2 577 Albania
W Andorra 1 1.3 3 3.7 4 4.8 2 2.4 6 7.1 2 2.4 2 2.4 61 Andorra
E Armenia 66 2.1 109 3.4 136 4.2 149 4.6 148 4.6 182 5.6 228 7.0 1 381 Armenia
E Azerbaijan 239 2.8 437 5.1 433 5.0 455 5.1 459 5.1 548 6.0 517 5.6 3 784 Azerbaijan
E Belarus 733 7.6 993 10.3 883 9.2 1 073 11.2 1 063 11.2 1 196 12.8 1 223 13.1 13 623 Belarus
C Bosnia and Herzegovina 17 0.4 4 0.1 9 0.2 7 0.2 7 0.2 28 0.7 25 0.7 223 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 8 0.4 5 0.2 4 0.2 6 0.3 5 0.2 1 0.0 14 0.7 55 former Yugoslav Republic of Macedonia, the
E Georgia 276 6.3 344 7.9 351 8.1 385 8.9 455 10.4 424 9.6 526 11.9 3 641 Georgia
W Israel 336 5.0 365 5.3 394 5.5 387 5.3 424 5.7 453 6.0 487 6.4 7 517 Israel
E Kazakhstan 1 745 11.5 1 979 12.9 2 335 15.0 2 081 13.2 1 988 12.5 2 006 12.5 2 014 12.4 19 774 Kazakhstan
E Kyrgyzstan 244 4.8 409 8.0 551 10.6 687 13.0 570 10.7 598 11.1 724 13.2 4 609 Kyrgyzstan
E Moldova 621 17.4 731 20.4 793 22.2 704 19.7 703 19.7 721 20.3 757 21.3 7 834 Moldova
W Monaco 1 3.0 1 3.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 34 Monaco
C Montenegro 5 0.8 11 1.8 11 1.8 14 2.2 15 2.4 9 1.5 13 2.1 142 Montenegro
E Russia - - - - 62 581 44.1 - - 62 581 Russia
W San Marino 2 6.7 0 0.0 4 12.5 1 3.2 6 19.2 8 25.1 5 15.5 81 San Marino
C Serbia*** 88 1.2 91 1.2 118 1.6 131 1.8 148 2.0 127 1.7 125 1.7 2 850 Serbia
W Switzerland 760 10.2 757 10.1 768 10.1 658 8.5 607 7.8 562 7.1 643 8.1 33 403 Switzerland
E Tajikistan 204 2.9 305 4.3 331 4.5 418 5.6 1 004 13.2 989 12.7 828 10.3 4 585 Tajikistan
C Turkey 260 0.4 399 0.6 393 0.6 470 0.7 489 0.7 699 0.9 1 068 1.4 5 450 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 Turkmenistan
E Ukraine 13 256 28.4 13 496 29.0 15 671 33.9 16 241 35.3 16 643 36.4 17 336 38.0 16 872 37.1 187 316 Ukraine
E Uzbekistan 2 205 8.4 3 169 11.9 3 061 11.3 4 041 14.8 3 809 13.7 - - 24 057 Uzbekistan
Total non-EU/EEA 21 099 9.1 23 652 10.2 26 299 11.3 27 972 11.9 91 178 24.1 25 961 12.3 26 161 12.3 383 580 Total non-EU/EEA
Geographic area Geographic area
West 27 007 7.8 28 359 7.8 29 242 7.8 28 567 7.2 29 801 7.4 28 860 7.1 27 553 6.7 450 043 West
Centre 1 753 0.9 1 972 1.1 2 256 1.2 2 305 1.2 2 931 1.5 3 446 1.8 3 658 1.9 39 895 Centre
East 20 656 15.1 23 061 16.8 25 543 18.6 27 100 19.6 90 222 32.1 24 835 22.4 24 503 22.0 349 151 East
Total WHO European Region 49 416 7.3 53 392 7.8 57 041 8.2 57 972 8.0 122 954 14.1 57 141 8.1 55 714 7.8 839 089 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
*** Excluding 38 HIV cases from Kosovo (without prejudice to positions on status, and is in line with UNSCR 1244 and the IСJ Opinion on the Kosovo Declaration of 
Independence)
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Table 2: HIV diagnoses in males and rates per 100 000 population, by country and year of diagnosis (2006–2012) and 
cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 243 6.1 259 6.4 266 6.6 235 5.8 257 6.3 242 5.9 245 5.9 5 674 Austria
W Belgium 674 13.1 660 12.7 744 14.2 746 14.2 793 14.9 783 14.5 833 15.3 16 038 Belgium
C Bulgaria 71 1.9 105 2.8 102 2.8 133 3.6 132 3.6 163 4.5 123 3.4 1 233 Bulgaria
C Croatia 48 2.3 44 2.1 68 3.2 48 2.3 67 3.2 66 3.1 71 3.4 875 Croatia
C Cyprus 21 5.6 31 8.1 24 6.2 26 6.6 34 8.5 39 9.5 49 11.7 551 Cyprus
C Czech Republic 72 1.4 97 1.9 121 2.4 130 2.5 159 3.1 140 2.7 185 3.6 1 554 Czech Republic
W Denmark 174 6.5 224 8.3 204 7.5 179 6.6 201 7.3 192 7.0 146 5.3 4 598 Denmark
E Estonia 429 69.3 374 60.5 315 51.0 243 39.4 230 37.3 226 36.6 209 33.8 5 664 Estonia
W Finland 134 5.2 136 5.3 105 4.0 106 4.1 130 5.0 112 4.2 111 4.2 2 234 Finland
W France 3 571 11.7 3 663 11.9 3 744 12.1 3 588 11.5 3 650 11.7 3 566 11.3 2 754 8.7 34 565 France
W Germany 2 138 5.3 2 324 5.8 2 357 5.9 2 404 6.0 2 472 6.2 2 427 6.1 2 502 6.2 36 420 Germany
W Greece 398 7.2 463 8.4 502 9.0 501 9.0 548 9.8 797 14.2 897 16.1 10 370 Greece
C Hungary 49 1.0 88 1.9 110 2.3 107 2.3 142 3.0 122 2.6 186 4.0 1 793 Hungary
W Iceland 8 5.3 6 3.8 7 4.4 6 3.7 17 10.6 12 7.5 13 8.1 211 Iceland
W Ireland 221 10.5 243 11.3 258 11.7 258 11.6 241 10.9 235 10.4 244 10.7 3 408 Ireland
W Italy 1 327 11.3 1 396 9.3 1 514 8.4 1 906 7.3 2 969 10.4 2 830 9.8 3 072 10.4 17 242 Italy
E Latvia 185 17.5 224 21.3 231 22.1 170 16.3 170 16.4 196 20.7 218 23.4 3 811 Latvia
E Lithuania 78 4.9 74 4.7 65 4.1 131 8.4 125 8.1 134 9.5 114 8.2 1 687 Lithuania
W Luxembourg 36 15.5 33 14.0 47 19.6 38 15.5 34 13.6 34 13.4 41 15.7 871 Luxembourg
W Malta 16 8.0 8 4.0 17 8.3 10 4.9 16 7.8 17 8.2 23 11.1 130 Malta
W Netherlands 898 11.1 984 12.2 1 092 13.5 976 12.0 975 11.9 923 11.2 828 10.0 16 553 Netherlands
W Norway 179 7.8 166 7.1 182 7.7 183 7.6 173 7.1 190 7.7 166 6.6 3 460 Norway
C Poland 609 3.3 573 3.1 612 3.3 728 4.0 711 3.9 916 4.9 899 4.8 12 546 Poland
W Portugal 1 298 25.4 1 267 25.0 1 313 25.8 1 169 23.0 1 045 20.6 857 17.2 513 10.4 22 106 Portugal
C Romania 96 0.9 88 0.8 148 1.4 144 1.4 179 1.7 304 2.9 359 3.5 3 077 Romania
C Slovakia 20 0.8 32 1.2 48 1.8 48 1.8 25 0.9 46 1.8 44 1.7 390 Slovakia
C Slovenia 30 3.1 35 3.5 45 4.6 40 4.0 31 3.1 48 4.7 42 4.1 512 Slovenia
W Spain 1 370 15.5 2 113 17.7 2 506 18.2 2 652 16.4 2 925 18.1 2 687 16.7 2 713 14.6 20 557 Spain
W Sweden 241 5.4 297 6.6 261 5.7 274 6.0 270 5.8 240 5.1 217 4.6 7 054 Sweden
W United Kingdom 4 508 15.3 4 709 15.9 4 616 15.4 4 472 14.8 4 317 14.2 4 425 14.4 4 553 14.9 88 997 United Kingdom
Total EU/EEA 19 142 8.9 20 716 9.3 21 624 9.5 21 651 9.1 23 038 9.5 22 969 9.5 22 370 9.1 324 181 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 21 1.3 31 2.0 34 2.1 44 2.8 30 1.9 54 3.8 58 4.1 405 Albania
W Andorra 0 0.0 4 9.4 3 6.9 2 4.5 4 9.1 2 4.5 2 4.5 49 Andorra
E Armenia 42 2.7 75 4.8 104 6.7 96 6.1 98 6.2 115 7.3 157 9.9 971 Armenia
E Azerbaijan 213 5.1 380 9.0 350 8.2 377 8.7 365 8.2 410 9.1 357 7.8 3 025 Azerbaijan
E Belarus 391 8.6 541 12.0 455 10.1 563 12.5 567 12.8 620 14.1 659 15.1 8 144 Belarus
C Bosnia and Herzegovina 9 0.5 4 0.2 7 0.4 6 0.3 7 0.4 23 1.2 23 1.2 180 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 2 0.2 2 0.2 3 0.3 6 0.6 5 0.5 0 0.0 10 1.0 35 former Yugoslav Republic of Macedonia, the
E Georgia 197 9.5 242 11.7 249 12.0 276 13.3 322 15.3 300 14.2 381 17.9 2 671 Georgia
W Israel 218 6.5 247 7.2 251 7.2 267 7.4 289 7.9 299 8.0 354 9.4 4 860 Israel
E Kazakhstan 1 288 17.6 1 388 18.7 1 653 22.0 1 394 18.4 1 254 16.3 1 212 15.6 1 170 14.9 12 601 Kazakhstan
E Kyrgyzstan 181 7.2 287 11.3 309 12.0 514 19.8 399 15.2 422 15.8 406 15.0 3 208 Kyrgyzstan
E Moldova 369 21.5 422 24.5 438 25.5 400 23.3 341 19.9 377 22.0 375 21.9 4 599 Moldova
W Monaco 1 6.2 1 6.2 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 21 Monaco
C Montenegro 5 1.6 10 3.3 8 2.6 12 3.9 15 4.9 8 2.6 13 4.2 119 Montenegro
E Russia - - - - 36 172 55.1 - - 36 172 Russia
W San Marino 2 13.6 0 0.0 2 12.2 1 6.5 6 39.1 6 38.4 2 12.7 63 San Marino
C Serbia 73 2.0 75 2.1 98 2.7 122 3.4 132 3.7 110 3.1 115 3.3 2 210 Serbia
W Switzerland 498 13.6 524 14.2 555 14.9 473 12.5 445 11.6 422 10.9 477 12.2 20 984 Switzerland
E Tajikistan 155 4.4 241 6.7 184 5.0 327 8.7 850 22.2 672 17.1 535 13.3 3 393 Tajikistan
C Turkey 193 0.5 248 0.7 273 0.8 344 1.0 384 1.1 485 1.3 819 2.2 3 840 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 Turkmenistan
E Ukraine 7 890 36.6 8 201 38.3 8 644 40.6 9 168 43.3 9 524 45.1 9 558 45.4 9 484 45.2 112 645 Ukraine
E Uzbekistan 1 683 12.8 2 087 15.7 1 830 13.6 2 248 16.5 2 062 14.9 - - 16 262 Uzbekistan
Total non-EU/EEA 13 431 7.5 15 010 8.4 15 450 8.6 16 640 9.2 53 271 29.4 15 095 8.3 15 397 8.4 236 458 Total non-EU/EEA
Geographic area Geographic area
West 18 153 10.6 19 727 11.1 20 546 11.2 20 446 10.5 21 777 11.0 21 298 10.7 20 706 10.2 316 465 West
Centre 1 319 1.4 1 463 1.6 1 701 1.8 1 938 2.1 2 053 2.2 2 524 2.7 2 996 3.2 29 320 Centre
East 13 101 10.0 14 536 11.1 14 827 11.3 15 907 12.1 52 479 39.7 14 242 10.7 14 065 10.6 214 854 East
Total WHO European Region 32 573 8.2 35 726 8.9 37 074 9.1 38 291 9.1 76 309 18.0 38 064 9.0 37 767 8.8 560 639 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 2: HIV diagnoses in males and rates per 100 000 population, by country and year of diagnosis (2006–2012) and 
cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 243 6.1 259 6.4 266 6.6 235 5.8 257 6.3 242 5.9 245 5.9 5 674 Austria
W Belgium 674 13.1 660 12.7 744 14.2 746 14.2 793 14.9 783 14.5 833 15.3 16 038 Belgium
C Bulgaria 71 1.9 105 2.8 102 2.8 133 3.6 132 3.6 163 4.5 123 3.4 1 233 Bulgaria
C Croatia 48 2.3 44 2.1 68 3.2 48 2.3 67 3.2 66 3.1 71 3.4 875 Croatia
C Cyprus 21 5.6 31 8.1 24 6.2 26 6.6 34 8.5 39 9.5 49 11.7 551 Cyprus
C Czech Republic 72 1.4 97 1.9 121 2.4 130 2.5 159 3.1 140 2.7 185 3.6 1 554 Czech Republic
W Denmark 174 6.5 224 8.3 204 7.5 179 6.6 201 7.3 192 7.0 146 5.3 4 598 Denmark
E Estonia 429 69.3 374 60.5 315 51.0 243 39.4 230 37.3 226 36.6 209 33.8 5 664 Estonia
W Finland 134 5.2 136 5.3 105 4.0 106 4.1 130 5.0 112 4.2 111 4.2 2 234 Finland
W France 3 571 11.7 3 663 11.9 3 744 12.1 3 588 11.5 3 650 11.7 3 566 11.3 2 754 8.7 34 565 France
W Germany 2 138 5.3 2 324 5.8 2 357 5.9 2 404 6.0 2 472 6.2 2 427 6.1 2 502 6.2 36 420 Germany
W Greece 398 7.2 463 8.4 502 9.0 501 9.0 548 9.8 797 14.2 897 16.1 10 370 Greece
C Hungary 49 1.0 88 1.9 110 2.3 107 2.3 142 3.0 122 2.6 186 4.0 1 793 Hungary
W Iceland 8 5.3 6 3.8 7 4.4 6 3.7 17 10.6 12 7.5 13 8.1 211 Iceland
W Ireland 221 10.5 243 11.3 258 11.7 258 11.6 241 10.9 235 10.4 244 10.7 3 408 Ireland
W Italy 1 327 11.3 1 396 9.3 1 514 8.4 1 906 7.3 2 969 10.4 2 830 9.8 3 072 10.4 17 242 Italy
E Latvia 185 17.5 224 21.3 231 22.1 170 16.3 170 16.4 196 20.7 218 23.4 3 811 Latvia
E Lithuania 78 4.9 74 4.7 65 4.1 131 8.4 125 8.1 134 9.5 114 8.2 1 687 Lithuania
W Luxembourg 36 15.5 33 14.0 47 19.6 38 15.5 34 13.6 34 13.4 41 15.7 871 Luxembourg
W Malta 16 8.0 8 4.0 17 8.3 10 4.9 16 7.8 17 8.2 23 11.1 130 Malta
W Netherlands 898 11.1 984 12.2 1 092 13.5 976 12.0 975 11.9 923 11.2 828 10.0 16 553 Netherlands
W Norway 179 7.8 166 7.1 182 7.7 183 7.6 173 7.1 190 7.7 166 6.6 3 460 Norway
C Poland 609 3.3 573 3.1 612 3.3 728 4.0 711 3.9 916 4.9 899 4.8 12 546 Poland
W Portugal 1 298 25.4 1 267 25.0 1 313 25.8 1 169 23.0 1 045 20.6 857 17.2 513 10.4 22 106 Portugal
C Romania 96 0.9 88 0.8 148 1.4 144 1.4 179 1.7 304 2.9 359 3.5 3 077 Romania
C Slovakia 20 0.8 32 1.2 48 1.8 48 1.8 25 0.9 46 1.8 44 1.7 390 Slovakia
C Slovenia 30 3.1 35 3.5 45 4.6 40 4.0 31 3.1 48 4.7 42 4.1 512 Slovenia
W Spain 1 370 15.5 2 113 17.7 2 506 18.2 2 652 16.4 2 925 18.1 2 687 16.7 2 713 14.6 20 557 Spain
W Sweden 241 5.4 297 6.6 261 5.7 274 6.0 270 5.8 240 5.1 217 4.6 7 054 Sweden
W United Kingdom 4 508 15.3 4 709 15.9 4 616 15.4 4 472 14.8 4 317 14.2 4 425 14.4 4 553 14.9 88 997 United Kingdom
Total EU/EEA 19 142 8.9 20 716 9.3 21 624 9.5 21 651 9.1 23 038 9.5 22 969 9.5 22 370 9.1 324 181 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 21 1.3 31 2.0 34 2.1 44 2.8 30 1.9 54 3.8 58 4.1 405 Albania
W Andorra 0 0.0 4 9.4 3 6.9 2 4.5 4 9.1 2 4.5 2 4.5 49 Andorra
E Armenia 42 2.7 75 4.8 104 6.7 96 6.1 98 6.2 115 7.3 157 9.9 971 Armenia
E Azerbaijan 213 5.1 380 9.0 350 8.2 377 8.7 365 8.2 410 9.1 357 7.8 3 025 Azerbaijan
E Belarus 391 8.6 541 12.0 455 10.1 563 12.5 567 12.8 620 14.1 659 15.1 8 144 Belarus
C Bosnia and Herzegovina 9 0.5 4 0.2 7 0.4 6 0.3 7 0.4 23 1.2 23 1.2 180 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 2 0.2 2 0.2 3 0.3 6 0.6 5 0.5 0 0.0 10 1.0 35 former Yugoslav Republic of Macedonia, the
E Georgia 197 9.5 242 11.7 249 12.0 276 13.3 322 15.3 300 14.2 381 17.9 2 671 Georgia
W Israel 218 6.5 247 7.2 251 7.2 267 7.4 289 7.9 299 8.0 354 9.4 4 860 Israel
E Kazakhstan 1 288 17.6 1 388 18.7 1 653 22.0 1 394 18.4 1 254 16.3 1 212 15.6 1 170 14.9 12 601 Kazakhstan
E Kyrgyzstan 181 7.2 287 11.3 309 12.0 514 19.8 399 15.2 422 15.8 406 15.0 3 208 Kyrgyzstan
E Moldova 369 21.5 422 24.5 438 25.5 400 23.3 341 19.9 377 22.0 375 21.9 4 599 Moldova
W Monaco 1 6.2 1 6.2 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 21 Monaco
C Montenegro 5 1.6 10 3.3 8 2.6 12 3.9 15 4.9 8 2.6 13 4.2 119 Montenegro
E Russia - - - - 36 172 55.1 - - 36 172 Russia
W San Marino 2 13.6 0 0.0 2 12.2 1 6.5 6 39.1 6 38.4 2 12.7 63 San Marino
C Serbia 73 2.0 75 2.1 98 2.7 122 3.4 132 3.7 110 3.1 115 3.3 2 210 Serbia
W Switzerland 498 13.6 524 14.2 555 14.9 473 12.5 445 11.6 422 10.9 477 12.2 20 984 Switzerland
E Tajikistan 155 4.4 241 6.7 184 5.0 327 8.7 850 22.2 672 17.1 535 13.3 3 393 Tajikistan
C Turkey 193 0.5 248 0.7 273 0.8 344 1.0 384 1.1 485 1.3 819 2.2 3 840 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 Turkmenistan
E Ukraine 7 890 36.6 8 201 38.3 8 644 40.6 9 168 43.3 9 524 45.1 9 558 45.4 9 484 45.2 112 645 Ukraine
E Uzbekistan 1 683 12.8 2 087 15.7 1 830 13.6 2 248 16.5 2 062 14.9 - - 16 262 Uzbekistan
Total non-EU/EEA 13 431 7.5 15 010 8.4 15 450 8.6 16 640 9.2 53 271 29.4 15 095 8.3 15 397 8.4 236 458 Total non-EU/EEA
Geographic area Geographic area
West 18 153 10.6 19 727 11.1 20 546 11.2 20 446 10.5 21 777 11.0 21 298 10.7 20 706 10.2 316 465 West
Centre 1 319 1.4 1 463 1.6 1 701 1.8 1 938 2.1 2 053 2.2 2 524 2.7 2 996 3.2 29 320 Centre
East 13 101 10.0 14 536 11.1 14 827 11.3 15 907 12.1 52 479 39.7 14 242 10.7 14 065 10.6 214 854 East
Total WHO European Region 32 573 8.2 35 726 8.9 37 074 9.1 38 291 9.1 76 309 18.0 38 064 9.0 37 767 8.8 560 639 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 3: HIV diagnoses in females and rates per 100 000 population, by country and year of diagnosis (2006–2012) and 
cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 79 1.9 76 1.8 79 1.9 66 1.5 60 1.4 67 1.6 61 1.4 1 917 Austria
W Belgium 338 6.3 403 7.5 343 6.3 381 6.9 403 7.3 399 7.1 393 7.0 9 403 Belgium
C Bulgaria 20 0.5 21 0.5 21 0.5 38 1.0 31 0.8 38 1.0 34 0.9 397 Bulgaria
C Croatia 9 0.4 5 0.2 3 0.1 6 0.3 3 0.1 11 0.5 3 0.1 150 Croatia
C Cyprus 14 3.6 15 3.8 13 3.3 12 3.0 7 1.7 15 3.5 9 2.0 243 Cyprus
C Czech Republic 19 0.4 24 0.5 27 0.5 26 0.5 21 0.4 13 0.2 27 0.5 333 Czech Republic
W Denmark 71 2.6 82 3.0 81 2.9 57 2.1 74 2.7 74 2.6 54 1.9 1 740 Denmark
E Estonia 239 32.9 259 35.8 230 31.8 168 23.2 146 20.2 140 19.4 106 14.7 2 701 Estonia
W Finland 57 2.1 51 1.9 42 1.6 66 2.4 54 2.0 60 2.2 45 1.6 827 Finland
W France 2 115 6.5 1 996 6.1 1 999 6.1 1 840 5.5 1 877 5.6 1 808 5.4 1 312 3.9 19 758 France
W Germany 505 1.2 452 1.1 469 1.1 465 1.1 436 1.0 454 1.1 448 1.1 8 786 Germany
W Greece 103 1.8 88 1.6 101 1.8 91 1.6 78 1.4 143 2.5 162 2.8 2 284 Greece
C Hungary 13 0.2 10 0.2 9 0.2 15 0.3 9 0.2 11 0.2 14 0.3 258 Hungary
W Iceland 3 2.0 7 4.6 3 1.9 9 5.7 7 4.4 11 6.9 6 3.8 88 Iceland
W Ireland 132 6.3 148 6.9 146 6.6 137 6.1 89 4.0 88 3.8 95 4.1 2 016 Ireland
W Italy 478 3.8 564 3.5 524 2.7 657 2.4 956 3.1 918 3.0 824 2.6 5 849 Italy
E Latvia 114 9.2 126 10.2 127 10.4 105 8.6 104 8.6 103 9.1 121 10.9 1 716 Latvia
E Lithuania 22 1.2 32 1.8 30 1.7 49 2.7 28 1.6 32 1.9 46 2.8 373 Lithuania
W Luxembourg 15 6.3 11 4.6 10 4.1 16 6.4 15 5.9 14 5.4 13 4.9 298 Luxembourg
W Malta 8 3.9 6 2.9 11 5.4 9 4.4 2 1.0 4 1.9 7 3.3 57 Malta
W Netherlands 219 2.7 235 2.8 196 2.4 197 2.4 182 2.2 160 1.9 148 1.8 4 268 Netherlands
W Norway 97 4.1 82 3.5 117 4.9 99 4.1 85 3.5 79 3.2 76 3.1 1 677 Norway
C Poland 172 0.9 156 0.8 153 0.8 155 0.8 154 0.8 157 0.8 159 0.8 3 459 Poland
W Portugal 619 11.4 594 11.1 587 11.0 539 10.1 466 8.7 361 6.7 208 3.9 9 033 Portugal
C Romania 91 0.8 85 0.8 111 1.0 109 1.0 95 0.9 123 1.1 130 1.2 2 493 Romania
C Slovakia 7 0.3 7 0.3 5 0.2 5 0.2 3 0.1 3 0.1 6 0.2 66 Slovakia
C Slovenia 3 0.3 2 0.2 3 0.3 8 0.8 4 0.4 7 0.7 3 0.3 76 Slovenia
W Spain 395 4.3 558 4.5 682 4.8 688 4.1 650 3.9 557 3.3 497 2.6 5 174 Spain
W Sweden 149 3.3 182 4.0 154 3.3 146 3.1 178 3.8 142 3.0 145 3.0 3 269 Sweden
W United Kingdom 2 981 9.8 2 672 8.7 2 652 8.6 2 200 7.0 2 041 6.5 1 786 5.7 1 805 5.8 39 616 United Kingdom
Total EU/EEA 9 087 4.0 8 949 3.8 8 928 3.7 8 359 3.3 8 258 3.3 7 778 3.1 6 957 2.7 128 325 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 11 0.7 13 0.8 20 1.3 18 1.1 14 0.9 21 1.5 23 1.6 172 Albania
W Andorra 1 2.7 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 12 Andorra
E Armenia 25 1.5 32 1.9 32 1.9 53 3.2 51 3.1 67 4.0 70 4.2 410 Armenia
E Azerbaijan 26 0.6 57 1.3 83 1.9 78 1.7 94 2.1 138 3.0 160 3.4 759 Azerbaijan
E Belarus 342 6.7 452 8.8 428 8.4 510 10.0 496 9.8 574 11.5 564 11.3 5 479 Belarus
C Bosnia and Herzegovina 2 0.1 0 0.0 2 0.1 0 0.0 0 0.0 4 0.2 2 0.1 40 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 5 0.5 1 0.1 1 0.1 0 0.0 0 0.0 0 0.0 3 0.3 15 former Yugoslav Republic of Macedonia, the
E Georgia 75 3.3 98 4.3 101 4.4 109 4.8 133 5.8 124 5.4 145 6.3 970 Georgia
W Israel 118 3.4 116 3.3 143 4.0 120 3.3 135 3.6 153 4.0 131 3.4 2 547 Israel
E Kazakhstan 457 5.8 591 7.4 682 8.5 687 8.4 734 8.9 794 9.5 844 10.0 5 910 Kazakhstan
E Kyrgyzstan 63 2.5 115 4.4 182 6.9 182 6.8 168 6.2 192 7.0 294 10.6 1 332 Kyrgyzstan
E Moldova 249 13.4 309 16.6 355 19.1 304 16.4 362 19.6 344 18.6 382 20.7 3 217 Moldova
W Monaco 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 13 Monaco
C Montenegro 0 0.0 1 0.3 3 0.9 2 0.6 0 0.0 1 0.3 0 0.0 23 Montenegro
E Russia - - - - 26 409 34.6 - - 26 409 Russia
W San Marino 0 0.0 0 0.0 2 12.8 0 0.0 0 0.0 2 12.3 3 18.3 18 San Marino
C Serbia 15 0.4 16 0.4 20 0.5 9 0.2 16 0.4 17 0.5 10 0.3 640 Serbia
W Switzerland 254 6.7 222 5.8 203 5.3 179 4.6 161 4.1 133 3.3 155 3.8 9 716 Switzerland
E Tajikistan 48 1.4 64 1.8 62 1.7 91 2.5 202 5.3 283 7.3 279 7.0 1 106 Tajikistan
C Turkey 83 0.2 100 0.3 122 0.3 126 0.4 139 0.4 166 0.5 249 0.7 1 608 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 Turkmenistan
E Ukraine 5 366 21.3 5 038 20.1 6 683 26.8 7 073 28.5 6 916 28.0 7 778 31.7 7 388 30.2 73 867 Ukraine
E Uzbekistan 522 3.9 1 082 8.1 1 231 9.1 1 807 13.1 1 733 12.4 - - 7 794 Uzbekistan
Total non-EU/EEA 7 662 3.9 8 307 4.3 10 355 5.3 11 348 5.8 37 763 19.1 10 791 5.4 10 702 5.4 142 058 Total non-EU/EEA
Geographic area Geographic area
West 8 737 4.9 8 545 4.6 8 544 4.5 7 962 3.9 7 949 3.9 7 413 3.6 6 588 3.1 128 366 West
Centre 464 0.5 456 0.5 513 0.5 529 0.6 496 0.5 587 0.6 672 0.7 9 973 Centre
East 7 548 5.1 8 255 5.6 10 226 6.9 11 216 7.6 37 576 25.3 10 569 7.1 10 399 6.9 132 044 East
Total WHO European Region 16 749 4.0 17 256 4.0 19 283 4.4 19 707 4.4 46 021 10.2 18 569 4.1 17 659 3.9 270 383 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 3: HIV diagnoses in females and rates per 100 000 population, by country and year of diagnosis (2006–2012) and 
cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 79 1.9 76 1.8 79 1.9 66 1.5 60 1.4 67 1.6 61 1.4 1 917 Austria
W Belgium 338 6.3 403 7.5 343 6.3 381 6.9 403 7.3 399 7.1 393 7.0 9 403 Belgium
C Bulgaria 20 0.5 21 0.5 21 0.5 38 1.0 31 0.8 38 1.0 34 0.9 397 Bulgaria
C Croatia 9 0.4 5 0.2 3 0.1 6 0.3 3 0.1 11 0.5 3 0.1 150 Croatia
C Cyprus 14 3.6 15 3.8 13 3.3 12 3.0 7 1.7 15 3.5 9 2.0 243 Cyprus
C Czech Republic 19 0.4 24 0.5 27 0.5 26 0.5 21 0.4 13 0.2 27 0.5 333 Czech Republic
W Denmark 71 2.6 82 3.0 81 2.9 57 2.1 74 2.7 74 2.6 54 1.9 1 740 Denmark
E Estonia 239 32.9 259 35.8 230 31.8 168 23.2 146 20.2 140 19.4 106 14.7 2 701 Estonia
W Finland 57 2.1 51 1.9 42 1.6 66 2.4 54 2.0 60 2.2 45 1.6 827 Finland
W France 2 115 6.5 1 996 6.1 1 999 6.1 1 840 5.5 1 877 5.6 1 808 5.4 1 312 3.9 19 758 France
W Germany 505 1.2 452 1.1 469 1.1 465 1.1 436 1.0 454 1.1 448 1.1 8 786 Germany
W Greece 103 1.8 88 1.6 101 1.8 91 1.6 78 1.4 143 2.5 162 2.8 2 284 Greece
C Hungary 13 0.2 10 0.2 9 0.2 15 0.3 9 0.2 11 0.2 14 0.3 258 Hungary
W Iceland 3 2.0 7 4.6 3 1.9 9 5.7 7 4.4 11 6.9 6 3.8 88 Iceland
W Ireland 132 6.3 148 6.9 146 6.6 137 6.1 89 4.0 88 3.8 95 4.1 2 016 Ireland
W Italy 478 3.8 564 3.5 524 2.7 657 2.4 956 3.1 918 3.0 824 2.6 5 849 Italy
E Latvia 114 9.2 126 10.2 127 10.4 105 8.6 104 8.6 103 9.1 121 10.9 1 716 Latvia
E Lithuania 22 1.2 32 1.8 30 1.7 49 2.7 28 1.6 32 1.9 46 2.8 373 Lithuania
W Luxembourg 15 6.3 11 4.6 10 4.1 16 6.4 15 5.9 14 5.4 13 4.9 298 Luxembourg
W Malta 8 3.9 6 2.9 11 5.4 9 4.4 2 1.0 4 1.9 7 3.3 57 Malta
W Netherlands 219 2.7 235 2.8 196 2.4 197 2.4 182 2.2 160 1.9 148 1.8 4 268 Netherlands
W Norway 97 4.1 82 3.5 117 4.9 99 4.1 85 3.5 79 3.2 76 3.1 1 677 Norway
C Poland 172 0.9 156 0.8 153 0.8 155 0.8 154 0.8 157 0.8 159 0.8 3 459 Poland
W Portugal 619 11.4 594 11.1 587 11.0 539 10.1 466 8.7 361 6.7 208 3.9 9 033 Portugal
C Romania 91 0.8 85 0.8 111 1.0 109 1.0 95 0.9 123 1.1 130 1.2 2 493 Romania
C Slovakia 7 0.3 7 0.3 5 0.2 5 0.2 3 0.1 3 0.1 6 0.2 66 Slovakia
C Slovenia 3 0.3 2 0.2 3 0.3 8 0.8 4 0.4 7 0.7 3 0.3 76 Slovenia
W Spain 395 4.3 558 4.5 682 4.8 688 4.1 650 3.9 557 3.3 497 2.6 5 174 Spain
W Sweden 149 3.3 182 4.0 154 3.3 146 3.1 178 3.8 142 3.0 145 3.0 3 269 Sweden
W United Kingdom 2 981 9.8 2 672 8.7 2 652 8.6 2 200 7.0 2 041 6.5 1 786 5.7 1 805 5.8 39 616 United Kingdom
Total EU/EEA 9 087 4.0 8 949 3.8 8 928 3.7 8 359 3.3 8 258 3.3 7 778 3.1 6 957 2.7 128 325 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 11 0.7 13 0.8 20 1.3 18 1.1 14 0.9 21 1.5 23 1.6 172 Albania
W Andorra 1 2.7 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 12 Andorra
E Armenia 25 1.5 32 1.9 32 1.9 53 3.2 51 3.1 67 4.0 70 4.2 410 Armenia
E Azerbaijan 26 0.6 57 1.3 83 1.9 78 1.7 94 2.1 138 3.0 160 3.4 759 Azerbaijan
E Belarus 342 6.7 452 8.8 428 8.4 510 10.0 496 9.8 574 11.5 564 11.3 5 479 Belarus
C Bosnia and Herzegovina 2 0.1 0 0.0 2 0.1 0 0.0 0 0.0 4 0.2 2 0.1 40 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 5 0.5 1 0.1 1 0.1 0 0.0 0 0.0 0 0.0 3 0.3 15 former Yugoslav Republic of Macedonia, the
E Georgia 75 3.3 98 4.3 101 4.4 109 4.8 133 5.8 124 5.4 145 6.3 970 Georgia
W Israel 118 3.4 116 3.3 143 4.0 120 3.3 135 3.6 153 4.0 131 3.4 2 547 Israel
E Kazakhstan 457 5.8 591 7.4 682 8.5 687 8.4 734 8.9 794 9.5 844 10.0 5 910 Kazakhstan
E Kyrgyzstan 63 2.5 115 4.4 182 6.9 182 6.8 168 6.2 192 7.0 294 10.6 1 332 Kyrgyzstan
E Moldova 249 13.4 309 16.6 355 19.1 304 16.4 362 19.6 344 18.6 382 20.7 3 217 Moldova
W Monaco 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 13 Monaco
C Montenegro 0 0.0 1 0.3 3 0.9 2 0.6 0 0.0 1 0.3 0 0.0 23 Montenegro
E Russia - - - - 26 409 34.6 - - 26 409 Russia
W San Marino 0 0.0 0 0.0 2 12.8 0 0.0 0 0.0 2 12.3 3 18.3 18 San Marino
C Serbia 15 0.4 16 0.4 20 0.5 9 0.2 16 0.4 17 0.5 10 0.3 640 Serbia
W Switzerland 254 6.7 222 5.8 203 5.3 179 4.6 161 4.1 133 3.3 155 3.8 9 716 Switzerland
E Tajikistan 48 1.4 64 1.8 62 1.7 91 2.5 202 5.3 283 7.3 279 7.0 1 106 Tajikistan
C Turkey 83 0.2 100 0.3 122 0.3 126 0.4 139 0.4 166 0.5 249 0.7 1 608 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 Turkmenistan
E Ukraine 5 366 21.3 5 038 20.1 6 683 26.8 7 073 28.5 6 916 28.0 7 778 31.7 7 388 30.2 73 867 Ukraine
E Uzbekistan 522 3.9 1 082 8.1 1 231 9.1 1 807 13.1 1 733 12.4 - - 7 794 Uzbekistan
Total non-EU/EEA 7 662 3.9 8 307 4.3 10 355 5.3 11 348 5.8 37 763 19.1 10 791 5.4 10 702 5.4 142 058 Total non-EU/EEA
Geographic area Geographic area
West 8 737 4.9 8 545 4.6 8 544 4.5 7 962 3.9 7 949 3.9 7 413 3.6 6 588 3.1 128 366 West
Centre 464 0.5 456 0.5 513 0.5 529 0.6 496 0.5 587 0.6 672 0.7 9 973 Centre
East 7 548 5.1 8 255 5.6 10 226 6.9 11 216 7.6 37 576 25.3 10 569 7.1 10 399 6.9 132 044 East
Total WHO European Region 16 749 4.0 17 256 4.0 19 283 4.4 19 707 4.4 46 021 10.2 18 569 4.1 17 659 3.9 270 383 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 4: HIV diagnoses in men infected through sex with men, by country and year of diagnosis (2006–2012) and 
cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
Year of report Cumulative 
total**2006 2007 2008 2009 2010 2011 2012
EU/EEA
W Austria 126 126 155 137 159 152 143 2 673
W Belgium 297 298 366 375 397 403 388 5 973
C Bulgaria 10 24 17 28 32 47 59 252
C Croatia 37 30 52 42 60 49 62 570
C Cyprus 7 20 9 9 22 27 31 286
C Czech Republic 55 77 92 107 129 113 152 1 175
W Denmark 100 142 133 108 112 113 82 2 545
E Estonia - - - - - - 1 94
W Finland 62 72 49 43 48 36 47 976
W France 1 357 1 450 1 479 1 419 1 497 1 383 1 081 13 276
W Germany 1 385 1 568 1 576 1 646 1 685 1 573 1 697 21 177
W Greece 247 291 319 324 358 319 282 5 937
C Hungary 39 63 93 87 125 106 146 1 316
W Iceland 2 0 2 2 5 0 1 105
W Ireland 89 80 100 138 135 136 166 1 732
W Italy 476 491 595 776 1 223 1 236 1 472 7 005
E Latvia 15 15 21 14 18 20 18 258
E Lithuania 9 4 9 9 6 9 11 127
W Luxembourg 15 18 28 24 21 24 26 449
W Malta 7 0 0 4 6 4 8 37
W Netherlands 658 761 838 756 747 710 636 11 788
W Norway 90 77 92 87 85 97 76 1 623
C Poland 50 33 59 78 157 311 271 1 657
W Portugal 301 278 372 339 351 311 183 4 142
C Romania 11 6 34 32 45 78 69 321
C Slovakia 14 25 33 35 21 32 28 286
C Slovenia 25 30 34 29 28 35 33 371
W Spain 605 1 201 1 427 1 500 1 768 1 715 1 641 11 261
W Sweden 101 121 116 119 111 92 108 3 440
W United Kingdom 2 612 2 831 2 656 2 654 2 689 2 775 2 959 56 635
Total EU/EEA 8 802 10 132 10 756 10 921 12 040 11 906 11 877 157 487
Non-EU/EEA
C Albania 0 1 10 8 4 9 8 57
W Andorra 0 2 3 1 3 1 1 20
E Armenia 2 2 3 5 0 4 4 24
E Azerbaijan 3 3 2 2 7 5 12 41
E Belarus 1 4 5 10 14 27 31 119
C Bosnia and Herzegovina 5 0 1 3 4 12 21 66
C former Yugoslav Republic of Macedonia, the 2 3 0 3 5 1 7 23
E Georgia 4 11 6 7 26 25 43 151
W Israel 77 123 124 141 147 152 152 1 703
E Kazakhstan 8 4 12 20 19 27 24 133
E Kyrgyzstan 1 1 0 0 0 0 3 5
E Moldova 2 0 2 12 6 5 4 45
W Monaco 0 1 0 0 0 0 0 14
C Montenegro 2 6 6 7 13 4 5 57
E Russia - - - - - - - -
W San Marino 0 0 0 0 0 4 0 21
C Serbia 45 40 66 84 81 66 83 791
W Switzerland 263 270 266 251 245 210 229 5 110
E Tajikistan 0 0 0 0 0 0 0 0
C Turkey 29 25 0 2 32 0 0 218
E Turkmenistan 0 0 0 0 0 0 0 0
E Ukraine 35 48 64 94 90 143 152 701
E Uzbekistan 0 0 0 1 0 - - 29
Total non-EU/EEA 479 544 570 651 696 695 779 9 328
Geographic area
West 8 870 10 201 10 696 10 844 11 792 11 446 11 378 157 642
Centre 331 383 506 554 758 890 975 7 446
East 80 92 124 174 186 265 303 1 727
Total WHO European Region 9 281 10 676 11 326 11 572 12 736 12 601 12 656 166 815
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 5: HIV diagnoses in persons infected through injecting drug use, by country and year of diagnosis (2006–2012) 
and cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
Year of report Cumulative 
total**2006 2007 2008 2009 2010 2011 2012
EU/EEA
W Austria 39 52 35 29 30 37 38 1 636
W Belgium 19 21 18 14 15 16 4 825
C Bulgaria 34 43 54 74 56 63 40 395
C Croatia 3 2 1 0 2 3 1 63
C Cyprus 0 2 1 0 0 0 0 9
C Czech Republic 4 12 8 4 5 9 6 87
W Denmark 10 21 13 14 8 10 11 506
E Estonia 191 115 36 85 62 69 72 3 811
W Finland 10 12 7 13 8 8 7 371
W France 172 154 141 125 124 116 76 1 493
W Germany 164 154 126 101 93 90 81 3 216
W Greece 12 12 9 15 25 307 484 1 162
C Hungary 0 3 2 0 0 0 0 22
W Iceland 1 1 0 5 9 12 3 51
W Ireland 58 50 36 30 22 16 13 1 497
W Italy 161 167 155 141 251 174 208 1 598
E Latvia 108 141 100 78 86 90 94 2 966
E Lithuania 62 59 43 118 107 86 62 1 403
W Luxembourg 3 6 5 0 1 0 4 133
W Malta 3 0 2 0 0 0 0 6
W Netherlands 15 12 8 6 6 5 7 750
W Norway 7 13 12 11 11 10 11 596
C Poland 127 91 52 56 41 65 42 5 983
W Portugal 443 363 341 226 181 90 56 10 671
C Romania 4 4 4 7 9 116 170 327
C Slovakia 1 1 3 1 2 1 1 12
C Slovenia 0 0 0 0 0 0 1 14
W Spain 280 255 268 289 228 202 166 2 648
W Sweden 34 61 23 24 23 13 16 1 179
W United Kingdom 195 175 175 154 148 131 111 5 689
Total EU/EEA 2 160 2 002 1 678 1 620 1 553 1 739 1 785 49 119
Non-EU/EEA
C Albania 0 0 0 1 0 0 0 1
W Andorra 0 0 0 0 0 0 0 0
E Armenia 24 32 36 46 49 41 44 472
E Azerbaijan 172 316 284 292 271 318 213 2 234
E Belarus 242 300 195 212 221 260 247 5 928
C Bosnia and Herzegovina 1 0 0 0 0 0 0 21
C former Yugoslav Republic of Macedonia, the 1 0 0 0 0 0 0 2
E Georgia 152 183 196 224 215 187 224 1 948
W Israel 49 40 42 42 41 41 69 1 037
E Kazakhstan 1 162 1 246 1 410 1 150 1 043 877 773 11 921
E Kyrgyzstan 168 254 294 466 347 355 255 2 778
E Moldova 236 224 136 62 59 61 40 2 681
W Monaco 1 0 0 0 0 0 0 8
C Montenegro 1 0 0 0 0 0 1 4
E Russia - - - - - - - -
W San Marino 0 0 0 0 0 0 0 11
C Serbia 8 12 10 9 6 9 5 953
W Switzerland 56 50 27 26 20 21 25 3 743
E Tajikistan 99 138 157 232 556 377 256 2 151
C Turkey 5 5 0 1 0 5 6 95
E Turkmenistan 0 0 0 0 0 0 0 0
E Ukraine 7 127 7 087 7 014 7 113 6 938 6 588 5 933 100 292
E Uzbekistan 1 454 1 816 1 561 612 1 850 - - 11 410
Total non-EU/EEA 10 958 11 703 11 362 10 488 11 616 9 140 8 091 147 690
Geographic area
West 1 732 1 619 1 443 1 265 1 244 1 299 1 390 38 826
Centre 189 175 135 153 121 271 273 7 988
East 11 197 11 911 11 462 10 690 11 804 9 309 8 213 149 995
Total WHO European Region 13 118 13 705 13 040 12 108 13 169 10 879 9 876 196 809
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 6: HIV diagnoses in persons infected through heterosexual contact, by country and year of diagnosis (2006–2012) 
and cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
Year of report Cumulative 
total**2006 2007 2008 2009 2010 2011 2012
EU/EEA
W Austria 131 136 138 119 103 96 106 2 601
W Belgium 419 436 398 417 435 435 472 10 116
C Bulgaria 46 58 52 68 71 89 58 942
C Croatia 15 15 15 11 7 22 7 322
C Cyprus 28 21 22 27 15 23 23 455
C Czech Republic 26 28 45 43 38 25 40 513
W Denmark 127 130 122 105 141 132 96 2 832
E Estonia 0 0 3 17 71 56 127 634
W Finland 93 74 59 91 94 88 71 1 223
W France 2 399 2 307 2 467 2 240 2 173 1 978 1 409 23 248
W Germany 697 674 712 710 684 693 477 11 710
W Greece 152 131 155 111 117 144 123 2 789
C Hungary 14 15 17 23 18 18 23 362
W Iceland 7 0 6 8 10 6 0 100
W Ireland 181 159 184 162 123 115 131 2 554
W Italy 820 964 952 1 266 1 828 1 737 1 668 10 684
E Latvia 87 127 164 133 131 144 112 1 361
E Lithuania 16 27 27 36 26 32 46 326
W Luxembourg 31 19 24 24 26 24 22 475
W Malta 10 12 24 9 10 13 15 110
W Netherlands 364 368 355 331 331 284 265 6 525
W Norway 164 141 185 170 157 155 142 2 684
C Poland 73 72 60 74 99 89 96 1 171
W Portugal 1 122 1 169 1 125 1 074 921 781 463 15 368
C Romania 99 113 135 144 148 149 164 1 948
C Slovakia 8 12 8 9 4 12 14 112
C Slovenia 3 2 4 6 7 8 4 97
W Spain 764 1 041 1 221 1 222 1 221 1 039 996 9 604
W Sweden 197 223 201 204 235 215 194 4 585
W United Kingdom 4 358 4 034 3 940 3 284 2 990 2 778 2 580 57 785
Total EU/EEA 12 451 12 508 12 820 12 138 12 234 11 380 9 944 173 236
Non-EU/EEA
C Albania 25 34 40 46 38 63 69 464
W Andorra 1 1 0 1 1 1 1 19
E Armenia 37 70 86 83 86 127 160 784
E Azerbaijan 41 77 99 116 130 186 241 1 100
E Belarus 464 658 658 822 786 884 919 7 230
C Bosnia and Herzegovina 4 4 8 3 3 14 4 114
C former Yugoslav Republic of Macedonia, the 5 2 3 2 0 0 6 24
E Georgia 109 125 131 146 200 202 242 1 414
W Israel 186 176 201 179 210 208 195 3 909
E Kazakhstan 325 498 680 742 830 1 023 1 141 6 162
E Kyrgyzstan 71 107 162 173 186 181 306 1 354
E Moldova 366 500 588 574 606 613 664 4 757
W Monaco 0 0 0 0 0 0 0 11
C Montenegro 1 5 4 4 2 4 6 61
E Russia - - - - - - - -
W San Marino 1 0 0 0 0 4 3 23
C Serbia 24 23 28 23 35 37 25 651
W Switzerland 340 295 282 255 225 215 225 6 936
E Tajikistan 52 91 119 127 262 356 318 1 378
C Turkey 153 295 274 218 202 250 376 2 692
E Turkmenistan 0 0 0 0 0 0 0 0
E Ukraine 5 646 5 736 7 880 8 541 9 122 10 248 10 440 79 873
E Uzbekistan 495 701 716 955 852 - - 4 730
Total non-EU/EEA 8 346 9 398 11 959 13 010 13 776 14 616 15 341 123 686
Geographic area
West 12 564 12 490 12 751 11 982 12 035 11 141 9 654 175 891
Centre 524 699 715 701 687 803 915 9 928
East 7 709 8 717 11 313 12 465 13 288 14 052 14 716 111 103
Total WHO European Region 20 797 21 906 24 779 25 148 26 010 25 996 25 285 296 911
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 7: HIV diagnoses in persons infected through mother-to-child transmission, by country and year of diagnosis 
(2006–2012) and cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
Year of report Cumulative 
total**2006 2007 2008 2009 2010 2011 2012
EU/EEA
W Austria 2 4 1 2 1 1 0 51
W Belgium 6 19 8 4 7 10 10 422
C Bulgaria 0 1 0 1 4 2 0 14
C Croatia 1 1 0 0 0 1 0 12
C Cyprus 0 0 0 0 0 0 1 3
C Czech Republic 0 0 0 0 0 0 2 6
W Denmark 2 7 4 0 3 3 4 91
E Estonia 4 2 8 3 2 2 4 44
W Finland 1 0 1 2 1 1 2 22
W France 27 38 29 33 41 35 33 346
W Germany 20 27 16 11 20 15 20 304
W Greece 3 3 1 0 3 4 0 63
C Hungary 0 2 0 2 0 0 1 10
W Iceland 0 0 0 0 0 0 0 1
W Ireland 2 6 7 5 9 3 5 72
W Italy 9 2 7 10 11 21 9 108
E Latvia 5 8 8 2 4 2 7 49
E Lithuania 0 1 0 0 0 1 0 2
W Luxembourg 0 0 0 1 0 0 0 6
W Malta 0 0 0 0 0 0 0 0
W Netherlands 7 11 20 17 19 7 2 260
W Norway 6 9 4 4 1 4 7 75
C Poland 25 16 14 11 11 7 4 190
W Portugal 12 17 15 15 17 8 4 249
C Romania 11 5 6 11 16 12 11 227
C Slovakia 0 0 0 0 0 0 0 0
C Slovenia 0 0 0 0 0 1 0 6
W Spain 4 10 8 12 15 8 6 73
W Sweden 9 8 16 11 16 13 6 196
W United Kingdom 132 119 106 121 104 105 76 2 286
Total EU/EEA 288 316 279 278 305 266 214 5 188
Non-EU/EEA
C Albania 5 3 2 2 0 3 2 22
W Andorra 0 0 0 0 0 0 0 1
E Armenia 4 3 0 3 3 2 3 23
E Azerbaijan 1 3 5 5 11 9 14 55
E Belarus 19 25 17 15 22 23 16 214
C Bosnia and Herzegovina 1 0 0 0 0 0 0 1
C former Yugoslav Republic of Macedonia, the 0 0 0 0 0 0 0 0
E Georgia 6 15 12 4 13 6 9 77
W Israel 13 11 16 9 7 8 7 221
E Kazakhstan 15 32 43 22 21 18 30 203
E Kyrgyzstan 2 8 25 16 19 20 33 125
E Moldova 14 7 17 8 10 16 9 109
W Monaco 0 0 0 0 0 0 0 1
C Montenegro 0 0 1 0 0 0 0 3
E Russia - - - - - - - -
W San Marino 0 0 0 0 0 0 0 1
C Serbia 0 1 1 2 0 1 0 39
W Switzerland 1 7 2 4 7 4 2 186
E Tajikistan 1 7 4 9 15 28 34 98
C Turkey 3 3 8 7 0 4 12 71
E Turkmenistan 0 0 0 0 0 0 0 0
E Ukraine 0 257 344 142 203 169 177 1 292
E Uzbekistan 31 84 57 96 73 - - 363
Total non-EU/EEA 116 466 554 344 404 311 348 3 105
Geographic area
West 256 298 261 261 282 250 193 5 035
Centre 46 32 32 36 31 31 33 604
East 102 452 540 325 396 296 336 2 654
Total WHO European Region 404 782 833 622 709 577 562 8 293
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 8: HIV diagnoses*, by geographical area, sex, transmission group and year of diagnosis (2006–2012) and 
cumulative totals.
Table 8a: EU/EEA and non-EU/EEA countries
Transmission mode
2006 2007 2008 2009 2010 2011 2012 Cumulative total**
Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
EU/EEA
Men who have sex with men 0 7 661 0 8 387 0 8 653 0 8 546 21 0 8 883 9 0 8 642 2 0 8 491 1 0 137 380 90 137 470
Injecting drug use 298 1 099 306 1 064 235 930 224 822 3 190 781 0 240 989 0 249 1 048 0 7 883 26 381 815 35 079
Heterosexual contact 6 231 4 550 5 826 4 585 5 832 4 731 5 205 4 345 9 4 867 4 142 6 4 449 4 007 3 3 873 3 184 0 83 871 66 733 539 151 143
Mother-to-child 134 112 165 120 118 124 142 100 0 150 116 0 124 104 0 97 94 0 2 490 2 268 15 4 773
Haemophiliac/transfusion recipient 34 40 29 31 26 23 19 27 0 38 23 0 28 20 0 17 20 0 1 155 3 251 8 4 414
Nosocomial infection 11 7 13 14 11 9 8 13 0 10 11 0 7 7 0 4 3 0 728 817 0 1 545
Other/undetermined 1 095 1 938 1 073 2 059 1 117 2 207 1 093 2 269 25 1 097 2 247 39 1 158 2 541 33 1 131 2 637 24 15 015 31 342 1 174 47 531
Total EU/EEA 7 803 15 407 7 412 16 260 7 339 16 677 6 691 16 122 58 6 352 16 203 54 6 006 16 310 38 5 371 15 477 25 111 142 268 172 2 641 381 955
Non-EU/EEA
Men who have sex with men 0 449 0 517 0 570 0 648 0 0 664 0 0 694 1 0 777 2 197 8 878 6 9 081
Injecting drug use 1 810 7 689 1 860 8 016 1 715 7 991 1 686 8 189 0 1 608 8 158 0 1 702 7 433 0 1 340 6 745 0 27 777 107 236 1 185 136 198
Heterosexual contact 4 871 2 827 4 869 3 531 6 842 4 097 7 295 4 542 0 7 572 5 150 0 8 493 5 872 1 8 657 6 305 3 69 015 47 089 160 116 264
Mother-to-child 39 43 58 64 67 74 109 132 0 48 80 203 153 153 1 159 176 1 862 999 812 2 673
Haemophiliac/transfusion recipient 10 8 7 4 3 6 7 5 0 4 1 0 2 6 0 6 4 0 172 355 2 529
Nosocomial infection 13 26 20 39 32 33 16 25 0 7 9 0 23 32 0 39 57 0 160 229 13 402
Other/undetermined 314 513 311 504 343 576 302 507 6 243 591 1 252 420 6 252 514 8 7 809 15 653 2 883 26 345
Total non-EU/EEA 7 057 11 555 7 125 12 675 9 002 13 347 9 415 14 048 6 9 482 14 653 204 10 625 14 610 9 10 453 14 578 14 105 992 180 439 5 061 291 492
Total WHO European Region 14 860 26 962 14 537 28 935 16 341 30 024 16 106 30 170 64 15 834 30 856 258 16 631 30 920 47 15 824 30 055 39 217 134 448 611 7 702 673 447
Table 8b: Geographical areas, WHO European Region
Transmission mode
2006 2007 2008 2009 2010 2011 2012 Cumulative total**
Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
West
Men who have sex with men 0 7 779 0 8 489 0 8 652 0 8 549 19 0 8 792 9 0 8 493 2 0 8 263 2 0 139 287 89 139 376
Injecting drug use 285 1 002 277 916 213 805 193 639 3 171 594 0 190 733 0 179 837 0 8 297 25 471 825 34 593
Heterosexual contact 6 349 4 618 5 876 4 588 5 863 4 693 5 165 4 320 9 4 886 4 094 6 4 452 3 909 4 3 869 3 118 3 86 573 68 460 570 155 603
Mother-to-child 133 110 164 121 125 121 139 100 0 146 110 0 123 97 1 91 86 1 2 537 2 300 17 4 854
Haemophiliac/transfusion recipient 36 43 32 31 27 25 24 30 0 42 23 0 27 23 0 17 22 0 1 145 3 218 8 4 371
Nosocomial infection 11 6 11 12 10 8 8 13 0 9 11 0 7 6 0 3 3 0 120 119 0 239
Other/undetermined 1 050 1 898 1 063 2 061 1 100 2 222 1 088 2 237 15 1 089 2 259 9 1 139 2 520 10 1 108 2 592 13 18 671 39 811 3 662 62 144
Total West 7 864 15 456 7 423 16 218 7 338 16 526 6 617 15 888 46 6 343 15 883 24 5 938 15 781 17 5 267 14 921 19 117 343 278 666 5 171 401 180
Centre
Men who have sex with men 0 251 0 323 0 447 0 472 2 0 569 0 0 578 1 0 703 1 197 5 367 7 5 571
Injecting drug use 8 49 13 66 7 76 13 83 0 9 71 0 38 163 0 46 179 0 191 1 719 0 1 910
Heterosexual contact 145 153 141 191 169 212 188 221 0 149 237 0 172 292 0 166 277 0 2 556 3 509 0 6 065
Mother-to-child 7 11 9 4 4 6 11 7 0 9 11 0 8 12 0 8 9 0 155 190 0 345
Haemophiliac/transfusion recipient 3 0 2 3 0 2 0 1 0 0 1 0 2 1 0 1 0 0 147 357 0 504
Nosocomial infection 0 1 2 2 1 1 0 0 0 1 0 0 0 1 0 1 0 0 608 698 0 1 306
Other/undetermined 46 52 33 53 57 72 36 82 16 35 69 31 44 76 29 42 110 19 797 1 349 284 2 430
Total Centre 209 517 200 642 238 816 248 866 18 203 958 31 264 1 123 30 264 1 278 20 4 651 13 189 291 18 131
East
Men who have sex with men 0 80 0 92 0 124 0 173 0 0 186 0 0 265 0 0 302 0 0 1 604 0 1 604
Injecting drug use 1 815 7 737 1 876 8 098 1 730 8 040 1 704 8 289 0 1 618 8 274 0 1 714 7 526 0 1 364 6 777 0 27 172 106 427 1 175 134 774
Heterosexual contact 4 608 2 606 4 678 3 337 6 642 3 923 7 147 4 346 0 7 404 4 961 0 8 318 5 678 0 8 495 6 094 0 63 757 41 853 129 105 739
Mother-to-child 33 34 50 59 56 71 101 125 0 43 75 203 146 148 0 157 175 0 660 777 810 2 247
Haemophiliac/transfusion recipient 5 5 2 1 2 2 2 1 0 0 0 0 1 2 0 5 2 0 35 31 2 68
Nosocomial infection 13 26 20 39 32 33 16 25 0 7 9 0 23 32 0 39 57 0 160 229 13 402
Other/undetermined 313 501 288 449 303 489 271 457 0 216 510 0 227 365 0 233 449 0 3 356 5 835 111 9 302
Total East 6 787 10 989 6 914 12 075 8 765 12 682 9 241 13 416 0 9 288 14 015 203 10 429 14 016 0 10 293 13 856 0 95 140 156 756 2 240 254 136
Total WHO European Region 14 860 26 962 14 537 28 935 16 341 30 024 16 106 30 170 64 15 834 30 856 258 16 631 30 920 47 15 824 30 055 39 217 134 448 611 7 702 673 447
* Data from countries not consistently reporting for the period 2004–2012 (Estonia, Italy, Poland, Russia, Spain, Turkey, and Uzbekistan) are not included in this 
table 
** Cumulative total is the total number of cases reported by country since the start of reporting
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Table 8: HIV diagnoses*, by geographical area, sex, transmission group and year of diagnosis (2006–2012) and 
cumulative totals.
Table 8a: EU/EEA and non-EU/EEA countries
Transmission mode
2006 2007 2008 2009 2010 2011 2012 Cumulative total**
Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
EU/EEA
Men who have sex with men 0 7 661 0 8 387 0 8 653 0 8 546 21 0 8 883 9 0 8 642 2 0 8 491 1 0 137 380 90 137 470
Injecting drug use 298 1 099 306 1 064 235 930 224 822 3 190 781 0 240 989 0 249 1 048 0 7 883 26 381 815 35 079
Heterosexual contact 6 231 4 550 5 826 4 585 5 832 4 731 5 205 4 345 9 4 867 4 142 6 4 449 4 007 3 3 873 3 184 0 83 871 66 733 539 151 143
Mother-to-child 134 112 165 120 118 124 142 100 0 150 116 0 124 104 0 97 94 0 2 490 2 268 15 4 773
Haemophiliac/transfusion recipient 34 40 29 31 26 23 19 27 0 38 23 0 28 20 0 17 20 0 1 155 3 251 8 4 414
Nosocomial infection 11 7 13 14 11 9 8 13 0 10 11 0 7 7 0 4 3 0 728 817 0 1 545
Other/undetermined 1 095 1 938 1 073 2 059 1 117 2 207 1 093 2 269 25 1 097 2 247 39 1 158 2 541 33 1 131 2 637 24 15 015 31 342 1 174 47 531
Total EU/EEA 7 803 15 407 7 412 16 260 7 339 16 677 6 691 16 122 58 6 352 16 203 54 6 006 16 310 38 5 371 15 477 25 111 142 268 172 2 641 381 955
Non-EU/EEA
Men who have sex with men 0 449 0 517 0 570 0 648 0 0 664 0 0 694 1 0 777 2 197 8 878 6 9 081
Injecting drug use 1 810 7 689 1 860 8 016 1 715 7 991 1 686 8 189 0 1 608 8 158 0 1 702 7 433 0 1 340 6 745 0 27 777 107 236 1 185 136 198
Heterosexual contact 4 871 2 827 4 869 3 531 6 842 4 097 7 295 4 542 0 7 572 5 150 0 8 493 5 872 1 8 657 6 305 3 69 015 47 089 160 116 264
Mother-to-child 39 43 58 64 67 74 109 132 0 48 80 203 153 153 1 159 176 1 862 999 812 2 673
Haemophiliac/transfusion recipient 10 8 7 4 3 6 7 5 0 4 1 0 2 6 0 6 4 0 172 355 2 529
Nosocomial infection 13 26 20 39 32 33 16 25 0 7 9 0 23 32 0 39 57 0 160 229 13 402
Other/undetermined 314 513 311 504 343 576 302 507 6 243 591 1 252 420 6 252 514 8 7 809 15 653 2 883 26 345
Total non-EU/EEA 7 057 11 555 7 125 12 675 9 002 13 347 9 415 14 048 6 9 482 14 653 204 10 625 14 610 9 10 453 14 578 14 105 992 180 439 5 061 291 492
Total WHO European Region 14 860 26 962 14 537 28 935 16 341 30 024 16 106 30 170 64 15 834 30 856 258 16 631 30 920 47 15 824 30 055 39 217 134 448 611 7 702 673 447
Table 8b: Geographical areas, WHO European Region
Transmission mode
2006 2007 2008 2009 2010 2011 2012 Cumulative total**
Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
West
Men who have sex with men 0 7 779 0 8 489 0 8 652 0 8 549 19 0 8 792 9 0 8 493 2 0 8 263 2 0 139 287 89 139 376
Injecting drug use 285 1 002 277 916 213 805 193 639 3 171 594 0 190 733 0 179 837 0 8 297 25 471 825 34 593
Heterosexual contact 6 349 4 618 5 876 4 588 5 863 4 693 5 165 4 320 9 4 886 4 094 6 4 452 3 909 4 3 869 3 118 3 86 573 68 460 570 155 603
Mother-to-child 133 110 164 121 125 121 139 100 0 146 110 0 123 97 1 91 86 1 2 537 2 300 17 4 854
Haemophiliac/transfusion recipient 36 43 32 31 27 25 24 30 0 42 23 0 27 23 0 17 22 0 1 145 3 218 8 4 371
Nosocomial infection 11 6 11 12 10 8 8 13 0 9 11 0 7 6 0 3 3 0 120 119 0 239
Other/undetermined 1 050 1 898 1 063 2 061 1 100 2 222 1 088 2 237 15 1 089 2 259 9 1 139 2 520 10 1 108 2 592 13 18 671 39 811 3 662 62 144
Total West 7 864 15 456 7 423 16 218 7 338 16 526 6 617 15 888 46 6 343 15 883 24 5 938 15 781 17 5 267 14 921 19 117 343 278 666 5 171 401 180
Centre
Men who have sex with men 0 251 0 323 0 447 0 472 2 0 569 0 0 578 1 0 703 1 197 5 367 7 5 571
Injecting drug use 8 49 13 66 7 76 13 83 0 9 71 0 38 163 0 46 179 0 191 1 719 0 1 910
Heterosexual contact 145 153 141 191 169 212 188 221 0 149 237 0 172 292 0 166 277 0 2 556 3 509 0 6 065
Mother-to-child 7 11 9 4 4 6 11 7 0 9 11 0 8 12 0 8 9 0 155 190 0 345
Haemophiliac/transfusion recipient 3 0 2 3 0 2 0 1 0 0 1 0 2 1 0 1 0 0 147 357 0 504
Nosocomial infection 0 1 2 2 1 1 0 0 0 1 0 0 0 1 0 1 0 0 608 698 0 1 306
Other/undetermined 46 52 33 53 57 72 36 82 16 35 69 31 44 76 29 42 110 19 797 1 349 284 2 430
Total Centre 209 517 200 642 238 816 248 866 18 203 958 31 264 1 123 30 264 1 278 20 4 651 13 189 291 18 131
East
Men who have sex with men 0 80 0 92 0 124 0 173 0 0 186 0 0 265 0 0 302 0 0 1 604 0 1 604
Injecting drug use 1 815 7 737 1 876 8 098 1 730 8 040 1 704 8 289 0 1 618 8 274 0 1 714 7 526 0 1 364 6 777 0 27 172 106 427 1 175 134 774
Heterosexual contact 4 608 2 606 4 678 3 337 6 642 3 923 7 147 4 346 0 7 404 4 961 0 8 318 5 678 0 8 495 6 094 0 63 757 41 853 129 105 739
Mother-to-child 33 34 50 59 56 71 101 125 0 43 75 203 146 148 0 157 175 0 660 777 810 2 247
Haemophiliac/transfusion recipient 5 5 2 1 2 2 2 1 0 0 0 0 1 2 0 5 2 0 35 31 2 68
Nosocomial infection 13 26 20 39 32 33 16 25 0 7 9 0 23 32 0 39 57 0 160 229 13 402
Other/undetermined 313 501 288 449 303 489 271 457 0 216 510 0 227 365 0 233 449 0 3 356 5 835 111 9 302
Total East 6 787 10 989 6 914 12 075 8 765 12 682 9 241 13 416 0 9 288 14 015 203 10 429 14 016 0 10 293 13 856 0 95 140 156 756 2 240 254 136
Total WHO European Region 14 860 26 962 14 537 28 935 16 341 30 024 16 106 30 170 64 15 834 30 856 258 16 631 30 920 47 15 824 30 055 39 217 134 448 611 7 702 673 447
* Data from countries not consistently reporting for the period 2004–2012 (Estonia, Italy, Poland, Russia, Spain, Turkey, and Uzbekistan) are not included in this 
table 
** Cumulative total is the total number of cases reported by country since the start of reporting
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Table 9: HIV diagnoses, by geographical area, sex, age and year of diagnosis (2006–2012) and cumulative totals
Table 9a: EU/EEA and non-EU/EEA countries
Age category
2006 2007 2008 2009 2010 2011 2012 Cumulative total*
Age category
Female Male Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown
EU/EEA EU/EEA
<15 172 155 190 141 148 152 144 122 159 129 - 135 115 - 109 91 1 3 813 4 436 74 <15
15–19 318 254 332 282 302 308 280 315 232 330 - 206 311 - 179 318 - 5 536 6 390 31 15–19
20–24 1 011 1 321 1 042 1 639 924 1 750 871 1 761 754 1 951 5 752 1 930 2 601 2 011 5 16 247 28 118 142 20–24
25–29 1 750 2 553 1 697 2 996 1 616 3 045 1 402 2 933 1 384 3 224 15 1 343 3 503 2 1 112 3 412 7 26 451 51 566 291 25–29
30–39 3 134 6 492 2 976 6 820 2 989 6 805 2 694 6 622 2 823 7 504 32 2 744 7 441 3 2 472 7 301 9 43 174 113 927 481 30–39
40–49 1 332 4 471 1 462 4 782 1 556 5 243 1 442 5 099 1 757 6 035 20 1 549 5 887 6 1 447 5 612 5 18 327 69 260 214 40–49
50+ 797 2 369 762 2 735 914 2 884 951 2 997 1 137 3 805 7 1 041 3 735 2 1 023 3 564 - 10 880 39 764 91 50+
Unknown 573 1 527 488 1 321 479 1 437 575 1 802 12 60 71 8 47 65 14 61 27 3 897 10 720 1 927 Unknown
Total EU/EEA 9 087 19 142 8 949 20 716 8 928 21 624 8 359 21 651 8 258 23 038 150 7 778 22 969 80 6 957 22 370 54 128 325 324 181 3 251 Total EU/EEA
Non-EU/EEA Non-EU/EEA
<15 141 203 243 230 370 580 452 755 487 672 203 203 233 1 238 345 1 2 664 3 618 864 <15
15–19 422 178 470 151 416 115 406 100 335 116 - 296 82 - 284 77 - 5 916 4 121 17 15–19
20–24 327 330 526 421 2 111 1 181 2 115 1 155 1 807 1 214 - 1 596 929 1 1 454 780 1 13 029 9 956 147 20–24
25–29 371 746 649 982 2 660 3 205 2 856 3 122 2 785 3 001 - 2 362 2 517 1 2 265 2 402 - 17 363 22 677 241 25–29
30–39 2 260 5 568 2 828 6 428 3 245 6 599 3 611 7 287 3 790 7 451 1 3 790 6 859 1 3 750 6 810 4 35 218 78 184 350 30–39
40–49 796 2 238 967 2 745 1 157 2 938 1 398 3 254 1 548 3 518 - 1 774 3 284 2 1 847 3 513 - 12 320 31 826 109 40–49
50+ 215 568 304 717 379 806 502 946 595 1 114 - 762 1 179 1 853 1 454 1 4 649 9 912 38 50+
Unknown 3 130 3 600 2 320 3 336 17 26 8 21 26 416 36 185 - 8 12 4 11 16 7 50 644 76 419 3 298 Unknown
Total non-EU/EEA 7 662 13 431 8 307 15 010 10 355 15 450 11 348 16 640 37 763 53 271 204 10 791 15 095 11 10 702 15 397 14 141 803 236 713 5 064 Total non-EU/EEA
Total WHO European Region 16 749 32 573 17 256 35 726 19 283 37 074 19 707 38 291 46 021 76 309 354 18 569 38 064 91 17 659 37 767 68 270 128 560 894 8 315 Total WHO European Region
Table 9b: Geographical areas, WHO European Region
Age category
2006 2007 2008 2009 2010 2011 2012 Cumulative total*
Age category
Female Male Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown
West West
<15 156 137 174 134 140 139 136 116 150 115 - 128 102 1 96 79 2 3 080 3 543 115 <15
15–19 236 196 253 244 247 257 226 263 198 297 - 182 270 - 151 274 - 4 246 4 467 42 15–19
20–24 963 1 183 897 1 391 789 1 533 741 1 575 647 1 694 1 626 1 685 1 488 1 758 3 16 018 25 868 230 20–24
25–29 1 702 2 365 1 580 2 638 1 520 2 702 1 300 2 596 1 314 2 882 6 1 240 3 063 1 1 039 3 009 1 27 404 50 268 415 25–29
30–39 3 108 6 206 2 931 6 577 2 934 6 459 2 615 6 150 2 780 7 030 10 2 653 6 775 4 2 379 6 631 6 44 371 112 850 638 30–39
40–49 1 324 4 430 1 465 4 727 1 538 5 169 1 425 5 015 1 731 5 943 10 1 526 5 700 5 1 414 5 373 - 18 563 69 684 244 40–49
50+ 806 2 391 758 2 720 898 2 863 942 2 957 1 115 3 774 1 1 049 3 672 3 1 006 3 533 1 11 116 40 537 109 50+
Unknown 442 1 245 487 1 296 478 1 424 577 1 774 14 42 3 9 31 2 15 49 8 3 568 9 248 3 419 Unknown
Total West 8 737 18 153 8 545 19 727 8 544 20 546 7 962 20 446 7 949 21 777 31 7 413 21 298 17 6 588 20 706 21 128 366 316 465 5 212 Total West
Centre Centre
<15 20 28 24 15 18 17 18 18 15 19 - 15 20 - 20 25 - 1 147 1 328 2 <15
15–19 32 27 42 35 33 47 35 50 23 38 - 20 53 - 28 59 - 802 903 4 15–19
20–24 74 173 79 191 90 195 99 221 87 292 4 108 323 2 103 378 3 1 895 4 211 50 20–24
25–29 121 274 98 332 113 357 107 377 101 414 9 114 522 2 119 617 6 1 792 5 704 89 25–29
30–39 125 466 128 460 158 582 162 705 148 712 23 184 907 - 213 1 060 7 2 162 8 913 116 30–39
40–49 56 208 39 228 48 299 52 331 65 333 10 94 428 3 119 549 5 860 4 096 59 40–49
50+ 30 105 41 161 49 173 53 204 53 222 6 49 251 - 68 286 - 584 2 293 16 50+
Unknown 6 38 5 41 4 31 3 32 4 23 68 3 20 67 2 22 26 476 2 127 514 Unknown
Total Centre 464 1 319 456 1 463 513 1 701 529 1 938 496 2 053 120 587 2 524 74 672 2 996 47 9 718 29 575 850 Total Centre
East  East
<15 137 193 235 222 360 576 442 743 481 667 203 195 226 - 231 332 - 2 250 3 183 821 <15
15–19 472 209 507 154 438 119 425 102 346 111 - 300 70 - 284 62 - 6 404 5 141 2 15–19
20–24 301 295 592 478 2 156 1 203 2 146 1 120 1 827 1 179 - 1 614 851 - 1 464 655 - 11 363 7 995 9 20–24
25–29 298 660 668 1 008 2 643 3 191 2 851 3 082 2 754 2 929 - 2 351 2 435 - 2 219 2 188 - 14 618 18 271 28 25–29
30–39 2 161 5 388 2 745 6 211 3 142 6 363 3 528 7 054 3 685 7 213 - 3 697 6 618 - 3 630 6 420 - 31 859 70 348 77 30–39
40–49 748 2 071 925 2 572 1 127 2 713 1 363 3 007 1 509 3 277 - 1 703 3 043 - 1 761 3 203 - 11 224 27 306 20 40–49
50+ 176 441 267 571 346 654 458 782 564 923 - 705 991 - 802 1 199 - 3 829 6 846 4 50+
Unknown 3 255 3 844 2 316 3 320 14 8 3 17 26 410 36 180 - 4 8 - 8 6 - 50 497 75 764 1 292 Unknown
Total East 7 548 13 101 8 255 14 536 10 226 14 827 11 216 15 907 37 576 52 479 203 10 569 14 242 - 10 399 14 065 - 132 044 214 854 2 253 Total East
Total WHO European Region 16 749 32 573 17 256 35 726 19 283 37 074 19 707 38 291 46 021 76 309 354 18 569 38 064 91 17 659 37 767 68 270 128 560 894 8 315 Total WHO European Region
*  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 9: HIV diagnoses, by geographical area, sex, age and year of diagnosis (2006–2012) and cumulative totals
Table 9a: EU/EEA and non-EU/EEA countries
Age category
2006 2007 2008 2009 2010 2011 2012 Cumulative total*
Age category
Female Male Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown
EU/EEA EU/EEA
<15 172 155 190 141 148 152 144 122 159 129 - 135 115 - 109 91 1 3 813 4 436 74 <15
15–19 318 254 332 282 302 308 280 315 232 330 - 206 311 - 179 318 - 5 536 6 390 31 15–19
20–24 1 011 1 321 1 042 1 639 924 1 750 871 1 761 754 1 951 5 752 1 930 2 601 2 011 5 16 247 28 118 142 20–24
25–29 1 750 2 553 1 697 2 996 1 616 3 045 1 402 2 933 1 384 3 224 15 1 343 3 503 2 1 112 3 412 7 26 451 51 566 291 25–29
30–39 3 134 6 492 2 976 6 820 2 989 6 805 2 694 6 622 2 823 7 504 32 2 744 7 441 3 2 472 7 301 9 43 174 113 927 481 30–39
40–49 1 332 4 471 1 462 4 782 1 556 5 243 1 442 5 099 1 757 6 035 20 1 549 5 887 6 1 447 5 612 5 18 327 69 260 214 40–49
50+ 797 2 369 762 2 735 914 2 884 951 2 997 1 137 3 805 7 1 041 3 735 2 1 023 3 564 - 10 880 39 764 91 50+
Unknown 573 1 527 488 1 321 479 1 437 575 1 802 12 60 71 8 47 65 14 61 27 3 897 10 720 1 927 Unknown
Total EU/EEA 9 087 19 142 8 949 20 716 8 928 21 624 8 359 21 651 8 258 23 038 150 7 778 22 969 80 6 957 22 370 54 128 325 324 181 3 251 Total EU/EEA
Non-EU/EEA Non-EU/EEA
<15 141 203 243 230 370 580 452 755 487 672 203 203 233 1 238 345 1 2 664 3 618 864 <15
15–19 422 178 470 151 416 115 406 100 335 116 - 296 82 - 284 77 - 5 916 4 121 17 15–19
20–24 327 330 526 421 2 111 1 181 2 115 1 155 1 807 1 214 - 1 596 929 1 1 454 780 1 13 029 9 956 147 20–24
25–29 371 746 649 982 2 660 3 205 2 856 3 122 2 785 3 001 - 2 362 2 517 1 2 265 2 402 - 17 363 22 677 241 25–29
30–39 2 260 5 568 2 828 6 428 3 245 6 599 3 611 7 287 3 790 7 451 1 3 790 6 859 1 3 750 6 810 4 35 218 78 184 350 30–39
40–49 796 2 238 967 2 745 1 157 2 938 1 398 3 254 1 548 3 518 - 1 774 3 284 2 1 847 3 513 - 12 320 31 826 109 40–49
50+ 215 568 304 717 379 806 502 946 595 1 114 - 762 1 179 1 853 1 454 1 4 649 9 912 38 50+
Unknown 3 130 3 600 2 320 3 336 17 26 8 21 26 416 36 185 - 8 12 4 11 16 7 50 644 76 419 3 298 Unknown
Total non-EU/EEA 7 662 13 431 8 307 15 010 10 355 15 450 11 348 16 640 37 763 53 271 204 10 791 15 095 11 10 702 15 397 14 141 803 236 713 5 064 Total non-EU/EEA
Total WHO European Region 16 749 32 573 17 256 35 726 19 283 37 074 19 707 38 291 46 021 76 309 354 18 569 38 064 91 17 659 37 767 68 270 128 560 894 8 315 Total WHO European Region
Table 9b: Geographical areas, WHO European Region
Age category
2006 2007 2008 2009 2010 2011 2012 Cumulative total*
Age category
Female Male Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown
West West
<15 156 137 174 134 140 139 136 116 150 115 - 128 102 1 96 79 2 3 080 3 543 115 <15
15–19 236 196 253 244 247 257 226 263 198 297 - 182 270 - 151 274 - 4 246 4 467 42 15–19
20–24 963 1 183 897 1 391 789 1 533 741 1 575 647 1 694 1 626 1 685 1 488 1 758 3 16 018 25 868 230 20–24
25–29 1 702 2 365 1 580 2 638 1 520 2 702 1 300 2 596 1 314 2 882 6 1 240 3 063 1 1 039 3 009 1 27 404 50 268 415 25–29
30–39 3 108 6 206 2 931 6 577 2 934 6 459 2 615 6 150 2 780 7 030 10 2 653 6 775 4 2 379 6 631 6 44 371 112 850 638 30–39
40–49 1 324 4 430 1 465 4 727 1 538 5 169 1 425 5 015 1 731 5 943 10 1 526 5 700 5 1 414 5 373 - 18 563 69 684 244 40–49
50+ 806 2 391 758 2 720 898 2 863 942 2 957 1 115 3 774 1 1 049 3 672 3 1 006 3 533 1 11 116 40 537 109 50+
Unknown 442 1 245 487 1 296 478 1 424 577 1 774 14 42 3 9 31 2 15 49 8 3 568 9 248 3 419 Unknown
Total West 8 737 18 153 8 545 19 727 8 544 20 546 7 962 20 446 7 949 21 777 31 7 413 21 298 17 6 588 20 706 21 128 366 316 465 5 212 Total West
Centre Centre
<15 20 28 24 15 18 17 18 18 15 19 - 15 20 - 20 25 - 1 147 1 328 2 <15
15–19 32 27 42 35 33 47 35 50 23 38 - 20 53 - 28 59 - 802 903 4 15–19
20–24 74 173 79 191 90 195 99 221 87 292 4 108 323 2 103 378 3 1 895 4 211 50 20–24
25–29 121 274 98 332 113 357 107 377 101 414 9 114 522 2 119 617 6 1 792 5 704 89 25–29
30–39 125 466 128 460 158 582 162 705 148 712 23 184 907 - 213 1 060 7 2 162 8 913 116 30–39
40–49 56 208 39 228 48 299 52 331 65 333 10 94 428 3 119 549 5 860 4 096 59 40–49
50+ 30 105 41 161 49 173 53 204 53 222 6 49 251 - 68 286 - 584 2 293 16 50+
Unknown 6 38 5 41 4 31 3 32 4 23 68 3 20 67 2 22 26 476 2 127 514 Unknown
Total Centre 464 1 319 456 1 463 513 1 701 529 1 938 496 2 053 120 587 2 524 74 672 2 996 47 9 718 29 575 850 Total Centre
East  East
<15 137 193 235 222 360 576 442 743 481 667 203 195 226 - 231 332 - 2 250 3 183 821 <15
15–19 472 209 507 154 438 119 425 102 346 111 - 300 70 - 284 62 - 6 404 5 141 2 15–19
20–24 301 295 592 478 2 156 1 203 2 146 1 120 1 827 1 179 - 1 614 851 - 1 464 655 - 11 363 7 995 9 20–24
25–29 298 660 668 1 008 2 643 3 191 2 851 3 082 2 754 2 929 - 2 351 2 435 - 2 219 2 188 - 14 618 18 271 28 25–29
30–39 2 161 5 388 2 745 6 211 3 142 6 363 3 528 7 054 3 685 7 213 - 3 697 6 618 - 3 630 6 420 - 31 859 70 348 77 30–39
40–49 748 2 071 925 2 572 1 127 2 713 1 363 3 007 1 509 3 277 - 1 703 3 043 - 1 761 3 203 - 11 224 27 306 20 40–49
50+ 176 441 267 571 346 654 458 782 564 923 - 705 991 - 802 1 199 - 3 829 6 846 4 50+
Unknown 3 255 3 844 2 316 3 320 14 8 3 17 26 410 36 180 - 4 8 - 8 6 - 50 497 75 764 1 292 Unknown
Total East 7 548 13 101 8 255 14 536 10 226 14 827 11 216 15 907 37 576 52 479 203 10 569 14 242 - 10 399 14 065 - 132 044 214 854 2 253 Total East
Total WHO European Region 16 749 32 573 17 256 35 726 19 283 37 074 19 707 38 291 46 021 76 309 354 18 569 38 064 91 17 659 37 767 68 270 128 560 894 8 315 Total WHO European Region
*  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 10: HIV diagnoses in persons infected through heterosexual contact, by country and transmission subcategory, 
cases diagnosed in 2012, in EU/EEA and other countries of the WHO European Region
Area Country*
Case from country 
with generalised 
HIV epidemic
 Partner from a 
country with a 
generalised HIV 
epidemic
Partner IDU Bisexual partner Other/ undetermined Total
N % N % N % N % N % N
EU/EEA
W Austria 31 29.2 21 19.8 2 1.9 0 0.0 52 49.1 106
W Belgium 251 53.2 38 8.1 5 1.1 0 0.0 178 37.7 472
C Bulgaria 0 0.0 0 0.0 0 0.0 0 0.0 58 100.0 58
C Croatia 0 0.0 0 0.0 0 0.0 0 0.0 7 100.0 7
C Cyprus 0 0.0 0 0.0 0 0.0 0 0.0 23 100.0 23
C Czech Republic 0 0.0 3 7.5 2 5.0 0 0.0 35 87.5 40
W Denmark 0 0.0 74 77.1 0 0.0 1 1.0 21 21.9 96
E Estonia 0 0.0 0 0.0 5 3.9 0 0.0 122 96.1 127
W Finland 4 5.6 37 52.1 1 1.4 0 0.0 29 40.8 71
W France 0 0.0 694 49.3 7 0.5 6 0.4 702 49.8 1 409
W Germany 240 50.3 42 8.8 8 1.7 2 0.4 185 38.8 477
W Greece 43 35.0 3 2.4 4 3.3 0 0.0 73 59.3 123
C Hungary 0 0.0 1 4.3 0 0.0 0 0.0 22 95.7 23
W Iceland 0 0 0 0 0 0
W Ireland 87 66.4 9 6.9 5 3.8 1 0.8 29 22.1 131
W Italy 0 0.0 0 0.0 0 0.0 0 0.0 1 668 100.0 1 668
E Latvia 0 0.0 0 0.0 9 8.0 0 0.0 103 92.0 112
E Lithuania 0 0.0 0 0.0 0 0.0 0 0.0 46 100.0 46
W Luxembourg 7 31.8 0 0.0 0 0.0 0 0.0 15 68.2 22
W Malta 5 33.3 0 0.0 0 0.0 0 0.0 10 66.7 15
W Netherlands 78 29.4 0 0.0 0 0.0 0 0.0 187 70.6 265
W Norway 62 43.7 9 6.3 0 0.0 1 0.7 70 49.3 142
C Poland 0 0.0 0 0.0 1 1.0 0 0.0 95 99.0 96
W Portugal 128 27.6 5 1.1 2 0.4 0 0.0 328 70.8 463
C Romania 0 0.0 0 0.0 6 3.7 1 0.6 157 95.7 164
C Slovakia 0 0.0 3 21.4 0 0.0 0 0.0 11 78.6 14
C Slovenia 1 25.0 0 0.0 1 25.0 1 25.0 1 25.0 4
W Spain 183 18.4 0 0.0 0 0.0 0 0.0 813 81.6 996
W Sweden 93 47.9 0 0.0 0 0.0 0 0.0 101 52.1 194
W United Kingdom 842 32.6 0 0.0 2 0.1 0 0.0 1 736 67.3 2 580
Total EU/EEA 2 055 20.7 939 9.4 60 0.6 13 0.1 6 877 69.2 9 944
Non-EU/EEA
C Albania 0 0.0 0 0.0 0 0.0 0 0.0 69 100.0 69
W Andorra 0 0.0 0 0.0 0 0.0 0 0.0 1 100.0 1
E Armenia 0 0.0 0 0.0 8 5.0 0 0.0 152 95.0 160
E Azerbaijan 0 0.0 0 0.0 50 20.7 0 0.0 191 79.3 241
E Belarus 0 0.0 0 0.0 0 0.0 0 0.0 919 100.0 919
C Bosnia and Herzegovina 0 0.0 0 0.0 0 0.0 0 0.0 4 100.0 4
C former Yugoslav Republic of 
Macedonia, the
0 0.0 0 0.0 0 0.0 0 0.0 6 100.0 6
E Georgia 0 0.0 36 14.9 45 18.6 2 0.8 159 65.7 242
W Israel 110 56.4 1 0.5 9 4.6 1 0.5 74 37.9 195
E Kazakhstan 0 0.0 0 0.0 0 0.0 0 0.0 1 141 100.0 1 141
E Kyrgyzstan 0 0.0 0 0.0 0 0.0 0 0.0 306 100.0 306
E Moldova 0 0.0 0 0.0 0 0.0 0 0.0 664 100.0 664
W Monaco 0 0 0 0 0 0
C Montenegro 0 0.0 0 0.0 0 0.0 0 0.0 6 100.0 6
E Russia - - - - - 0
W San Marino 0 0.0 0 0.0 0 0.0 0 0.0 3 100.0 3
C Serbia 0 0.0 1 4.0 0 0.0 0 0.0 24 96.0 25
W Switzerland 58 25.8 0 0.0 4 1.8 0 0.0 163 72.4 225
E Tajikistan 0 0.0 0 0.0 35 11.0 0 0.0 283 89.0 318
C Turkey 0 0.0 0 0.0 0 0.0 0 0.0 376 100.0 376
E Turkmenistan 0 0 0 0 0 0
E Ukraine 0 0.0 0 0.0 0 0.0 0 0.0 10 440 100.0 10 440
E Uzbekistan - - - - - -
Total non-EU/EEA 168 1.1 38 0.2 151 1.0 3 0.0 14 981 97.7 15 341
Geographical area
West 2 222 23.0 933 9.7 49 0.5 12 0.1 6 438 66.7 9 654
Centre 1 0.1 8 0.9 10 1.1 2 0.2 894 97.7 915
East 0 0.0 36 0.2 152 1.0 2 0.0 14 526 98.7 14 716
Total WHO European Region 2 223 8.8 977 3.9 211 0.8 16 0.1 21 858 86.4 25 285
* Country-specific comments are in Annex 5
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Table 11: HIV diagnoses, by country of report and country or subcontinent of origin, cases diagnosed in 2012, in EU/EEA 
and other countries of the WHO European Region
Area Country*
Country of report Western Europe Central & Eastern Europe Sub-Saharan Africa
Latin America & 
Caribbean South & South-east Asia Other Unknown Total Country
N % N % N % N % N Rate N % N % N %
EU/EEA EU/EEA
W Austria 185 60.5 48 15.7 33 10.8 25 8.2 4 1.3 10 3.3 1 0.3 0 0.0 306 Austria
W Belgium 434 35.4 79 6.4 40 3.3 282 23.0 33 2.7 19 1.5 16 1.3 324 26.4 1 227 Belgium
C Bulgaria 152 96.8 1 0.6 2 1.3 1 0.6 0 0.0 0 0.0 1 0.6 0 0.0 157 Bulgaria
C Croatia 69 93.2 0 0.0 3 4.1 1 1.4 1 1.4 0 0.0 0 0.0 0 0.0 74 Croatia
C Cyprus 36 62.1 6 10.3 11 19.0 4 6.9 0 0.0 0 0.0 0 0.0 1 1.7 58 Cyprus
C Czech Republic 151 71.2 3 1.4 51 24.1 0 0.0 0 0.0 6 2.8 1 0.5 0 0.0 212 Czech Republic
W Denmark 100 49.8 20 10.0 14 7.0 39 19.4 2 1.0 14 7.0 9 4.5 3 1.5 201 Denmark
E Estonia 308 97.8 0 0.0 6 1.9 0 0.0 0 0.0 0 0.0 1 0.3 0 0.0 315 Estonia
W Finland 87 55.8 2 1.3 24 15.4 20 12.8 2 1.3 8 5.1 0 0.0 13 8.3 156 Finland
W France 1 423 35.0 38 0.9 71 1.7 835 20.5 188 4.6 27 0.7 93 2.3 1 391 34.2 4 066 France
W Germany 1 972 66.8 79 2.7 255 8.6 223 7.6 64 2.2 72 2.4 43 1.5 245 8.3 2 953 Germany
W Greece 766 72.3 6 0.6 103 9.7 39 3.7 3 0.3 49 4.6 32 3.0 61 5.8 1 059 Greece
C Hungary 207 94.5 3 1.4 3 1.4 2 0.9 0 0.0 0 0.0 3 1.4 1 0.5 219 Hungary
W Iceland 11 57.9 0 0.0 3 15.8 1 5.3 0 0.0 0 0.0 1 5.3 3 15.8 19 Iceland
W Ireland 124 36.6 20 5.9 22 6.5 89 26.3 24 7.1 8 2.4 3 0.9 49 14.5 339 Ireland
W Italy 2 876 73.8 27 0.7 242 6.2 421 10.8 195 5.0 39 1.0 63 1.6 35 0.9 3 898 Italy
E Latvia 105 31.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 234 69.0 339 Latvia
E Lithuania 154 96.3 0 0.0 5 3.1 0 0.0 0 0.0 0 0.0 0 0.0 1 0.6 160 Lithuania
W Luxembourg 12 22.2 23 42.6 5 9.3 7 13.0 3 5.6 1 1.9 2 3.7 1 1.9 54 Luxembourg
W Malta 13 43.3 3 10.0 2 6.7 12 40.0 0 0.0 0 0.0 0 0.0 0 0.0 30 Malta
W Netherlands 603 61.8 42 4.3 46 4.7 98 10.0 110 11.3 49 5.0 26 2.7 2 0.2 976 Netherlands
W Norway 90 37.2 9 3.7 13 5.4 72 29.8 8 3.3 31 12.8 7 2.9 12 5.0 242 Norway
C Poland 857 79.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 228 21.0 1 085 Poland
W Portugal 504 69.9 8 1.1 16 2.2 137 19.0 43 6.0 2 0.3 2 0.3 9 1.2 721 Portugal
C Romania 486 99.4 1 0.2 1 0.2 0 0.0 0 0.0 1 0.2 0 0.0 0 0.0 489 Romania
C Slovakia 43 86.0 1 2.0 4 8.0 0 0.0 0 0.0 1 2.0 1 2.0 0 0.0 50 Slovakia
C Slovenia 36 80.0 0 0.0 5 11.1 1 2.2 2 4.4 0 0.0 0 0.0 1 2.2 45 Slovenia
W Spain 2 097 65.3 144 4.5 115 3.6 193 6.0 582 18.1 0 0.0 46 1.4 33 1.0 3 210 Spain
W Sweden 109 30.0 10 2.8 22 6.1 129 35.5 10 2.8 40 11.0 12 3.3 31 8.5 363 Sweden
W United Kingdom 2 211 34.8 377 5.9 290 4.6 1 424 22.4 258 4.1 259 4.1 133 2.1 1 406 22.1 6 358 United Kingdom
Total EU/EEA 16 221 55.2 950 3.2 1 407 4.8 4 055 13.8 1 532 5.2 636 2.2 496 1.7 4 084 13.9 29 381 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 81 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 81 Albania
W Andorra 1 50.0 1 50.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 Andorra
E Armenia 227 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 227 Armenia
E Azerbaijan 502 97.1 0 0.0 14 2.7 0 0.0 0 0.0 0 0.0 1 0.2 0 0.0 517 Azerbaijan
E Belarus 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 223 100.0 1 223 Belarus
C Bosnia and Herzegovina 25 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 25 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 13 92.9 0 0.0 1 7.1 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 14 former Yugoslav Republic of Macedonia, the
E Georgia 520 98.9 0 0.0 4 0.8 2 0.4 0 0.0 0 0.0 0 0.0 0 0.0 526 Georgia
W Israel 158 32.4 7 1.4 147 30.2 105 21.6 11 2.3 1 0.2 20 4.1 38 7.8 487 Israel
E Kazakhstan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 014 100.0 2 014 Kazakhstan
E Kyrgyzstan 700 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 700 Kyrgyzstan
E Moldova 751 99.2 0 0.0 6 0.8 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 757 Moldova
W Monaco 0 0 0 0 0 0 0 0 0 Monaco
C Montenegro 13 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 13 Montenegro
E Russia - - - - - - - - - Russia
W San Marino 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 5 100.0 5 San Marino
C Serbia 125 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 125 Serbia
W Switzerland 226 35.1 67 10.4 18 2.8 82 12.8 23 3.6 22 3.4 7 1.1 198 30.8 643 Switzerland
E Tajikistan 814 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 814 Tajikistan
C Turkey 880 82.4 14 1.3 71 6.6 36 3.4 1 0.1 4 0.4 19 1.8 43 4.0 1 068 Turkey
E Turkmenistan 0 0 0 0 0 0 0 0 0 Turkmenistan
E Ukraine 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 16 872 100.0 16 872 Ukraine
E Uzbekistan - - - - - - - - - Uzbekistan
Total non-EU/EEA 5 036 19.3 89 0.3 261 1.0 225 0.9 41 0.2 27 0.1 47 0.2 20 387 78.1 26 113 Total non-EU/EEA
Geographical area Geographical area
West 14 002 51.3 1 010 3.7 1 481 5.4 4 233 15.5 1 563 5.7 651 2.4 516 1.9 3 859 14.1 27 315 West
Centre 3 174 85.4 29 0.8 152 4.1 45 1.2 10 0.3 12 0.3 25 0.7 268 7.2 3 715 Centre
East 4 081 16.7 0 0.0 35 0.1 2 0.0 0 0.0 0 0.0 2 0.0 20 344 83.2 24 464 East
Total WHO European Region 21 257 38.3 1 039 1.9 1 668 3.0 4 280 7.7 1 573 2.8 663 1.2 543 1.0 24 471 44.1 55 494 Total WHO European Region
*  Country-specific comments are in Annex 5
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Table 11: HIV diagnoses, by country of report and country or subcontinent of origin, cases diagnosed in 2012, in EU/EEA 
and other countries of the WHO European Region
Area Country*
Country of report Western Europe Central & Eastern Europe Sub-Saharan Africa
Latin America & 
Caribbean South & South-east Asia Other Unknown Total Country
N % N % N % N % N Rate N % N % N %
EU/EEA EU/EEA
W Austria 185 60.5 48 15.7 33 10.8 25 8.2 4 1.3 10 3.3 1 0.3 0 0.0 306 Austria
W Belgium 434 35.4 79 6.4 40 3.3 282 23.0 33 2.7 19 1.5 16 1.3 324 26.4 1 227 Belgium
C Bulgaria 152 96.8 1 0.6 2 1.3 1 0.6 0 0.0 0 0.0 1 0.6 0 0.0 157 Bulgaria
C Croatia 69 93.2 0 0.0 3 4.1 1 1.4 1 1.4 0 0.0 0 0.0 0 0.0 74 Croatia
C Cyprus 36 62.1 6 10.3 11 19.0 4 6.9 0 0.0 0 0.0 0 0.0 1 1.7 58 Cyprus
C Czech Republic 151 71.2 3 1.4 51 24.1 0 0.0 0 0.0 6 2.8 1 0.5 0 0.0 212 Czech Republic
W Denmark 100 49.8 20 10.0 14 7.0 39 19.4 2 1.0 14 7.0 9 4.5 3 1.5 201 Denmark
E Estonia 308 97.8 0 0.0 6 1.9 0 0.0 0 0.0 0 0.0 1 0.3 0 0.0 315 Estonia
W Finland 87 55.8 2 1.3 24 15.4 20 12.8 2 1.3 8 5.1 0 0.0 13 8.3 156 Finland
W France 1 423 35.0 38 0.9 71 1.7 835 20.5 188 4.6 27 0.7 93 2.3 1 391 34.2 4 066 France
W Germany 1 972 66.8 79 2.7 255 8.6 223 7.6 64 2.2 72 2.4 43 1.5 245 8.3 2 953 Germany
W Greece 766 72.3 6 0.6 103 9.7 39 3.7 3 0.3 49 4.6 32 3.0 61 5.8 1 059 Greece
C Hungary 207 94.5 3 1.4 3 1.4 2 0.9 0 0.0 0 0.0 3 1.4 1 0.5 219 Hungary
W Iceland 11 57.9 0 0.0 3 15.8 1 5.3 0 0.0 0 0.0 1 5.3 3 15.8 19 Iceland
W Ireland 124 36.6 20 5.9 22 6.5 89 26.3 24 7.1 8 2.4 3 0.9 49 14.5 339 Ireland
W Italy 2 876 73.8 27 0.7 242 6.2 421 10.8 195 5.0 39 1.0 63 1.6 35 0.9 3 898 Italy
E Latvia 105 31.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 234 69.0 339 Latvia
E Lithuania 154 96.3 0 0.0 5 3.1 0 0.0 0 0.0 0 0.0 0 0.0 1 0.6 160 Lithuania
W Luxembourg 12 22.2 23 42.6 5 9.3 7 13.0 3 5.6 1 1.9 2 3.7 1 1.9 54 Luxembourg
W Malta 13 43.3 3 10.0 2 6.7 12 40.0 0 0.0 0 0.0 0 0.0 0 0.0 30 Malta
W Netherlands 603 61.8 42 4.3 46 4.7 98 10.0 110 11.3 49 5.0 26 2.7 2 0.2 976 Netherlands
W Norway 90 37.2 9 3.7 13 5.4 72 29.8 8 3.3 31 12.8 7 2.9 12 5.0 242 Norway
C Poland 857 79.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 228 21.0 1 085 Poland
W Portugal 504 69.9 8 1.1 16 2.2 137 19.0 43 6.0 2 0.3 2 0.3 9 1.2 721 Portugal
C Romania 486 99.4 1 0.2 1 0.2 0 0.0 0 0.0 1 0.2 0 0.0 0 0.0 489 Romania
C Slovakia 43 86.0 1 2.0 4 8.0 0 0.0 0 0.0 1 2.0 1 2.0 0 0.0 50 Slovakia
C Slovenia 36 80.0 0 0.0 5 11.1 1 2.2 2 4.4 0 0.0 0 0.0 1 2.2 45 Slovenia
W Spain 2 097 65.3 144 4.5 115 3.6 193 6.0 582 18.1 0 0.0 46 1.4 33 1.0 3 210 Spain
W Sweden 109 30.0 10 2.8 22 6.1 129 35.5 10 2.8 40 11.0 12 3.3 31 8.5 363 Sweden
W United Kingdom 2 211 34.8 377 5.9 290 4.6 1 424 22.4 258 4.1 259 4.1 133 2.1 1 406 22.1 6 358 United Kingdom
Total EU/EEA 16 221 55.2 950 3.2 1 407 4.8 4 055 13.8 1 532 5.2 636 2.2 496 1.7 4 084 13.9 29 381 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 81 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 81 Albania
W Andorra 1 50.0 1 50.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 Andorra
E Armenia 227 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 227 Armenia
E Azerbaijan 502 97.1 0 0.0 14 2.7 0 0.0 0 0.0 0 0.0 1 0.2 0 0.0 517 Azerbaijan
E Belarus 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 223 100.0 1 223 Belarus
C Bosnia and Herzegovina 25 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 25 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 13 92.9 0 0.0 1 7.1 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 14 former Yugoslav Republic of Macedonia, the
E Georgia 520 98.9 0 0.0 4 0.8 2 0.4 0 0.0 0 0.0 0 0.0 0 0.0 526 Georgia
W Israel 158 32.4 7 1.4 147 30.2 105 21.6 11 2.3 1 0.2 20 4.1 38 7.8 487 Israel
E Kazakhstan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 014 100.0 2 014 Kazakhstan
E Kyrgyzstan 700 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 700 Kyrgyzstan
E Moldova 751 99.2 0 0.0 6 0.8 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 757 Moldova
W Monaco 0 0 0 0 0 0 0 0 0 Monaco
C Montenegro 13 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 13 Montenegro
E Russia - - - - - - - - - Russia
W San Marino 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 5 100.0 5 San Marino
C Serbia 125 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 125 Serbia
W Switzerland 226 35.1 67 10.4 18 2.8 82 12.8 23 3.6 22 3.4 7 1.1 198 30.8 643 Switzerland
E Tajikistan 814 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 814 Tajikistan
C Turkey 880 82.4 14 1.3 71 6.6 36 3.4 1 0.1 4 0.4 19 1.8 43 4.0 1 068 Turkey
E Turkmenistan 0 0 0 0 0 0 0 0 0 Turkmenistan
E Ukraine 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 16 872 100.0 16 872 Ukraine
E Uzbekistan - - - - - - - - - Uzbekistan
Total non-EU/EEA 5 036 19.3 89 0.3 261 1.0 225 0.9 41 0.2 27 0.1 47 0.2 20 387 78.1 26 113 Total non-EU/EEA
Geographical area Geographical area
West 14 002 51.3 1 010 3.7 1 481 5.4 4 233 15.5 1 563 5.7 651 2.4 516 1.9 3 859 14.1 27 315 West
Centre 3 174 85.4 29 0.8 152 4.1 45 1.2 10 0.3 12 0.3 25 0.7 268 7.2 3 715 Centre
East 4 081 16.7 0 0.0 35 0.1 2 0.0 0 0.0 0 0.0 2 0.0 20 344 83.2 24 464 East
Total WHO European Region 21 257 38.3 1 039 1.9 1 668 3.0 4 280 7.7 1 573 2.8 663 1.2 543 1.0 24 471 44.1 55 494 Total WHO European Region
*  Country-specific comments are in Annex 5
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Table 12: HIV diagnoses, by geographical area, transmission mode and country or subcontinent of origin, cases 
reported in 2012
Table 12a: EU/EEA and non-EU/EEA countries
Transmission mode
Country of report Western Europe Central & Eastern Europe Sub-Saharan Africa Latin America & Caribbean South & South-east Asia Other Unknown
Total Transmission mode
N % N % N % N % N % N % N % N %
EU/EEA EU/EEA
Men who have sex with men 8 509 71.6 621 5.2 420 3.5 184 1.5 864 7.3 240 2.0 238 2.0 801 6.7 11 877 Men who have sex with men
Injecting drug use 1 271 71.2 41 2.3 235 13.2 11 0.6 9 0.5 51 2.9 40 2.2 127 7.1 1 785 Injecting drug use
Heterosexual contact 4 090 41.1 215 2.2 510 5.1 3 476 35.0 529 5.3 277 2.8 159 1.6 688 6.9 9 944 Heterosexual contact
Mother-to-child 73 34.1 7 3.3 11 5.1 82 38.3 6 2.8 5 2.3 5 2.3 25 11.7 214 Mother-to-child
Haemophiliac/transfusion recipient 20 37.7 0 0.0 8 15.1 16 30.2 0 0.0 2 3.8 1 1.9 6 11.3 53 Haemophiliac/transfusion recipient
Nosocomial infection 1 14.3 0 0.0 4 57.1 0 0.0 0 0.0 2 28.6 0 0.0 0 0.0 7 Nosocomial infection
Other/undetermined 2 257 41.0 66 1.2 219 4.0 286 5.2 124 2.3 59 1.1 53 1.0 2 437 44.3 5 501 Other/undetermined
Total EU/EEA 16 221 55.2 950 3.2 1 407 4.8 4 055 13.8 1 532 5.2 636 2.2 496 1.7 4 084 13.9 29 381 Total EU/EEA
Non-EU/EEA Non-EU/EEA
Men who have sex with men 419 53.8 43 5.5 29 3.7 2 0.3 21 2.7 12 1.5 10 1.3 243 31.2 779 Men who have sex with men
Injecting drug use 1 060 13.1 3 0.0 62 0.8 1 0.0 3 0.0 1 0.0 2 0.0 6 959 86.0 8 091 Injecting drug use
Heterosexual contact 2 429 15.8 27 0.2 107 0.7 184 1.2 10 0.1 11 0.1 23 0.1 12 550 81.8 15 341 Heterosexual contact
Mother-to-child 118 33.9 0 0.0 1 0.3 5 1.4 0 0.0 0 0.0 0 0.0 224 64.4 348 Mother-to-child
Haemophiliac/transfusion recipient 145 93.5 3 1.9 1 0.6 0 0.0 0 0.0 1 0.6 0 0.0 5 3.2 155 Haemophiliac/transfusion recipient
Nosocomial infection 96 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 96 Nosocomial infection
Other/undetermined 769 59.0 13 1.0 61 4.7 33 2.5 7 0.5 2 0.2 12 0.9 406 31.2 1 303 Other/undetermined
Total non-EU/EEA 5 036 19.3 89 0.3 261 1.0 225 0.9 41 0.2 27 0.1 47 0.2 20 387 78.1 26 113 Total non-EU/EEA
Total WHO European Region 21 257 38.3 1 039 1.9 1 668 3.0 4 280 7.7 1 573 2.8 663 1.2 543 1.0 24 471 44.1 55 494 Total WHO European Region
Table 12b: Geographical areas, WHO European Region
Transmission mode
Country of report Western Europe Central & Eastern Europe Sub-Saharan Africa Latin America & Caribbean South & South-east Asia Other Unknown
Total Transmission mode
N % N % N % N % N % N % N % N %
West West
Men who have sex with men 7 988 70.2 655 5.8 404 3.6 185 1.6 882 7.8 252 2.2 244 2.1 768 6.7 11 378 Men who have sex with men
Injecting drug use 890 64.0 43 3.1 282 20.3 12 0.9 12 0.9 52 3.7 41 2.9 58 4.2 1 390 Injecting drug use
Heterosexual contact 3 599 37.3 238 2.5 548 5.7 3 642 37.7 537 5.6 283 2.9 172 1.8 635 6.6 9 654 Heterosexual contact
Mother-to-child 51 26.4 7 3.6 10 5.2 87 45.1 6 3.1 5 2.6 5 2.6 22 11.4 193 Mother-to-child
Haemophiliac/transfusion recipient 20 36.4 0 0.0 8 14.5 15 27.3 0 0.0 3 5.5 1 1.8 8 14.5 55 Haemophiliac/transfusion recipient
Nosocomial infection 1 16.7 0 0.0 3 50.0 0 0.0 0 0.0 2 33.3 0 0.0 0 0.0 6 Nosocomial infection
Other/undetermined 1 453 31.3 67 1.4 226 4.9 292 6.3 126 2.7 54 1.2 53 1.1 2 368 51.0 4 639 Other/undetermined
Total West 14 002 51.3 1 010 3.7 1 481 5.4 4 233 15.5 1 563 5.7 651 2.4 516 1.9 3 859 14.1 27 315 Total West
Centre Centre
Men who have sex with men 850 87.2 9 0.9 45 4.6 1 0.1 3 0.3 0 0.0 4 0.4 63 6.5 975 Men who have sex with men
Injecting drug use 265 97.1 1 0.4 3 1.1 0 0.0 0 0.0 0 0.0 0 0.0 4 1.5 273 Injecting drug use
Heterosexual contact 807 88.2 4 0.4 47 5.1 16 1.7 2 0.2 5 0.5 9 1.0 25 2.7 915 Heterosexual contact
Mother-to-child 30 90.9 0 0.0 2 6.1 0 0.0 0 0.0 0 0.0 0 0.0 1 3.0 33 Mother-to-child
Haemophiliac/transfusion recipient 140 95.9 3 2.1 1 0.7 1 0.7 0 0.0 0 0.0 0 0.0 1 0.7 146 Haemophiliac/transfusion recipient
Nosocomial infection 0 0.0 0 0.0 1 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 Nosocomial infection
Other/undetermined 1 082 78.9 12 0.9 53 3.9 27 2.0 5 0.4 7 0.5 12 0.9 174 12.7 1 372 Other/undetermined
Total Centre 3 174 85.4 29 0.8 152 4.1 45 1.2 10 0.3 12 0.3 25 0.7 268 7.2 3 715 Total Centre
East East
Men who have sex with men 90 29.7 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 213 70.3 303 Men who have sex with men
Injecting drug use 1 176 14.3 0 0.0 12 0.1 0 0.0 0 0.0 0 0.0 1 0.0 7 024 85.5 8 213 Injecting drug use
Heterosexual contact 2 113 14.4 0 0.0 22 0.1 2 0.0 0 0.0 0 0.0 1 0.0 12 578 85.5 14 716 Heterosexual contact
Mother-to-child 110 32.7 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 226 67.3 336 Mother-to-child
Haemophiliac/transfusion recipient 5 71.4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 28.6 7 Haemophiliac/transfusion recipient
Nosocomial infection 96 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 96 Nosocomial infection
Other/undetermined 491 61.9 0 0.0 1 0.1 0 0.0 0 0.0 0 0.0 0 0.0 301 38.0 793 Other/undetermined
Total East 4 081 16.7 0 0.0 35 0.1 2 0.0 0 0.0 0 0.0 2 0.0 20 344 83.2 24 464 Total East
Total WHO European Region 21 257 38.3 1 039 1.9 1 668 3.0 4 280 7.7 1 573 2.8 663 1.2 543 1.0 24 471 44.1 55 494 Total WHO European Region
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Table 12: HIV diagnoses, by geographical area, transmission mode and country or subcontinent of origin, cases 
reported in 2012
Table 12a: EU/EEA and non-EU/EEA countries
Transmission mode
Country of report Western Europe Central & Eastern Europe Sub-Saharan Africa Latin America & Caribbean South & South-east Asia Other Unknown
Total Transmission mode
N % N % N % N % N % N % N % N %
EU/EEA EU/EEA
Men who have sex with men 8 509 71.6 621 5.2 420 3.5 184 1.5 864 7.3 240 2.0 238 2.0 801 6.7 11 877 Men who have sex with men
Injecting drug use 1 271 71.2 41 2.3 235 13.2 11 0.6 9 0.5 51 2.9 40 2.2 127 7.1 1 785 Injecting drug use
Heterosexual contact 4 090 41.1 215 2.2 510 5.1 3 476 35.0 529 5.3 277 2.8 159 1.6 688 6.9 9 944 Heterosexual contact
Mother-to-child 73 34.1 7 3.3 11 5.1 82 38.3 6 2.8 5 2.3 5 2.3 25 11.7 214 Mother-to-child
Haemophiliac/transfusion recipient 20 37.7 0 0.0 8 15.1 16 30.2 0 0.0 2 3.8 1 1.9 6 11.3 53 Haemophiliac/transfusion recipient
Nosocomial infection 1 14.3 0 0.0 4 57.1 0 0.0 0 0.0 2 28.6 0 0.0 0 0.0 7 Nosocomial infection
Other/undetermined 2 257 41.0 66 1.2 219 4.0 286 5.2 124 2.3 59 1.1 53 1.0 2 437 44.3 5 501 Other/undetermined
Total EU/EEA 16 221 55.2 950 3.2 1 407 4.8 4 055 13.8 1 532 5.2 636 2.2 496 1.7 4 084 13.9 29 381 Total EU/EEA
Non-EU/EEA Non-EU/EEA
Men who have sex with men 419 53.8 43 5.5 29 3.7 2 0.3 21 2.7 12 1.5 10 1.3 243 31.2 779 Men who have sex with men
Injecting drug use 1 060 13.1 3 0.0 62 0.8 1 0.0 3 0.0 1 0.0 2 0.0 6 959 86.0 8 091 Injecting drug use
Heterosexual contact 2 429 15.8 27 0.2 107 0.7 184 1.2 10 0.1 11 0.1 23 0.1 12 550 81.8 15 341 Heterosexual contact
Mother-to-child 118 33.9 0 0.0 1 0.3 5 1.4 0 0.0 0 0.0 0 0.0 224 64.4 348 Mother-to-child
Haemophiliac/transfusion recipient 145 93.5 3 1.9 1 0.6 0 0.0 0 0.0 1 0.6 0 0.0 5 3.2 155 Haemophiliac/transfusion recipient
Nosocomial infection 96 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 96 Nosocomial infection
Other/undetermined 769 59.0 13 1.0 61 4.7 33 2.5 7 0.5 2 0.2 12 0.9 406 31.2 1 303 Other/undetermined
Total non-EU/EEA 5 036 19.3 89 0.3 261 1.0 225 0.9 41 0.2 27 0.1 47 0.2 20 387 78.1 26 113 Total non-EU/EEA
Total WHO European Region 21 257 38.3 1 039 1.9 1 668 3.0 4 280 7.7 1 573 2.8 663 1.2 543 1.0 24 471 44.1 55 494 Total WHO European Region
Table 12b: Geographical areas, WHO European Region
Transmission mode
Country of report Western Europe Central & Eastern Europe Sub-Saharan Africa Latin America & Caribbean South & South-east Asia Other Unknown
Total Transmission mode
N % N % N % N % N % N % N % N %
West West
Men who have sex with men 7 988 70.2 655 5.8 404 3.6 185 1.6 882 7.8 252 2.2 244 2.1 768 6.7 11 378 Men who have sex with men
Injecting drug use 890 64.0 43 3.1 282 20.3 12 0.9 12 0.9 52 3.7 41 2.9 58 4.2 1 390 Injecting drug use
Heterosexual contact 3 599 37.3 238 2.5 548 5.7 3 642 37.7 537 5.6 283 2.9 172 1.8 635 6.6 9 654 Heterosexual contact
Mother-to-child 51 26.4 7 3.6 10 5.2 87 45.1 6 3.1 5 2.6 5 2.6 22 11.4 193 Mother-to-child
Haemophiliac/transfusion recipient 20 36.4 0 0.0 8 14.5 15 27.3 0 0.0 3 5.5 1 1.8 8 14.5 55 Haemophiliac/transfusion recipient
Nosocomial infection 1 16.7 0 0.0 3 50.0 0 0.0 0 0.0 2 33.3 0 0.0 0 0.0 6 Nosocomial infection
Other/undetermined 1 453 31.3 67 1.4 226 4.9 292 6.3 126 2.7 54 1.2 53 1.1 2 368 51.0 4 639 Other/undetermined
Total West 14 002 51.3 1 010 3.7 1 481 5.4 4 233 15.5 1 563 5.7 651 2.4 516 1.9 3 859 14.1 27 315 Total West
Centre Centre
Men who have sex with men 850 87.2 9 0.9 45 4.6 1 0.1 3 0.3 0 0.0 4 0.4 63 6.5 975 Men who have sex with men
Injecting drug use 265 97.1 1 0.4 3 1.1 0 0.0 0 0.0 0 0.0 0 0.0 4 1.5 273 Injecting drug use
Heterosexual contact 807 88.2 4 0.4 47 5.1 16 1.7 2 0.2 5 0.5 9 1.0 25 2.7 915 Heterosexual contact
Mother-to-child 30 90.9 0 0.0 2 6.1 0 0.0 0 0.0 0 0.0 0 0.0 1 3.0 33 Mother-to-child
Haemophiliac/transfusion recipient 140 95.9 3 2.1 1 0.7 1 0.7 0 0.0 0 0.0 0 0.0 1 0.7 146 Haemophiliac/transfusion recipient
Nosocomial infection 0 0.0 0 0.0 1 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 Nosocomial infection
Other/undetermined 1 082 78.9 12 0.9 53 3.9 27 2.0 5 0.4 7 0.5 12 0.9 174 12.7 1 372 Other/undetermined
Total Centre 3 174 85.4 29 0.8 152 4.1 45 1.2 10 0.3 12 0.3 25 0.7 268 7.2 3 715 Total Centre
East East
Men who have sex with men 90 29.7 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 213 70.3 303 Men who have sex with men
Injecting drug use 1 176 14.3 0 0.0 12 0.1 0 0.0 0 0.0 0 0.0 1 0.0 7 024 85.5 8 213 Injecting drug use
Heterosexual contact 2 113 14.4 0 0.0 22 0.1 2 0.0 0 0.0 0 0.0 1 0.0 12 578 85.5 14 716 Heterosexual contact
Mother-to-child 110 32.7 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 226 67.3 336 Mother-to-child
Haemophiliac/transfusion recipient 5 71.4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 28.6 7 Haemophiliac/transfusion recipient
Nosocomial infection 96 100.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 96 Nosocomial infection
Other/undetermined 491 61.9 0 0.0 1 0.1 0 0.0 0 0.0 0 0.0 0 0.0 301 38.0 793 Other/undetermined
Total East 4 081 16.7 0 0.0 35 0.1 2 0.0 0 0.0 0 0.0 2 0.0 20 344 83.2 24 464 Total East
Total WHO European Region 21 257 38.3 1 039 1.9 1 668 3.0 4 280 7.7 1 573 2.8 663 1.2 543 1.0 24 471 44.1 55 494 Total WHO European Region
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Table 13: HIV infections newly diagnosed, by probable region of infection, cases diagnosed in 2012, in EU/EEA and 
other countries of the WHO European Region
Area Country*
Country of report Western Europe Central & Eastern Europe Sub-Saharan Africa
Latin America & 
Caribbean South & South-east Asia Other Unknown Total Country
N % N % N % N % N Rate N % N % N %
EU/EEA EU/EEA
W Austria 43 14.1 6 2.0 2 0.7 4 1.3 2 0.7 10 3.3 0 0.0 239 78.1 306 Austria
W Belgium 341 27.8 39 3.2 19 1.5 191 15.6 18 1.5 21 1.7 9 0.7 589 48.0 1 227 Belgium
C Bulgaria 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 157 100.0 157 Bulgaria
C Croatia 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 74 100.0 74 Croatia
C Cyprus 30 51.7 13 22.4 2 3.4 3 5.2 0 0.0 0 0.0 0 0.0 10 17.2 58 Cyprus
C Czech Republic 0 0.0 4 1.9 2 0.9 2 0.9 0 0.0 0 0.0 0 0.0 204 96.2 212 Czech Republic
W Denmark 87 43.3 22 10.9 10 5.0 38 18.9 2 1.0 25 12.4 4 2.0 13 6.5 201 Denmark
E Estonia 217 68.9 1 0.3 1 0.3 1 0.3 0 0.0 0 0.0 1 0.3 94 29.8 315 Estonia
W Finland 7 4.5 17 10.9 26 16.7 22 14.1 0 0.0 28 17.9 0 0.0 56 35.9 156 Finland
W France 1 319 32.4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 747 67.6 4 066 France
W Germany 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 953 100.0 2 953 Germany
W Greece 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 059 100.0 1 059 Greece
C Hungary 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 219 100.0 219 Hungary
W Iceland 2 10.5 2 10.5 1 5.3 1 5.3 0 0.0 0 0.0 1 5.3 12 63.2 19 Iceland
W Ireland 122 36.0 12 3.5 6 1.8 60 17.7 9 2.7 9 2.7 2 0.6 119 35.1 339 Ireland
W Italy 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 3 898 100.0 3 898 Italy
E Latvia 332 97.9 4 1.2 3 0.9 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 339 Latvia
E Lithuania 102 63.7 2 1.3 7 4.4 0 0.0 0 0.0 0 0.0 0 0.0 49 30.6 160 Lithuania
W Luxembourg 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 54 100.0 54 Luxembourg
W Malta 0 0.0 2 6.7 0 0.0 1 3.3 0 0.0 0 0.0 0 0.0 27 90.0 30 Malta
W Netherlands 612 62.7 16 1.6 10 1.0 39 4.0 23 2.4 24 2.5 3 0.3 249 25.5 976 Netherlands
W Norway 0 0.0 15 6.2 18 7.4 74 30.6 7 2.9 34 14.0 8 3.3 86 35.5 242 Norway
C Poland 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 085 100.0 1 085 Poland
W Portugal 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 721 100.0 721 Portugal
C Romania 437 89.4 1 0.2 4 0.8 0 0.0 0 0.0 0 0.0 0 0.0 47 9.6 489 Romania
C Slovakia 0 0.0 1 2.0 3 6.0 0 0.0 0 0.0 1 2.0 0 0.0 45 90.0 50 Slovakia
C Slovenia 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 45 100.0 45 Slovenia
W Spain 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 3 210 100.0 3 210 Spain
W Sweden 117 32.2 13 3.6 17 4.7 123 33.9 5 1.4 57 15.7 13 3.6 18 5.0 363 Sweden
W United Kingdom 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 6 358 100.0 6 358 United Kingdom
Total EU/EEA 3 768 12.8 170 0.6 131 0.4 559 1.9 66 0.2 209 0.7 41 0.1 24 437 83.2 29 381 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 81 100.0 81 Albania
W Andorra 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 100.0 2 Andorra
E Armenia 73 32.2 3 1.3 136 59.9 0 0.0 0 0.0 0 0.0 1 0.4 14 6.2 227 Armenia
E Azerbaijan 304 58.8 1 0.2 95 18.4 1 0.2 0 0.0 3 0.6 0 0.0 113 21.9 517 Azerbaijan
E Belarus 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 223 100.0 1 223 Belarus
C Bosnia and Herzegovina 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 25 100.0 25 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 14 100.0 14 former Yugoslav Republic of Macedonia, the
E Georgia 185 35.2 26 4.9 164 31.2 2 0.4 0 0.0 0 0.0 3 0.6 146 27.8 526 Georgia
W Israel 268 55.0 3 0.6 68 14.0 79 16.2 8 1.6 3 0.6 16 3.3 42 8.6 487 Israel
E Kazakhstan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 014 100.0 2 014 Kazakhstan
E Kyrgyzstan 681 97.3 0 0.0 19 2.7 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 700 Kyrgyzstan
E Moldova 711 93.9 0 0.0 46 6.1 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 757 Moldova
W Monaco 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 Monaco
C Montenegro 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 13 100.0 13 Montenegro
E Russia - - 0.0 - 0.0 - - - - - . Russia
W San Marino 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 5 100.0 5 San Marino
C Serbia 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 125 100.0 125 Serbia
W Switzerland 213 33.1 33 5.1 6 0.9 58 9.0 18 2.8 22 3.4 7 1.1 286 44.5 643 Switzerland
E Tajikistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 814 100.0 814 Tajikistan
C Turkey 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 068 100.0 1 068 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 . Turkmenistan
E Ukraine 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 16 872 100.0 16 872 Ukraine
E Uzbekistan - - 0.0 - 0.0 - - - - - . Uzbekistan
Total non-EU/EEA 2 435 9.3 66 0.3 534 2.0 140 0.5 26 0.1 28 0.1 27 0.1 22 857 87.5 26 113 Total non-EU/EEA
Geographical area Geographical area
West 3 131 11.5 180 0.7 183 0.7 690 2.5 92 0.3 233 0.9 63 0.2 22 743 83.3 27 315 West
Centre 467 12.6 19 0.5 11 0.3 5 0.1 0 0.0 1 0.0 0 0.0 3 212 86.5 3 715 Centre
East 2 605 10.6 37 0.2 471 1.9 4 0.0 0 0.0 3 0.0 5 0.0 21 339 87.2 24 464 East
Total WHO European Region 6 203 11.2 236 0.4 665 1.2 699 1.3 92 0.2 237 0.4 68 0.1 47 294 85.2 55 494 Total WHO European Region
*  Country-specific comments are in Annex 5
43
HIV/AIDS surveillance in Europe 2012SURVEILLANCE REPORT
Table 13: HIV infections newly diagnosed, by probable region of infection, cases diagnosed in 2012, in EU/EEA and 
other countries of the WHO European Region
Area Country*
Country of report Western Europe Central & Eastern Europe Sub-Saharan Africa
Latin America & 
Caribbean South & South-east Asia Other Unknown Total Country
N % N % N % N % N Rate N % N % N %
EU/EEA EU/EEA
W Austria 43 14.1 6 2.0 2 0.7 4 1.3 2 0.7 10 3.3 0 0.0 239 78.1 306 Austria
W Belgium 341 27.8 39 3.2 19 1.5 191 15.6 18 1.5 21 1.7 9 0.7 589 48.0 1 227 Belgium
C Bulgaria 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 157 100.0 157 Bulgaria
C Croatia 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 74 100.0 74 Croatia
C Cyprus 30 51.7 13 22.4 2 3.4 3 5.2 0 0.0 0 0.0 0 0.0 10 17.2 58 Cyprus
C Czech Republic 0 0.0 4 1.9 2 0.9 2 0.9 0 0.0 0 0.0 0 0.0 204 96.2 212 Czech Republic
W Denmark 87 43.3 22 10.9 10 5.0 38 18.9 2 1.0 25 12.4 4 2.0 13 6.5 201 Denmark
E Estonia 217 68.9 1 0.3 1 0.3 1 0.3 0 0.0 0 0.0 1 0.3 94 29.8 315 Estonia
W Finland 7 4.5 17 10.9 26 16.7 22 14.1 0 0.0 28 17.9 0 0.0 56 35.9 156 Finland
W France 1 319 32.4 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 747 67.6 4 066 France
W Germany 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 953 100.0 2 953 Germany
W Greece 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 059 100.0 1 059 Greece
C Hungary 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 219 100.0 219 Hungary
W Iceland 2 10.5 2 10.5 1 5.3 1 5.3 0 0.0 0 0.0 1 5.3 12 63.2 19 Iceland
W Ireland 122 36.0 12 3.5 6 1.8 60 17.7 9 2.7 9 2.7 2 0.6 119 35.1 339 Ireland
W Italy 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 3 898 100.0 3 898 Italy
E Latvia 332 97.9 4 1.2 3 0.9 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 339 Latvia
E Lithuania 102 63.7 2 1.3 7 4.4 0 0.0 0 0.0 0 0.0 0 0.0 49 30.6 160 Lithuania
W Luxembourg 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 54 100.0 54 Luxembourg
W Malta 0 0.0 2 6.7 0 0.0 1 3.3 0 0.0 0 0.0 0 0.0 27 90.0 30 Malta
W Netherlands 612 62.7 16 1.6 10 1.0 39 4.0 23 2.4 24 2.5 3 0.3 249 25.5 976 Netherlands
W Norway 0 0.0 15 6.2 18 7.4 74 30.6 7 2.9 34 14.0 8 3.3 86 35.5 242 Norway
C Poland 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 085 100.0 1 085 Poland
W Portugal 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 721 100.0 721 Portugal
C Romania 437 89.4 1 0.2 4 0.8 0 0.0 0 0.0 0 0.0 0 0.0 47 9.6 489 Romania
C Slovakia 0 0.0 1 2.0 3 6.0 0 0.0 0 0.0 1 2.0 0 0.0 45 90.0 50 Slovakia
C Slovenia 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 45 100.0 45 Slovenia
W Spain 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 3 210 100.0 3 210 Spain
W Sweden 117 32.2 13 3.6 17 4.7 123 33.9 5 1.4 57 15.7 13 3.6 18 5.0 363 Sweden
W United Kingdom 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 6 358 100.0 6 358 United Kingdom
Total EU/EEA 3 768 12.8 170 0.6 131 0.4 559 1.9 66 0.2 209 0.7 41 0.1 24 437 83.2 29 381 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 81 100.0 81 Albania
W Andorra 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 100.0 2 Andorra
E Armenia 73 32.2 3 1.3 136 59.9 0 0.0 0 0.0 0 0.0 1 0.4 14 6.2 227 Armenia
E Azerbaijan 304 58.8 1 0.2 95 18.4 1 0.2 0 0.0 3 0.6 0 0.0 113 21.9 517 Azerbaijan
E Belarus 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 223 100.0 1 223 Belarus
C Bosnia and Herzegovina 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 25 100.0 25 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 14 100.0 14 former Yugoslav Republic of Macedonia, the
E Georgia 185 35.2 26 4.9 164 31.2 2 0.4 0 0.0 0 0.0 3 0.6 146 27.8 526 Georgia
W Israel 268 55.0 3 0.6 68 14.0 79 16.2 8 1.6 3 0.6 16 3.3 42 8.6 487 Israel
E Kazakhstan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 014 100.0 2 014 Kazakhstan
E Kyrgyzstan 681 97.3 0 0.0 19 2.7 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 700 Kyrgyzstan
E Moldova 711 93.9 0 0.0 46 6.1 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 757 Moldova
W Monaco 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 Monaco
C Montenegro 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 13 100.0 13 Montenegro
E Russia - - 0.0 - 0.0 - - - - - . Russia
W San Marino 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 5 100.0 5 San Marino
C Serbia 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 125 100.0 125 Serbia
W Switzerland 213 33.1 33 5.1 6 0.9 58 9.0 18 2.8 22 3.4 7 1.1 286 44.5 643 Switzerland
E Tajikistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 814 100.0 814 Tajikistan
C Turkey 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 068 100.0 1 068 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 . Turkmenistan
E Ukraine 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 16 872 100.0 16 872 Ukraine
E Uzbekistan - - 0.0 - 0.0 - - - - - . Uzbekistan
Total non-EU/EEA 2 435 9.3 66 0.3 534 2.0 140 0.5 26 0.1 28 0.1 27 0.1 22 857 87.5 26 113 Total non-EU/EEA
Geographical area Geographical area
West 3 131 11.5 180 0.7 183 0.7 690 2.5 92 0.3 233 0.9 63 0.2 22 743 83.3 27 315 West
Centre 467 12.6 19 0.5 11 0.3 5 0.1 0 0.0 1 0.0 0 0.0 3 212 86.5 3 715 Centre
East 2 605 10.6 37 0.2 471 1.9 4 0.0 0 0.0 3 0.0 5 0.0 21 339 87.2 24 464 East
Total WHO European Region 6 203 11.2 236 0.4 665 1.2 699 1.3 92 0.2 237 0.4 68 0.1 47 294 85.2 55 494 Total WHO European Region
*  Country-specific comments are in Annex 5
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Table 14: Proportion of CD4 cell counts reported for HIV cases older than 14 years, diagnosed in 2012, CD4 less than 
200 among all CD4 cell counts reported, less than 350 among all CD4 cell counts reported, and less than 350 by 










CD4 <200 (%) CD4 <350 (%)
Hetero IDU MSM MTCT** Unknown 
N % N %
EU/EEA
W Austria 276 90.2 83 30.1 142 51.4 65.3 51.6 40.3 - 52.9
W Belgium 662 54.4 155 23.4 275 41.5 51.6 0.0 30.1 0.0 52.2
C Bulgaria 131 85.1 32 24.4 61 46.6 62.0 50.0 30.9 - -
C Croatia - - - - - - - - - - -
C Cyprus 50 87.7 10 20.0 15 30.0 44.4 - 16.7 0.0 100.0
C Czech Republic 185 88.1 35 18.9 52 28.1 44.7 40.0 21.5 0.0 50.0
W Denmark 158 80.2 57 36.1 83 52.5 54.5 70.0 43.9 100.0 100.0
E Estonia - - - - - - - - - - -
W Finland 121 78.6 33 27.3 57 47.1 48.4 66.7 39.5 0.0 83.3
W France 2 269 56.3 646 28.5 1 109 48.9 56.4 56.6 37.0 17.2 64.5
W Germany - - - - - - - - - - -
W Greece 652 61.6 232 35.6 388 59.5 76.6 64.1 45.5 - 75.0
C Hungary - - - - - - - - - - -
W Iceland - - - - - - - - - - -
W Ireland 254 76.0 60 23.6 121 47.6 57.4 55.6 38.8 0.0 66.7
W Italy 3 072 79.2 1 152 37.5 1 715 55.8 64.0 58.6 43.8 14.3 64.4
E Latvia 196 59.0 56 28.6 99 50.5 45.6 54.3 64.7 100.0 50.0
E Lithuania - - - - - - - - - - -
W Luxembourg 39 72.2 7 17.9 16 41.0 60.0 50.0 28.6 - 0.0
W Malta - - - - - - - - - - -
W Netherlands 843 86.7 208 24.7 360 42.7 55.5 75.0 34.7 0.0 72.7
W Norway - - - - - - - - - - -
C Poland - - - - - - - - - - -
W Portugal 73 10.2 38 52.1 58 79.5 81.0 88.9 72.7 - -
C Romania 409 85.7 28 6.8 131 32.0 33.6 25.7 33.3 11.1 44.2
C Slovakia 34 69.4 9 26.5 14 41.2 63.6 - 25.0 - 66.7
C Slovenia 44 97.8 17 38.6 29 65.9 50.0 100.0 63.6 - 83.3
W Spain 2 753 86.0 780 28.3 1 313 47.7 58.7 63.6 39.1 25.0 50.6
W Sweden - - - - - - - - - - -
W United Kingdom 3 929 62.2 1 150 29.3 1 928 49.1 61.1 65.8 37.4 50.0 62.5
Total EU/EEA 16 150 55.3 4 788 29.6 7 966 49.3 59.1 55.9 38.4 22.5 59.8
Non-EU/EEA
C Albania - - - - - - - - - - -
W Andorra - - - - - - - - - - -
E Armenia 182 81.6 79 43.4 112 61.5 56.8 73.7 33.3 33.3 88.9
E Azerbaijan 269 53.8 111 41.3 176 65.4 58.9 76.7 50.0 37.5 50.0
E Belarus - - - - - - - - - - -
C Bosnia and Herzegovina 12 48.0 4 33.3 9 75.0 66.7 - 77.8 - -
C
former Yugoslav 
Republic of Macedonia, 
the
- - - - - - - - - - -
E Georgia 433 83.8 190 43.9 305 70.4 66.8 82.5 41.5 33.3 66.7
W Israel 336 70.0 92 27.4 168 50.0 65.0 52.0 33.1 33.3 57.1
E Kazakhstan - - - - - - - - - - -
E Kyrgyzstan 108 19.1 20 18.5 59 54.6 53.2 57.8 0.0 14.3 -
E Moldova - - - - - - - - - - -
W Monaco - - - - - - - - - - -
C Montenegro 11 84.6 5 45.5 6 54.5 50.0 100.0 33.3 - 100.0
E Russia - - - - - - - - - - -
W San Marino - - - - - - - - - - -
C Serbia 96 76.8 34 35.4 51 53.1 58.8 50.0 46.4 - 100.0
W Switzerland 325 50.9 100 30.8 175 53.8 57.8 60.0 47.1 100.0 66.7
E Tajikistan 448 66.0 131 29.2 242 54.0 50.2 60.8 - 17.4 50.9
C Turkey - - - - - - - - - - -
E Turkmenistan - - - - - - - - - - -
E Ukraine - - - - - - - - - - -
E Uzbekistan - - - - - - - - - - -
Total non-EU/EEA 2 220 8.7 766 34.5 1 303 58.7 58.6 69.9 42.0 27.3 61.6
Total WHO European 
Region 18 369 33.6 5 553 30.2 9 268 50.5 59.0 61.1 38.6 24.4 60.0
* Country-specific comments are in Annex 5
** Includes all ages
Hetero: heterosexual contact; IDU: injecting drug use; MSM: men who have sex with men; MTCT: mother-to-child transmission.
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Table 15: AIDS cases and rates per 100 000 population, by country and year of diagnosis (2006–2012) and cumulative 
totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 118 1.4 129 1.6 110 1.3 102 1.2 94 1.1 66 0.8 28 0.3 3 792 Austria
W Belgium 105 1.0 103 1.0 118 1.1 121 1.1 101 0.9 83 0.8 82 0.7 4 334 Belgium
C Bulgaria 16 0.2 22 0.3 31 0.4 30 0.4 32 0.4 40 0.5 65 0.9 397 Bulgaria
C Croatia 20 0.5 11 0.3 25 0.6 22 0.5 21 0.5 26 0.6 28 0.6 402 Cyprus
C Cyprus 8 1.0 12 1.5 12 1.5 8 1.0 10 1.2 5 0.6 5 0.6 243 Cyprus
C Czech Republic 18 0.2 23 0.2 29 0.3 23 0.2 26 0.2 24 0.2 29 0.3 374 Czech Republic
W Denmark 51 0.9 32 0.6 40 0.7 36 0.7 44 0.8 59 1.1 41 0.7 2 889 Denmark
E Estonia 32 2.4 57 4.2 61 4.5 38 2.8 26 1.9 38 2.8 36 2.7 390 Estonia
W Finland 26 0.5 33 0.6 27 0.5 23 0.4 32 0.6 25 0.5 19 0.4 596 Finland
W France 1 175 1.9 1 009 1.6 1 051 1.6 947 1.5 961 1.5 810 1.2 497 0.8 68 241 France
W Germany 710 0.9 641 0.8 567 0.7 605 0.7 457 0.6 442 0.5 280 0.3 29 294 Germany
W Greece 89 0.8 90 0.8 103 0.9 99 0.9 102 0.9 97 0.9 108 1.0 3 386 Greece
C Hungary 22 0.2 23 0.2 23 0.2 23 0.2 28 0.3 32 0.3 48 0.5 703 Hungary
W Iceland 3 1.0 0 0.0 2 0.6 0 0.0 1 0.3 2 0.6 1 0.3 66 Iceland
W Ireland 42 1.0 35 0.8 36 0.8 35 0.8 38 0.9 47 1.0 34 0.7 1 162 Ireland
W Italy 1 454 2.5 1 401 2.4 1 332 2.2 1 192 2.0 1 125 1.9 1 018 1.7 715 1.2 64 898 Italy
E Latvia 90 3.9 81 3.6 103 4.5 101 4.5 132 5.9 111 5.4 139 6.8 1 216 Latvia
E Lithuania 27 0.8 28 0.8 54 1.6 37 1.1 33 1.0 21 0.7 38 1.3 334 Lithuania
W Luxembourg 9 1.9 11 2.3 8 1.7 3 0.6 8 1.6 11 2.1 7 1.3 267 Luxembourg
W Malta 7 1.7 2 0.5 9 2.2 1 0.2 6 1.4 5 1.2 6 1.4 102 Malta
W Netherlands 291 1.8 298 1.8 270 1.6 267 1.6 274 1.7 220 1.3 208 1.2 3 825 Netherlands
W Norway 32 0.7 9 0.2 18 0.4 18 0.4 22 0.5 19 0.4 25 0.5 1 041 Norway
C Poland 167 0.4 141 0.4 179 0.5 129 0.3 173 0.5 181 0.5 147 0.4 2 907 Poland
W Portugal 732 6.9 630 6.0 610 5.8 485 4.6 495 4.7 394 3.8 249 2.4 17 373 Portugal
C Romania 289 1.3 288 1.3 281 1.3 257 1.2 247 1.2 299 1.4 293 1.4 12 936 Romania
C Slovakia 4 0.1 6 0.1 1 0.0 4 0.1 2 0.0 4 0.1 7 0.1 68 Slovakia
C Slovenia 5 0.2 9 0.4 11 0.5 18 0.9 7 0.3 15 0.7 11 0.5 201 Slovenia
W Spain 1 734 4.0 1 621 3.6 1 525 3.4 1 392 3.0 1 172 2.5 1 015 2.2 777 1.7 82 905 Spain
W Sweden 55 0.6 62 0.7 - - - - - - - 2 168 Sweden
W United Kingdom 882 1.5 838 1.4 827 1.4 649 1.1 659 1.1 411 0.7 390 0.6 27 789 United Kingdom
Total EU/EEA 8 213 1.6 7 645 1.5 7 463 1.5 6 665 1.3 6 328 1.3 5 520 1.1 4 313 0.9 334 299 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 8 0.3 17 0.5 28 0.9 32 1.0 24 0.8 40 1.4 40 1.4 250 Albania
W Andorra 0 0.0 0 0.0 2 2.4 0 0.0 0 0.0 1 1.2 0 0.0 5 Andorra
E Armenia 46 1.4 59 1.8 83 2.6 84 2.6 94 2.9 87 2.7 133 4.1 691 Armenia
E Azerbaijan 21 0.2 200 2.3 76 0.9 109 1.2 210 2.3 195 2.1 235 2.5 1 130 Azerbaijan
E Belarus 332 3.4 309 3.2 387 4.0 500 5.2 545 5.7 585 6.2 527 5.6 3 523 Belarus
C Bosnia and Herzegovina 4 0.1 4 0.1 5 0.1 2 0.1 6 0.2 7 0.2 4 0.1 120 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 10 0.5 10 0.5 9 0.4 2 0.1 6 0.3 8 0.4 9 0.4 122 former Yugoslav Republic of Macedonia, the
E Georgia 162 3.7 183 4.2 232 5.3 284 6.5 339 7.7 395 8.9 359 8.1 2 361 Georgia
W Israel 71 1.1 49 0.7 53 0.7 49 0.7 37 0.5 53 0.7 37 0.5 1 415 Israel
E Kazakhstan 132 0.9 175 1.1 174 1.1 173 1.1 264 1.7 226 1.4 234 1.4 1 710 Kazakhstan
E Kyrgyzstan 29 0.6 24 0.5 36 0.7 75 1.4 130 2.4 90 1.7 88 1.6 530 Kyrgyzstan
E Moldova 93 2.6 218 6.1 92 2.6 262 7.3 306 8.6 439 12.3 183 5.1 1 817 Moldova
W Monaco 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 49 Monaco
C Montenegro 3 0.5 3 0.5 5 0.8 6 1.0 6 1.0 3 0.5 7 1.1 69 Montenegro
E Russia - - - - - - - - Russia
W San Marino 1 3.3 0 0.0 0 0.0 0 0.0 0 0.0 1 3.1 2 6.2 23 San Marino
C Serbia*** 52 0.7 42 0.6 38 0.5 55 0.7 50 0.7 53 0.7 50 0.7 1 643 Serbia
W Switzerland 158 2.1 173 2.3 158 2.1 146 1.9 156 2.0 119 1.5 58 0.7 9 422 Switzerland
E Tajikistan 1 0.0 31 0.4 43 0.6 11 0.1 75 1.0 94 1.2 87 1.1 343 Tajikistan
C Turkey 30 0.0 30 0.0 55 0.1 67 0.1 60 0.1 80 0.1 95 0.1 1 016 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 Turkmenistan
E Ukraine**** - - - - - - - - - - - - - - - Ukraine
E Uzbekistan 13 0.0 35 0.1 184 0.7 129 0.5 220 0.8 - - - - 651 Uzbekistan
Total non-EU/EEA 1 166 0.6 1 562 0.9 1 660 0.9 1 986 1.1 2 528 1.3 2 476 1.5 2 148 1.3 26 842 Total non-EU/EEA
Geographic area Geographic area
West 7 745 1.9 7 166 1.7 6 866 1.7 6 170 1.5 5 784 1.4 4 898 1.2 3 564 0.9 324 993 West
Centre 656 0.3 641 0.3 732 0.4 678 0.4 698 0.4 817 0.4 838 0.4 21 451 Centre
East 978 1.2 1 400 1.6 1 525 1.7 1 803 2.0 2 374 2.5 2 281 3.5 2 059 3.1 14 697 East
Total WHO European Region 9 379 1.4 9 207 1.3 9 123 1.3 8 651 1.3 8 856 1.3 7 996 1.2 6 461 1.0 361 141 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
*** Excluding 48 AIDS diagnoses reported from Kosovo (without prejudice to positions on status, and is in line with UNSCR 1244 and the IС J Opinion on the Kosovo 
Declaration of Independence)
**** Case-based data reported through TESSy are incomplete. The total numbers of AIDS cases diagnosed annually during 2006–2012 in Ukraine are: 4723, 4573, 
4380, 4419, 5869, 9190, 10073 and the cumulative number is 57 126 (ref: http://ucdc.gov.ua/uk/statystyka/informatsijni-byuleteni)
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Table 15: AIDS cases and rates per 100 000 population, by country and year of diagnosis (2006–2012) and cumulative 
totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 118 1.4 129 1.6 110 1.3 102 1.2 94 1.1 66 0.8 28 0.3 3 792 Austria
W Belgium 105 1.0 103 1.0 118 1.1 121 1.1 101 0.9 83 0.8 82 0.7 4 334 Belgium
C Bulgaria 16 0.2 22 0.3 31 0.4 30 0.4 32 0.4 40 0.5 65 0.9 397 Bulgaria
C Croatia 20 0.5 11 0.3 25 0.6 22 0.5 21 0.5 26 0.6 28 0.6 402 Cyprus
C Cyprus 8 1.0 12 1.5 12 1.5 8 1.0 10 1.2 5 0.6 5 0.6 243 Cyprus
C Czech Republic 18 0.2 23 0.2 29 0.3 23 0.2 26 0.2 24 0.2 29 0.3 374 Czech Republic
W Denmark 51 0.9 32 0.6 40 0.7 36 0.7 44 0.8 59 1.1 41 0.7 2 889 Denmark
E Estonia 32 2.4 57 4.2 61 4.5 38 2.8 26 1.9 38 2.8 36 2.7 390 Estonia
W Finland 26 0.5 33 0.6 27 0.5 23 0.4 32 0.6 25 0.5 19 0.4 596 Finland
W France 1 175 1.9 1 009 1.6 1 051 1.6 947 1.5 961 1.5 810 1.2 497 0.8 68 241 France
W Germany 710 0.9 641 0.8 567 0.7 605 0.7 457 0.6 442 0.5 280 0.3 29 294 Germany
W Greece 89 0.8 90 0.8 103 0.9 99 0.9 102 0.9 97 0.9 108 1.0 3 386 Greece
C Hungary 22 0.2 23 0.2 23 0.2 23 0.2 28 0.3 32 0.3 48 0.5 703 Hungary
W Iceland 3 1.0 0 0.0 2 0.6 0 0.0 1 0.3 2 0.6 1 0.3 66 Iceland
W Ireland 42 1.0 35 0.8 36 0.8 35 0.8 38 0.9 47 1.0 34 0.7 1 162 Ireland
W Italy 1 454 2.5 1 401 2.4 1 332 2.2 1 192 2.0 1 125 1.9 1 018 1.7 715 1.2 64 898 Italy
E Latvia 90 3.9 81 3.6 103 4.5 101 4.5 132 5.9 111 5.4 139 6.8 1 216 Latvia
E Lithuania 27 0.8 28 0.8 54 1.6 37 1.1 33 1.0 21 0.7 38 1.3 334 Lithuania
W Luxembourg 9 1.9 11 2.3 8 1.7 3 0.6 8 1.6 11 2.1 7 1.3 267 Luxembourg
W Malta 7 1.7 2 0.5 9 2.2 1 0.2 6 1.4 5 1.2 6 1.4 102 Malta
W Netherlands 291 1.8 298 1.8 270 1.6 267 1.6 274 1.7 220 1.3 208 1.2 3 825 Netherlands
W Norway 32 0.7 9 0.2 18 0.4 18 0.4 22 0.5 19 0.4 25 0.5 1 041 Norway
C Poland 167 0.4 141 0.4 179 0.5 129 0.3 173 0.5 181 0.5 147 0.4 2 907 Poland
W Portugal 732 6.9 630 6.0 610 5.8 485 4.6 495 4.7 394 3.8 249 2.4 17 373 Portugal
C Romania 289 1.3 288 1.3 281 1.3 257 1.2 247 1.2 299 1.4 293 1.4 12 936 Romania
C Slovakia 4 0.1 6 0.1 1 0.0 4 0.1 2 0.0 4 0.1 7 0.1 68 Slovakia
C Slovenia 5 0.2 9 0.4 11 0.5 18 0.9 7 0.3 15 0.7 11 0.5 201 Slovenia
W Spain 1 734 4.0 1 621 3.6 1 525 3.4 1 392 3.0 1 172 2.5 1 015 2.2 777 1.7 82 905 Spain
W Sweden 55 0.6 62 0.7 - - - - - - - 2 168 Sweden
W United Kingdom 882 1.5 838 1.4 827 1.4 649 1.1 659 1.1 411 0.7 390 0.6 27 789 United Kingdom
Total EU/EEA 8 213 1.6 7 645 1.5 7 463 1.5 6 665 1.3 6 328 1.3 5 520 1.1 4 313 0.9 334 299 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 8 0.3 17 0.5 28 0.9 32 1.0 24 0.8 40 1.4 40 1.4 250 Albania
W Andorra 0 0.0 0 0.0 2 2.4 0 0.0 0 0.0 1 1.2 0 0.0 5 Andorra
E Armenia 46 1.4 59 1.8 83 2.6 84 2.6 94 2.9 87 2.7 133 4.1 691 Armenia
E Azerbaijan 21 0.2 200 2.3 76 0.9 109 1.2 210 2.3 195 2.1 235 2.5 1 130 Azerbaijan
E Belarus 332 3.4 309 3.2 387 4.0 500 5.2 545 5.7 585 6.2 527 5.6 3 523 Belarus
C Bosnia and Herzegovina 4 0.1 4 0.1 5 0.1 2 0.1 6 0.2 7 0.2 4 0.1 120 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 10 0.5 10 0.5 9 0.4 2 0.1 6 0.3 8 0.4 9 0.4 122 former Yugoslav Republic of Macedonia, the
E Georgia 162 3.7 183 4.2 232 5.3 284 6.5 339 7.7 395 8.9 359 8.1 2 361 Georgia
W Israel 71 1.1 49 0.7 53 0.7 49 0.7 37 0.5 53 0.7 37 0.5 1 415 Israel
E Kazakhstan 132 0.9 175 1.1 174 1.1 173 1.1 264 1.7 226 1.4 234 1.4 1 710 Kazakhstan
E Kyrgyzstan 29 0.6 24 0.5 36 0.7 75 1.4 130 2.4 90 1.7 88 1.6 530 Kyrgyzstan
E Moldova 93 2.6 218 6.1 92 2.6 262 7.3 306 8.6 439 12.3 183 5.1 1 817 Moldova
W Monaco 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 49 Monaco
C Montenegro 3 0.5 3 0.5 5 0.8 6 1.0 6 1.0 3 0.5 7 1.1 69 Montenegro
E Russia - - - - - - - - Russia
W San Marino 1 3.3 0 0.0 0 0.0 0 0.0 0 0.0 1 3.1 2 6.2 23 San Marino
C Serbia*** 52 0.7 42 0.6 38 0.5 55 0.7 50 0.7 53 0.7 50 0.7 1 643 Serbia
W Switzerland 158 2.1 173 2.3 158 2.1 146 1.9 156 2.0 119 1.5 58 0.7 9 422 Switzerland
E Tajikistan 1 0.0 31 0.4 43 0.6 11 0.1 75 1.0 94 1.2 87 1.1 343 Tajikistan
C Turkey 30 0.0 30 0.0 55 0.1 67 0.1 60 0.1 80 0.1 95 0.1 1 016 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 Turkmenistan
E Ukraine**** - - - - - - - - - - - - - - - Ukraine
E Uzbekistan 13 0.0 35 0.1 184 0.7 129 0.5 220 0.8 - - - - 651 Uzbekistan
Total non-EU/EEA 1 166 0.6 1 562 0.9 1 660 0.9 1 986 1.1 2 528 1.3 2 476 1.5 2 148 1.3 26 842 Total non-EU/EEA
Geographic area Geographic area
West 7 745 1.9 7 166 1.7 6 866 1.7 6 170 1.5 5 784 1.4 4 898 1.2 3 564 0.9 324 993 West
Centre 656 0.3 641 0.3 732 0.4 678 0.4 698 0.4 817 0.4 838 0.4 21 451 Centre
East 978 1.2 1 400 1.6 1 525 1.7 1 803 2.0 2 374 2.5 2 281 3.5 2 059 3.1 14 697 East
Total WHO European Region 9 379 1.4 9 207 1.3 9 123 1.3 8 651 1.3 8 856 1.3 7 996 1.2 6 461 1.0 361 141 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
*** Excluding 48 AIDS diagnoses reported from Kosovo (without prejudice to positions on status, and is in line with UNSCR 1244 and the IС J Opinion on the Kosovo 
Declaration of Independence)
**** Case-based data reported through TESSy are incomplete. The total numbers of AIDS cases diagnosed annually during 2006–2012 in Ukraine are: 4723, 4573, 
4380, 4419, 5869, 9190, 10073 and the cumulative number is 57 126 (ref: http://ucdc.gov.ua/uk/statystyka/informatsijni-byuleteni)
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Table 15a: AIDS cases and rates per 100 000 population, by country and year of statistics (2006–2012) and cumulative 
totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 118 1.4 129 1.6 110 1.3 102 1.2 94 1.1 66 0.8 28 0.3 3 792 Austria
W Belgium 105 1.0 103 1.0 118 1.1 121 1.1 101 0.9 83 0.8 82 0.7 4 334 Belgium
C Bulgaria 16 0.2 22 0.3 31 0.4 30 0.4 32 0.4 40 0.5 65 0.9 397 Bulgaria
C Croatia 20 0.5 11 0.3 25 0.6 22 0.5 21 0.5 26 0.6 28 0.6 402 Croatia
C Cyprus 8 1.0 12 1.5 12 1.5 8 1.0 10 1.2 5 0.6 5 0.6 243 Cyprus
C Czech Republic 18 0.2 23 0.2 29 0.3 23 0.2 26 0.2 24 0.2 29 0.3 374 Czech Republic
W Denmark 51 0.9 32 0.6 40 0.7 36 0.7 44 0.8 59 1.1 41 0.7 2 889 Denmark
E Estonia 32 2.4 57 4.2 61 4.5 38 2.8 25 1.9 39 2.9 36 2.7 390 Estonia
W Finland 26 0.5 33 0.6 27 0.5 23 0.4 32 0.6 25 0.5 19 0.4 596 Finland
W France 1 175 1.9 1 009 1.6 1 051 1.6 947 1.5 961 1.5 810 1.2 497 0.8 68 241 France
W Germany 710 0.9 641 0.8 567 0.7 605 0.7 457 0.6 442 0.5 280 0.3 29 294 Germany
W Greece 89 0.8 90 0.8 103 0.9 99 0.9 102 0.9 97 0.9 108 1.0 3 386 Greece
C Hungary 22 0.2 23 0.2 23 0.2 23 0.2 28 0.3 32 0.3 48 0.5 703 Hungary
W Iceland 3 1.0 0 0.0 2 0.6 0 0.0 1 0.3 2 0.6 1 0.3 66 Iceland
W Ireland 42 1.0 35 0.8 36 0.8 35 0.8 38 0.9 47 1.0 34 0.7 1 162 Ireland
W Italy 1 454 2.5 1 401 2.4 1 332 2.2 1 192 2.0 1 125 1.9 1 018 1.7 715 1.2 64 898 Italy
E Latvia 90 3.9 81 3.6 103 4.5 101 4.5 132 5.9 111 5.4 139 6.8 1 216 Latvia
E Lithuania 27 0.8 28 0.8 54 1.6 37 1.1 33 1.0 21 0.7 38 1.3 334 Lithuania
W Luxembourg 9 1.9 11 2.3 8 1.7 3 0.6 8 1.6 11 2.1 7 1.3 267 Luxembourg
W Malta 7 1.7 2 0.5 9 2.2 1 0.2 6 1.4 5 1.2 6 1.4 102 Malta
W Netherlands 291 1.8 298 1.8 270 1.6 267 1.6 274 1.7 220 1.3 208 1.2 3 825 Netherlands
W Norway 32 0.7 9 0.2 18 0.4 18 0.4 22 0.5 19 0.4 25 0.5 1 041 Norway
C Poland 122 0.3 183 0.5 159 0.4 126 0.3 127 0.3 264 0.7 144 0.4 2 848 Poland
W Portugal 732 6.9 630 6.0 610 5.8 485 4.6 495 4.7 394 3.8 249 2.4 17 373 Portugal
C Romania 289 1.3 288 1.3 281 1.3 257 1.2 247 1.2 299 1.4 293 1.4 12 936 Romania
C Slovakia 4 0.1 6 0.1 1 0.0 4 0.1 2 0.0 4 0.1 7 0.1 68 Slovakia
C Slovenia 5 0.2 9 0.4 11 0.5 18 0.9 7 0.3 15 0.7 11 0.5 201 Slovenia
W Spain 1 734 4.0 1 621 3.6 1 525 3.4 1 392 3.0 1 172 2.5 1 015 2.2 777 1.7 82 905 Spain
W Sweden 47 0.5 73 0.8 - - - - - - - - - - 2 168 Sweden
W United Kingdom 882 1.5 838 1.4 827 1.4 649 1.1 659 1.1 411 0.7 390 0.6 27 789 United Kingdom
Total EU/EEA 8 160 1.6 7 698 1.5 7 443 1.5 6 662 1.3 6 281 1.3 5 604 1.1 4 310 0.9 334 240 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 8 0.3 17 0.5 24 0.8 32 1.0 25 0.8 38 1.3 46 1.6 250 Albania
W Andorra 0 0.0 0 0.0 1 1.2 0 0.0 0 0.0 1 1.2 0 0.0 5 Andorra
E Armenia 46 1.4 59 1.8 83 2.6 84 2.6 94 2.9 87 2.7 133 4.1 691 Armenia
E Azerbaijan 21 0.2 200 2.3 76 0.9 109 1.2 210 2.3 195 2.1 235 2.5 1 130 Azerbaijan
E Belarus 331 3.4 308 3.2 351 3.7 532 5.6 475 5.0 590 6.3 598 6.4 3 523 Belarus
C Bosnia and Herzegovina 8 0.2 4 0.1 5 0.1 2 0.1 6 0.2 7 0.2 4 0.1 120 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 9 0.4 11 0.5 10 0.5 2 0.1 8 0.4 6 0.3 9 0.4 122 former Yugoslav Republic of Macedonia, the
E Georgia 162 3.7 183 4.2 232 5.3 284 6.5 339 7.7 395 8.9 359 8.1 2 361 Georgia
W Israel 71 1.1 49 0.7 53 0.7 49 0.7 37 0.5 53 0.7 37 0.5 1 415 Israel
E Kazakhstan 132 0.9 175 1.1 174 1.1 173 1.1 256 1.6 234 1.5 234 1.4 1 710 Kazakhstan
E Kyrgyzstan 27 0.6 22 0.5 36 0.7 77 1.5 120 2.2 95 1.8 95 1.7 530 Kyrgyzstan
E Moldova 94 2.6 214 6.0 82 2.3 276 7.7 290 8.1 420 11.8 222 6.2 1 817 Moldova
W Monaco 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 49 Monaco
C Montenegro 2 0.3 4 0.6 5 0.8 6 1.0 6 1.0 3 0.5 7 1.1 69 Montenegro
E Russia - - - - - - - - Russia
W San Marino 1 3.3 0 0.0 0 0.0 0 0.0 0 0.0 1 3.1 2 6.2 23 San Marino
C Serbia*** 52 0.7 42 0.6 38 0.5 55 0.7 50 0.7 53 0.7 50 0.7 1 643 Serbia
W Switzerland 158 2.1 173 2.3 158 2.1 146 1.9 156 2.0 119 1.5 58 0.7 9 422 Switzerland
E Tajikistan 0 0.0 32 0.5 43 0.6 11 0.1 76 1.0 93 1.2 87 1.1 343 Tajikistan
C Turkey 35 0.0 29 0.0 54 0.1 72 0.1 63 0.1 80 0.1 95 0.1 1 016 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 Turkmenistan
E Ukraine - - - - - - - - Ukraine
E Uzbekistan 13 0.0 35 0.1 184 0.7 129 0.5 220 0.8 - - 651 Uzbekistan
Total non-EU/EEA 1 170 0.6 1 557 0.9 1 609 0.9 2 039 1.1 2 431 1.3 2 470 1.5 2 271 1.4 26 842 Total non-EU/EEA
Geographic area Geographic area
West 7 737 1.9 7 177 1.7 6 865 1.7 6 170 1.5 5 784 1.4 4 898 1.2 3 564 0.9 324 993 West
Centre 618 0.3 684 0.4 708 0.4 680 0.4 658 0.3 896 0.5 841 0.4 21 392 Centre
East 975 1.1 1 394 1.6 1 479 1.6 1 851 2.0 2 270 2.4 2 280 3.5 2 176 3.3 14 697 East
Total WHO European Region 9 330 1.4 9 255 1.4 9 052 1.3 8 701 1.3 8 712 1.3 8 074 1.2 6 581 1.0 361 082 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
*** Excluding 48 AIDS diagnoses reported from Kosovo (without prejudice to positions on status, and is in line with UNSCR 1244 and the IС J Opinion on the Kosovo 
Declaration of Independence)
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Table 15a: AIDS cases and rates per 100 000 population, by country and year of statistics (2006–2012) and cumulative 
totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 118 1.4 129 1.6 110 1.3 102 1.2 94 1.1 66 0.8 28 0.3 3 792 Austria
W Belgium 105 1.0 103 1.0 118 1.1 121 1.1 101 0.9 83 0.8 82 0.7 4 334 Belgium
C Bulgaria 16 0.2 22 0.3 31 0.4 30 0.4 32 0.4 40 0.5 65 0.9 397 Bulgaria
C Croatia 20 0.5 11 0.3 25 0.6 22 0.5 21 0.5 26 0.6 28 0.6 402 Croatia
C Cyprus 8 1.0 12 1.5 12 1.5 8 1.0 10 1.2 5 0.6 5 0.6 243 Cyprus
C Czech Republic 18 0.2 23 0.2 29 0.3 23 0.2 26 0.2 24 0.2 29 0.3 374 Czech Republic
W Denmark 51 0.9 32 0.6 40 0.7 36 0.7 44 0.8 59 1.1 41 0.7 2 889 Denmark
E Estonia 32 2.4 57 4.2 61 4.5 38 2.8 25 1.9 39 2.9 36 2.7 390 Estonia
W Finland 26 0.5 33 0.6 27 0.5 23 0.4 32 0.6 25 0.5 19 0.4 596 Finland
W France 1 175 1.9 1 009 1.6 1 051 1.6 947 1.5 961 1.5 810 1.2 497 0.8 68 241 France
W Germany 710 0.9 641 0.8 567 0.7 605 0.7 457 0.6 442 0.5 280 0.3 29 294 Germany
W Greece 89 0.8 90 0.8 103 0.9 99 0.9 102 0.9 97 0.9 108 1.0 3 386 Greece
C Hungary 22 0.2 23 0.2 23 0.2 23 0.2 28 0.3 32 0.3 48 0.5 703 Hungary
W Iceland 3 1.0 0 0.0 2 0.6 0 0.0 1 0.3 2 0.6 1 0.3 66 Iceland
W Ireland 42 1.0 35 0.8 36 0.8 35 0.8 38 0.9 47 1.0 34 0.7 1 162 Ireland
W Italy 1 454 2.5 1 401 2.4 1 332 2.2 1 192 2.0 1 125 1.9 1 018 1.7 715 1.2 64 898 Italy
E Latvia 90 3.9 81 3.6 103 4.5 101 4.5 132 5.9 111 5.4 139 6.8 1 216 Latvia
E Lithuania 27 0.8 28 0.8 54 1.6 37 1.1 33 1.0 21 0.7 38 1.3 334 Lithuania
W Luxembourg 9 1.9 11 2.3 8 1.7 3 0.6 8 1.6 11 2.1 7 1.3 267 Luxembourg
W Malta 7 1.7 2 0.5 9 2.2 1 0.2 6 1.4 5 1.2 6 1.4 102 Malta
W Netherlands 291 1.8 298 1.8 270 1.6 267 1.6 274 1.7 220 1.3 208 1.2 3 825 Netherlands
W Norway 32 0.7 9 0.2 18 0.4 18 0.4 22 0.5 19 0.4 25 0.5 1 041 Norway
C Poland 122 0.3 183 0.5 159 0.4 126 0.3 127 0.3 264 0.7 144 0.4 2 848 Poland
W Portugal 732 6.9 630 6.0 610 5.8 485 4.6 495 4.7 394 3.8 249 2.4 17 373 Portugal
C Romania 289 1.3 288 1.3 281 1.3 257 1.2 247 1.2 299 1.4 293 1.4 12 936 Romania
C Slovakia 4 0.1 6 0.1 1 0.0 4 0.1 2 0.0 4 0.1 7 0.1 68 Slovakia
C Slovenia 5 0.2 9 0.4 11 0.5 18 0.9 7 0.3 15 0.7 11 0.5 201 Slovenia
W Spain 1 734 4.0 1 621 3.6 1 525 3.4 1 392 3.0 1 172 2.5 1 015 2.2 777 1.7 82 905 Spain
W Sweden 47 0.5 73 0.8 - - - - - - - - - - 2 168 Sweden
W United Kingdom 882 1.5 838 1.4 827 1.4 649 1.1 659 1.1 411 0.7 390 0.6 27 789 United Kingdom
Total EU/EEA 8 160 1.6 7 698 1.5 7 443 1.5 6 662 1.3 6 281 1.3 5 604 1.1 4 310 0.9 334 240 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 8 0.3 17 0.5 24 0.8 32 1.0 25 0.8 38 1.3 46 1.6 250 Albania
W Andorra 0 0.0 0 0.0 1 1.2 0 0.0 0 0.0 1 1.2 0 0.0 5 Andorra
E Armenia 46 1.4 59 1.8 83 2.6 84 2.6 94 2.9 87 2.7 133 4.1 691 Armenia
E Azerbaijan 21 0.2 200 2.3 76 0.9 109 1.2 210 2.3 195 2.1 235 2.5 1 130 Azerbaijan
E Belarus 331 3.4 308 3.2 351 3.7 532 5.6 475 5.0 590 6.3 598 6.4 3 523 Belarus
C Bosnia and Herzegovina 8 0.2 4 0.1 5 0.1 2 0.1 6 0.2 7 0.2 4 0.1 120 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 9 0.4 11 0.5 10 0.5 2 0.1 8 0.4 6 0.3 9 0.4 122 former Yugoslav Republic of Macedonia, the
E Georgia 162 3.7 183 4.2 232 5.3 284 6.5 339 7.7 395 8.9 359 8.1 2 361 Georgia
W Israel 71 1.1 49 0.7 53 0.7 49 0.7 37 0.5 53 0.7 37 0.5 1 415 Israel
E Kazakhstan 132 0.9 175 1.1 174 1.1 173 1.1 256 1.6 234 1.5 234 1.4 1 710 Kazakhstan
E Kyrgyzstan 27 0.6 22 0.5 36 0.7 77 1.5 120 2.2 95 1.8 95 1.7 530 Kyrgyzstan
E Moldova 94 2.6 214 6.0 82 2.3 276 7.7 290 8.1 420 11.8 222 6.2 1 817 Moldova
W Monaco 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 49 Monaco
C Montenegro 2 0.3 4 0.6 5 0.8 6 1.0 6 1.0 3 0.5 7 1.1 69 Montenegro
E Russia - - - - - - - - Russia
W San Marino 1 3.3 0 0.0 0 0.0 0 0.0 0 0.0 1 3.1 2 6.2 23 San Marino
C Serbia*** 52 0.7 42 0.6 38 0.5 55 0.7 50 0.7 53 0.7 50 0.7 1 643 Serbia
W Switzerland 158 2.1 173 2.3 158 2.1 146 1.9 156 2.0 119 1.5 58 0.7 9 422 Switzerland
E Tajikistan 0 0.0 32 0.5 43 0.6 11 0.1 76 1.0 93 1.2 87 1.1 343 Tajikistan
C Turkey 35 0.0 29 0.0 54 0.1 72 0.1 63 0.1 80 0.1 95 0.1 1 016 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 Turkmenistan
E Ukraine - - - - - - - - Ukraine
E Uzbekistan 13 0.0 35 0.1 184 0.7 129 0.5 220 0.8 - - 651 Uzbekistan
Total non-EU/EEA 1 170 0.6 1 557 0.9 1 609 0.9 2 039 1.1 2 431 1.3 2 470 1.5 2 271 1.4 26 842 Total non-EU/EEA
Geographic area Geographic area
West 7 737 1.9 7 177 1.7 6 865 1.7 6 170 1.5 5 784 1.4 4 898 1.2 3 564 0.9 324 993 West
Centre 618 0.3 684 0.4 708 0.4 680 0.4 658 0.3 896 0.5 841 0.4 21 392 Centre
East 975 1.1 1 394 1.6 1 479 1.6 1 851 2.0 2 270 2.4 2 280 3.5 2 176 3.3 14 697 East
Total WHO European Region 9 330 1.4 9 255 1.4 9 052 1.3 8 701 1.3 8 712 1.3 8 074 1.2 6 581 1.0 361 082 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
*** Excluding 48 AIDS diagnoses reported from Kosovo (without prejudice to positions on status, and is in line with UNSCR 1244 and the IС J Opinion on the Kosovo 
Declaration of Independence)
50
SURVEILLANCE REPORTHIV/AIDS surveillance in Europe 2012
Table 16: AIDS cases in males and rates per 100 000 population, by country and year of diagnosis (2006–2012) and 
cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 95 2.4 101 2.5 89 2.2 70 1.7 73 1.8 47 1.1 21 0.5 2 928 Austria
W Belgium 65 1.3 65 1.3 75 1.4 76 1.4 59 1.1 53 1.0 49 0.9 2 952 Belgium
C Bulgaria 12 0.3 18 0.5 21 0.6 22 0.6 21 0.6 38 1.1 47 1.3 296 Bulgaria
C Croatia 14 0.7 10 0.5 24 1.1 20 0.9 20 0.9 25 1.2 26 1.2 353 Croatia
C Cyprus 7 1.9 8 2.1 10 2.6 8 2.0 7 1.8 2 0.5 4 1.0 189 Cyprus
C Czech Republic 13 0.3 18 0.4 22 0.4 17 0.3 20 0.4 16 0.3 23 0.4 305 Czech Republic
W Denmark 31 1.2 22 0.8 33 1.2 25 0.9 34 1.2 40 1.5 35 1.3 2 459 Denmark
E Estonia 22 3.6 46 7.4 44 7.1 26 4.2 21 3.4 31 5.0 25 4.0 288 Estonia
W Finland 20 0.8 22 0.9 24 0.9 15 0.6 23 0.9 18 0.7 16 0.6 487 Finland
W France 811 2.7 689 2.2 710 2.3 672 2.2 662 2.1 593 1.9 344 1.1 53 870 France
W Germany 586 1.5 514 1.3 474 1.2 493 1.2 377 0.9 373 0.9 224 0.6 25 132 Germany
W Greece 64 1.2 69 1.2 91 1.6 79 1.4 83 1.5 81 1.4 87 1.6 2 849 Greece
C Hungary 15 0.3 17 0.4 21 0.4 17 0.4 26 0.6 27 0.6 45 1.0 617 Hungary
W Iceland 2 1.3 0 2 1.2 0 1 0.6 1 0.6 1 0.6 57 Iceland
W Ireland 34 1.6 18 0.8 27 1.2 27 1.2 27 1.2 34 1.5 26 1.1 895 Ireland
W Italy 1 080 3.8 1 074 3.7 985 3.4 897 3.1 830 2.8 776 2.6 527 1.8 50 087 Italy
E Latvia 63 6.0 59 5.6 77 7.4 67 6.4 86 8.3 79 8.3 99 10.6 856 Latvia
E Lithuania 22 1.4 26 1.6 45 2.9 28 1.8 27 1.7 15 1.1 28 2.0 275 Lithuania
W Luxembourg 6 2.6 8 3.4 5 2.1 2 0.8 4 1.6 7 2.7 5 1.9 208 Luxembourg
W Malta 5 2.5 2 1.0 9 4.4 1 0.5 4 1.9 3 1.5 5 2.4 88 Malta
W Netherlands 231 2.9 228 2.8 217 2.7 226 2.8 217 2.6 173 2.1 163 2.0 2 994 Netherlands
W Norway 24 1.0 6 0.3 11 0.5 13 0.5 20 0.8 17 0.7 23 0.9 816 Norway
C Poland 130 0.7 108 0.6 139 0.8 99 0.5 132 0.7 139 0.7 115 0.6 2 291 Poland
W Portugal 548 10.7 482 9.5 456 9.0 356 7.0 364 7.2 305 6.1 183 3.7 14 029 Portugal
C Romania 161 1.5 170 1.6 154 1.5 161 1.5 135 1.3 200 1.9 212 2.0 7 444 Romania
C Slovakia 4 0.2 4 0.2 0 3 0.1 2 0.1 4 0.2 7 0.3 57 Slovakia
C Slovenia 5 0.5 7 0.7 9 0.9 16 1.6 7 0.7 12 1.2 10 1.0 175 Slovenia
W Spain 1 342 6.2 1 269 5.8 1 160 5.2 1 068 4.7 908 4.0 792 3.5 598 2.6 66 099 Spain
W Sweden 33 0.7 40 0.9 - - - - - 1 773 Sweden
W United Kingdom 525 1.8 552 1.9 512 1.7 441 1.5 434 1.4 286 0.9 269 0.9 21 833 United Kingdom
Total EU/EEA 5 970 2.4 5 652 2.3 5 446 2.2 4 945 2.0 4 624 1.9 4 187 1.7 3 217 1.3 262 702 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 5 0.3 15 1.0 21 1.3 25 1.6 17 1.1 31 2.2 27 1.9 191 Albania
W Andorra 0 0 2 4.6 0 0 1 2.3 0 4 Andorra
E Armenia 37 2.4 46 3.0 62 4.0 57 3.6 73 4.6 65 4.1 95 6.0 522 Armenia
E Azerbaijan 19 0.5 169 4.0 68 1.6 90 2.1 195 4.4 171 3.8 210 4.6 997 Azerbaijan
E Belarus 221 4.9 208 4.6 254 5.6 307 6.8 333 7.5 362 8.3 331 7.6 2 253 Belarus
C Bosnia and Herzegovina 3 0.2 4 0.2 4 0.2 2 0.1 6 0.3 4 0.2 4 0.2 96 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 9 0.9 9 0.9 5 0.5 2 0.2 6 0.6 5 0.5 7 0.7 87 former Yugoslav Republic of Macedonia, the
E Georgia 129 6.2 138 6.7 179 8.6 208 10.0 245 11.7 277 13.1 248 11.7 1 758 Georgia
W Israel 53 1.6 38 1.1 34 1.0 32 0.9 21 0.6 35 0.9 27 0.7 1 027 Israel
E Kazakhstan 88 1.2 110 1.5 124 1.7 111 1.5 194 2.5 150 1.9 180 2.3 1 216 Kazakhstan
E Kyrgyzstan 23 0.9 24 0.9 24 0.9 61 2.3 111 4.2 69 2.6 65 2.4 428 Kyrgyzstan
E Moldova 53 3.1 137 8.0 59 3.4 166 9.7 179 10.4 269 15.7 93 5.4 1 124 Moldova
W Monaco 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 38 Monaco
C Montenegro 3 1.0 3 1.0 4 1.3 4 1.3 6 2.0 3 1.0 7 2.3 57 Montenegro
E Russia - - - - - - - - Russia
W San Marino 1 6.8 0 0.0 0 0.0 0 0.0 0 0.0 1 6.4 2 12.7 21 San Marino
C Serbia 40 1.1 27 0.8 30 0.8 45 1.3 43 1.2 46 1.3 44 1.2 1 236 Serbia
W Switzerland 112 3.1 124 3.4 112 3.0 105 2.8 115 3.0 82 2.1 38 1.0 7 016 Switzerland
E Tajikistan 1 0.0 30 0.8 35 1.0 10 0.3 65 1.7 77 2.0 65 1.6 284 Tajikistan
C Turkey 26 0.1 25 0.1 48 0.1 60 0.2 46 0.1 65 0.2 83 0.2 853 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 Turkmenistan
E Ukraine - - - - - - - - - - - - - - - Ukraine
E Uzbekistan 9 0.1 27 0.2 141 1.0 92 0.7 163 1.2 - - 494 Uzbekistan
Total non-EU/EEA 832 0.9 1 134 1.2 1 206 1.3 1 377 1.5 1 818 1.9 1 713 2.1 1 526 1.9 19 664 Total non-EU/EEA
Geographic area
West 5 668 2.8 5 323 2.6 5 028 2.5 4 598 2.3 4 256 2.1 3 718 1.8 2 643 1.3 257 624 West
Centre 447 0.5 443 0.5 512 0.6 501 0.5 494 0.5 617 0.7 661 0.7 14 247 Centre
East 687 1.6 1 020 2.3 1 112 2.5 1 223 2.7 1 692 3.7 1 565 4.9 1 439 4.5 10 495 East
Total WHO European Region 6 802 2.0 6 786 2.0 6 652 2.0 6 322 1.8 6 442 1.9 5 900 1.8 4 743 1.4 282 366 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 16: AIDS cases in males and rates per 100 000 population, by country and year of diagnosis (2006–2012) and 
cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 95 2.4 101 2.5 89 2.2 70 1.7 73 1.8 47 1.1 21 0.5 2 928 Austria
W Belgium 65 1.3 65 1.3 75 1.4 76 1.4 59 1.1 53 1.0 49 0.9 2 952 Belgium
C Bulgaria 12 0.3 18 0.5 21 0.6 22 0.6 21 0.6 38 1.1 47 1.3 296 Bulgaria
C Croatia 14 0.7 10 0.5 24 1.1 20 0.9 20 0.9 25 1.2 26 1.2 353 Croatia
C Cyprus 7 1.9 8 2.1 10 2.6 8 2.0 7 1.8 2 0.5 4 1.0 189 Cyprus
C Czech Republic 13 0.3 18 0.4 22 0.4 17 0.3 20 0.4 16 0.3 23 0.4 305 Czech Republic
W Denmark 31 1.2 22 0.8 33 1.2 25 0.9 34 1.2 40 1.5 35 1.3 2 459 Denmark
E Estonia 22 3.6 46 7.4 44 7.1 26 4.2 21 3.4 31 5.0 25 4.0 288 Estonia
W Finland 20 0.8 22 0.9 24 0.9 15 0.6 23 0.9 18 0.7 16 0.6 487 Finland
W France 811 2.7 689 2.2 710 2.3 672 2.2 662 2.1 593 1.9 344 1.1 53 870 France
W Germany 586 1.5 514 1.3 474 1.2 493 1.2 377 0.9 373 0.9 224 0.6 25 132 Germany
W Greece 64 1.2 69 1.2 91 1.6 79 1.4 83 1.5 81 1.4 87 1.6 2 849 Greece
C Hungary 15 0.3 17 0.4 21 0.4 17 0.4 26 0.6 27 0.6 45 1.0 617 Hungary
W Iceland 2 1.3 0 2 1.2 0 1 0.6 1 0.6 1 0.6 57 Iceland
W Ireland 34 1.6 18 0.8 27 1.2 27 1.2 27 1.2 34 1.5 26 1.1 895 Ireland
W Italy 1 080 3.8 1 074 3.7 985 3.4 897 3.1 830 2.8 776 2.6 527 1.8 50 087 Italy
E Latvia 63 6.0 59 5.6 77 7.4 67 6.4 86 8.3 79 8.3 99 10.6 856 Latvia
E Lithuania 22 1.4 26 1.6 45 2.9 28 1.8 27 1.7 15 1.1 28 2.0 275 Lithuania
W Luxembourg 6 2.6 8 3.4 5 2.1 2 0.8 4 1.6 7 2.7 5 1.9 208 Luxembourg
W Malta 5 2.5 2 1.0 9 4.4 1 0.5 4 1.9 3 1.5 5 2.4 88 Malta
W Netherlands 231 2.9 228 2.8 217 2.7 226 2.8 217 2.6 173 2.1 163 2.0 2 994 Netherlands
W Norway 24 1.0 6 0.3 11 0.5 13 0.5 20 0.8 17 0.7 23 0.9 816 Norway
C Poland 130 0.7 108 0.6 139 0.8 99 0.5 132 0.7 139 0.7 115 0.6 2 291 Poland
W Portugal 548 10.7 482 9.5 456 9.0 356 7.0 364 7.2 305 6.1 183 3.7 14 029 Portugal
C Romania 161 1.5 170 1.6 154 1.5 161 1.5 135 1.3 200 1.9 212 2.0 7 444 Romania
C Slovakia 4 0.2 4 0.2 0 3 0.1 2 0.1 4 0.2 7 0.3 57 Slovakia
C Slovenia 5 0.5 7 0.7 9 0.9 16 1.6 7 0.7 12 1.2 10 1.0 175 Slovenia
W Spain 1 342 6.2 1 269 5.8 1 160 5.2 1 068 4.7 908 4.0 792 3.5 598 2.6 66 099 Spain
W Sweden 33 0.7 40 0.9 - - - - - 1 773 Sweden
W United Kingdom 525 1.8 552 1.9 512 1.7 441 1.5 434 1.4 286 0.9 269 0.9 21 833 United Kingdom
Total EU/EEA 5 970 2.4 5 652 2.3 5 446 2.2 4 945 2.0 4 624 1.9 4 187 1.7 3 217 1.3 262 702 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 5 0.3 15 1.0 21 1.3 25 1.6 17 1.1 31 2.2 27 1.9 191 Albania
W Andorra 0 0 2 4.6 0 0 1 2.3 0 4 Andorra
E Armenia 37 2.4 46 3.0 62 4.0 57 3.6 73 4.6 65 4.1 95 6.0 522 Armenia
E Azerbaijan 19 0.5 169 4.0 68 1.6 90 2.1 195 4.4 171 3.8 210 4.6 997 Azerbaijan
E Belarus 221 4.9 208 4.6 254 5.6 307 6.8 333 7.5 362 8.3 331 7.6 2 253 Belarus
C Bosnia and Herzegovina 3 0.2 4 0.2 4 0.2 2 0.1 6 0.3 4 0.2 4 0.2 96 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 9 0.9 9 0.9 5 0.5 2 0.2 6 0.6 5 0.5 7 0.7 87 former Yugoslav Republic of Macedonia, the
E Georgia 129 6.2 138 6.7 179 8.6 208 10.0 245 11.7 277 13.1 248 11.7 1 758 Georgia
W Israel 53 1.6 38 1.1 34 1.0 32 0.9 21 0.6 35 0.9 27 0.7 1 027 Israel
E Kazakhstan 88 1.2 110 1.5 124 1.7 111 1.5 194 2.5 150 1.9 180 2.3 1 216 Kazakhstan
E Kyrgyzstan 23 0.9 24 0.9 24 0.9 61 2.3 111 4.2 69 2.6 65 2.4 428 Kyrgyzstan
E Moldova 53 3.1 137 8.0 59 3.4 166 9.7 179 10.4 269 15.7 93 5.4 1 124 Moldova
W Monaco 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 38 Monaco
C Montenegro 3 1.0 3 1.0 4 1.3 4 1.3 6 2.0 3 1.0 7 2.3 57 Montenegro
E Russia - - - - - - - - Russia
W San Marino 1 6.8 0 0.0 0 0.0 0 0.0 0 0.0 1 6.4 2 12.7 21 San Marino
C Serbia 40 1.1 27 0.8 30 0.8 45 1.3 43 1.2 46 1.3 44 1.2 1 236 Serbia
W Switzerland 112 3.1 124 3.4 112 3.0 105 2.8 115 3.0 82 2.1 38 1.0 7 016 Switzerland
E Tajikistan 1 0.0 30 0.8 35 1.0 10 0.3 65 1.7 77 2.0 65 1.6 284 Tajikistan
C Turkey 26 0.1 25 0.1 48 0.1 60 0.2 46 0.1 65 0.2 83 0.2 853 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 Turkmenistan
E Ukraine - - - - - - - - - - - - - - - Ukraine
E Uzbekistan 9 0.1 27 0.2 141 1.0 92 0.7 163 1.2 - - 494 Uzbekistan
Total non-EU/EEA 832 0.9 1 134 1.2 1 206 1.3 1 377 1.5 1 818 1.9 1 713 2.1 1 526 1.9 19 664 Total non-EU/EEA
Geographic area
West 5 668 2.8 5 323 2.6 5 028 2.5 4 598 2.3 4 256 2.1 3 718 1.8 2 643 1.3 257 624 West
Centre 447 0.5 443 0.5 512 0.6 501 0.5 494 0.5 617 0.7 661 0.7 14 247 Centre
East 687 1.6 1 020 2.3 1 112 2.5 1 223 2.7 1 692 3.7 1 565 4.9 1 439 4.5 10 495 East
Total WHO European Region 6 802 2.0 6 786 2.0 6 652 2.0 6 322 1.8 6 442 1.9 5 900 1.8 4 743 1.4 282 366 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 17: AIDS cases in females and rates per 100 000 population, by country and year of diagnosis (2006–2012) and 
cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 23 0.5 28 0.7 21 0.5 32 0.7 21 0.5 19 0.4 7 0.2 864 Austria
W Belgium 40 0.7 38 0.7 43 0.8 45 0.8 42 0.8 30 0.5 33 0.6 1 380 Belgium
C Bulgaria 4 0.1 4 0.1 10 0.3 8 0.2 11 0.3 2 0.1 18 0.5 101 Bulgaria
C Croatia 6 0.3 1 0.0 1 0.0 2 0.1 1 0.0 1 0.0 2 0.1 49 Croatia
C Cyprus 1 0.3 4 1.0 2 0.5 0 0.0 3 0.7 3 0.7 1 0.2 54 Cyprus
C Czech Republic 5 0.1 5 0.1 7 0.1 6 0.1 6 0.1 8 0.1 6 0.1 69 Czech Republic
W Denmark 20 0.7 10 0.4 7 0.3 11 0.4 10 0.4 19 0.7 6 0.2 430 Denmark
E Estonia 10 1.4 11 1.5 17 2.3 12 1.7 5 0.7 7 1.0 11 1.5 102 Estonia
W Finland 6 0.2 11 0.4 3 0.1 8 0.3 9 0.3 7 0.3 3 0.1 109 Finland
W France 362 1.1 315 1.0 338 1.0 273 0.8 298 0.9 217 0.6 153 0.5 14 354 France
W Germany 124 0.3 127 0.3 93 0.2 112 0.3 80 0.2 69 0.2 56 0.1 4 162 Germany
W Greece 25 0.4 21 0.4 12 0.2 20 0.4 19 0.3 16 0.3 21 0.4 537 Greece
C Hungary 7 0.1 6 0.1 2 0.0 6 0.1 2 0.0 5 0.1 3 0.1 86 Hungary
W Iceland 1 0.7 0 0.0 0 0.0 0 0.0 0 0.0 1 0.6 0 9 Iceland
W Ireland 8 0.4 15 0.7 9 0.4 8 0.4 11 0.5 13 0.6 8 0.3 265 Ireland
W Italy 374 1.2 327 1.1 347 1.1 295 1.0 295 0.9 242 0.8 188 0.6 14 811 Italy
E Latvia 27 2.2 22 1.8 26 2.1 34 2.8 46 3.8 32 2.8 40 3.6 360 Latvia
E Lithuania 5 0.3 2 0.1 9 0.5 9 0.5 6 0.3 6 0.4 10 0.6 59 Lithuania
W Luxembourg 3 1.3 3 1.2 3 1.2 1 0.4 4 1.6 4 1.6 2 0.8 59 Luxembourg
W Malta 2 1.0 0 0.0 0 0.0 0 0.0 2 1.0 2 1.0 1 0.5 14 Malta
W Netherlands 60 0.7 70 0.8 53 0.6 41 0.5 57 0.7 47 0.6 45 0.5 831 Netherlands
W Norway 8 0.3 3 0.1 7 0.3 5 0.2 2 0.1 2 0.1 2 0.1 225 Norway
C Poland 37 0.2 33 0.2 40 0.2 30 0.2 41 0.2 42 0.2 32 0.2 616 Poland
W Portugal 184 3.4 148 2.8 154 2.9 129 2.4 131 2.4 89 1.7 66 1.2 3 343 Portugal
C Romania 128 1.2 118 1.1 127 1.2 96 0.9 112 1.0 99 0.9 81 0.7 5 492 Romania
C Slovakia 0 0.0 2 0.1 1 0.0 1 0.0 0 0.0 0 0 11 Slovakia
C Slovenia 0 0.0 2 0.2 2 0.2 2 0.2 0 0.0 3 0.3 1 0.1 26 Slovenia
W Spain 392 1.8 352 1.6 365 1.6 324 1.4 264 1.1 223 1.0 179 0.8 16 806 Spain
W Sweden 22 0.5 22 0.5 - - - - - 395 Sweden
W United Kingdom 357 1.2 286 0.9 315 1.0 208 0.7 225 0.7 125 0.4 121 0.4 5 956 United Kingdom
Total EU/EEA 2 241 0.9 1 986 0.8 2 014 0.8 1 718 0.7 1 703 0.7 1 333 0.5 1 096 0.4 71 575 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 3 0.2 2 0.1 7 0.4 7 0.4 7 0.4 9 0.6 13 0.9 59 Albania
W Andorra 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 Andorra
E Armenia 9 0.5 13 0.8 21 1.3 27 1.6 21 1.3 22 1.3 38 2.3 169 Armenia
E Azerbaijan 2 31 0.7 8 0.2 19 0.4 15 0.3 24 0.5 25 0.5 133 Azerbaijan
E Belarus 111 2.2 101 2.0 133 2.6 193 3.8 212 4.2 223 4.5 196 3.9 1 270 Belarus
C Bosnia and Herzegovina 1 0.1 0 0.0 1 0.1 0 0.0 0 0.0 3 0.2 0 0.0 22 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 1 0.1 1 0.1 4 0.4 0 0.0 0 0.0 0 0.0 2 0.2 29 former Yugoslav Republic of Macedonia, the
E Georgia 33 1.4 45 2.0 53 2.3 76 3.3 94 4.1 118 5.1 111 4.8 603 Georgia
W Israel 18 0.5 11 0.3 19 0.5 17 0.5 16 0.4 18 0.5 10 0.3 388 Israel
E Kazakhstan 44 0.6 65 0.8 50 0.6 62 0.8 70 0.8 76 0.9 54 0.6 490 Kazakhstan
E Kyrgyzstan 6 0.2 0 0.0 9 0.3 14 0.5 19 0.7 21 0.8 23 0.8 99 Kyrgyzstan
E Moldova 40 2.2 81 4.4 33 1.8 96 5.2 127 6.9 170 9.2 90 4.9 693 Moldova
W Monaco 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 11 Monaco
C Montenegro 0 0.0 0 0.0 1 0.3 2 0.6 0 0.0 0 0.0 0 0.0 12 Montenegro
E Russia - - - - - - - 0 Russia
W San Marino 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 San Marino
C Serbia 12 0.3 15 0.4 8 0.2 10 0.3 7 0.2 7 0.2 6 0.2 407 Serbia
W Switzerland 46 1.2 49 1.3 46 1.2 41 1.0 41 1.0 37 0.9 20 0.5 2 406 Switzerland
E Tajikistan 0 0.0 1 0.0 8 0.2 1 0.0 10 0.3 17 0.4 22 0.6 59 Tajikistan
C Turkey 4 0.0 5 0.0 7 0.0 7 0.0 14 0.0 15 0.0 12 0.0 163 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 Turkmenistan
E Ukraine - - - - - - - - - - - - - - - Ukraine
E Uzbekistan 4 8 0.1 43 0.3 37 0.3 57 0.4 - - 157 Uzbekistan
Total non-EU/EEA 334 0.4 428 0.5 451 0.5 609 0.6 710 0.7 760 0.9 622 0.7 7 162 Total non-EU/EEA
Geographic area Geographic area
West 2 075 1.0 1 836 0.9 1 835 0.9 1 570 0.7 1 527 0.7 1 180 0.6 921 0.4 67 357 West
Centre 209 0.2 198 0.2 220 0.2 177 0.2 204 0.2 197 0.2 177 0.2 7 196 Centre
East 291 0.6 380 0.8 410 0.9 580 1.2 682 1.4 716 2.1 620 1.8 4 195 East
Total WHO European Region 2 575 0.7 2 414 0.7 2 465 0.7 2 327 0.7 2 413 0.7 2 093 0.6 1 718 0.5 78 737 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 17: AIDS cases in females and rates per 100 000 population, by country and year of diagnosis (2006–2012) and 
cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
2006 2007 2008 2009 2010 2011 2012 Cumulative 
total** Country*N Rate N Rate N Rate N Rate N Rate N Rate N Rate
EU/EEA EU/EEA
W Austria 23 0.5 28 0.7 21 0.5 32 0.7 21 0.5 19 0.4 7 0.2 864 Austria
W Belgium 40 0.7 38 0.7 43 0.8 45 0.8 42 0.8 30 0.5 33 0.6 1 380 Belgium
C Bulgaria 4 0.1 4 0.1 10 0.3 8 0.2 11 0.3 2 0.1 18 0.5 101 Bulgaria
C Croatia 6 0.3 1 0.0 1 0.0 2 0.1 1 0.0 1 0.0 2 0.1 49 Croatia
C Cyprus 1 0.3 4 1.0 2 0.5 0 0.0 3 0.7 3 0.7 1 0.2 54 Cyprus
C Czech Republic 5 0.1 5 0.1 7 0.1 6 0.1 6 0.1 8 0.1 6 0.1 69 Czech Republic
W Denmark 20 0.7 10 0.4 7 0.3 11 0.4 10 0.4 19 0.7 6 0.2 430 Denmark
E Estonia 10 1.4 11 1.5 17 2.3 12 1.7 5 0.7 7 1.0 11 1.5 102 Estonia
W Finland 6 0.2 11 0.4 3 0.1 8 0.3 9 0.3 7 0.3 3 0.1 109 Finland
W France 362 1.1 315 1.0 338 1.0 273 0.8 298 0.9 217 0.6 153 0.5 14 354 France
W Germany 124 0.3 127 0.3 93 0.2 112 0.3 80 0.2 69 0.2 56 0.1 4 162 Germany
W Greece 25 0.4 21 0.4 12 0.2 20 0.4 19 0.3 16 0.3 21 0.4 537 Greece
C Hungary 7 0.1 6 0.1 2 0.0 6 0.1 2 0.0 5 0.1 3 0.1 86 Hungary
W Iceland 1 0.7 0 0.0 0 0.0 0 0.0 0 0.0 1 0.6 0 9 Iceland
W Ireland 8 0.4 15 0.7 9 0.4 8 0.4 11 0.5 13 0.6 8 0.3 265 Ireland
W Italy 374 1.2 327 1.1 347 1.1 295 1.0 295 0.9 242 0.8 188 0.6 14 811 Italy
E Latvia 27 2.2 22 1.8 26 2.1 34 2.8 46 3.8 32 2.8 40 3.6 360 Latvia
E Lithuania 5 0.3 2 0.1 9 0.5 9 0.5 6 0.3 6 0.4 10 0.6 59 Lithuania
W Luxembourg 3 1.3 3 1.2 3 1.2 1 0.4 4 1.6 4 1.6 2 0.8 59 Luxembourg
W Malta 2 1.0 0 0.0 0 0.0 0 0.0 2 1.0 2 1.0 1 0.5 14 Malta
W Netherlands 60 0.7 70 0.8 53 0.6 41 0.5 57 0.7 47 0.6 45 0.5 831 Netherlands
W Norway 8 0.3 3 0.1 7 0.3 5 0.2 2 0.1 2 0.1 2 0.1 225 Norway
C Poland 37 0.2 33 0.2 40 0.2 30 0.2 41 0.2 42 0.2 32 0.2 616 Poland
W Portugal 184 3.4 148 2.8 154 2.9 129 2.4 131 2.4 89 1.7 66 1.2 3 343 Portugal
C Romania 128 1.2 118 1.1 127 1.2 96 0.9 112 1.0 99 0.9 81 0.7 5 492 Romania
C Slovakia 0 0.0 2 0.1 1 0.0 1 0.0 0 0.0 0 0 11 Slovakia
C Slovenia 0 0.0 2 0.2 2 0.2 2 0.2 0 0.0 3 0.3 1 0.1 26 Slovenia
W Spain 392 1.8 352 1.6 365 1.6 324 1.4 264 1.1 223 1.0 179 0.8 16 806 Spain
W Sweden 22 0.5 22 0.5 - - - - - 395 Sweden
W United Kingdom 357 1.2 286 0.9 315 1.0 208 0.7 225 0.7 125 0.4 121 0.4 5 956 United Kingdom
Total EU/EEA 2 241 0.9 1 986 0.8 2 014 0.8 1 718 0.7 1 703 0.7 1 333 0.5 1 096 0.4 71 575 Total EU/EEA
Non-EU/EEA Non-EU/EEA
C Albania 3 0.2 2 0.1 7 0.4 7 0.4 7 0.4 9 0.6 13 0.9 59 Albania
W Andorra 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 Andorra
E Armenia 9 0.5 13 0.8 21 1.3 27 1.6 21 1.3 22 1.3 38 2.3 169 Armenia
E Azerbaijan 2 31 0.7 8 0.2 19 0.4 15 0.3 24 0.5 25 0.5 133 Azerbaijan
E Belarus 111 2.2 101 2.0 133 2.6 193 3.8 212 4.2 223 4.5 196 3.9 1 270 Belarus
C Bosnia and Herzegovina 1 0.1 0 0.0 1 0.1 0 0.0 0 0.0 3 0.2 0 0.0 22 Bosnia and Herzegovina
C former Yugoslav Republic of Macedonia, the 1 0.1 1 0.1 4 0.4 0 0.0 0 0.0 0 0.0 2 0.2 29 former Yugoslav Republic of Macedonia, the
E Georgia 33 1.4 45 2.0 53 2.3 76 3.3 94 4.1 118 5.1 111 4.8 603 Georgia
W Israel 18 0.5 11 0.3 19 0.5 17 0.5 16 0.4 18 0.5 10 0.3 388 Israel
E Kazakhstan 44 0.6 65 0.8 50 0.6 62 0.8 70 0.8 76 0.9 54 0.6 490 Kazakhstan
E Kyrgyzstan 6 0.2 0 0.0 9 0.3 14 0.5 19 0.7 21 0.8 23 0.8 99 Kyrgyzstan
E Moldova 40 2.2 81 4.4 33 1.8 96 5.2 127 6.9 170 9.2 90 4.9 693 Moldova
W Monaco 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 11 Monaco
C Montenegro 0 0.0 0 0.0 1 0.3 2 0.6 0 0.0 0 0.0 0 0.0 12 Montenegro
E Russia - - - - - - - 0 Russia
W San Marino 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 San Marino
C Serbia 12 0.3 15 0.4 8 0.2 10 0.3 7 0.2 7 0.2 6 0.2 407 Serbia
W Switzerland 46 1.2 49 1.3 46 1.2 41 1.0 41 1.0 37 0.9 20 0.5 2 406 Switzerland
E Tajikistan 0 0.0 1 0.0 8 0.2 1 0.0 10 0.3 17 0.4 22 0.6 59 Tajikistan
C Turkey 4 0.0 5 0.0 7 0.0 7 0.0 14 0.0 15 0.0 12 0.0 163 Turkey
E Turkmenistan 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 Turkmenistan
E Ukraine - - - - - - - - - - - - - - - Ukraine
E Uzbekistan 4 8 0.1 43 0.3 37 0.3 57 0.4 - - 157 Uzbekistan
Total non-EU/EEA 334 0.4 428 0.5 451 0.5 609 0.6 710 0.7 760 0.9 622 0.7 7 162 Total non-EU/EEA
Geographic area Geographic area
West 2 075 1.0 1 836 0.9 1 835 0.9 1 570 0.7 1 527 0.7 1 180 0.6 921 0.4 67 357 West
Centre 209 0.2 198 0.2 220 0.2 177 0.2 204 0.2 197 0.2 177 0.2 7 196 Centre
East 291 0.6 380 0.8 410 0.9 580 1.2 682 1.4 716 2.1 620 1.8 4 195 East
Total WHO European Region 2 575 0.7 2 414 0.7 2 465 0.7 2 327 0.7 2 413 0.7 2 093 0.6 1 718 0.5 78 737 Total WHO European Region
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 18: AIDS cases in men who have sex with men, by country and year of diagnosis (2006–2012) and cumulative 
totals, by country and year of diagnosis (2006–2012) and cumulative totals, in EU/EEA and other countries of the WHO 
European Region
Area Country*
Year of diagnosis Cumulative 
total**2006 2007 2008 2009 2010 2011 2012
EU/EEA
W Austria 33 39 28 28 25 21 9 1 248
W Belgium 25 25 22 34 31 28 21 1 389
C Bulgaria 4 4 4 4 5 2 8 55
C Croatia 11 6 12 17 19 18 22 209
C Cyprus 2 4 4 4 4 0 0 100
C Czech Republic 3 8 7 10 10 10 11 180
W Denmark 17 13 16 12 15 13 13 1 713
E Estonia 1 0 1 0 0 0 1 26
W Finland 8 13 10 6 7 6 2 282
W France 291 243 254 261 246 221 107 27 512
W Germany 336 308 259 270 225 193 120 17 350
W Greece 37 40 55 49 62 50 43 1 886
C Hungary 10 12 16 13 23 24 37 484
W Iceland 2 0 1 0 0 0 0 43
W Ireland 8 7 8 10 13 17 13 361
W Italy 309 315 298 290 249 257 160 10 925
E Latvia 3 3 3 7 10 6 4 89
E Lithuania 1 2 7 1 0 2 2 63
W Luxembourg 2 2 0 1 2 5 3 115
W Malta 3 0 1 0 0 1 0 40
W Netherlands 128 137 129 131 124 105 100 1 680
W Norway 11 2 6 7 9 9 10 471
C Poland 14 19 27 26 29 45 25 544
W Portugal 65 52 72 46 58 59 39 2 160
C Romania 8 6 11 20 15 18 11 184
C Slovakia 3 2 0 1 1 3 3 39
C Slovenia 3 6 7 10 7 7 7 110
W Spain 300 297 318 310 325 299 244 12 286
W Sweden 9 17 - - - - - 1 085
W United Kingdom 241 246 226 186 199 145 138 14 601
Total EU/EEA 1 888 1 828 1 802 1 754 1 713 1 564 1 153 97 230
Non-EU/EEA
C Albania 0 0 8 7 2 2 2 27
W Andorra 0 0 1 0 0 1 0 2
E Armenia 0 1 3 0 1 2 2 10
E Azerbaijan 0 2 1 1 4 1 1 11
E Belarus 0 0 0 0 2 6 3 14
C Bosnia and Herzegovina 0 0 0 0 5 2 4 25
C former Yugoslav Republic of Macedonia, the 2 2 2 1 1 4 3 29
E Georgia 3 3 7 3 10 11 11 67
W Israel 9 5 5 7 6 8 4 290
E Kazakhstan 0 0 1 0 0 1 0 2
E Kyrgyzstan 0 1 0 0 0 0 0 1
E Moldova 0 2 0 2 2 2 0 10
W Monaco - - - - - - - -
C Montenegro 2 2 4 2 4 2 1 27
E Russia - - - - - - - -
W San Marino 0 0 0 0 0 1 2 11
C Serbia 14 12 15 24 21 22 27 330
W Switzerland 42 61 48 41 57 31 19 3 175
E Tajikistan 0 0 0 0 0 0 0 0
C Turkey 4 5 11 2 3 0 0 81
E Turkmenistan 0 0 0 0 0 0 0 0
E Ukraine - - - - - - - -
E Uzbekistan - - - - - - - 1
Total non-EU/EEA 76 96 106 90 118 96 79 4 113
Geographical area
West 1 876 1 822 1 757 1 689 1 653 1 470 1 047 98 625
Centre 80 88 128 141 149 159 161 2 424
East 8 14 23 14 29 31 24 294
Total WHO European Region 1 964 1 924 1 908 1 844 1 831 1 660 1 232 101 343
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 19: AIDS cases in persons infected through injecting drug use, by country and year of diagnosis (2006–2012) and 
cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
Year of diagnosis Cumulative 
total**2006 2007 2008 2009 2010 2011 2012
EU/EEA
W Austria 21 26 27 16 11 11 5 922
W Belgium 7 3 8 5 3 4 1 280
C Bulgaria 0 1 4 7 10 17 39 80
C Croatia 1 1 0 0 1 1 1 25
C Cyprus 0 0 0 0 0 0 0 3
C Czech Republic 4 3 5 2 4 1 2 29
W Denmark 3 3 6 3 4 4 4 248
E Estonia 23 45 41 26 14 20 15 226
W Finland 1 8 1 2 3 0 4 53
W France 104 87 85 57 60 54 26 13 711
W Germany 80 61 49 47 29 36 26 4 212
W Greece 5 3 3 4 3 8 19 150
C Hungary 0 1 0 0 0 0 0 6
W Iceland 0 0 0 0 0 0 0 5
W Ireland 9 10 11 8 6 10 2 372
W Italy 398 381 315 274 223 186 119 34 390
E Latvia 51 45 60 49 70 57 70 700
E Lithuania 17 21 35 20 20 9 20 158
W Luxembourg 0 2 0 0 0 1 0 38
W Malta 2 0 0 0 0 0 0 3
W Netherlands 10 11 7 8 6 6 4 156
W Norway 4 0 2 1 3 0 1 154
C Poland 90 77 73 55 70 60 54 1 413
W Portugal 277 199 179 127 128 76 38 7 801
C Romania 3 5 1 6 9 37 79 148
C Slovakia 0 0 0 0 0 0 0 1
C Slovenia 1 0 0 0 0 0 0 9
W Spain 739 664 533 442 325 277 186 49 349
W Sweden 3 6 - - - - - 242
W United Kingdom 25 30 27 19 27 12 9 1 461
Total EU/EEA 1 878 1 693 1 472 1 178 1 029 887 724 116 345
Non-EU/EEA
C Albania 0 0 0 0 0 0 0 0
W Andorra 0 0 1 0 0 0 0 2
E Armenia 28 25 30 33 42 33 42 303
E Azerbaijan 13 131 50 69 160 148 159 787
E Belarus 217 198 209 250 236 264 212 1 780
C Bosnia and Herzegovina 1 1 0 0 0 0 0 18
C former Yugoslav Republic of Macedonia, the 2 1 0 0 0 0 0 9
E Georgia 105 103 134 170 186 191 160 1 316
W Israel 14 9 12 7 3 7 7 208
E Kazakhstan 102 95 118 104 185 132 151 887
E Kyrgyzstan 19 20 27 53 102 58 55 379
E Moldova 45 101 55 103 95 101 17 673
W Monaco - - - - - - - -
C Montenegro 0 0 0 0 0 0 1 2
E Russia - - - - - - - -
W San Marino 0 0 0 0 0 0 0 6
C Serbia 9 14 5 13 8 11 7 642
W Switzerland 29 20 19 13 11 17 6 3 271
E Tajikistan 0 15 27 7 43 35 30 158
C Turkey 1 2 1 4 2 2 1 58
E Turkmenistan 0 0 0 0 0 0 0 0
E Ukraine - - - - - - - -
E Uzbekistan 9 20 116 70 131 - - 380
Total non-EU/EEA 594 755 804 896 1 204 999 848 10 879
Geographical area
West 1 731 1 523 1 285 1 033 845 709 457 117 034
Centre 112 106 89 87 104 129 184 2 443
East 629 819 902 954 1 284 1 048 931 7 747
Total WHO European Region 2 472 2 448 2 276 2 074 2 233 1 886 1 572 127 224
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 20: AIDS cases in men infected through heterosexual contact, by country and year of diagnosis (2006–2012) and 
cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
Year of diagnosis Cumulative 
total**2006 2007 2008 2009 2010 2011 2012
EU/EEA
W Austria 47 42 38 45 37 22 10 916
W Belgium 63 65 75 73 63 47 58 2 246
C Bulgaria 12 17 17 19 14 20 15 240
C Croatia 8 4 10 4 1 6 4 140
C Cyprus 6 6 7 4 5 5 3 121
C Czech Republic 9 11 14 11 12 12 12 133
W Denmark 29 16 16 18 23 40 22 744
E Estonia 8 10 17 10 7 9 16 107
W Finland 15 11 11 12 12 15 10 201
W France 604 540 583 504 516 421 304 18 932
W Germany 190 171 147 148 107 132 72 3 686
W Greece 41 35 41 33 31 33 33 882
C Hungary 11 5 5 8 4 7 6 130
W Iceland 1 0 0 0 1 2 1 15
W Ireland 22 14 13 15 12 17 19 310
W Italy 626 614 602 521 551 483 352 15 410
E Latvia 21 22 25 32 36 34 53 307
E Lithuania 3 4 6 15 11 9 13 86
W Luxembourg 7 7 8 1 6 5 4 98
W Malta 2 2 5 1 6 3 5 35
W Netherlands 109 110 101 104 114 80 79 1 511
W Norway 16 7 10 10 10 9 12 359
C Poland 34 29 34 23 52 44 35 558
W Portugal 375 368 339 296 292 249 164 6 707
C Romania 113 120 123 124 113 140 125 2 224
C Slovakia 1 3 1 1 1 1 3 23
C Slovenia 0 2 2 0 0 3 2 39
W Spain 531 485 525 481 383 327 274 14 779
W Sweden 36 30 - - - - - 665
W United Kingdom 560 508 517 384 374 239 229 9 643
Total EU/EEA 3 500 3 258 3 292 2 897 2 794 2 414 1 935 81 247
Non-EU/EEA
C Albania 8 12 20 24 20 37 38 213
W Andorra 0 0 0 0 0 0 0 1
E Armenia 17 32 46 45 41 50 83 342
E Azerbaijan 6 55 14 34 38 44 68 284
E Belarus 103 100 160 240 287 303 307 1 601
C Bosnia and Herzegovina 3 3 5 2 1 4 0 65
C former Yugoslav Republic of Macedonia, the 6 4 4 1 3 3 5 67
E Georgia 53 61 76 102 132 181 184 885
W Israel 42 33 34 32 26 36 25 773
E Kazakhstan 19 33 38 55 70 81 76 372
E Kyrgyzstan 8 0 6 17 24 26 27 119
E Moldova 43 108 31 101 146 321 118 921
W Monaco - - - - - - - -
C Montenegro 1 1 1 3 2 0 4 33
E Russia - - - - - - - -
W San Marino 0 0 0 0 0 0 0 5
C Serbia 13 7 11 12 11 12 7 341
W Switzerland 84 84 71 73 80 64 30 2 506
E Tajikistan 0 10 13 1 26 44 21 115
C Turkey 15 20 32 28 26 36 35 492
E Turkmenistan 0 0 0 0 0 0 0 0
E Ukraine - - - - - - - -
E Uzbekistan 2 6 51 40 68 - - 183
Total non-EU/EEA 423 569 613 810 1 001 1 242 1 028 9 318
Geographical area
West 3 400 3 142 3 136 2 751 2 644 2 224 1 703 80 424
Centre 240 244 286 264 265 330 294 4 819
East 283 441 483 692 886 1 102 966 5 322
Total WHO European Region 3 923 3 827 3 905 3 707 3 795 3 656 2 963 90 565
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 21: AIDS cases in persons infected through mother-to-child transmission, by country and year of diagnosis 
(2006–2012) and cumulative totals, in EU/EEA and other countries of the WHO European Region
Area Country*
Year of diagnosis Cumulative 
total**2006 2007 2008 2009 2010 2011 2012
EU/EEA
W Austria 0 1 0 2 0 1 0 47
W Belgium 1 4 4 1 0 0 0 122
C Bulgaria 0 0 0 0 2 1 0 4
C Croatia 0 0 0 0 0 1 0 4
C Cyprus 0 0 0 0 0 0 0 2
C Czech Republic 0 0 0 0 0 0 0 0
W Denmark 2 0 0 0 1 0 0 24
E Estonia 0 0 0 0 0 0 0 0
W Finland 0 1 0 0 0 0 0 6
W France 6 8 9 10 5 8 4 759
W Germany 1 1 0 0 1 2 1 111
W Greece 1 0 0 0 1 0 0 24
C Hungary 0 0 0 1 0 0 1 4
W Iceland 0 0 0 0 0 0 0 0
W Ireland 0 1 3 1 1 0 0 35
W Italy 9 2 2 3 2 3 1 723
E Latvia 2 0 5 1 0 2 1 16
E Lithuania 0 0 0 0 0 0 0 0
W Luxembourg 0 0 0 0 0 0 0 3
W Malta 0 0 0 0 0 0 0 1
W Netherlands 2 5 1 2 5 2 0 40
W Norway 0 0 0 0 0 0 0 6
C Poland 4 1 5 7 1 3 1 67
W Portugal 4 3 4 3 1 1 1 112
C Romania 8 3 8 12 11 10 8 431
C Slovakia 0 0 0 0 0 0 0 0
C Slovenia 0 0 0 0 0 0 0 2
W Spain 7 10 8 8 3 3 3 969
W Sweden 1 2 - - - - - 22
W United Kingdom 25 26 20 19 8 2 0 670
Total EU/EEA 73 68 69 70 42 39 21 4 204
Non-EU/EEA
C Albania 0 0 0 1 0 1 0 3
W Andorra 0 0 0 0 0 0 0 0
E Armenia 1 1 0 2 1 1 0 9
E Azerbaijan 0 2 0 2 1 1 3 9
E Belarus 10 7 14 8 13 12 4 94
C Bosnia and Herzegovina 0 0 0 0 0 0 0 0
C former Yugoslav Republic of Macedonia, the 0 1 0 0 1 0 1 5
E Georgia 1 13 10 4 11 8 1 58
W Israel 2 1 1 1 1 1 0 37
E Kazakhstan 1 5 4 5 2 5 2 24
E Kyrgyzstan 1 0 2 0 0 3 4 10
E Moldova 4 7 6 1 3 3 1 32
W Monaco - - - - - - - -
C Montenegro 0 0 0 0 0 0 0 1
E Russia - - - - - - - -
W San Marino 0 0 0 0 0 0 0 0
C Serbia 1 1 2 1 1 0 0 25
W Switzerland 0 1 0 1 2 0 1 107
E Tajikistan 0 0 0 2 0 0 1 3
C Turkey 0 0 0 2 0 0 1 12
E Turkmenistan 0 0 0 0 0 0 0 0
E Ukraine - - - - - - - -
E Uzbekistan 2 3 6 3 8 - - 22
Total non-EU/EEA 23 42 45 33 44 35 19 451
Geographical area
West 61 66 52 51 31 23 11 3 818
Centre 13 6 15 24 16 16 12 560
East 22 38 47 28 39 35 17 277
Total WHO European Region 96 110 114 103 86 74 40 4 655
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 22: AIDS cases*, by geographical area, sex, transmission mode and year of diagnosis (2006–2012) and 
cumulative totals
Table 22a: EU/EEA and non-EU/EEA countries
Transmission mode
2006 2007 2008 2009 2010 2011 2012 Cumulative total**
Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
EU/EEA
Men who have sex with men 0 1 877 0 1 805 0 1 799 0 1 753 1 0 1 712 1 0 1 564 0 0 1 153 0 0 96 128 17 96 145
Injecting drug use 371 1 504 342 1 345 315 1 157 236 942 0 214 815 0 157 730 0 134 590 0 23 945 92 157 1 116 103
Heterosexual contact 1 567 1 897 1 372 1 855 1 432 1 860 1 227 1 670 0 1 250 1 544 0 990 1 424 0 837 1 098 0 35 000 45 579 3 80 582
Mother-to-child 31 41 31 35 31 38 36 34 0 33 9 0 20 19 0 15 6 0 2 057 2 127 0 4 184
Haemophiliac/transfusion recipient 19 29 10 14 12 23 11 15 0 4 14 0 5 1 0 3 6 0 2 733 6 528 0 9 261
Nosocomial infection 4 4 2 2 3 5 2 3 0 4 3 0 1 1 0 2 0 0 2 367 3 189 0 5 556
Other/undetermined 227 585 207 556 221 564 206 528 1 198 527 0 160 448 0 105 364 0 5 078 15 221 1 20 300
Total EU/EEA 2 219 5 937 1 964 5 612 2 014 5 446 1 718 4 945 2 1 703 4 624 1 1 333 4 187 0 1 096 3 217 0 71 180 260 929 22 332 131
Non-EU/EEA
Men who have sex with men 0 76 0 96 0 106 0 90 0 0 118 0 0 94 2 0 79 0 0 4 110 2 4 112
Injecting drug use 105 480 117 618 91 594 115 711 0 123 950 0 117 882 0 62 786 0 2 033 8 463 3 10 499
Heterosexual contact 205 216 256 307 271 291 400 370 0 463 470 0 604 637 1 503 525 0 4 267 4 866 2 9 135
Mother-to-child 7 14 18 21 18 21 16 14 0 17 19 0 12 23 0 11 8 0 205 223 1 429
Haemophiliac/transfusion recipient 1 2 1 3 0 1 6 3 0 2 1 0 0 9 0 1 9 0 102 286 0 388
Nosocomial infection 1 0 12 14 2 1 2 3 0 1 4 0 1 2 0 1 1 0 22 28 0 50
Other/undetermined 11 35 16 48 26 51 33 94 0 47 93 0 26 66 0 44 118 0 377 1 194 7 1 578
Total non-EU/EEA 330 823 420 1 107 408 1 065 572 1 285 0 653 1 655 0 760 1 713 3 622 1 526 0 7 006 19 170 15 26 191
Total WHO European Region 2 549 6 760 2 384 6 719 2 422 6 511 2 290 6 230 2 2 356 6 279 1 2 093 5 900 3 1 718 4 743 0 78 186 280 099 37 358 322
Table 22b: Geographical areas, WHO European Region
Transmission mode
2006 2007 2008 2009 2010 2011 2012 Cumulative total**
Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
West
Men who have sex with men 0 1 865 0 1 799 0 1 754 0 1 688 1 0 1 652 1 0 1 470 0 0 1 047 0 0 97 523 17 97 540
Injecting drug use 345 1 383 310 1 207 279 1 006 212 821 0 176 669 0 125 584 0 86 371 0 24 460 92 331 1 116 792
Heterosexual contact 1 525 1 839 1 338 1 773 1 374 1 762 1 168 1 583 0 1 191 1 453 0 931 1 293 0 747 956 0 34 846 44 910 3 79 759
Mother-to-child 26 34 29 35 23 29 24 27 0 22 9 0 14 9 0 9 2 0 1 906 1 890 0 3 796
Haemophiliac/transfusion recipient 11 22 9 12 12 20 15 15 0 6 13 0 5 2 0 3 6 0 1 960 5 485 0 7 445
Nosocomial infection 3 4 2 2 3 4 2 3 0 3 3 0 1 1 0 1 0 0 44 48 0 92
Other/undetermined 143 488 126 455 144 453 149 461 1 129 457 0 104 359 0 75 261 0 3 736 13 664 1 17 401
Total West 2 053 5 635 1 814 5 283 1 835 5 028 1 570 4 598 2 1 527 4 256 1 1 180 3 718 0 921 2 643 0 66 952 255 851 22 322 825
Centre
Men who have sex with men 0 80 0 88 0 128 0 141 0 0 149 0 0 157 2 0 161 0 0 2 422 2 2 424
Injecting drug use 17 95 28 78 21 68 16 71 0 22 82 0 24 105 0 38 146 0 528 1 915 0 2 443
Heterosexual contact 95 145 85 159 107 179 93 171 0 98 167 0 105 224 1 97 197 0 1 793 3 024 2 4 819
Mother-to-child 4 9 4 2 7 8 14 10 0 12 4 0 6 10 0 8 4 0 237 322 1 560
Haemophiliac/transfusion recipient 8 9 1 4 0 4 0 2 0 0 1 0 0 7 0 0 9 0 868 1 317 0 2 185
Nosocomial infection 1 0 1 0 0 1 0 0 0 1 0 0 0 0 0 1 0 0 2 324 3 143 0 5 467
Other/undetermined 84 109 79 112 85 124 54 106 0 71 91 0 62 114 0 33 144 0 1 446 2 104 3 3 553
Total Centre 209 447 198 443 220 512 177 501 0 204 494 0 197 617 3 177 661 0 7 196 14 247 8 21 451
East
Men who have sex with men 0 8 0 14 0 23 0 14 0 0 29 0 0 31 0 0 24 0 0 293 0 293
Injecting drug use 114 506 121 678 106 677 123 761 0 139 1 014 0 125 923 0 72 859 0 990 6 374 3 7 367
Heterosexual contact 152 129 205 230 222 210 366 286 0 424 394 0 558 544 0 496 470 0 2 628 2 511 0 5 139
Mother-to-child 8 12 16 19 19 22 14 11 0 16 15 0 12 23 0 9 8 0 119 138 0 257
Haemophiliac/transfusion recipient 1 0 1 1 0 0 2 1 0 0 1 0 0 1 0 1 0 0 7 12 0 19
Nosocomial infection 1 0 11 14 2 1 2 3 0 1 4 0 1 2 0 1 1 0 21 26 0 47
Other/undetermined 11 23 18 37 18 38 36 55 0 45 72 0 20 41 0 41 77 0 273 647 4 924
Total East 287 678 372 993 367 971 543 1 131 0 625 1 529 0 716 1 565 0 620 1 439 0 4 038 10 001 7 14 046
Total WHO European Region 2 549 6 760 2 384 6 719 2 422 6 511 2 290 6 230 2 2 356 6 279 1 2 093 5 900 3 1 718 4 743 0 78 186 280 099 37 358 322
* Data from countries not consistently reporting for the period 2006–2012 (Estonia, Italy, Poland, Russia, Spain, Turkey and Uzbekistan) are not included in this table 
** Cumulative total is the total number of cases reported by country since the start of reporting
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Table 22: AIDS cases*, by geographical area, sex, transmission mode and year of diagnosis (2006–2012) and 
cumulative totals
Table 22a: EU/EEA and non-EU/EEA countries
Transmission mode
2006 2007 2008 2009 2010 2011 2012 Cumulative total**
Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
EU/EEA
Men who have sex with men 0 1 877 0 1 805 0 1 799 0 1 753 1 0 1 712 1 0 1 564 0 0 1 153 0 0 96 128 17 96 145
Injecting drug use 371 1 504 342 1 345 315 1 157 236 942 0 214 815 0 157 730 0 134 590 0 23 945 92 157 1 116 103
Heterosexual contact 1 567 1 897 1 372 1 855 1 432 1 860 1 227 1 670 0 1 250 1 544 0 990 1 424 0 837 1 098 0 35 000 45 579 3 80 582
Mother-to-child 31 41 31 35 31 38 36 34 0 33 9 0 20 19 0 15 6 0 2 057 2 127 0 4 184
Haemophiliac/transfusion recipient 19 29 10 14 12 23 11 15 0 4 14 0 5 1 0 3 6 0 2 733 6 528 0 9 261
Nosocomial infection 4 4 2 2 3 5 2 3 0 4 3 0 1 1 0 2 0 0 2 367 3 189 0 5 556
Other/undetermined 227 585 207 556 221 564 206 528 1 198 527 0 160 448 0 105 364 0 5 078 15 221 1 20 300
Total EU/EEA 2 219 5 937 1 964 5 612 2 014 5 446 1 718 4 945 2 1 703 4 624 1 1 333 4 187 0 1 096 3 217 0 71 180 260 929 22 332 131
Non-EU/EEA
Men who have sex with men 0 76 0 96 0 106 0 90 0 0 118 0 0 94 2 0 79 0 0 4 110 2 4 112
Injecting drug use 105 480 117 618 91 594 115 711 0 123 950 0 117 882 0 62 786 0 2 033 8 463 3 10 499
Heterosexual contact 205 216 256 307 271 291 400 370 0 463 470 0 604 637 1 503 525 0 4 267 4 866 2 9 135
Mother-to-child 7 14 18 21 18 21 16 14 0 17 19 0 12 23 0 11 8 0 205 223 1 429
Haemophiliac/transfusion recipient 1 2 1 3 0 1 6 3 0 2 1 0 0 9 0 1 9 0 102 286 0 388
Nosocomial infection 1 0 12 14 2 1 2 3 0 1 4 0 1 2 0 1 1 0 22 28 0 50
Other/undetermined 11 35 16 48 26 51 33 94 0 47 93 0 26 66 0 44 118 0 377 1 194 7 1 578
Total non-EU/EEA 330 823 420 1 107 408 1 065 572 1 285 0 653 1 655 0 760 1 713 3 622 1 526 0 7 006 19 170 15 26 191
Total WHO European Region 2 549 6 760 2 384 6 719 2 422 6 511 2 290 6 230 2 2 356 6 279 1 2 093 5 900 3 1 718 4 743 0 78 186 280 099 37 358 322
Table 22b: Geographical areas, WHO European Region
Transmission mode
2006 2007 2008 2009 2010 2011 2012 Cumulative total**
Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
West
Men who have sex with men 0 1 865 0 1 799 0 1 754 0 1 688 1 0 1 652 1 0 1 470 0 0 1 047 0 0 97 523 17 97 540
Injecting drug use 345 1 383 310 1 207 279 1 006 212 821 0 176 669 0 125 584 0 86 371 0 24 460 92 331 1 116 792
Heterosexual contact 1 525 1 839 1 338 1 773 1 374 1 762 1 168 1 583 0 1 191 1 453 0 931 1 293 0 747 956 0 34 846 44 910 3 79 759
Mother-to-child 26 34 29 35 23 29 24 27 0 22 9 0 14 9 0 9 2 0 1 906 1 890 0 3 796
Haemophiliac/transfusion recipient 11 22 9 12 12 20 15 15 0 6 13 0 5 2 0 3 6 0 1 960 5 485 0 7 445
Nosocomial infection 3 4 2 2 3 4 2 3 0 3 3 0 1 1 0 1 0 0 44 48 0 92
Other/undetermined 143 488 126 455 144 453 149 461 1 129 457 0 104 359 0 75 261 0 3 736 13 664 1 17 401
Total West 2 053 5 635 1 814 5 283 1 835 5 028 1 570 4 598 2 1 527 4 256 1 1 180 3 718 0 921 2 643 0 66 952 255 851 22 322 825
Centre
Men who have sex with men 0 80 0 88 0 128 0 141 0 0 149 0 0 157 2 0 161 0 0 2 422 2 2 424
Injecting drug use 17 95 28 78 21 68 16 71 0 22 82 0 24 105 0 38 146 0 528 1 915 0 2 443
Heterosexual contact 95 145 85 159 107 179 93 171 0 98 167 0 105 224 1 97 197 0 1 793 3 024 2 4 819
Mother-to-child 4 9 4 2 7 8 14 10 0 12 4 0 6 10 0 8 4 0 237 322 1 560
Haemophiliac/transfusion recipient 8 9 1 4 0 4 0 2 0 0 1 0 0 7 0 0 9 0 868 1 317 0 2 185
Nosocomial infection 1 0 1 0 0 1 0 0 0 1 0 0 0 0 0 1 0 0 2 324 3 143 0 5 467
Other/undetermined 84 109 79 112 85 124 54 106 0 71 91 0 62 114 0 33 144 0 1 446 2 104 3 3 553
Total Centre 209 447 198 443 220 512 177 501 0 204 494 0 197 617 3 177 661 0 7 196 14 247 8 21 451
East
Men who have sex with men 0 8 0 14 0 23 0 14 0 0 29 0 0 31 0 0 24 0 0 293 0 293
Injecting drug use 114 506 121 678 106 677 123 761 0 139 1 014 0 125 923 0 72 859 0 990 6 374 3 7 367
Heterosexual contact 152 129 205 230 222 210 366 286 0 424 394 0 558 544 0 496 470 0 2 628 2 511 0 5 139
Mother-to-child 8 12 16 19 19 22 14 11 0 16 15 0 12 23 0 9 8 0 119 138 0 257
Haemophiliac/transfusion recipient 1 0 1 1 0 0 2 1 0 0 1 0 0 1 0 1 0 0 7 12 0 19
Nosocomial infection 1 0 11 14 2 1 2 3 0 1 4 0 1 2 0 1 1 0 21 26 0 47
Other/undetermined 11 23 18 37 18 38 36 55 0 45 72 0 20 41 0 41 77 0 273 647 4 924
Total East 287 678 372 993 367 971 543 1 131 0 625 1 529 0 716 1 565 0 620 1 439 0 4 038 10 001 7 14 046
Total WHO European Region 2 549 6 760 2 384 6 719 2 422 6 511 2 290 6 230 2 2 356 6 279 1 2 093 5 900 3 1 718 4 743 0 78 186 280 099 37 358 322
* Data from countries not consistently reporting for the period 2006–2012 (Estonia, Italy, Poland, Russia, Spain, Turkey and Uzbekistan) are not included in this table 
** Cumulative total is the total number of cases reported by country since the start of reporting
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Table 23: AIDS cases, by geographical area,  sex, age and year of diagnosis (2006–2012) and cumulative totals
Table 23a: EU/EEA and non-EU/EEA countries
Age category
2006 2007 2008 2009 2010 2011 2012 Cumulative total*
Age category
Female Male Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
EU/EEA EU/EEA
<15 35 43 29 29 24 38 32 30 30 11 - 18 18 - 13 6 - 5 482 7 070 - 12 552 <15
15–19 78 70 57 68 54 42 29 17 12 10 - 17 11 - 10 15 - 986 1 489 - 2 475 15–19
20–24 107 123 89 153 100 128 88 109 111 135 - 80 100 - 70 123 - 4 995 9 892 1 14 888 20–24
25–29 280 431 247 421 225 408 179 312 164 306 - 137 319 - 106 245 - 14 233 39 140 5 53 378 25–29
30–39 841 2 031 718 1 790 675 1 689 595 1 479 516 1 328 1 399 1 194 - 344 926 - 28 358 111 144 12 139 514 30–39
40–49 610 2 088 559 2 011 635 1 963 524 1 797 536 1 627 - 430 1 470 - 327 1 086 - 11 074 59 032 3 70 109 40–49
50+ 287 1 179 286 1 178 299 1 177 271 1 199 334 1 206 - 251 1 074 - 226 814 - 6 405 34 752 - 41 157 50+
Unknown 3 5 1 2 2 1 - 2 - 1 - 1 1 - - 2 - 42 183 1 226 Unknown
Total EU/EEA 2 241 5 970 1 986 5 652 2 014 5 446 1 718 4 945 1 703 4 624 1 1 333 4 187 - 1 096 3 217 - 71 575 262 702 22 334 299 Total EU/EEA
Non-EU/EEA Non-EU/EEA
<15 10 15 38 44 22 30 19 26 23 28 - 18 30 - 19 27 - 262 334 1 597 <15
15–19 2 3 7 11 7 12 14 14 9 15 - 2 3 - - 3 - 72 124 - 196 15–19
20–24 21 18 37 35 33 51 51 39 44 72 - 49 49 - 26 25 - 549 649 2 1 200 20–24
25–29 68 120 75 146 88 146 111 168 114 208 - 120 180 - 91 118 - 1 398 2 558 2 3 958 25–29
30–39 147 395 155 516 198 535 244 617 320 824 - 336 781 - 263 638 - 3 101 8 625 3 11 729 30–39
40–49 60 192 86 274 75 317 126 366 137 480 - 160 466 1 159 507 - 1 210 4 893 1 6 104 40–49
50+ 24 86 30 108 27 114 43 144 63 191 - 74 200 - 64 208 - 564 2 402 1 2 967 50+
Unknown 2 3 - - 1 1 1 3 - - - 1 4 2 - - - 18 117 5 140 Unknown
Total non-EU/EEA 334 832 428 1 134 451 1 206 609 1 377 710 1 818 - 760 1 713 3 622 1 526 - 7 174 19 702 15 26 891 Total non-EU/EEA
Total WHO European Region 2 575 6 802 2 414 6 786 2 465 6 652 2 327 6 322 2 413 6 442 1 2 093 5 900 3 1 718 4 743 - 78 749 282 404 37 361 190 Total WHO European Region
Table 23b: Geographical areas , WHO European Region
Age category
2006 2007 2008 2009 2010 2011 2012 Cumulative total*
Age category
Female Male Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Unknown
West West
<15 25 34 27 27 16 28 17 23 19 9 0 10 8 0 7 3 0 2 018 2 326 0 4 344 <15
15–19 17 18 22 20 23 15 18 8 10 8 0 12 7 0 6 8 0 596 1 109 0 1 705 15–19
20–24 93 94 69 117 68 93 60 77 66 104 0 41 69 0 37 66 0 4 676 9 624 1 14 301 20–24
25–29 251 382 214 347 192 341 147 258 144 251 0 117 240 0 82 155 0 14 212 38 968 5 53 185 25–29
30–39 812 1 930 676 1 660 640 1 529 551 1 343 468 1 176 1 355 990 0 287 699 0 28 536 111 425 12 139 973 30–39
40–49 602 2 044 553 1 969 611 1 866 515 1 714 496 1 548 0 404 1 382 0 299 941 0 10 931 59 037 3 69 971 40–49
50+ 272 1 162 274 1 181 282 1 155 262 1 173 324 1 159 0 240 1 021 0 203 769 0 6 346 34 989 0 41 335 50+
Unknown 3 4 1 2 3 1 0 2 0 1 0 1 1 0 0 2 0 43 184 1 228 Unknown
Total West 2 075 5 668 1 836 5 323 1 835 5 028 1 570 4 598 1 527 4 256 1 1 180 3 718 0 921 2 643 0 67 358 257 662 22 325 042 Total West
Centre Centre
<15 9 11 4 3 7 9 16 10 12 4 0 8 10 0 8 4 0 3 556 4 849 1 8 406 <15
15–19 62 54 36 49 30 28 14 9 4 5 0 5 4 0 4 7 0 414 435 0 849 15–19
20–24 12 23 15 30 32 37 28 35 43 38 0 41 40 0 30 59 0 515 534 0 1 049 20–24
25–29 25 48 33 51 31 51 25 56 21 60 0 21 81 0 20 87 0 616 1 271 0 1 887 25–29
30–39 47 145 55 154 62 160 51 161 59 165 0 54 228 0 54 231 0 1 158 3 461 0 4 619 30–39
40–49 28 91 30 93 32 146 24 134 37 115 0 37 142 1 39 175 0 572 2 226 1 2 799 40–49
50+ 24 71 25 63 26 80 19 96 28 107 0 31 111 0 22 98 0 358 1 424 1 1 783 50+
Unknown 2 4 0 0 0 1 0 0 0 0 0 0 1 2 0 0 0 7 47 5 59 Unknown
Total Centre 209 447 198 443 220 512 177 501 204 494 0 197 617 3 177 661 0 7 196 14 247 8 21 451 Total Centre
East     East
<15 11 13 36 43 23 31 18 23 22 26 0 18 30 0 17 26 0 170 229 0 399 <15
15–19 1 1 6 10 8 11 11 14 7 12 0 2 3 0 0 3 0 48 69 0 117 15–19
20–24 23 24 42 41 33 49 51 36 46 65 0 47 40 0 29 23 0 353 383 2 738 20–24
25–29 72 121 75 169 90 162 118 166 113 203 0 119 178 0 95 121 0 803 1 459 2 2 264 25–29
30–39 129 351 142 492 171 535 237 592 309 811 0 326 757 0 266 634 0 1 765 4 883 3 6 651 30–39
40–49 40 145 62 223 67 268 111 315 140 444 0 149 412 0 148 477 0 781 2 662 0 3 443 40–49
50+ 15 32 17 42 18 56 33 74 45 131 0 54 142 0 65 155 0 265 741 0 1 006 50+
Unknown 0 0 0 0 0 0 1 3 0 0 0 1 3 0 0 0 0 10 69 0 79 Unknown
Total East 291 687 380 1 020 410 1 112 580 1 223 682 1 692 0 716 1 565 0 620 1 439 0 4 195 10 495 7 14 697 Total East
Total WHO European Region 2 575 6 802 2 414 6 786 2 465 6 652 2 327 6 322 2 413 6 442 1 2 093 5 900 3 1 718 4 743 0 78 749 282 404 37 361 190 Total WHO European Region
*  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 23: AIDS cases, by geographical area,  sex, age and year of diagnosis (2006–2012) and cumulative totals
Table 23a: EU/EEA and non-EU/EEA countries
Age category
2006 2007 2008 2009 2010 2011 2012 Cumulative total*
Age category
Female Male Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
EU/EEA EU/EEA
<15 35 43 29 29 24 38 32 30 30 11 - 18 18 - 13 6 - 5 482 7 070 - 12 552 <15
15–19 78 70 57 68 54 42 29 17 12 10 - 17 11 - 10 15 - 986 1 489 - 2 475 15–19
20–24 107 123 89 153 100 128 88 109 111 135 - 80 100 - 70 123 - 4 995 9 892 1 14 888 20–24
25–29 280 431 247 421 225 408 179 312 164 306 - 137 319 - 106 245 - 14 233 39 140 5 53 378 25–29
30–39 841 2 031 718 1 790 675 1 689 595 1 479 516 1 328 1 399 1 194 - 344 926 - 28 358 111 144 12 139 514 30–39
40–49 610 2 088 559 2 011 635 1 963 524 1 797 536 1 627 - 430 1 470 - 327 1 086 - 11 074 59 032 3 70 109 40–49
50+ 287 1 179 286 1 178 299 1 177 271 1 199 334 1 206 - 251 1 074 - 226 814 - 6 405 34 752 - 41 157 50+
Unknown 3 5 1 2 2 1 - 2 - 1 - 1 1 - - 2 - 42 183 1 226 Unknown
Total EU/EEA 2 241 5 970 1 986 5 652 2 014 5 446 1 718 4 945 1 703 4 624 1 1 333 4 187 - 1 096 3 217 - 71 575 262 702 22 334 299 Total EU/EEA
Non-EU/EEA Non-EU/EEA
<15 10 15 38 44 22 30 19 26 23 28 - 18 30 - 19 27 - 262 334 1 597 <15
15–19 2 3 7 11 7 12 14 14 9 15 - 2 3 - - 3 - 72 124 - 196 15–19
20–24 21 18 37 35 33 51 51 39 44 72 - 49 49 - 26 25 - 549 649 2 1 200 20–24
25–29 68 120 75 146 88 146 111 168 114 208 - 120 180 - 91 118 - 1 398 2 558 2 3 958 25–29
30–39 147 395 155 516 198 535 244 617 320 824 - 336 781 - 263 638 - 3 101 8 625 3 11 729 30–39
40–49 60 192 86 274 75 317 126 366 137 480 - 160 466 1 159 507 - 1 210 4 893 1 6 104 40–49
50+ 24 86 30 108 27 114 43 144 63 191 - 74 200 - 64 208 - 564 2 402 1 2 967 50+
Unknown 2 3 - - 1 1 1 3 - - - 1 4 2 - - - 18 117 5 140 Unknown
Total non-EU/EEA 334 832 428 1 134 451 1 206 609 1 377 710 1 818 - 760 1 713 3 622 1 526 - 7 174 19 702 15 26 891 Total non-EU/EEA
Total WHO European Region 2 575 6 802 2 414 6 786 2 465 6 652 2 327 6 322 2 413 6 442 1 2 093 5 900 3 1 718 4 743 - 78 749 282 404 37 361 190 Total WHO European Region
Table 23b: Geographical areas , WHO European Region
Age category
2006 2007 2008 2009 2010 2011 2012 Cumulative total*
Age category
Female Male Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Unknown
West West
<15 25 34 27 27 16 28 17 23 19 9 0 10 8 0 7 3 0 2 018 2 326 0 4 344 <15
15–19 17 18 22 20 23 15 18 8 10 8 0 12 7 0 6 8 0 596 1 109 0 1 705 15–19
20–24 93 94 69 117 68 93 60 77 66 104 0 41 69 0 37 66 0 4 676 9 624 1 14 301 20–24
25–29 251 382 214 347 192 341 147 258 144 251 0 117 240 0 82 155 0 14 212 38 968 5 53 185 25–29
30–39 812 1 930 676 1 660 640 1 529 551 1 343 468 1 176 1 355 990 0 287 699 0 28 536 111 425 12 139 973 30–39
40–49 602 2 044 553 1 969 611 1 866 515 1 714 496 1 548 0 404 1 382 0 299 941 0 10 931 59 037 3 69 971 40–49
50+ 272 1 162 274 1 181 282 1 155 262 1 173 324 1 159 0 240 1 021 0 203 769 0 6 346 34 989 0 41 335 50+
Unknown 3 4 1 2 3 1 0 2 0 1 0 1 1 0 0 2 0 43 184 1 228 Unknown
Total West 2 075 5 668 1 836 5 323 1 835 5 028 1 570 4 598 1 527 4 256 1 1 180 3 718 0 921 2 643 0 67 358 257 662 22 325 042 Total West
Centre Centre
<15 9 11 4 3 7 9 16 10 12 4 0 8 10 0 8 4 0 3 556 4 849 1 8 406 <15
15–19 62 54 36 49 30 28 14 9 4 5 0 5 4 0 4 7 0 414 435 0 849 15–19
20–24 12 23 15 30 32 37 28 35 43 38 0 41 40 0 30 59 0 515 534 0 1 049 20–24
25–29 25 48 33 51 31 51 25 56 21 60 0 21 81 0 20 87 0 616 1 271 0 1 887 25–29
30–39 47 145 55 154 62 160 51 161 59 165 0 54 228 0 54 231 0 1 158 3 461 0 4 619 30–39
40–49 28 91 30 93 32 146 24 134 37 115 0 37 142 1 39 175 0 572 2 226 1 2 799 40–49
50+ 24 71 25 63 26 80 19 96 28 107 0 31 111 0 22 98 0 358 1 424 1 1 783 50+
Unknown 2 4 0 0 0 1 0 0 0 0 0 0 1 2 0 0 0 7 47 5 59 Unknown
Total Centre 209 447 198 443 220 512 177 501 204 494 0 197 617 3 177 661 0 7 196 14 247 8 21 451 Total Centre
East     East
<15 11 13 36 43 23 31 18 23 22 26 0 18 30 0 17 26 0 170 229 0 399 <15
15–19 1 1 6 10 8 11 11 14 7 12 0 2 3 0 0 3 0 48 69 0 117 15–19
20–24 23 24 42 41 33 49 51 36 46 65 0 47 40 0 29 23 0 353 383 2 738 20–24
25–29 72 121 75 169 90 162 118 166 113 203 0 119 178 0 95 121 0 803 1 459 2 2 264 25–29
30–39 129 351 142 492 171 535 237 592 309 811 0 326 757 0 266 634 0 1 765 4 883 3 6 651 30–39
40–49 40 145 62 223 67 268 111 315 140 444 0 149 412 0 148 477 0 781 2 662 0 3 443 40–49
50+ 15 32 17 42 18 56 33 74 45 131 0 54 142 0 65 155 0 265 741 0 1 006 50+
Unknown 0 0 0 0 0 0 1 3 0 0 0 1 3 0 0 0 0 10 69 0 79 Unknown
Total East 291 687 380 1 020 410 1 112 580 1 223 682 1 692 0 716 1 565 0 620 1 439 0 4 195 10 495 7 14 697 Total East
Total WHO European Region 2 575 6 802 2 414 6 786 2 465 6 652 2 327 6 322 2 413 6 442 1 2 093 5 900 3 1 718 4 743 0 78 749 282 404 37 361 190 Total WHO European Region
*  Cumulative total is the total number of cases reported by country since the start of reporting
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Table 24: The most common AIDS-indicative diseases diagnosed in 2012, by geographical area ordered by frequency
Table 24a: EU/EEA and non-EU/EEA countries
Diseases
Men Women Total Children
N % N % N % N %
EU/EEA
Pneumocystis pneumonia 843 26.3 247 22.8 1,090 25.4 5 26.3
Candidiasis, oesophageal 397 12.4 144 13.3 541 12.6 2 10.5
Mycobacterium tuberculosis, pulmonary in an adult or an adolescent (aged 
13 years or over) 312 9.7 131 12.1 443 10.3 2 10.5
Wasting syndrome due to HIV 296 9.2 86 7.9 382 8.9 4 21.1
Mycobacterium tuberculosis, extrapulmonary 210 6.5 110 10.2 320 7.5 0 0.0
Toxoplasmosis of brain in a patient over one month of age 208 6.5 102 9.4 310 7.2 0 0.0
Kaposi’s sarcoma 284 8.8 22 2.0 306 7.1 0 0.0
Cytomegalovirus disease (other than liver, spleen, or nodes) in a patient 
over one month of age 190 5.9 61 5.6 251 5.8 2 10.5
Encephalopathy, HIV-related 126 3.9 49 4.5 175 4.1 2 10.5
Progressive multifocal leukoencephalopathy 104 3.2 27 2.5 131 3.1 0 0.0
Cryptococcosis, extrapulmonary 78 2.4 25 2.3 103 2.4 0 0.0
Opportunistic infection(s), not specified 656 20.4 241 22.3 897 20.9 6 31.6
Non-EU/EEA
Mycobacterium tuberculosis, pulmonary in an adult or an adolescent (aged 
13 years or over) 499 33.3 126 20.9 625 29.7 9 19.6
Wasting syndrome due to HIV 422 28.2 203 33.7 625 29.7 9 19.6
Candidiasis, oesophageal 340 22.7 180 29.9 520 24.7 7 15.2
Mycobacterium tuberculosis, extrapulmonary 193 12.9 44 7.3 237 11.3 1 2.2
Pneumocystis pneumonia 78 5.2 38 6.3 116 5.5 6 13.0
Encephalopathy, HIV-related 75 5.0 32 5.3 107 5.1 3 6.5
Pneumonia, recurrent in an adult or an adolescent (aged 13 years or over) 38 2.5 16 2.7 54 2.6 1 2.2
Herpes simplex: chronic ulcer(s) (>1 months duration); or bronchitis, 
pneumonitis, or oesophagitis in a patient over one month of age 23 1.5 20 3.3 43 2.0 2 4.3
Kaposi’s sarcoma 33 2.2 6 1.0 39 1.9 0 0.0
Candidiasis of bronchi, trachea, or lungs 26 1.7 8 1.3 34 1.6 5 10.9
Toxoplasmosis of brain in a patient over one month of age 23 1.5 11 1.8 34 1.6 0 0.0
Opportunistic infection(s), not specified 487 32.5 238 39.5 725 34.5 21 45.7
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Table 24b: Geographical areas, WHO European Region
Diseases
Men Women Total Children
N % N % N % N %
West
Pneumocystis pneumonia 759 28.8 234 25.6 993 27.9 3 30.0
Candidiasis, oesophageal 350 13.3 128 14.0 478 13.4 2 20.0
Mycobacterium tuberculosis, pulmonary in an adult or an adolescent (aged 
13 years or over) 202 7.7 101 11.1 303 8.5 1 10.0
Mycobacterium tuberculosis, extrapulmonary 189 7.2 108 11.8 297 8.4 0 0.0
Kaposi’s sarcoma 275 10.4 21 2.3 296 8.3 0 0.0
Toxoplasmosis of brain in a patient over one month of age 181 6.9 98 10.7 279 7.9 0 0.0
Wasting syndrome due to HIV 203 7.7 53 5.8 256 7.2 1 10.0
Cytomegalovirus disease (other than liver, spleen, or nodes) in a patient 
over one month of age 178 6.7 52 5.7 230 6.5 2 20.0
Encephalopathy, HIV-related 105 4.0 47 5.1 152 4.3 0 0.0
Progressive multifocal leukoencephalopathy 95 3.6 26 2.8 121 3.4 0 0.0
Opportunistic infection(s), not specified 467 17.7 176 19.3 643 18.1 0 0.0
Centre
Wasting syndrome due to HIV 126 19.2 32 18.9 158 19.1 3 25.0
Pneumocystis pneumonia 85 12.9 11 6.5 96 11.6 3 25.0
Mycobacterium tuberculosis, pulmonary in an adult or an adolescent (aged 
13 years or over) 61 9.3 16 9.5 77 9.3 2 16.7
Candidiasis, oesophageal 61 9.3 15 8.9 76 9.2 0 0.0
Pneumonia, recurrent in an adult or an adolescent (aged 13 years or over) 24 3.7 6 3.6 30 3.6 1 8.3
Toxoplasmosis of brain in a patient over one month of age 24 3.7 4 2.4 28 3.4 0 0.0
Encephalopathy, HIV-related 23 3.5 3 1.8 26 3.1 2 16.7
Kaposi’s sarcoma 22 3.3 0 0.0 22 2.7 0 0.0
Cryptococcosis, extrapulmonary 13 2.0 4 2.4 17 2.1 0 0.0
Mycobacterium tuberculosis, extrapulmonary 8 1.2 6 3.6 14 1.7 1 8.3
Opportunistic infection(s), not specified 281 42.8 76 45.0 357 43.2 9 75.0
East
Mycobacterium tuberculosis, pulmonary in an adult or an adolescent (aged 
13 years or over) 548 38.8 141 23.4 689 34.2 10 23.3
Wasting syndrome due to HIV 389 27.5 204 33.8 593 29.4 9 20.9
Candidiasis, oesophageal 326 23.1 180 29.9 506 25.1 5 11.6
Mycobacterium tuberculosis, extrapulmonary 201 14.2 42 7.0 243 12.1 1 2.3
Pneumocystis pneumonia 77 5.4 40 6.6 117 5.8 5 11.6
Encephalopathy, HIV-related 73 5.2 31 5.1 104 5.2 3 7.0
Pneumonia, recurrent in an adult or an adolescent (aged 13 years or over) 33 2.3 15 2.5 48 2.4 1 2.3
Herpes simplex: chronic ulcer(s) (>1 months duration); or bronchitis, 
pneumonitis, or oesophagitis in a patient over one month of age 20 1.4 18 3.0 38 1.9 2 4.7
Toxoplasmosis of brain in a patient over one month of age 26 1.8 11 1.8 37 1.8 0 0.0
Candidiasis of bronchi, trachea, or lungs 28 2.0 8 1.3 36 1.8 4 9.3
Opportunistic infection(s), not specified 395 28.0 227 37.6 622 30.9 18 41.9
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Table 25: Deaths among AIDS cases, by country and year of death (2006–2012) and cumulative totals in EU/EEA and 
other countries of the WHO European Region
Area Country*
Year of report Cumulative 
total**2006 2007 2008 2009 2010 2011 2012
EU/EEA
W Austria 39 56 34 37 43 29 9 1 972
W Belgium 33 33 25 9 19 30 27 1 980
C Bulgaria 8 6 9 2 14 17 16 129
C Croatia 6 2 7 7 10 6 7 168
C Cyprus 4 3 0 3 3 4 5 107
C Czech Republic 6 10 14 10 7 9 11 189
W Denmark 19 20 3 9 3 6 2 2 024
E Estonia 18 11 8 0 2 7 5 104
W Finland 3 9 11 7 8 5 0 303
W France 330 239 225 169 201 162 91 36 011
W Germany 160 160 114 112 100 114 58 14 267
W Greece 38 42 31 28 48 53 48 1 756
C Hungary 6 10 4 9 10 12 9 336
W Iceland 1 0 0 0 0 1 1 39
W Ireland 8 6 3 5 5 4 1 414
W Italy 815 819 763 709 643 147 45 41 940
E Latvia 40 47 58 69 57 80 80 526
E Lithuania 9 15 20 17 12 9 10 138
W Luxembourg 0 0 0 0 0 0 0 0
W Malta 7 1 0 0 0 1 2 60
W Netherlands 31 32 34 35 23 7 0 323
W Norway 6 1 3 3 0 1 1 623
C Poland 43 61 71 46 53 68 53 1 206
W Portugal 236 212 198 185 179 151 94 7 987
C Romania 202 172 158 132 146 221 121 6 075
C Slovakia 4 3 0 2 1 1 3 39
C Slovenia 0 2 5 1 2 1 1 88
W Spain 1 015 992 824 485 327 243 179 47 083
W Sweden 8 6 - - - - - 1 323
W United Kingdom 315 315 309 279 305 151 138 15 812
Total EU/EEA 3 410 3 285 2 931 2 370 2 221 1 540 1 017 183 022
Non-EU/EEA
C Albania 3 6 2 5 6 10 8 48
W Andorra 0 0 1 0 0 0 0 1
E Armenia 15 22 31 39 17 22 36 229
E Azerbaijan 21 43 43 27 45 39 31 333
E Belarus 138 141 146 151 145 156 171 1 259
C Bosnia and Herzegovina 5 1 0 1 0 0 0 55
C former Yugoslav Republic of Macedonia, the 5 2 1 0 1 4 0 61
E Georgia 36 67 74 63 80 95 83 679
W Israel 37 40 30 20 22 28 15 852
E Kazakhstan 86 90 137 130 168 150 148 1 182
E Kyrgyzstan 16 18 15 21 26 19 19 183
E Moldova 45 68 65 54 72 127 11 642
W Monaco 1 0 0 0 0 0 0 20
C Montenegro 1 1 0 2 3 1 1 33
E Russia - - - - - - - -
W San Marino 0 0 0 0 0 0 0 8
C Serbia 24 15 22 26 27 31 17 1 046
W Switzerland 56 50 34 39 23 13 2 5 857
E Tajikistan 0 11 30 7 29 47 24 148
C Turkey 2 0 0 0 0 0 0 74
E Turkmenistan 0 0 0 0 0 0 0 1
E Ukraine*** - - - - - - - -
E Uzbekistan 9 19 124 40 66 - - 323
Total non-EU/EEA 500 594 755 625 730 742 566 13 032
Geographic area
West 3 158 3 033 2 642 2 131 1 949 1 146 713 180 655
Centre 319 294 293 246 283 385 252 9 654
East 433 552 751 618 719 751 618 5 747
Total WHO European Region 3 910 3 879 3 686 2 995 2 951 2 282 1 583 196 056
*  Country-specific comments are in Annex 5
**  Cumulative total is the total number of cases reported by country since the start of reporting
*** Case based data reported through TESSy are incomplete. The total numbers of annual deaths during 2006–2012 in Ukraine are: 2425, 2508, 2714, 2594, 3101, 
3741, 3875 and the cumulative number is 30619 (ref: http://ucdc.gov.ua/uk/statystyka/informatsijni-byuleteni)
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Table 26: Deaths among AIDS cases*, by geographic area, transmission mode and year of death (2006–2012) and 
cumulative totals
Table 26a: EU/EEA and non-EU/EEA countries
Transmission mode
2006 2007 2008 2009 2010 2011 2012 Cumulative total**
Female Male Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
EU/EEA
Men who have sex with men 589 0 562 0 487 0 434 0 438 0 0 331 0 0 220 0 0 55 849 0 0 55 849
Injecting drug use 1 163 248 1 157 267 958 251 740 169 568 140 0 327 78 0 221 65 0 60 377 14 749 0 75 126
Heterosexual contact 627 362 573 343 514 332 421 288 462 289 0 320 203 0 211 139 0 17 934 12 817 0 30 751
Mother-to-child 15 9 16 3 14 4 9 4 3 13 0 7 5 0 3 4 0 1 067 966 0 2 033
Haemophiliac/transfusion recipient 29 10 20 11 27 8 13 11 22 6 0 16 7 0 10 3 0 4 993 1 851 0 6 844
Nosocomial infection 40 24 27 26 25 19 25 14 20 14 0 20 25 0 9 14 0 1 761 1 170 0 2 931
Other/undetermined 210 81 196 75 199 82 164 71 178 60 8 130 66 5 92 26 5 7 124 2 061 308 9 493
Total EU/EEA 2 673 734 2 551 725 2 224 696 1 806 557 1 691 522 8 1 151 384 5 766 251 5 149 105 33 614 308 183 027
Non-EU/EEA
Men who have sex with men 23 0 16 0 22 0 19 0 22 0 0 19 0 0 8 0 0 2 463 0 0 2 463
Injecting drug use 232 56 290 60 355 60 278 50 346 51 0 297 32 0 281 26 0 4 688 1 309 1 5 998
Heterosexual contact 95 69 109 73 148 123 122 115 140 132 0 191 161 0 124 109 0 1 873 1 520 0 3 393
Mother-to-child 3 1 5 3 6 5 3 5 3 3 0 7 3 0 1 2 0 86 78 1 165
Haemophiliac/transfusion recipient 2 0 4 1 1 0 0 0 1 0 0 1 0 0 0 1 0 205 62 0 267
Nosocomial infection 0 1 3 0 0 0 1 1 0 0 0 0 0 0 0 0 0 5 4 0 9
Other/undetermined 12 6 22 8 24 10 23 8 22 10 0 22 9 0 12 2 0 569 164 4 737
Total non-EU/EEA 367 133 449 145 556 198 446 179 534 196 0 537 205 0 426 140 0 9 889 3 137 6 13 032
Total WHO European Region 3 040 867 3 000 870 2 780 894 2 252 736 2 225 718 8 1 688 589 5 1 192 391 5 158 994 36 751 314 196 059
Table 26b: Geographical areas, WHO European Region
Transmission mode
2006 2007 2008 2009 2010 2011 2012 Cumulative total**
Female Male Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
West
Men who have sex with men 587 0 545 0 471 0 414 0 409 0 0 299 0 0 193 0 0 57 132 0 0 57 132
Injecting drug use 1 119 239 1 086 261 885 241 684 160 526 127 0 258 57 0 140 39 0 61 264 15 367 0 76 631
Heterosexual contact 594 347 563 327 479 313 391 273 413 267 0 238 158 0 174 110 0 17 874 12 900 0 30 774
Mother-to-child 9 6 11 3 12 4 6 3 3 8 0 2 3 0 1 2 0 936 917 0 1 853
Haemophiliac/transfusion recipient 23 4 13 6 18 7 9 7 10 3 0 11 3 0 4 1 0 4 377 1 423 0 5 800
Nosocomial infection 0 2 0 1 1 1 2 1 0 0 0 0 0 0 0 0 0 17 19 0 36
Other/undetermined 170 55 161 47 149 50 129 45 138 37 8 87 25 5 40 9 5 6 521 1 603 308 8 432
Total West 2 502 653 2 379 645 2 015 616 1 635 489 1 499 442 8 895 246 5 895 246 5 148 121 32 229 308 180 658
Centre
Men who have sex with men 23 0 30 0 29 0 35 0 47 0 0 44 0 0 29 0 0 1 079 0 0 1 079
Injecting drug use 33 6 40 8 38 8 29 6 22 8 0 43 13 0 45 17 0 973 251 0 1 224
Heterosexual contact 66 34 50 24 54 27 42 25 53 31 0 83 55 0 40 21 0 966 609 0 1 575
Mother-to-child 7 3 5 0 3 1 4 2 0 6 0 7 2 0 2 2 0 182 100 1 283
Haemophiliac/transfusion recipient 8 6 10 6 10 1 4 4 13 3 0 5 4 0 6 2 0 816 489 0 1 305
Nosocomial infection 40 22 27 25 24 18 23 13 20 14 0 20 25 0 9 14 0 1 744 1 151 0 2 895
Other/undetermined 44 27 40 29 48 32 37 22 44 22 0 47 37 0 51 14 0 799 493 1 1 293
Total Centre 221 98 202 92 206 87 174 72 199 84 0 249 136 0 249 136 0 6 559 3 093 2 9 654
East
Men who have sex with men 2 0 3 0 9 0 4 0 4 0 0 7 0 0 6 0 0 101 0 0 101
Injecting drug use 243 59 321 58 390 62 305 53 366 56 0 323 40 0 317 35 0 2 828 440 1 3 269
Heterosexual contact 62 50 69 65 129 115 110 105 136 123 0 190 151 0 121 117 0 967 828 0 1 795
Mother-to-child 2 1 5 3 5 4 2 4 3 2 0 5 3 0 1 2 0 35 27 0 62
Haemophiliac/transfusion recipient 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 5 1 0 6
Nosocomial infection 0 1 3 0 0 0 1 1 0 0 0 0 0 0 0 0 0 5 4 0 9
Other/undetermined 8 5 17 7 26 10 21 12 18 11 0 18 13 0 13 5 0 373 129 3 505
Total East 317 116 419 133 559 191 443 175 527 192 0 544 207 0 544 207 0 4 314 1 429 4 5 747
Total WHO European Region 3 040 867 3 000 870 2 780 894 2 252 736 2 225 718 8 1 688 589 5 1 688 589 5 158 994 36 751 314 196 059
* Data from countries not consistently reporting for the period 2006–2012 (Estonia, Poland and Russia) are not included in this table 
** Cumulative total is the total number of cases reported by country since the start of reporting
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Table 26: Deaths among AIDS cases*, by geographic area, transmission mode and year of death (2006–2012) and 
cumulative totals
Table 26a: EU/EEA and non-EU/EEA countries
Transmission mode
2006 2007 2008 2009 2010 2011 2012 Cumulative total**
Female Male Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
EU/EEA
Men who have sex with men 589 0 562 0 487 0 434 0 438 0 0 331 0 0 220 0 0 55 849 0 0 55 849
Injecting drug use 1 163 248 1 157 267 958 251 740 169 568 140 0 327 78 0 221 65 0 60 377 14 749 0 75 126
Heterosexual contact 627 362 573 343 514 332 421 288 462 289 0 320 203 0 211 139 0 17 934 12 817 0 30 751
Mother-to-child 15 9 16 3 14 4 9 4 3 13 0 7 5 0 3 4 0 1 067 966 0 2 033
Haemophiliac/transfusion recipient 29 10 20 11 27 8 13 11 22 6 0 16 7 0 10 3 0 4 993 1 851 0 6 844
Nosocomial infection 40 24 27 26 25 19 25 14 20 14 0 20 25 0 9 14 0 1 761 1 170 0 2 931
Other/undetermined 210 81 196 75 199 82 164 71 178 60 8 130 66 5 92 26 5 7 124 2 061 308 9 493
Total EU/EEA 2 673 734 2 551 725 2 224 696 1 806 557 1 691 522 8 1 151 384 5 766 251 5 149 105 33 614 308 183 027
Non-EU/EEA
Men who have sex with men 23 0 16 0 22 0 19 0 22 0 0 19 0 0 8 0 0 2 463 0 0 2 463
Injecting drug use 232 56 290 60 355 60 278 50 346 51 0 297 32 0 281 26 0 4 688 1 309 1 5 998
Heterosexual contact 95 69 109 73 148 123 122 115 140 132 0 191 161 0 124 109 0 1 873 1 520 0 3 393
Mother-to-child 3 1 5 3 6 5 3 5 3 3 0 7 3 0 1 2 0 86 78 1 165
Haemophiliac/transfusion recipient 2 0 4 1 1 0 0 0 1 0 0 1 0 0 0 1 0 205 62 0 267
Nosocomial infection 0 1 3 0 0 0 1 1 0 0 0 0 0 0 0 0 0 5 4 0 9
Other/undetermined 12 6 22 8 24 10 23 8 22 10 0 22 9 0 12 2 0 569 164 4 737
Total non-EU/EEA 367 133 449 145 556 198 446 179 534 196 0 537 205 0 426 140 0 9 889 3 137 6 13 032
Total WHO European Region 3 040 867 3 000 870 2 780 894 2 252 736 2 225 718 8 1 688 589 5 1 192 391 5 158 994 36 751 314 196 059
Table 26b: Geographical areas, WHO European Region
Transmission mode
2006 2007 2008 2009 2010 2011 2012 Cumulative total**
Female Male Female Male Female Male Female Male Female Male Unknown Female Male Unknown Female Male Unknown Female Male Unknown Total
West
Men who have sex with men 587 0 545 0 471 0 414 0 409 0 0 299 0 0 193 0 0 57 132 0 0 57 132
Injecting drug use 1 119 239 1 086 261 885 241 684 160 526 127 0 258 57 0 140 39 0 61 264 15 367 0 76 631
Heterosexual contact 594 347 563 327 479 313 391 273 413 267 0 238 158 0 174 110 0 17 874 12 900 0 30 774
Mother-to-child 9 6 11 3 12 4 6 3 3 8 0 2 3 0 1 2 0 936 917 0 1 853
Haemophiliac/transfusion recipient 23 4 13 6 18 7 9 7 10 3 0 11 3 0 4 1 0 4 377 1 423 0 5 800
Nosocomial infection 0 2 0 1 1 1 2 1 0 0 0 0 0 0 0 0 0 17 19 0 36
Other/undetermined 170 55 161 47 149 50 129 45 138 37 8 87 25 5 40 9 5 6 521 1 603 308 8 432
Total West 2 502 653 2 379 645 2 015 616 1 635 489 1 499 442 8 895 246 5 895 246 5 148 121 32 229 308 180 658
Centre
Men who have sex with men 23 0 30 0 29 0 35 0 47 0 0 44 0 0 29 0 0 1 079 0 0 1 079
Injecting drug use 33 6 40 8 38 8 29 6 22 8 0 43 13 0 45 17 0 973 251 0 1 224
Heterosexual contact 66 34 50 24 54 27 42 25 53 31 0 83 55 0 40 21 0 966 609 0 1 575
Mother-to-child 7 3 5 0 3 1 4 2 0 6 0 7 2 0 2 2 0 182 100 1 283
Haemophiliac/transfusion recipient 8 6 10 6 10 1 4 4 13 3 0 5 4 0 6 2 0 816 489 0 1 305
Nosocomial infection 40 22 27 25 24 18 23 13 20 14 0 20 25 0 9 14 0 1 744 1 151 0 2 895
Other/undetermined 44 27 40 29 48 32 37 22 44 22 0 47 37 0 51 14 0 799 493 1 1 293
Total Centre 221 98 202 92 206 87 174 72 199 84 0 249 136 0 249 136 0 6 559 3 093 2 9 654
East
Men who have sex with men 2 0 3 0 9 0 4 0 4 0 0 7 0 0 6 0 0 101 0 0 101
Injecting drug use 243 59 321 58 390 62 305 53 366 56 0 323 40 0 317 35 0 2 828 440 1 3 269
Heterosexual contact 62 50 69 65 129 115 110 105 136 123 0 190 151 0 121 117 0 967 828 0 1 795
Mother-to-child 2 1 5 3 5 4 2 4 3 2 0 5 3 0 1 2 0 35 27 0 62
Haemophiliac/transfusion recipient 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 5 1 0 6
Nosocomial infection 0 1 3 0 0 0 1 1 0 0 0 0 0 0 0 0 0 5 4 0 9
Other/undetermined 8 5 17 7 26 10 21 12 18 11 0 18 13 0 13 5 0 373 129 3 505
Total East 317 116 419 133 559 191 443 175 527 192 0 544 207 0 544 207 0 4 314 1 429 4 5 747
Total WHO European Region 3 040 867 3 000 870 2 780 894 2 252 736 2 225 718 8 1 688 589 5 1 688 589 5 158 994 36 751 314 196 059
* Data from countries not consistently reporting for the period 2006–2012 (Estonia, Poland and Russia) are not included in this table 
** Cumulative total is the total number of cases reported by country since the start of reporting
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Table 27: Total number of HIV tests performed, excluding unlinked anonymous testing and testing of blood donations, 
by country and year (2006–2012) and number of tests per 1 000 population in 2012, WHO European Region
Area Country*
Number of HIV tests Tests/1000 
population2006 2007 2008 2009 2010 2011 2012
EU/EEA
W Austria 659 693 777 935 751 749 770 901 831 675 826 256
W Belgium 578 717 595 394 619 418 635 150 651 095 679 655 703 486 63.4
C Bulgaria 105 000 160 000 110 000 140 000 160 000 180 000 190 000 25.9
C Croatia 26 124 32 698 38 996
C Cyprus 37 763 41 913 42 294
C Czech Republic 317 823 344 874 342 223 347 135 353 507 334 569 349 205 33.2
W Denmark 154 332 141 880 - - - 137 877 134 709 24.1
E Estonia 65 861 68 478 74 357 78 735 78 054 85 025 73 367 54.8
W Finland 147 601 153 478 186 822 190 380 185 114
W France 5 170 541 5 143 332 5 039 396 5 010 163 4 993 210 5 196 817 5 242 855 80.3
W Germany
W Greece 9 840 17 374 21 097 21 345 18 426 19 278 20 986 1.9
C Hungary 80 168 65 980 83 408 91 181 89 137 84 464 93 060 9.5
W Iceland 9 106 9 351 9 522 7 794 7 318
W Ireland 63 000 184 980 180 055 184 521 175 488 38.3
W Italy
E Latvia 85 117 79 279 72 444 59 331 58 826 58 799 60 491 29.6
E Lithuania 52 988 60 333 162 381 100 799 178 554 102 234 101 042 33.6
W Luxembourg 14 339 13 379 13 366
W Malta 10 309 11 957
W Netherlands
W Norway 188 550
C Poland 159 180 176 728 181 118 213 138 229 783 317 286 358 953 9.3
W Portugal
C Romania 191 223 220 226 282 248 284 053 291 915 306 679 293 204 13.7
C Slovakia 93 426 85 520 66 926 132 990 109 261 110 025 110 506 20.5





C Albania 3 098 1 686 2 458 2 143 2 168 3 260 3 140 1.1
W Andorra 3 077 3 546 2 810 2 678 2 590 2 062 24.3
E Armenia 50 221 55 342 60 701 60 103 60 731 68 449 71 957 22.0
E Azerbaijan 237 183 293 086 322 525 340 048 353 772 365 090 514 434 55.7
E Belarus 441 299 437 983 430 175 459 032 517 625 621 780 683 125 73.1
C Bosnia and Herzegovina 20 904 16 858 20 793
C former Yugoslav Republic of Macedonia, the 11 172 10 574 17 811 18 105 8.8
E Georgia 16 989 16 989 18 792 17 562 25 370 21 799 15 562 3.5
W Israel 242 484 269 071 271 641 278 887 286 995 274 294 233 516 30.5
E Kazakhstan 862 058 1 491 190 1 643 938 1 758 026 1 786 289 1 897 476 2 026 174 124.5
E Kyrgyzstan 179 407 227 879 268 134 325 855 297 959 381 295 470 355 85.9
E Moldova 216 566 347 709 355 711 342 666 336 871 340 397 342 418 96.2
W Monaco
C Montenegro 3 988 3 838 4 229 5 812 6 492 6 914 6 781 10.9
E Russia 18 535 043 25 209 546
W San Marino 5 061 3 976 3 825 4 181 5 090 3 961 3 845 119.5
W Serbia 37 829 42 573 44 555 47 734 51 727 56 086 64 031 8.8
W Switzerland
E Tajikistan 91 310 92 474 129 330 214 207 280 281 438 532 447 636 55.9
C Turkey 1 908 257 1 998 163 5 045 319
E Turkmenistan 136 145 211 789
E Ukraine 1 661 600 1 937 440 2 280 442 2 347 084 2 319 946 2 392 970 2 343 099 51.6
E Uzbekistan 545 240 619 130 796 371 987 464 1 506 724
*  Country-specific comments are in Annex 5
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Data not included from West: Italy, Spain; Centre: Poland, Turkey; East: Estonia, Russia, Uzbekistan
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Map: HIV infections, per 100 000 population, reported for 2012: Heterosexual cases
Figure 2: HIV infections, per 100 000 population, reported for 2010 (maps): All cases; heterosexual cases; people who 
inject drugs cases; men who have sex with men cases
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Excludes persons originating from countries with generalised epidemics.
73
HIV/AIDS surveillance in Europe 2012SURVEILLANCE REPORT
Map: HIV infections, per 100 000 population, reported for 2012: People who inject drugs cases
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Data not included from West: Monaco, Sweden; East: Russia, Uzbekistan
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Since 2008, the European Centre for Disease Prevention 
and Control (ECDC) and the World Health Organization 
Regional Office for Europe (WHO Regional Office) have 
been carrying out the enhanced HIV/AIDS surveillance in 
Europe. Both strive to ensure a high quality of standard-
ised HIV/AIDS surveillance data from the 53 countries of 
the WHO European Region, including the 28 countries of 
the European Union (EU) and the three countries of the 
European Economic Area (EEA) (in this report referred to 
together as EU/EEA). 
1 Reporting in the joint 
database for HIV/AIDS 
surveillance
In the EU/EEA countries, the Member States’ Coordinating 
Competent Bodies have nominated national operational 
contact points for HIV/AIDS surveillance to work on the 
reporting of surveillance data to the joint ECDC/WHO 
database for HIV/AIDS surveillance. For the non-EU/EEA 
countries, nominations for national HIV/AIDS surveil-
lance focal points were received directly by the WHO 
Regional Office via the respective ministries of health. 
Data are submitted through a web-based platform to 
a joint database of The European Surveillance System 
(TESSy). Three types of data are collected: HIV (case-
based and aggregated), AIDS (case-based) and number 
of HIV tests performed (aggregated). Data are uploaded 
directly by the reporting country into the database. The 
set of validation rules ensures the verification of the 
data within the database by an automated procedure. 
This verification of the data during the uploading pro-
cess improves the quality of the data and allows each 
country to test their datasets before submission.
Russia and Uzbekistan did not report any data for 2012 
and Ukraine was unable to provide a complete case-
based AIDS dataset. HIV data for Russia and AIDS data 
for Ukraine were therefore obtained through publicly 
available sources and used to supplement the officially 
reported data to give a more complete presentation of 
the epidemiology of HIV and AIDS in Europe.
Surveillance systems – data source 
To describe the national source of data and specify the 
national surveillance system from which the reported 
data originate, the variable ‘data source’ is included as 
a compulsory part of reporting (Annex  3). International 
comparisons are hampered by differences in surveil-
lance systems as the quality and coverage of national 
surveillance are not consistent. Some countries have 
no national HIV/AIDS data or have only established or 
substantially modified the national reporting systems 
within the last few years. 
2 Data collection, validation
Data collection 2013
The 2012 data submission for HIV and AIDS surveillance 
took place between 21 March and 16 September 2013. 
On 26 August 2013, a reminding letter was sent to all 
countries, followed by individual reminders in some 
cases. Data presented in this report were extracted from 
the joint database on 16 October 2013.
Individual country datasets
Data were uploaded, validated and approved in the joint 
database for HIV/AIDS surveillance by the countries 
themselves. Once the data were submitted, individual 
datasets were validated. Twenty countries uploaded 
datasets containing only 2012 data for HIV, whereas 
the remainder uploaded data concerning longer peri-
ods. Four countries (Belarus, Kazakhstan, San Marino 
and Ukraine) reported aggregated HIV data compared 
with three countries in 2011; Belarus had reported case-
based data in 2011. Reporting of aggregated HIV data 
has an impact on the data presentation and analysis 
and the epidemiological overview of HIV/AIDS in Europe 
because fewer variables are available from the aggre-
gated datasets, hence reducing the amount of data that 
can be presented in selected tables.
3 Data recoding and 
adjustments
Dates used for data presentation
In this report the HIV and AIDS data are presented by 
‘date of diagnosis’. If countries could not provide this 
date, the ‘date of notification’ or ‘date of statistics’ was 
used instead. 
Region of origin 
The data are presented by ‘region of origin’ stratified 
by country (Table 11) and transmission mode (Table 12). 
Countries were encouraged to provide country-level 
data. All cases for which the value in ‘country of birth’ 
or ‘country of nationality’ was provided, were recoded 
appropriately for the variable ‘region of origin’.
Origin of reported cases 
Cases originating from countries with generalised 
epidemics are presented separately by mode of trans-
mission (Table  B). This approach more accurately 
reflects the transmission patterns in Europe, especially 
in the EU/EEA. In order to compare the impact of the 
epidemic on all transmission modes, cases reported as 
originating from regions or countries of sub-Saharan 
Africa were attributed as a proxy for cases originating 
Annex 1: Framework for data collection, 
validation and presentation
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from countries with a generalised epidemic (Table  12). 
As most of the cases originating from sub-Saharan 
Africa were reported from western European countries, 
this information is presented in detail in Chapter 1.
Reporting delay
Reporting trends for HIV/AIDS are incomplete and biased 
downwards because of delays in reporting. Ideally the 
surveillance data should be corrected to describe more 
accurately the trends in HIV and AIDS. Reporting delays 
refer to the time delay between HIV/AIDS diagnosis (or 
death) and the report of this event at national level, 
identified by ‘date of notification’. 
In this report, we apply a statistical approach, as 
described by Heisterkamp, et al [1] to adjust the surveil-
lance data for reporting delays. Yearly reporting delay 
probabilities were estimated using historical data from 
2004 to 2011. Countries were excluded from reporting 
delay adjustment:
1 when they showed an inconsistent and non-stationary 
pattern in their reporting delay distribution during the 
period 2004–2011,
2 when they reported aggregated data during the period 
2004–2011, or
3 when the average number of diagnosed HIV cases per 
year over the period 2004–2011 was lower than 50. 
Making adjustment for reporting delays is a valuable 
tool for more precisely determining HIV trends, as well 
as in monitoring the timeliness of data collection, an 
important aspect of quality control. 
Reporting delays were applied for the graphs represent-
ing trends for the WHO European Region and EU/EEA and 
by transmission mode. The list of countries with number 




Data are presented for the WHO European Region and 
the EU/EEA. The EU comprises 28 Member States and the 
EEA comprises an additional three countries (Norway, 
Iceland, Liechtenstein), of which Norway and Iceland are 
included in the overview of the EU/EEA. Liechtenstein 
is not presented separately in the tables as their data 
are included in the data reported by Switzerland (see 
Annex 5).
The tables are presented by EU/EEA countries, non-EU/
EEA countries, by individual countries and by totals. The 
54 countries are also subdivided into three geographi-
cal areas based on epidemiological considerations and 
in accordance with the division used in previous reports 
on HIV/AIDS surveillance in Europe: West (24 coun-
tries), Centre (15 countries) and East (15 countries) (see 
Figure A1). The division reflects similarities in epidemio-
logical dynamics such as epidemic levels, trends over 
time and transmission patterns. In this report these geo-
graphical/epidemiological areas are referred to as ‘by 
geographical area’. Of the EU/EEA countries, 19 Member 
States are classified as being in the West, nine in the 
Centre and three in the East.
Population data and rates
Data are presented in absolute numbers and rates as 
cases per 100 000 population.
The population estimates up to 2012 were derived 
from Eurostat for all countries except the five central 
Asian republics (Kazakhstan, Kyrgyzstan, Tajikistan, 
Turkmenistan, Uzbekistan) and Israel, for which Eurostat 
data were not available. United Nations (UN) Population 
Division data were used for those countries [2]. The 
Eurostat data are from 18 July 2013 (www.epp.eurostat.
ec.europa.eu) which are consistent with the UN popula-
tion data. 
The population data used for HIV for Spain were adjusted 
according to the extent of regional coverage. 
For data presented by gender, rates were calculated 
using appropriate gender populations.
Data are presented by year but also as cumulative totals 
per country. The cumulative total includes all data 
reported by that particular country since the beginning 
of national reporting and is not limited to the selected 
number of years presented.
For maps presenting figures for MSM, rates are calcu-
lated using male population aged 15–65.
Table A1: Number of cases reported without the date of 
diagnosis for the period 2006–2012 










Total EU/EEA 9 232
Non EU/EEA
E Belarus 1 223
C former Yugoslav Republic of 
Macedonia, the
625
E Kazakhstan 14 148
E Kyrgyzstan 1
C Montenegro 3
W San Marino 26
E Tajikistan 1 259
C Turkey 1
E Ukraine 45 168
Total non EU/EEA 62 454
Total WHO European Region 71 686
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Trend data
For presentation of the overall trends, only countries 
reporting consistently were included (e.g. data from 
Uzbekistan and Russia were not included in the presen-
tation of HIV trends for 2006–2012).
When presenting HIV trends for 2006–2012 by transmis-
sion mode, in addition, countries reporting transmission 
mode for less than 50% of cases were also excluded (e.g. 
Estonia, Poland and Turkey were excluded from Table 8).
5 Data limitations
Surveillance systems are not similar in Europe, and 
the differences in methods could impact the results 
and introduce bias in comparisons between countries. 
Particularly, factors such as underreporting and report-
ing delay may influence the country figures and ranking 
presented in the report.
The data in the report are to be considered as provi-
sional because they are subject to regular updates 
(e.g. detection and deletion of duplicate cases, inclu-
sion of new information about cases already reported). 
The limitations described below need to be taken into 
account when interpreting the data presented in this 
report.
Official reports of newly diagnosed cases of HIV do not 
represent true incidence. Newly reported HIV diagnoses 
include recently infected individuals as well as those 
who were infected several years ago but only recently 
presented to a clinic. These reports are also influenced 
by several factors such as the uptake of HIV testing, pat-
terns of reporting, the long incubation period and a slow 
progression of the disease. In order to better interpret 
trends in HIV case reporting data, the total numbers of 
HIV tests performed annually for diagnostic purposes 
(excluding unlinked anonymous tests and screening of 
blood donations) are presented to help provide some 
background on HIV testing patterns.
No adjustments are made for underreporting or 
under-ascertainment bias. Previous estimates of under-
reporting range from 0% to 25% for AIDS cases [3], while 
national estimates of underreporting can range from 
10% (Iceland, Italy) to around 40% (Germany, UK) [4]. In 
France, underreporting has been estimated at 34% for 
2004–2006. For HIV cases and AIDS deaths, estimates 










Figure A1: Geographical/epidemiological division of the WHO European Region
The countries covered by the report are grouped as follows:
•	 West,	23	countries:	Andorra,	Austria*,	Belgium*,	Denmark*,	Finland*,	France*,	Germany*,	Greece*,	Iceland,	Ireland*,	Israel,	Italy*,	Liechtenstein,	
Luxembourg*, Malta*, Monaco, Netherlands*, Norway, Portugal*, San Marino, Spain*, Sweden*, Switzerland, United Kingdom*.
•	 Centre,	15	countries:	Albania,	Bosnia	and	Herzegovina,	Bulgaria*,	Croatia*,	Cyprus*,	Czech	Republic*,	Hungary*,	the	former	Yugoslav	Republic	of	
Macedonia, Montenegro, Poland*, Romania*, Serbia, Slovakia*, Slovenia*, Turkey.
•	 East,	15	countries:	Armenia,	Azerbaijan,	Belarus,	Estonia*,	Georgia,	Kazakhstan,	Kyrgyzstan,	Latvia*,	Lithuania*,	Moldova,	Russia,	Tajikistan,	
Turkmenistan, Ukraine, Uzbekistan.
* Countries which constitute the European Union as of 1 July 2013.
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countries have evaluated their surveillance systems for 
underreporting and only two have published the results 
[4]. For HIV, underreporting could range from less than 
2% in Belarus to 28% in France [5]. 
When interpreting the data presented in this report, 
country-specific comments included in Annex  5 should 
be considered and the following noted: 
•	 Data	 from	Kosovo1 are not included in the tables, but 
as footnotes to Tables 1 and 15. 
•	 More	detailed	information	regarding	the	country-spe-
cific HIV and AIDS case reporting systems is available 
in Annexes 3–4. 
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Annex 2
List of variables* in the new TESSy format for the 2012 HIV/AIDS data collection
HIV case-based AIDS case-based HIV aggregated HIV tests (aggregated)




























































































* New optional variables ‘PlaceOfNotification’ and ‘PlaceOfResidence’ have been added in metadataset Nr.20 for all diseases.
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Annex 3










% Minimal Maximal 
HIV dataset
Age 49 99.7 81.0 100 49 99.8 83.3 100
Gender 48 99.8 82.1 100 49 99.9 91.3 100
Outcome 41 30.4 0.2 100 39 29.2 0.2 100
Date of onset 18 2.1 1.0 100 15 2.4 0.3 100
Date of diagnosis 49 100.0 100.0 100 49 100.0 100.0 100
Date of notification 42 48.1 1.3 100 41 45.1 15.6 100
Date used for statistics 49 100.0 100.0 100 49 100.0 100.0 100
HIV type 42 52.7 81.0 100 41 49.7 12.4 100
Stage 43 37.4 4.8 100 43 34.4 5.4 100
Transmission 49 88.6 34.7 100 49 87.7 21.1 100
Transmission/hetero 44 48.7 34.7 100 42 34.2 38.1 100
Transmission/MTCT 41 48.0 1.9 100 40 44.2 1.7 100
HIV status 28 19.0 0.2 100 27 16.5 0.2 100
Date of AIDS diagnosis 44 36.7 2.7 100 42 33.5 5.4 100
Date of death 41 30.4 0.3 100 39 29.2 0.6 100
Country of birth 35 42.2 39.6 100 35 40.4 37.2 100
Country of nationality 35 27.9 30.4 100 34 25.1 31.0 100
Region of origin 41 46.1 30.4 100 40 41.5 25.6 100
CD4 cell count 30 33.7 1.3 100 29 33.7 10.1 100
Probable country of infection 25 16.2 2.6 100 25 14.8 3.8 100
AIDS dataset
Age 47 99.9 62.5 100 46 100.0 83.3 100
Gender 47 100.0 62.5 100 46 100.0 100.0 100
Outcome 44 70.3 7.9 100 43 71.1 5.0 100
Date of onset 9 6.6 0.3 100 9 6.8 0.3 100
Date of diagnosis 47 100.0 100.0 100 46 100.0 100.0 100
Date of notification 46 99.3 3.8 100 45 99.1 3.6 100
Date used for statistics 47 100.0 100.0 100 46 100.0 100.0 100
HIV type 42 80.6 72.3 100 41 82.0 25.9 100
ART treatment 35 60.7 3.8 100 33 62.0 4.8 100
Transmission 47 91.2 56.3 100 46 90.2 48.4 100
Transmission/hetero 46 63.8 56.3 100 43 63.8 48.4 100
Transmission/MTCT 43 90.0 66.6 100 45 89.6 11.1 100
Date of HIV 43 82.8 3.0 100 42 84.8 17.9 100
Date of death 44 70.2 7.9 100 43 70.9 5.0 100
Date of reported death 44 68.0 7.9 100 42 68.9 5.0 100
Country of birth 35 75.8 3.0 100 34 74.4 14.3 100
Country of nationality 36 57.1 20.0 100 35 59.1 23.7 100
Region of origin 42 82.8 35.1 100 43 83.7 23.7 100
AIDS indicator disease 47 100.0 100.0 100 46 100.0 100.0 100
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Annex 4a
HIV surveillance system overview: data source information
Country Data source Type Period Legal Coverage
EU/EEA
Austria AT-HIV C 1979–2013 C Co
Belgium BE-HIV/AIDS C 1980–2012 V Co
Bulgaria BG-HIV C 1986–2012 C Co
Cyprus CY-HIV/AIDS C 1986–2012 C Co
Croatia HR-CNIPH C 1985–2012 C Co
Czech Republic CZ-HIV/AIDS C 1985–2012 C Co
Denmark DK-HIV C 1990–2012 C Co
Estonia EE-HIV C 1988–2012 C Co
Finland FI-NIDR C 1980–2013 C Co
France FR-MNOID-HIV C 2003–2012 C Co
Germany DE-HIV-Pre-IfSG C 1993–2001 C Co
Germany DE-SURVNET@RKI7.3-HIV C 2001–2012 C Co
Greece GR-NOTIFIABLE_DISEASES C 1981–2012 C Co
Hungary HU-HIV/AIDS C 1985–2012 C Co
Iceland IS-SUBJECT_TO_REGISTRATION C 1983–2012 C Co
Ireland IE-HIV/AIDS C 1981–2011 V Co
Ireland IE-HIV/AIDS C 2012–2012 C Co
Italy IT-COA-ISS C 2004–2012 C Co
Latvia LV-HIV/AIDS C 1987–2012 C Co
Lithuania LT-AIDS_CENTRE C 1988–2012 C Co
Luxembourg LU-HIV C 1980–2012 V Co
Malta MT-DISEASE_SURVEILLANCE C 1986–2012 C Co
Netherlands NL-HIV/AIDS C 1980–2013 V Co
Norway NO-MSIS_B C 1980–2012 C Co
Poland PL-HIV C 1985–2013 C Co
Portugal PT-HIV/AIDS C 1983–2012 C Co
Romania RO-RSS C 1987–2013 C Co
Slovakia SK-EPIS C 1985–2012 C Co
Slovenia SI-HIVSUR-HIV C 1985–2012 C Co
Spain ES-HIV C 2003–2012 C Co
Sweden SE-SweHIVReg C 1983–2009 C Co
Sweden SE-SmiNet C 2010–2012 C Co
United Kingdom UK-HIV C 1981–2013 V Co
Non-EU/EEA
Albania AL-NIoPH C 1993–2012 C Co
Andorra AD-MoHWFH C 2004–2012 V Co
Armenia AM-NAC C 1988–2012 V Co
Azerbaijan AZ-AIDS-CENTER C 1987–2012 V Se
Belarus BY-NAC C 1981–2012 C Co
Bosnia and Herzegovina BA-FMoH-MoHSWRS C 1986–2012 C Co
former Yugoslav Republic of Macedonia, the MK-NHASS C 1987–2012 C Co
Georgia GE-IDACIRC C 1989–2012 C Co
Israel IL-MOH C 1980–2013 C Co
Kazakhstan KZ-RCfAPC A 1987–2012 NS/unk NS/unk
Kyrgyzstan KG-RCfAPC-GEN C 1987–2007 V Co
Kyrgyzstan KG-HIV KG 2008 C 2008–2012 - -
Moldova MD-NAC A 1987–2006 V Other
Moldova MD-NAC C 2012–2012 V Other
Moldova MD-NAC-NCfPC-GEN C 2008–2011 NS/unk NS/unk
Montenegro ME-IOPH C 1989–2012 C Co
Monaco MC-MoSH-GEN C 1985–2012 C Co
Russia RU-MOH A 2010–2010 C Co
San Marino SM-AIDS/HIV A 1985–2012 C Co
Serbia RS-NAC C 1984–2012 C Co
Serbia RS-Kosova NIPH C 2000–2012 C Co
Switzerland CH-FOPH C 1985–2012 C Co
Tajikistan TJ-RHAC C 1991–2012 C Co
Turkey TR-MOH C 1984–2012 C Co
Turkmenistan TM-NAC C 1981–2012 V Co
Ukraine UA-NAC A 1987–2012 V Other
Uzbekistan UZ-RAC C 1981–2010 V Co
Type: aggregated (A), case-based (C )
Legal: voluntary reporting (V), compulsory reporting (C ), not specified/unknown (NS/unk)
Coverage: sentinel system (Se), comprehensive (Co), not specified/unknown (NS/unk)
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Annex 4b
AIDS surveillance system overview: data source information
Country Data source Type Period Legal Coverage
EU/EEA
Albania AL-NIoPH C 1993–2012 C Co
Austria AT-AIDS C 1979–2013 C Co
Belgium BE-HIV/AIDS C 1978–2012 V Co
Bulgaria BG-AIDS C 1987–2012 C Co
Cyprus CY-HIV/AIDS C 1986–2012 C Co
Croatia HR-CNIPH C 1985–2012 C Co
Czech Republic CZ-HIV/AIDS C 1985–2013 C Co
Denmark DK-MIS C 1980–2012 C Co
Estonia EE-AIDS C 1988–2012 C Co
Finland FI-NIDR C 1980–2013 C Co
France FR-AIDS C 1978–2012 C Co
Germany DE-AIDS C 1970–2012 V Co
Greece GR-NOTIFIABLE_DISEASES C 1981–2012 C Co
Hungary HU-HIV/AIDS C 1985–2012 C Co
Iceland IS-SUBJECT_TO_REGISTRATION C 1983–2012 C Co
Ireland IE-HIV/AIDS C 1981–2011 V Co
Ireland IE-CIDR C 2012–2012 V Co
Italy IT-COA-ISS C 1982–2012 C Co
Latvia LV-AIDS C 1990–2012 C Co
Lithuania LT-AIDS_CENTRE C 1988–2012 C Co
Luxembourg LU-AIDS C 1980–2012 V Co
Malta MT-DISEASE_SURVEILLANCE C 1986–2012 C Co
Netherlands NL-HIV/AIDS C 1983–2012 V Co
Norway NO-MSIS_A C 1980–2012 C Co
Poland PL-AIDS C 1985–2013 C Co
Portugal PT-HIV/AIDS C 1983–2012 C Co
Romania RO-RSS C 1985–2013 C Co
Slovakia SK-EPIS C 1985–2012 C Co
Slovenia SI-HIVSUR C 1985–2012 C Co
Spain ES-AIDS C 1981–2012 C Co
Sweden SE-SweHIVReg C 1982–2007 C Co
United Kingdom UK-AIDS C 1980–2013 V Co
Non-EU/EEA
Andorra AD-MoHWFH C 2004–2012 V Co
Armenia AM-NAC C 1988–2012 V Co
Azerbaijan AZ-AIDS-CENTER C 1987–2012 V Se
Belarus BY-NAC C 1991–2012 C Co
Bosnia and Herzegovina BA-FMoH-MoHSWRS C 1986–2012 C Co
former Yugoslav Republic of Macedonia, the MK-NHASS C 1987–2012 C Co
Georgia GE-IDACIRC C 1989–2012 C Co
Israel IL-MOH C 1980–2013 C Co
Kazakhstan KZ-RCfAPC C 1993–2012 NS NS
Kyrgyzstan KG-RCfAPC-GEN C 1987–2007 V Co
Kyrgyzstan KG-HIV KG 2008 C 2008–2012 NS NS
Moldova MD-NAC C 1989–2007 V Co
Moldova MD-NAC-NCfPC-GEN C 2008–2011 NS NS
Moldova MD-NAC C 2012–2012 V Co
Monaco MC-MoSH-GEN C 1985–2012 C Co
Montenegro ME-IOPH C 1990–2012 C Co
Russia - - – - -
San Marino SM-AIDS/HIV C 1985–2012 C Co
Serbia RS-NAC C 1985–2012 C Co
Serbia RS-Kosova NIPH C 1986–2012 C Co
Switzerland CH-FOPH C 1980–2012 C Co
Tajikistan TJ-RHAC C 1998–2012 C Co
Turkey TR-MOH C 1984–2012 C Co
Turkmenistan TM-NAC C 1981–2006 V Co
Turkmenistan TM-NAC C 2008–2012 V Co
Ukraine UA-NAC C 1988–2012 V Co
Uzbekistan UZ-RAC C 1992–2010 V Co
Type: aggregated (A), case-based (C )
Legal: voluntary reporting (V), compulsory reporting (C ), not specified/unknown (NS/unk)
Coverage: sentinel system (Se), comprehensive (Co), not specified/unknown (NS/unk)
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Annex 5
Country-specific comments regarding national HIV and AIDS reporting
Country Comments
EU/EEA
Bulgaria Case-based reporting of HIV is available from 2007 onwards.
Czech Republic Foreigners with short-term stay in the Czech Republic are not included in reported data.
Estonia Surveillance system was substantially modified in 2008. Previously, the probable mode of HIV transmission was not reported by Estonia 
(from 2003 to 2007 Estonia supplied partial information on PWID only).
France HIV reporting system started in March 2003; data in the MSM transmission group include cases that are both MSM and injecting drug users. 
Most recent estimates of underreporting are 41% in 2007-2009 for AIDS and 28% in 2012 for HIV. Estimated number of new HIV diagnoses in 
2012 is 6372 and estimated number or new AIDS diagnoses is 1507. Detailed comment for Tables 1, 1a, 15 and 15a: Case-based data reported 
through TESSy are not exhaustive. The total numbers of HIV cases diagnosed annually during 2006-2012 in France are: 7127, 6516, 6221, 
6320, 6247, 6087, and 6372. The total numbers of AIDS cases diagnosed annually during 2006-2012 in France are: 1830, 1752, 1757, 1598, 
1622, 1546, and 1507.
Ireland HIV was made a notifiable disease in September 2011. HIV reporting system was modified substantially in 2012. AIDS cases and deaths 
among AIDS cases are now only reported if at the time of HIV diagnosis. 
Italy New HIV diagnoses were reported by 10 of the 22 Italian regions between 2004 and 2006, by 11 regions in 2007, 12 regions in 2008, 18 
regions in 2009, and all of the 22 regions since 2010. Between 2004 and 2009, rates are based on the population resident in the regions 
reporting cases; since 2010 the coverage of the system has been national.
Liechtenstein Liechtenstein with only 35 000 inhabitants has small numbers of communicable diseases. Therefore public health authorities refrain from 
collecting data due to limited public health added value. In 1970 Liechtenstein adopted the Swiss Law of Epidemiology. Since then all 
communicable disease data is reported to the officials in Switzerland as demanded by the Federal Office of Public Health.
Malta New HIV reporting system started in 2004.
Netherlands New HIV reporting system started in 2002; 2002 data include many cases diagnosed in previous years. Data prior to 2002 are from a national 
cohort of HIV-positive adults receiving antiretroviral therapy; 1999 data include many cases diagnosed in previous years.
Portugal HIV reporting system modified in 2000; data for 2000 include many cases diagnosed in previous years; data prior to 2000 not available by 
year.
Romania Due to technical problems, the data for HIV and AIDS on the following transmission modes was not reported: MSM and MTCT. For 2009, the 
HIV surveillance data show: 24 cases in MSM and 11 cases due to MTCT, AIDS diagnoses: 10 cases in MSM and 9 cases due to MTCT.
Spain HIV reporting has existed since the 1980s in some of the 19 Autonomous Regions of Spain. For 2003-11 data are available only for 9 Regions: 
Asturias, Balearic Islands, Basque Country, Canary Islands, Catalonia, Ceuta, Extremadura, La Rioja, and Navarre; since 2004, data are 
available for 10 Regions (+Galicia); since 2007, data are available for 11 Regions (+Madrid); since 2008, data are available for 14 Regions (+ 
Aragón, Castilla-La Mancha and Melilla); since 2009, data are available for 17 Regions (+Cantabria, Castilla-León and Murcia); and since 2012 
data are available for 18 Regions (+Valencia); rates based on the corresponding populations for each year.
Sweden Due to changes in the HIV/AIDS surveillance system, AIDS reporting has not been mandatory since 2000. Since 2008, no AIDS data are 
reported from Sweden because the national AIDS surveillance system has been discontinued.
Non-EU/EEA
Andorra New HIV reporting system started in 2004; 2004 data include many cases diagnosed in previous years.
Moldova Official data on incidence rates in the Republic of Moldova may vary from these ones, given that the incidence rate in Moldova is reported for 
both banks of the Dniester River, while the denominator is not inclusive of the left bank of the river (Transnistrian region).
Russia The rate of newly diagnosed HIV infections in natonal statistics may differ from the rate presented in this report because of different 
population data used.
Serbia The updated information from national statistics for two AIDS diagnoses was reported as date of diagnoses in 2008 instead of 2009.
Ukraine Case-based AIDS data are incomplete due to an ongoing revision of the country electronic reporting system and related lack of nationally 
representative data to meet the case-based reporting requirement. The total numbers of AIDS cases diagnosed annually during 2006–2012 
in Ukraine are: 4723, 4573, 4380, 4419, 5869, 9190, 10073 (http://ucdc.gov.ua/uk/statystyka/informatsijni-byuleteni).
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Annex 6
Number of reported HIV infections, adjustment coefficients*, estimated reporting delay for HIV diagnoses in EU/EEA 
countries and adjusted number and rate per 100 000 population, 2009–2012
Country**
2009 2010 2011 2012 Adjustment coefficients*
N Rate N Rate N Rate N Rate 2009 2010 2011 2012
EU/EEA
Austria 301 3.6 317 3.8 309 3.7 306 3.6 0 0 0 0
Belgium 1 130 10.5 1 198 11.1 1 182 10.7 1 227 13.7 0 0 0 0.46
Bulgaria 171 2.2 163 2.2 201 2.7 157 2.1 0 0 0 0
Croatia 54 1.2 70 1.6 77 1.8 74 1.7
Cyprus 38 4.8 41 5.0 54 6.4 62 7.2 0 0 0 0.08
Czech Republic 156 1.5 180 1.7 153 1.5 212 2.0 0 0 0 0
Denmark 236 4.3 275 5.0 267 4.8 219 3.9 0 0 0.01 0.1
Estonia 411 30.7 376 28.1 366 27.3 315 23.5 0 0 0 0
Finland 172 3.2 184 3.4 172 3.2 156 2.9 0 0 0 0
France 5 448 8.5 5 536 8.6 5 419 8.3 5 159 7.9 0 0 0.1 0.26
Germany 2 885 3.5 2 919 3.6 2 888 3.5 2 953 3.6 0 0 0 0
Greece 592 5.3 626 5.5 954 8.4 1 149 10.2 0 0 0.01 0.08
Hungary 140 1.4 182 1.8 162 1.7 219 2.2 0 0 0 0
Iceland 15 4.7 24 7.6 23 7.2 19 5.9 0 0 0 0
Ireland 395 8.9 330 7.4 323 7.1 339 7.4 0 0 0 0
Italy 2 588 4.8 3 932 6.7 3 748 6.3 3 898 6.4 0 0 0 0
Latvia 275 12.2 274 12.2 299 14.4 351 17.2 0 0 0 0.04
Lithuania 180 5.4 153 4.6 166 5.4 160 5.3 0 0 0 0
Luxembourg 54 10.9 49 9.8 48 9.4 54 10.3 0 0 0 0
Malta 19 4.6 18 4.3 21 5.1 31 7.4 0 0 0 0
Netherlands 1 182 7.2 1 175 7.1 1 134 6.8 1 158 6.9 0.01 0.02 0.02 0.15
Norway 282 5.9 258 5.3 269 5.5 242 4.9 0 0 0 0.15
Poland 950 2.5 954 2.5 1 101 2.9 853 2.2 0 0 0 0
Portugal 1 741 16.7 1 589 15.2 1 360 13.2 1 031 10.0 0.02 0.03 0.05 0.23
Romania 253 1.2 274 1.3 427 2.0 489 2.3 0 0 0 0
Slovakia 53 1.0 28 0.5 49 0.9 49 0.9 0 0 0 0
Slovenia 48 2.4 35 1.7 55 2.7 45 2.2 0 0 0 0.09
Spain 3 340 10.2 3 575 10.9 3 244 9.9 3 210 8.5 0 0 0 0
Sweden 425 4.6 461 4.9 402 4.3 405 4.3 0.01 0.02 0.02 0.06
United Kingdom 6 672 10.8 6 358 10.3 6 211 10.0 6 358 10.3 0.01 0.02 0.04 0.36
Total EU/EEA 30 206 6.2 31 554 6.4 31 084 6.3 30 900 6.2 0.01 0.01 0.01 0.07
* The coefficients present the adjustments for the current year of reporting
** Country-specific comments are in Annex 5
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Annex 7
HIV/AIDS surveillance in Europe: participating countries and national institutions
Country National institutions
EU/EEA
Austria Federal Ministry of Health, Family and Youth
Belgium Scientific Institute of Public Health Department Epidemiology
Bulgaria Ministry of Health
Croatia Croatian National Institute of Public Health
Cyprus Ministry of Health
Czech Republic National Institute of Public Health
Denmark Statens Serum Institut
Estonia Health Board 
Finland National Public Health Institute (KTL)
France Institut de veille sanitaire
Germany Robert Koch Institute
Greece Hellenic Center for Disease Control and Prevention
Hungary National Center for Epidemiology (Országos Epidemiológiai Központ)
Iceland Health Protection Agency Centre for Infections
Ireland Health Protection Surveillance Centre (HPSC)
Italy Ministry of Health DG Prevention - Unit V
Latvia Infectology center of Latvia
Lithuania Center for Communicable Diseases and AIDS
Luxembourg National Service of Infectious Diseases, Centre Hospitalier
Malta Department of Health Promotion and Disease Prevention
Netherlands National Institute for Public Health and the Environment (RIVM)
Norway Norwegian Institute of Public Health – Department of Infectious Disease Epidemiology
Poland National Institute of Public Health – National Institute of Hygiene (NIZP-PZH)
Portugal National Institute of Health Dr Ricardo Jorge (Instituto Nacional de Saúde Doutor Ricardo Jorge, I.P.)
Romania 1. Institute of Public Health 2. National Institute for Infectious Diseases “Prof. Dr. Matei Bals”
Slovakia Regional Public Health Authority of capital Bratislava
Slovenia National Institute of Public Health
Spain Instituto de Salud Carlos III Centro Nacional de Epidemiologia
Sweden Swedish Institute for Infectious Disease Control
United Kingdom Public Health England (PHE)
Non-EU/EEA
Albania National Institute of Public Health
Andorra Ministry of Health, Social Welfare and Family
Armenia National Center for AIDS Prevention
Azerbaijan National Azerbaijan AIDS Center
Belarus Ministry of Health, Centre for Hygiene, Epidemiology and Public Health
Bosnia and Herzegovina Federal Ministry of Health; Association of Public Health of the Republika Srpska
former Yugoslav Republic of 
Macedonia
Republic Institute for Health Protection
Georgia Infectious Diseases, AIDS & Clinical Immunology Research Center; National Centre for Disease Control and Public Health
Israel Ministry of Health
Kazakhstan Committee of State sanitary-epidemiological surveilance; Republican Centre on Prevention and Control of AIDS
Kyrgyzstan Republic Centre for AIDS Prevention and Control
Moldova National AIDS Center; National Center for Preventative Care
Monaco Ministry of Social Health
Montenegro Institute of Public Health of Montenegro
Russia Ministry of Health
San Marino Health Authority for Authorization, Accreditation and Quality of Health Services
Serbia Institute of Public Health of Serbia
Switzerland Swiss Federal Office of Public Health
Tajikistan National Centre for the Prevention and Control of AIDS
Turkey Ministry of Health
Turkmenistan Center of Communicable Diseases
Ukraine National AIDS Center
Uzbekistan Republican AIDS Center
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